measure_id,measure_name,location_id,location_name,sex_id,sex_name,age_id,age_name,cause_id,cause_name,metric_id,metric_name,year,val,upper,lower
1,Deaths,1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,674199.4127323164,720822.5506086979,623371.5464594928
1,Deaths,1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.009934558899582493,0.010476079062538949,0.009211172677538857
1,Deaths,1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,8.543520826385715,9.134333784563825,7.899425139172435
1,Deaths,1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,296667.2419142357,321905.71690746455,272058.62282246683
1,Deaths,1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.004370832527450107,0.004665640794378884,0.004067484553151962
1,Deaths,1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,3.75939627346874,4.079220694342982,3.4475534481137506
1,Deaths,1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,97672.08135002268,108061.53898314656,86515.79363692197
1,Deaths,1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0014393687901195944,0.001596532742895542,0.0012760870534725785
1,Deaths,1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,1.237710157279052,1.369366379439969,1.0963365894265524
1,Deaths,1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,432463.3321280798,463645.27659686544,381872.7851761238
1,Deaths,1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.006373284065022043,0.006894149210907406,0.005561410139333111
1,Deaths,1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,5.480217595726955,5.875358242463237,4.839129242133426
1,Deaths,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,1044072.2109567161,1120169.3353408312,950187.6097589601
1,Deaths,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.015383429587183722,0.01631168040633363,0.0141786606948987
1,Deaths,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,13.230585061486694,14.194895256253783,12.040870222728138
1,Deaths,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,208379.42822687645,224162.0771911071,191287.97335230542
1,Deaths,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0030704955328291587,0.003248949605208922,0.002815220403103333
1,Deaths,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,2.6406044728394216,2.8406037424545945,2.424019886860105
1,Deaths,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,75358.67023293299,83706.344289194,67515.37496030713
1,Deaths,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0011099874674527744,0.0012095128372642096,0.001010046204203113
1,Deaths,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,0.9549524316174716,1.0607349728132796,0.8555614276449168
1,Deaths,1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,98435.11468186467,105484.90263576568,91566.8111137236
1,Deaths,1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0014505251990759031,0.001562332514776441,0.0013497324447246514
1,Deaths,1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,1.2473793902073314,1.336714991912565,1.1603435763691925
1,Deaths,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,171961.16536888963,194238.42212608253,142351.84768481329
1,Deaths,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0025340682619751304,0.0028837086879545397,0.0020564983781358155
1,Deaths,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,2.1791086878949564,2.461408261975699,1.8038965214177132
1,Deaths,1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,505752.16383183165,543899.4068382942,461224.42425184237
1,Deaths,1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.007452222560487741,0.007937480256087143,0.0068266378575956264
1,Deaths,1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,6.408940831282599,6.892346421587252,5.844680965033568
1,Deaths,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,61549.73143579219,66265.02205197877,54852.449838530236
1,Deaths,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0009071030127995748,0.0009820367289674892,0.000812120548798736
1,Deaths,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,0.779964210068101,0.8397168334330312,0.6950956033535245
1,Deaths,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,56913.2307466503,63037.41545581188,48761.351319748515
1,Deaths,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0008385942650493289,0.000919020557841981,0.0007205233004097054
1,Deaths,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,0.7212100203563342,0.7988162873142225,0.6179086078326005
1,Deaths,1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,185608.6782150416,201012.67172322524,167961.97888577436
1,Deaths,1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.002735148956268283,0.0029248714724525917,0.0024616620951745036
1,Deaths,1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,2.3520513040223294,2.5472522147044185,2.1284306060665736
1,Deaths,1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,11388.300721894417,12055.62259560701,10770.696944634268
1,Deaths,1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.00016780298689369815,0.00017546379191126117,0.00016027985012097973
1,Deaths,1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,0.14431365936724572,0.1527700273472484,0.1364873239628694
1,Deaths,1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,161194.54180675137,169348.2848557712,150317.57158299707
1,Deaths,1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0023753465026745487,0.002479376403134991,0.0022278484983982265
1,Deaths,1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,2.0426729822330465,2.145998010758327,1.9048389528944258
1,Deaths,1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,221888.32315714975,242326.4608882479,200567.1678837723
1,Deaths,1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.003269610961526063,0.0035735001286049013,0.002983075000307832
1,Deaths,1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,2.811790509194026,3.070784587297008,2.541606746525834
1,Deaths,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,258626.79905479914,296133.93972036307,222185.21325288547
1,Deaths,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.003810447460705482,0.004349316719768002,0.003323016113016219
1,Deaths,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,3.2773440650614196,3.7526382159651863,2.815552729492895
1,Deaths,1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,44798.54165743666,48541.0043965831,39924.72756137713
1,Deaths,1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0006601187879905001,0.0007160611736603726,0.000586951523170184
1,Deaths,1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,0.5676914966313981,0.615116350094694,0.5059300482420187
1,Deaths,1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,29618.934346252634,31764.63026524193,27424.48097899445
1,Deaths,1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.00043649967774902164,0.0004668000427554768,0.0004027683412196016
1,Deaths,1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,0.37533402975987384,0.40252449807648516,0.34752570229527197
1,Deaths,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,28179.989584609102,35652.96385974608,20895.402708872487
1,Deaths,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00041528144234690903,0.0005216494380461858,0.00031299262300987486
1,Deaths,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,0.35709958115764545,0.4517978412702312,0.264788584575419
1,Deaths,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,267061.2032772285,288695.7236972967,246094.68959597455
1,Deaths,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.003935057903693779,0.0042307822018494,0.003624163444891538
1,Deaths,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,3.384225659396317,3.658380415818667,3.1185359496314473
1,Deaths,1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,116359.62665053726,128470.56755307346,103078.62447071595
1,Deaths,1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0017148113233837311,0.0018912098591173348,0.0015081069699744488
1,Deaths,1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,1.4745205570715003,1.627991583408667,1.3062223999153928
1,Deaths,1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,320283.6291596394,349049.9009372441,274969.4910875972
1,Deaths,1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.004719135500042232,0.005144679486328838,0.004124520764650628
1,Deaths,1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,4.058665439927069,4.423194446313224,3.48444025515682
1,Deaths,1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,1,Number,2021,32928.662814349416,35937.755486767805,29649.395820167072
1,Deaths,1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,2,Percent,2021,0.00048521316138390046,0.0005344333211919417,0.0004388052540490815
1,Deaths,1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,3,Rate,2021,0.4172752322629583,0.4554067485915527,0.37572004053335667
1,Deaths,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,79408.22698900283,151758.26526626217,33921.17691008779
1,Deaths,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.001169865197459805,0.0022092636521575675,0.000502543904824964
1,Deaths,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,1.0062688104658313,1.9230955640023095,0.42985246785124975
1,Deaths,1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,74705.62194184861,146947.03458134408,29410.04466850548
1,Deaths,1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0011005627637395582,0.002153775353134921,0.00043027126818635526
1,Deaths,1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,0.9466769398710413,1.8621271787132172,0.372686959355263
1,Deaths,1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,1032.8853806343873,1369.9907947054335,682.5123847354037
1,Deaths,1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,1.5220808786472101e-05,2.0058217683273435e-05,1.0118975136576733e-05
1,Deaths,1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,0.013088824454706103,0.017360657196492935,0.008648863619773376
1,Deaths,1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,414.3544311280182,605.4621429775416,265.1009267476656
1,Deaths,1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,6.107228831019046e-06,8.933675383187579e-06,3.9092229544721665e-06
1,Deaths,1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,0.005250739833042495,0.007672475428528077,0.0033593848436977054
1,Deaths,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,3255.365235391779,4304.142824314962,2161.4401091231175
1,Deaths,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,4.7974396102756476e-05,6.279408515503668e-05,3.184236419921762e-05
1,Deaths,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,0.041252306307042574,0.054542518377828496,0.02738998023217002
1,Deaths,1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,71846.39302436683,92908.27919160003,58044.95424306761
1,Deaths,1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0010586259346562412,0.0013577522083812056,0.0008552486644631415
1,Deaths,1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,0.9104445116864597,1.177342790911403,0.7355513310705738
1,Deaths,1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,26901.550697786446,42453.6613158975,18386.910150770098
1,Deaths,1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0003965483378622694,0.0006266035247234322,0.0002724446877181242
1,Deaths,1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,0.34089907868232366,0.5379769438522247,0.23300072180329512
1,Deaths,1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,36025.28294874764,44620.842542353086,26239.409555570037
1,Deaths,1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.000530666387416101,0.000657825676328848,0.00038648714422560073
1,Deaths,1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,0.4565159051410597,0.56543967608413,0.3325083614379893
1,Deaths,1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,5474.370252347495,9110.813200233251,2464.8132064726187
1,Deaths,1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,8.066236891564415e-05,0.00013435134329294754,3.636486839912539e-05
1,Deaths,1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,0.06937175467526993,0.11545311498574037,0.031234353760866175
1,Deaths,1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,3445.1891254852303,5842.003188845741,1885.144709028318
1,Deaths,1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,5.074884046222708e-05,8.713297922741567e-05,2.7560750882423158e-05
1,Deaths,1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,0.04365777318780772,0.07403043516374604,0.023888737928534673
1,Deaths,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,68623.05650562365,94765.73734153261,44039.093091435665
1,Deaths,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0010112035428365379,0.0013938845272906508,0.0006467872948456353
1,Deaths,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,0.8695980764059457,1.2008806820581426,0.5580676902060812
1,Deaths,1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,43768181.657328695,45882469.412486725,41841301.44180199
1,Deaths,1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.6448684913961369,0.657653470816649,0.6326437610160183
1,Deaths,1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,554.6346740454488,581.4271350414609,530.217059701072
1,Deaths,1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,9888413.461412141,10585373.154936502,9124879.131245876
1,Deaths,1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.14568875215961566,0.1528194029557499,0.13654278657758623
1,Deaths,1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,125.30694146574422,134.13888279397113,115.63135983775207
1,Deaths,1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,538601.9091872636,603405.5489056602,475943.9848084296
1,Deaths,1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.00793272638207372,0.008756245170722458,0.007126048318786331
1,Deaths,1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,6.825216013796043,7.6464140675231285,6.031208674484984
1,Deaths,1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,954373.6015463611,1089576.5838839228,821750.8059909112
1,Deaths,1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.014058499412868295,0.015719891086328402,0.012185762838676822
1,Deaths,1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,12.09391551962302,13.80722092092725,10.41330649730197
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,483875.12694864016,540177.1153918189,440400.31538804265
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.00712797180551558,0.007811678155594465,0.006603576433829089
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,6.131712882546073,6.84517718071539,5.58079582302821
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,181194.31763660698,221685.28139692958,148896.4832432221
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,0.0026683259019669543,0.0032056183024850703,0.0022238522055911913
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,2.2961120954961936,2.8092175441716516,1.8868307826146602
1,Deaths,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,222208.37152869167,240746.737961254,199406.3024104532
1,Deaths,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0032741924288648802,0.0035009465427847343,0.0029665998103457413
1,Deaths,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,2.815846193426437,3.0507661840296505,2.52689614583317
1,Deaths,1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,55179.06647064079,64295.47769535356,46760.974070001386
1,Deaths,1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0008132396125714324,0.0009478821577387857,0.0006884013899338853
1,Deaths,1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,0.6992345212255702,0.8147585749244333,0.5925596318900356
1,Deaths,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,19414853.087521862,20668512.493677627,17775807.463992976
1,Deaths,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.28605595738973055,0.2990352020696152,0.26407545382368663
1,Deaths,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,246.02691512625137,261.9134096016459,225.25676885266637
1,Deaths,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,373345.2125490109,444761.75851337955,324139.65308871766
1,Deaths,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.00550061064948961,0.00652654380843335,0.004840033621706409
1,Deaths,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,4.7310670086719675,5.636064456418739,4.1075293518839375
1,Deaths,1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,11083.370238571704,13978.868431639281,7959.67268422488
1,Deaths,1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,0.00016328125138248323,0.0002055525482333735,0.00011753196271886414
1,Deaths,1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,0.1404495504913426,0.1771415864795985,0.10086574990223096
1,Deaths,1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,33908.89522378624,45797.67262055602,23888.193198007833
1,Deaths,1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,0.0004994871276259626,0.0006773046120596077,0.0003518973068148928
1,Deaths,1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,0.42969683312253454,0.5803525818095994,0.30271351804475266
1,Deaths,1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,8086.541586598998,11726.667259361204,5685.421661027917
1,Deaths,1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,0.00011912262908597475,0.00017195159630259342,8.331928562683144e-05
1,Deaths,1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,0.10247344502801156,0.14860147318791303,0.07204621874546503
1,Deaths,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,1,Number,2021,35026.63900087194,43079.262580961506,28463.62105400581
1,Deaths,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0005160472668518476,0.0006335827889763627,0.0004222281494390894
1,Deaths,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,3,Rate,2021,0.44386099146760616,0.5459046242033936,0.3606937868481971
1,Deaths,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,175901.5380575136,190755.3707802846,154306.07188652275
1,Deaths,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.0025921527562992683,0.0027850728469207228,0.0022827698594627523
1,Deaths,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,2.2290414755735255,2.4172706950330083,1.9553816184110253
1,Deaths,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,118499.49897466808,128548.07727747956,103131.36464514241
1,Deaths,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.0017461778179554347,0.0018691816724263441,0.0015217746317661195
1,Deaths,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,1.5016372282251071,1.6289737942089213,1.3068907285583586
1,Deaths,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,37330.34841051817,43135.53926975925,31060.30451761872
1,Deaths,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,0.0005500454579720307,0.0006295027061421225,0.0004615389423856161
1,Deaths,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,0.4730538221754962,0.5466177679019842,0.3935992133910656
1,Deaths,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,1,Number,2021,81169.1505641501,88478.790466377,69942.03450271154
1,Deaths,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,2,Percent,2021,0.0011961323599834048,0.0012971820054473015,0.0010404722460728019
1,Deaths,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,3,Rate,2021,1.0285834060496135,1.1212118770311663,0.8863122944471565
1,Deaths,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,1198125.9091012387,1330491.8200814766,1093517.9695706356
1,Deaths,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.01765105768889374,0.019290708730895934,0.01626162542486674
1,Deaths,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,15.182768575182566,16.86012233106931,13.857166545416572
1,Deaths,1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,530946.5832043171,642418.9410838895,454278.9747743339
1,Deaths,1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.007819769606665222,0.009410466161122613,0.006819381846195657
1,Deaths,1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,6.728206975026613,8.140795584753839,5.756667550694889
1,Deaths,1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,56360.69717769142,69297.7211257686,45072.40236289682
1,Deaths,1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,0.0008299515295453156,0.0010074391217744303,0.0006695309666433298
1,Deaths,1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,0.7142082609888114,0.8781474923861136,0.5711618862467577
1,Deaths,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,250811.3246322369,304084.48713487765,207821.56328503432
1,Deaths,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,0.003694055394269363,0.004501139180824152,0.0030634114018936527
1,Deaths,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,3.178305609618927,3.8533883295581233,2.633535153793858
1,Deaths,1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,1718.6359194352658,4409.481488665246,484.75164131027407
1,Deaths,1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,2.530307196470563e-05,6.520995956896275e-05,7.122253527799874e-06
1,Deaths,1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,0.02177872227915979,0.05587738022390018,0.0061428201581708005
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,146522.0291951889,168518.94529831532,125936.13439572132
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,0.0021590017055089163,0.0024788307726290875,0.0018493281235637694
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,1.856741468937491,2.135488538861052,1.595874998828494
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,92227.78473711628,112160.26643595059,75053.11109914673
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,0.001358820937827889,0.0016128638377676456,0.001121142414932866
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,1.168719498700926,1.4213058541612462,0.9510803564214764
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,20589.92277652316,25047.613319357482,16371.18620677839
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,0.0003033091030796622,0.00036648858326812736,0.00024396752007147467
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,0.26091751302777055,0.3174058030960514,0.2074572710519147
1,Deaths,1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,117251.60135143438,125952.42430090674,109354.573488353
1,Deaths,1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0017275540159473906,0.0018331239643446123,0.001634949128135538
1,Deaths,1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,1.4858237476258176,1.5960814260985017,1.38575183901742
1,Deaths,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,2016547.4368651747,2218371.8903818233,1820497.6664727218
1,Deaths,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.029706893931436232,0.03198176920339367,0.02714374581454136
1,Deaths,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,25.553886133526984,28.111425326427483,23.069524289353904
1,Deaths,1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,231.4898294097733,261.7376539115771,195.14389141532135
1,Deaths,1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,3.4118832212273618e-06,3.853955072821309e-06,2.857997319451127e-06
1,Deaths,1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,0.0029334617344796126,0.0033167651217322273,0.002472882457271885
1,Deaths,1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,158468.68895055185,173258.8700243093,129565.45391887377
1,Deaths,1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.0023351060560257895,0.0025283535239361984,0.0019443797773434624
1,Deaths,1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,2.008130708527663,2.1955533280721755,1.6418660904047961
1,Deaths,1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,137277.9244023536,146181.35721937654,129268.62377468117
1,Deaths,1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.002023081492653789,0.0021631161658659643,0.0019144043932277923
1,Deaths,1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,1.739599269867912,1.8524244403768684,1.6381046298177406
1,Deaths,1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,99555.4615827129,108049.55321456962,92947.9297640914
1,Deaths,1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,0.001467182057919819,0.0015958819663817484,0.001368313767142849
1,Deaths,1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,1.2615765355910422,1.3692144946095708,1.1778452468398133
1,Deaths,1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,12555.16302347294,14508.403666395381,11405.883349886273
1,Deaths,1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,0.0001850582012277187,0.00021372631087165851,0.00016814736110816372
1,Deaths,1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,0.15910025245349407,0.18385190870920273,0.14453646814695398
1,Deaths,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,9879.874040904444,11061.272137759654,8919.91841339152
1,Deaths,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,0.00014557711242477596,0.00016236156595939,0.00013280793728921494
1,Deaths,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,0.1251987290947826,0.14016952119890205,0.11303407759675597
1,Deaths,1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,15287.425755263353,16286.684714265062,14298.809531365605
1,Deaths,1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.00022526412108147658,0.0002380575842971506,0.00021347464552287561
1,Deaths,1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,0.1937237527285932,0.20638645988312043,0.181195911353082
1,Deaths,1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,231.4898294097733,261.7376539115771,195.14389141532135
1,Deaths,1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,3.4118832212273618e-06,3.853955072821309e-06,2.857997319451127e-06
1,Deaths,1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,0.0029334617344796126,0.0033167651217322273,0.002472882457271885
1,Deaths,1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,231.4898294097733,261.7376539115771,195.14389141532135
1,Deaths,1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,3.4118832212273618e-06,3.853955072821309e-06,2.857997319451127e-06
1,Deaths,1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,0.0029334617344796126,0.0033167651217322273,0.002472882457271885
1,Deaths,1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,1656634.5255417156,1759551.409745094,1537698.765394509
1,Deaths,1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.024409709717132664,0.025553315700808002,0.022815744735603515
1,Deaths,1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,20.993034558300273,22.297207369746204,19.485868985874735
1,Deaths,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,10760.56180758103,13463.1896321998,7668.149449729521
1,Deaths,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,0.00015851534245304451,0.000197900121052146,0.00011264954984276618
1,Deaths,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,0.13635889051594383,0.17060685435207876,0.0971715389933358
1,Deaths,1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,1527638.725635783,1638913.8608955822,1389377.2991133637
1,Deaths,1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.022509546374458032,0.023888062533503524,0.020449493006947265
1,Deaths,1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,19.35838717920177,20.768476564622908,17.60632487438178
1,Deaths,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,454358.5390976148,524688.463656866,381290.7842200989
1,Deaths,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,0.006695214276525863,0.0077024320177847775,0.005589416903038262
1,Deaths,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,5.757675797572811,6.6489034727127025,4.831754069158084
1,Deaths,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,193997.40065612923,226569.352940245,162332.3183021462
1,Deaths,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,0.002858831191891122,0.0033265080898283363,0.002383111005372074
1,Deaths,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,2.458354014361025,2.8711089759347943,2.0570909971416897
1,Deaths,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,307990.080497229,357326.099727383,259416.75355194617
1,Deaths,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.004538586015837907,0.005243063614492768,0.003844840907605811
1,Deaths,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,3.9028803902162816,4.528071245953709,3.2873544456266024
1,Deaths,1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,29265.008605897932,45335.41515512477,22457.656472696908
1,Deaths,1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,0.00043104857095131103,0.0006674135895852763,0.00033591215099612435
1,Deaths,1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,0.3708490482001007,0.574494810045814,0.284585616900383
1,Deaths,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,21324.51298973053,31923.697513195064,17314.35807760751
1,Deaths,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,0.00031410445255963343,0.0004681645785028884,0.0002585982821056615
1,Deaths,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,0.270226311977864,0.40454021378317184,0.21940923714549704
1,Deaths,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,13599.8320973276,18111.398915032507,10506.150033667907
1,Deaths,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,0.00020029142498008033,0.00026787539092058306,0.00015778759306412258
1,Deaths,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,0.1723384010199362,0.229509416507006,0.13313495966127886
1,Deaths,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,7495.233287899368,11712.05402153993,5175.336738296594
1,Deaths,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,0.00011039137177077105,0.000171737394264523,7.704421217063648e-05
1,Deaths,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,0.0949803284969821,0.1484162928105511,0.0655823727701042
1,Deaths,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,48483.1492092689,60374.912688847115,36339.692535455586
1,Deaths,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,0.000714022350361616,0.0008877588897688139,0.0005412520935132636
1,Deaths,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,0.6143832035086856,0.765076792128835,0.4605001341411535
1,Deaths,1,Global,3,Both,22,All ages,652,Other congenital birth defects,1,Number,2021,101888.18928482947,140374.19975372206,79391.83039048669
1,Deaths,1,Global,3,Both,22,All ages,652,Other congenital birth defects,2,Percent,2021,0.0015006014402624201,0.0020497066409663465,0.0012055568188959049
1,Deaths,1,Global,3,Both,22,All ages,652,Other congenital birth defects,3,Rate,2021,1.2911370889361586,1.7788355736217756,1.006061031167513
1,Deaths,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,119128.85255429559,126523.79681485253,108213.51132612515
1,Deaths,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.001755570308718959,0.0018655127795005931,0.0015964782415635501
1,Deaths,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,1.50961245827302,1.603321914417435,1.371292187817657
1,Deaths,1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,28944.12590606714,33700.64494767178,24762.022792134576
1,Deaths,1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.00042657271656274394,0.0005030704655394957,0.00036640671241938683
1,Deaths,1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,0.3667827912781009,0.4270578652778819,0.31378677203332905
1,Deaths,1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,46124.66094375645,52559.095397602934,40459.31769810618
1,Deaths,1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.0006797538518369796,0.0007604685518465618,0.0005933760762214428
1,Deaths,1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,0.5844962097874504,0.6660339918209052,0.5127044266832803
1,Deaths,1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,1336219.8635309504,1797316.6511648702,978118.4695760497
1,Deaths,1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.019684014680559844,0.026329376254075887,0.014310039350652566
1,Deaths,1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,16.932708657282056,22.775772198623397,12.394812807132183
1,Deaths,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,107459.49100009071,180774.20398057043,56096.65958031558
1,Deaths,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,0.0015825540361050201,0.002650859980984027,0.0008123932210355865
1,Deaths,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,1.3617371685795274,2.290788374202442,0.7108623507587992
1,Deaths,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,62018.15387980423,97785.78956459304,36079.121574733974
1,Deaths,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,0.0009136036275686946,0.0014489066987065694,0.000529067292942174
1,Deaths,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,0.7859001050427709,1.239151078883204,0.4571981534695087
1,Deaths,1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,594021.2699654559,744199.6404781479,482343.3983647873
1,Deaths,1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.008750125327061344,0.010736435077274804,0.0071965707894968796
1,Deaths,1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,7.527495567963303,9.430570551295085,6.112302668283974
1,Deaths,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,2022687.2291300176,2325511.608933542,1752177.435434522
1,Deaths,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.0297860080205148,0.03359004178730236,0.026074049699518195
1,Deaths,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,25.631690180955278,29.469110307299964,22.203763646856736
1,Deaths,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,55134.69403219291,64252.9365997747,46727.68056031193
1,Deaths,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,0.0008125858091673013,0.0009474827919531174,0.0006877222209886418
1,Deaths,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,0.6986722293504394,0.8142194900050586,0.5921377332825264
1,Deaths,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,44.37243844791737,71.32281421606527,14.56446811438301
1,Deaths,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,6.538034041306564e-07,1.0444797259768513e-06,2.1547915774497769e-07
1,Deaths,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,0.0005622918751307436,0.0009038096698748215,0.00018456236287151196
1,Deaths,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,142204.99640607042,155574.74180833224,120674.90597531448
1,Deaths,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,0.002096095680393506,0.002319905876175613,0.0017504028845209557
1,Deaths,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,1.8020356076663422,1.9714583276072881,1.5292041982712037
1,Deaths,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,36843.50057288388,41571.67963559875,31883.466214121316
1,Deaths,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,0.0005430311840120603,0.0006112966533713879,0.0004666210787101136
1,Deaths,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,0.466884438812713,0.5268003858312305,0.40403039883077346
1,Deaths,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,1,Number,2021,2029.3583618949704,2552.5724765651335,1491.6376184272876
1,Deaths,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,2,Percent,2021,2.9902034330361686e-05,3.7603656223522786e-05,2.1925839795635153e-05
1,Deaths,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,3,Rate,2021,0.02571622742711213,0.03234644780542373,0.01890217763140315
1,Deaths,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,363623.7785614833,388675.96071496746,326931.5363354123
1,Deaths,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.005358775211777595,0.00576856077197199,0.0048331108073512066
1,Deaths,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,4.607876047412927,4.9253397472214,4.142908369148735
1,Deaths,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,300112.4972360798,324215.63346381026,267925.60543652595
1,Deaths,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.0044229985401363905,0.004773578761973396,0.003954614083396985
1,Deaths,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,3.803054885503282,4.108492182620276,3.3951794480096904
1,Deaths,1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,17672.102135974,21241.471597802083,13931.86291829642
1,Deaths,1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.00026038851720691354,0.0003117173478010053,0.0002052152982350477
1,Deaths,1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,0.22394260480415906,0.269174003346331,0.17654592802215163
1,Deaths,1,Global,3,Both,22,All ages,602,Other urinary diseases,1,Number,2021,45839.17918942933,54688.043428768375,35703.29889964131
1,Deaths,1,Global,3,Both,22,All ages,602,Other urinary diseases,2,Percent,2021,0.0006753881544342905,0.0008029021431844536,0.000521416000347997
1,Deaths,1,Global,3,Both,22,All ages,602,Other urinary diseases,3,Rate,2021,0.5808785571054891,0.6930122292667696,0.4524356918134393
1,Deaths,1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,8940.868932121388,10310.615017878094,6458.424039142557
1,Deaths,1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.00013174392501440104,0.0001524186453885601,9.487282959621038e-05
1,Deaths,1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,0.11329956461693416,0.13065712083772113,0.08184178040207274
1,Deaths,1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,2077.7452718950894,2574.2785113549494,1225.4149526860551
1,Deaths,1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,3.0611104030942405e-05,3.760462982004438e-05,1.8203477965995665e-05
1,Deaths,1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,0.026329391077960045,0.03262150879892636,0.015528578001586803
1,Deaths,1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,54.16875810783838,121.9196804970449,21.510534073939603
1,Deaths,1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,7.98643381131366e-07,1.7544713043162363e-06,3.1172383630105873e-07
1,Deaths,1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,0.0006864317949465698,0.0015449781026231203,0.00027258358933093417
1,Deaths,1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,486.12919176977977,704.4773078419724,352.4259737024735
1,Deaths,1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,7.165592276811823e-06,1.0328220701661452e-05,5.232174129947571e-06
1,Deaths,1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,0.006160276612178208,0.008927205271318895,0.004465976370231307
1,Deaths,1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,6322.825710348672,7597.824517434051,4706.051065456784
1,Deaths,1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,9.316858532551534e-05,0.00011069845930339712,6.85708537608827e-05
1,Deaths,1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,0.08012346513184934,0.09628037458065031,0.059635538875392365
1,Deaths,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,88105.44604982884,109774.18302487416,68077.66380384212
1,Deaths,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.001297938274946268,0.0016094071981567859,0.0010055702457377577
1,Deaths,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,1.1164808201094956,1.3910691720594202,0.8626868068049443
1,Deaths,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,71220.6722324959,83167.256682994,49169.16424003277
1,Deaths,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,0.0010492292550438077,0.0012284517649019753,0.0007136614069322604
1,Deaths,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,0.9025153166799174,1.0539036019994863,0.6230764530011352
1,Deaths,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,45573.23200838076,51084.923435824305,37692.988990325495
1,Deaths,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,0.0006715330345800089,0.0007366635400685829,0.0005514232900381871
1,Deaths,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,0.5775084484446122,0.6473531406969215,0.4776492390322395
1,Deaths,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,130189.06640470764,149385.6766584323,113625.41575481337
1,Deaths,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,0.0019182961052542854,0.0021779697271469595,0.001674683167696833
1,Deaths,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,1.6497685687512607,1.8930298893656454,1.4398723694727018
1,Deaths,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,23159.1308935119,28477.385942370125,17502.796561780186
1,Deaths,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,0.00034125261821996226,0.00042114904772620456,0.00025559602076873094
1,Deaths,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,0.2934747692939182,0.36086821685835807,0.2217971480270822
1,Deaths,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,56913.2307466503,63037.41545581188,48761.351319748515
1,Deaths,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,0.0008385942650493289,0.000919020557841981,0.0007205233004097054
1,Deaths,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,0.7212100203563342,0.7988162873142225,0.6179086078326005
1,Deaths,1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,12081.173399095822,15525.434771109234,10555.424104216721
1,Deaths,1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,0.00017802856836204552,0.00022940640611737257,0.00015723083419707834
1,Deaths,1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,0.1530938096253326,0.19673982623050554,0.13375936549727405
1,Deaths,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,1048031.4768535637,1199871.675981121,911266.8689034228
1,Deaths,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.015441640024834082,0.01758914820447131,0.013512939461209638
1,Deaths,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,13.280757265745713,15.204891103643174,11.547662792110474
1,Deaths,1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,0.32405125235664006,0.7211201138868356,0.15036277647325574
1,Deaths,1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,4.775830855889769e-09,1.0527649308355756e-08,2.222752970507076e-09
1,Deaths,1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,4.106409129170435e-06,9.138104535495858e-06,1.9054117936802315e-06
1,Deaths,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,1,Number,2021,64011.376653933454,69518.72274317719,56292.64972438266
1,Deaths,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,2,Percent,2021,0.0009434385804040819,0.0010327448850911843,0.0008278188767408349
1,Deaths,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,3,Rate,2021,0.8111584187713231,0.880948046473432,0.7133459570123518
1,Deaths,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,97403.36723695678,130168.31293774201,69529.54631323474
1,Deaths,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,0.0014353440137539455,0.0019065781752904804,0.0010119573344845232
1,Deaths,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,1.2343049857853274,1.64950557879029,0.8810852038106471
1,Deaths,1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,295746.61335290526,313389.2210902985,272117.6219073288
1,Deaths,1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.004358187548679577,0.004588282292418078,0.004056142980825822
1,Deaths,1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,3.7477299783955806,3.97129882729936,3.4483010902812414
1,Deaths,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,3195033.812985079,3391411.492198276,2968010.431762721
1,Deaths,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.047077771434043736,0.04923801380529775,0.043727823945531666
1,Deaths,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,40.487780628018,42.97629776480375,37.61091816133443
1,Deaths,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,48511.30055233202,53957.72368893249,43623.65240247262
1,Deaths,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,0.0007147621955878209,0.0007800944162390867,0.0006406933856617865
1,Deaths,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,0.6147399400783246,0.6837575461724582,0.5528031852076275
1,Deaths,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,1608123.2249893844,1708293.6406591984,1493437.6984882753
1,Deaths,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.02369494752154485,0.024801134225063203,0.02213116476644483
1,Deaths,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,20.37829461822197,21.64766391208483,18.924988421801032
1,Deaths,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,75068.78684982363,84557.17462845785,65890.74720847109
1,Deaths,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0011063265683997246,0.001250523248745861,0.0009692611439133136
1,Deaths,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,0.9512790010655506,1.0715167779972417,0.8349739860500274
1,Deaths,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,273012.5307485469,312977.23821423354,234892.83106176727
1,Deaths,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.004022248992164618,0.004579723866496905,0.003484521764441802
1,Deaths,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,3.4596414625483694,3.966078140043774,2.9765849038816876
1,Deaths,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,16706.426881195763,20349.45042957949,14140.391867504699
1,Deaths,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,0.00024606570464138627,0.0002956945273636437,0.00020969068527034842
1,Deaths,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,0.21170547363062814,0.2578702239535232,0.17918842723947537
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,40924.90296974398,49609.986962030765,32961.3632935547
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,0.0006029324926012775,0.0007298167749102315,0.0004934178951440039
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,0.5186043687324363,0.6286626016019933,0.4176896159302339
1,Deaths,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,94019.5999019788,119984.45807877794,71456.80530585018
1,Deaths,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,0.001385146217105417,0.0017709505269203282,0.0010644605229591772
1,Deaths,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,1.1914255555276407,1.520454775070599,0.9055076180552984
1,Deaths,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,477273.105482829,565951.0209818973,401541.08574097947
1,Deaths,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,0.007031768673097725,0.008277199841433595,0.0060030151806600455
1,Deaths,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,6.048051421524008,7.171786630423649,5.0883678684538785
1,Deaths,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,22020.532101938217,25351.581187837164,18239.163884644495
1,Deaths,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,0.00032444938791276385,0.00037321312755220627,0.0002693631448567648
1,Deaths,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,0.27904633416775304,0.3212577136226174,0.23112846668436934
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,2416.16963346055,3019.033246693635,1922.4685318857805
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,3.558166453088008e-05,4.393951680359971e-05,2.8779416216678365e-05
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,0.03061793765125523,0.03825748425698924,0.024361709058264312
1,Deaths,1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,31764.517361321577,37053.01640653449,25490.166777168964
1,Deaths,1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,0.00046794834267404,0.0005403105555161932,0.0003802857296823577
1,Deaths,1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,0.402523067346976,0.4695394439261063,0.3230138837502281
1,Deaths,1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,50141.52762054305,62836.10644662403,36917.80042031167
1,Deaths,1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,0.0007388244869441664,0.0009261374036538361,0.0005496478499051565
1,Deaths,1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,0.6353983367573633,0.7962652798822145,0.4678259737382977
1,Deaths,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,1,Number,2021,306262.17643666524,333295.2017770301,276191.4589676415
1,Deaths,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,2,Percent,2021,0.004512947559591101,0.0048836379181669675,0.004123054954594936
1,Deaths,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,3,Rate,2021,3.8809842211472567,4.2235493593452045,3.499925151517116
1,Deaths,1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,96488.90237297014,114211.36002908325,83568.74630534218
1,Deaths,1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.001422123397217576,0.001693991595083711,0.0012268124118657174
1,Deaths,1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,1.2227167976870825,1.4472975125621008,1.0589913177187986
1,Deaths,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,106817.97648845353,211853.75489193024,41611.69556622532
1,Deaths,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,0.0015734264366039053,0.0030922390173991035,0.0006259006635944478
1,Deaths,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,1.3536078340130844,2.684631479775338,0.5273074716136248
1,Deaths,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,7946.438628949165,14859.107076798471,3326.482472573687
1,Deaths,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,0.00011705308953078968,0.00022425340276651214,4.939450922416834e-05
1,Deaths,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,0.10069804666083029,0.1882960565890125,0.042153510884655986
1,Deaths,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,182597.4345353619,225076.20471031757,141923.37078958267
1,Deaths,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,0.0026917788967611676,0.003325853485200424,0.002050881518914052
1,Deaths,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,2.3138925299195727,2.852187655686877,1.7984668203398195
1,Deaths,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,17457.58267431888,32229.4883550364,7574.377010038123
1,Deaths,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,0.00025728971500171046,0.000475885582697591,0.00011331435266434471
1,Deaths,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,0.22122419322784595,0.4084152252062784,0.09598324547614383
1,Deaths,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,840.000341184036,1491.717706533,385.4444551084133
1,Deaths,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,1.2381857881602962e-05,2.2172752515426512e-05,5.574390657363831e-06
1,Deaths,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.010644566390220659,0.018903192515703222,0.004884389792462037
1,Deaths,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,797487.4449465129,892432.233941413,726812.6200120492
1,Deaths,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.011753783923128779,0.013143014974822578,0.010641711122568598
1,Deaths,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,10.105838815654453,11.308988457757124,9.210240529263626
1,Deaths,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,11253498.490568202,11842693.662269138,10790268.874020852
1,Deaths,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.16585915909111149,0.17442863697421773,0.15786736560301542
1,Deaths,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,142.60543232191003,150.07177110116285,136.73534136420346
1,Deaths,1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,67871076.62497172,70624188.62552176,65111321.61785815
1,Deaths,1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
1,Deaths,1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,860.0689138910507,894.9566181368125,825.097028817103
1,Deaths,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,17073660.72885238,18172000.28597648,16124483.293851264
1,Deaths,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.251582421946887,0.2654598682210679,0.24025466657060934
1,Deaths,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,216.35909682631302,230.2773630002684,204.33102763680841
1,Deaths,1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,1162795.8919709644,1313985.0465696654,1050008.015724133
1,Deaths,1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.01713211955096879,0.019217262463405556,0.01581486637400364
1,Deaths,1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,14.735063146419623,16.65094688444135,13.305804159418368
1,Deaths,1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,718079.2179575106,785447.0499669798,669270.7360323089
1,Deaths,1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,0.010583918725668976,0.011648387032005974,0.009819857238844208
1,Deaths,1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,9.099570005188616,9.953261754145794,8.481064153719124
1,Deaths,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,517184.200406646,594707.3971088638,455525.94248220435
1,Deaths,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,0.007622468256024503,0.008739410598675158,0.006689542973512014
1,Deaths,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,6.553808715650984,7.536190238158124,5.772469247315843
1,Deaths,1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,1165397.6747908166,1618357.7157917153,793421.3462860667
1,Deaths,1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.017168057725716786,0.023691624481065373,0.01194016459993762
1,Deaths,1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,14.768033192502942,20.507987085563066,10.054312816177704
1,Deaths,1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,93332.57070927697,158180.67934967758,46256.56215636472
1,Deaths,1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,0.0013744249631203762,0.002312859600659606,0.0006900963256104714
1,Deaths,1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,1.1827194544760304,2.0044810227272913,0.5861676748401665
1,Deaths,1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,14126.920290813845,28251.710628703608,6267.333749091984
1,Deaths,1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,0.00020812907298464365,0.0004171697172321752,9.18939534153437e-05
1,Deaths,1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,0.17901771410349673,0.3580084372354462,0.07942026557732555
1,Deaths,1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,1,Number,2021,1344.5438602390113,1740.9118158429305,989.1763805406745
1,Deaths,1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,2,Percent,2021,1.9799291169322775e-05,2.5433303420299047e-05,1.4607133259256366e-05
1,Deaths,1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,3,Rate,2021,0.017038191156808224,0.02206100461475844,0.012534939735216737
1,Deaths,1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,2183001.289024,2360083.9150337726,1979915.4614943087
1,Deaths,1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.0321624063762467,0.03443570612688961,0.029405760367243773
1,Deaths,1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,27.66320561036799,29.907213947863024,25.089682162739923
1,Deaths,1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,19611.486921276457,41577.14737669898,7037.532376947448
1,Deaths,1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.0002886591849141222,0.0006046957265373036,0.00010528726717880707
1,Deaths,1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,0.24851867827841123,0.5268696735806423,0.0891802978367269
1,Deaths,1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,535.8696898466467,1240.5300095545326,216.64090730662426
1,Deaths,1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,7.89638679376389e-06,1.7994790391602154e-05,3.220594188618433e-06
1,Deaths,1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,0.006790593063378136,0.01572011747894187,0.002745294742871741
1,Deaths,1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,213962.05365606284,265664.4207892214,175653.35931265468
1,Deaths,1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,0.003151679394988354,0.003944461422414554,0.0026205212432528677
1,Deaths,1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,2.711348047691957,3.366525495244798,2.225896530271995
1,Deaths,1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,91947.72633387746,106091.28107757116,78328.72064971611
1,Deaths,1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,0.0013547916133491422,0.0015450672466322674,0.0011566925204347512
1,Deaths,1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,1.1651705712538123,1.3443990787693616,0.9925892006682879
1,Deaths,1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,3824.742962615927,5393.77269139683,2610.2675269508645
1,Deaths,1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,5.631608744109321e-05,7.817008881859875e-05,3.884112832863764e-05
1,Deaths,1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,0.04846751649375184,0.06835041450864579,0.03307756512062907
1,Deaths,1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,52608.66229233244,106185.87516582235,23531.795494726593
1,Deaths,1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,0.0007743393353649142,0.0015284240207760035,0.00034739949566989887
1,Deaths,1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,0.666662108353526,1.3455977842973772,0.2981972115292674
1,Deaths,1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,21228.662659309502,32682.338547815583,9550.987138319773
1,Deaths,1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,0.0003128333933554991,0.000481935994115302,0.00014226754794195872
1,Deaths,1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,0.2690116872263398,0.4141537870919409,0.12103104213348696
1,Deaths,1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,56049.274448784316,87053.75409689858,32379.6714527491
1,Deaths,1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,0.000825110882320718,0.0012902591498950274,0.0004789788063328772
1,Deaths,1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,0.7102618817425812,1.1031536769332826,0.41031836009315054
1,Deaths,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,13930.698082483475,15604.980382722682,12584.928568881212
1,Deaths,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.0002052251427488466,0.00022520289353984317,0.00018598547833794713
1,Deaths,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,0.17653116710892755,0.1977478359923546,0.15947744435295558
1,Deaths,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,847472.272770177,1617955.7479787627,375547.1075201747
1,Deaths,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.012474858514648503,0.02394014240055603,0.005564599446241531
1,Deaths,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,10.739251437276419,20.502893310165696,4.758969636868296
1,Deaths,1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,8991636.683642179,9531130.166103108,8264123.214154982
1,Deaths,1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.1324895604983247,0.13868718014458198,0.12269304027847884
1,Deaths,1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,113.94289852413658,120.77941264156188,104.723776761852
1,Deaths,1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,7252675.540862945,7808179.59447613,6566884.207830604
1,Deaths,1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.1068469918034051,0.11297002390033144,0.09805512565226965
1,Deaths,1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,91.90661302901913,98.94601466829381,83.21619825607871
1,Deaths,1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,3591498.6204926027,3888326.8192393747,3213281.2510010954
1,Deaths,1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.05291444290057064,0.056362311683759755,0.04781865027817115
1,Deaths,1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,45.51182140275309,49.273257336928886,40.71901394530351
1,Deaths,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,3308366.7038433547,3594724.741167639,3021075.2995086694
1,Deaths,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,0.048734487965932376,0.05188932315340531,0.04486296993930699
1,Deaths,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,41.923946093422614,45.55270311913408,38.28336134976675
1,Deaths,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,352810.21652699064,401473.5431030257,309015.35041161184
1,Deaths,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,0.0051980609369020716,0.005912562226738409,0.00454918710305637
1,Deaths,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,4.470845532843521,5.087511961546917,3.9158727107386295
1,Deaths,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,1,Number,2021,1332099.1819047483,1468851.9738371773,1121130.975454956
1,Deaths,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,2,Percent,2021,0.019627785449440164,0.02149196406807854,0.01655880288841636
1,Deaths,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,3,Rate,2021,16.88049097713057,18.613435717034974,14.20708125373073
1,Deaths,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,402038.0704519204,432943.5614482174,368483.23555065726
1,Deaths,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,0.005924334482669226,0.006361690041452911,0.005441358975444005
1,Deaths,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,5.094665707265554,5.4863031085893965,4.669455561141186
1,Deaths,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,338946.5876157212,368613.19167294994,288954.49814251304
1,Deaths,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.004994895341254416,0.00543055080291836,0.004264722069901334
1,Deaths,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,4.295164272824776,4.671102377819391,3.661659630870312
1,Deaths,1,Global,3,Both,22,All ages,501,Aortic aneurysm,1,Number,2021,153927.20490557546,165738.6536673169,138413.35938418336
1,Deaths,1,Global,3,Both,22,All ages,501,Aortic aneurysm,2,Percent,2021,0.0022686471438517924,0.0024554651565433278,0.002034335064851837
1,Deaths,1,Global,3,Both,22,All ages,501,Aortic aneurysm,3,Rate,2021,1.950580579013743,2.1002564116828393,1.753987612887904
1,Deaths,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,67743.65796252899,74256.51041528679,59937.261459074405
1,Deaths,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.0009985121749887765,0.001100248908535334,0.0008721303720331247
1,Deaths,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,0.8584542521519686,0.9409857547289463,0.7595308329873056
1,Deaths,1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,77843.8913041983,86337.76206334078,69010.02386782353
1,Deaths,1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,0.001147183417280267,0.001263985335912019,0.0010131778781331494
1,Deaths,1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,0.9864453958348091,1.0940805559327216,0.8745017646258556
1,Deaths,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,181077.85534084946,195716.8515443565,155363.65830427583
1,Deaths,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,0.0026690288987359268,0.002938379143370953,0.002253307856407924
1,Deaths,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,2.2946362739061663,2.4801430640043383,1.9687834568213527
1,Deaths,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,1,Number,2021,221498.66888022338,241202.50911668822,200809.78361057577
1,Deaths,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,2,Percent,2021,0.0032639581423777432,0.0035503158040869477,0.0029911517552287984
1,Deaths,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,3,Rate,2021,2.806852772128193,3.0565417606394507,2.5446811967190697
1,Deaths,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,4414181.576204122,4866686.260730721,4005294.4751886358
1,Deaths,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.06503773578829922,0.07093103940512266,0.059491843939550815
1,Deaths,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,55.93694019238408,61.671123763714284,50.75548290067734
1,Deaths,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,3719936.5518393167,4084218.2012573075,3347912.318192967
1,Deaths,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.05480630334180785,0.05920789672761335,0.049606958881739736
1,Deaths,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,47.139399416966164,51.755612068145744,42.42507198200634
1,Deaths,1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,18322.534811381873,20916.36882737773,16041.351058676772
1,Deaths,1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,0.0002698934055875552,0.0003034838315413121,0.00024077904626111036
1,Deaths,1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,0.23218495121319635,0.26505426927747483,0.2032775678307862
1,Deaths,1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,10223.276048092266,12177.596741292278,8196.286057453688
1,Deaths,1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,0.0001505561720900437,0.0001763234873700119,0.0001231505385645544
1,Deaths,1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,0.1295503528797125,0.15431569563805786,0.1038641376845477
1,Deaths,1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,3321.820561184026,3938.4813310030236,2694.7595072799427
1,Deaths,1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,4.896098869753526e-05,5.786630156189521e-05,3.9323016908169935e-05
1,Deaths,1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.04209443468806464,0.04990882021001622,0.03414825575009519
1,Deaths,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,2580.482824801341,3617.6236877959,2145.391536242018
1,Deaths,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,3.801002045656314e-05,5.35742397858968e-05,3.180106035941335e-05
1,Deaths,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.03270013046507085,0.045842880807999135,0.027186611148699937
1,Deaths,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,2196.9553773042644,2905.3119629463636,1764.5846214571104
1,Deaths,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,3.236622434341318e-05,4.342811400065295e-05,2.6258627127883774e-05
1,Deaths,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.027840033180348344,0.03681639703894995,0.022360988720297893
1,Deaths,1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,436192.9483950869,555604.0797882279,357795.38844017615
1,Deaths,1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.006428530495888272,0.008204949466223575,0.005305464263193273
1,Deaths,1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,5.5274796574402085,7.04066918073729,4.534018118371006
1,Deaths,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,188222.3694559996,212251.5192212855,161405.6559351045
1,Deaths,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,0.002774014562597967,0.00311683008560201,0.002393447215753833
1,Deaths,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,2.3851722547813465,2.6896719882178886,2.0453482410930546
1,Deaths,1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,1,Number,2021,51507.171702337866,64065.62231273582,40567.27767009738
1,Deaths,1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,2,Percent,2021,0.0007589939824176268,0.0009343128762949656,0.0006034395364011228
1,Deaths,1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,3,Rate,2021,0.6527039119831856,0.8118458250593853,0.5140725059958755
1,Deaths,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,1425141.8597539822,1563089.0358095805,1308121.0115071393
1,Deaths,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.020997547869448806,0.022740264217048202,0.019445004963449586
1,Deaths,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,18.059536880962064,19.80761697316474,16.576637259221847
1,Deaths,1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,37032.7285190547,42236.63260720944,28523.11190150616
1,Deaths,1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,0.0005457249654778111,0.0006139288730654315,0.00041647295050697855
1,Deaths,1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,0.46928235383386774,0.5352267348523598,0.3614476606798855
1,Deaths,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,7027.337185417189,12769.897192841081,5734.944893033807
1,Deaths,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.00010351877484142336,0.00018698884781347342,8.479357975896279e-05
1,Deaths,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,0.08905110337360093,0.16182138482692404,0.07267378197978697
1,Deaths,1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,1,Number,2021,30607.69429597261,41094.367421034694,17810.16651912606
1,Deaths,1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,2,Percent,2021,0.00045067791419099246,0.0006029552187757852,0.0002642728569266873
1,Deaths,1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,3,Rate,2021,0.3878636924430457,0.520751838815608,0.2256921701561394
1,Deaths,1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,4343697.741305577,4631455.422529131,3984365.400892314
1,Deaths,1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.063997553909719,0.0668925333210638,0.059406406002169405
1,Deaths,1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,55.043762150387884,58.690255600333984,50.490267626456095
1,Deaths,1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,1274143.194755356,1360993.3328550758,1192623.703742223
1,Deaths,1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.01876996381449138,0.019425601738961688,0.018090087463791704
1,Deaths,1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,16.14606704576301,17.24664048088707,15.11304409131616
1,Deaths,1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,1195697.0619967494,1275660.8471424337,1118222.0226030438
1,Deaths,1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.017614168594356057,0.01821101841690989,0.016965988779465743
1,Deaths,1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,15.151989987379876,16.16529888508435,14.170218718991093
1,Deaths,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,440295.52220449055,487976.8269363389,392420.0071173964
1,Deaths,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.00648537618599964,0.007039712971820649,0.00578984272064736
1,Deaths,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,5.5794678735680945,6.18369002551995,4.972784669020533
1,Deaths,1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,68181.80121194327,78053.54055305074,59657.368614169034
1,Deaths,1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.0010043028370308195,0.0011470119911278056,0.0008889342412831957
1,Deaths,1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,0.8640064462144661,0.9891020915986737,0.7559840035115659
1,Deaths,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,238617.61905945803,261394.2146680546,213272.70421693174
1,Deaths,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.0035157881081106074,0.0038337998752948606,0.003122160963681559
1,Deaths,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,3.0237857812944617,3.3124130260848266,2.7026125442509157
1,Deaths,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,437292.87083273334,475593.70028519724,404348.9366170052
1,Deaths,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.006442099809708981,0.006919003569549975,0.0060325763165161635
1,Deaths,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,5.54141798203079,6.026769834784326,5.1239492290775726
1,Deaths,1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,11309.248688125408,12506.163045595671,10239.298402728917
1,Deaths,1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,0.00016660165350599452,0.00018356176284684637,0.0001544516700995398
1,Deaths,1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,0.1433119042720633,0.15847931994661119,0.1297533897230276
1,Deaths,1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,78446.13275860707,85424.56893525069,72656.34333502845
1,Deaths,1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,0.001155795220135334,0.0012421184375959766,0.0010922042197622185
1,Deaths,1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,0.9940770583831376,1.082508483396005,0.9207082811540589
1,Deaths,1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,1817195.2755347334,1978316.728272559,1571722.4625319568
1,Deaths,1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.02677406455754511,0.028827382786208753,0.02335579803343476
1,Deaths,1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,23.027676068749237,25.069422859160134,19.917020600063157
1,Deaths,1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,802802.571899152,874337.6838905279,681873.5448294674
1,Deaths,1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.011829559489013404,0.012785207140102157,0.009983509831141584
1,Deaths,1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,10.173192623677977,11.079692551702703,8.64076817807168
1,Deaths,1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,274230.1786877455,297954.0881415837,251982.96868344478
1,Deaths,1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,0.0040395895083365115,0.004316319704653015,0.003772295502050646
1,Deaths,1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,3.4750716161962174,3.7757033145845855,3.193152797503647
1,Deaths,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,117405.96138630158,135183.77606801176,92583.35907171135
1,Deaths,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.001729727240202538,0.00199566180599618,0.0013630256357071617
1,Deaths,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,1.4877798130683917,1.7130620175800728,1.1732253714079794
1,Deaths,1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,56209.28557538099,64266.12370643552,38578.16974428078
1,Deaths,1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,0.0008279018820811035,0.0009278394813956813,0.0005702443964446829
1,Deaths,1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,0.7122895583716541,0.8143865983090245,0.4888663360271539
1,Deaths,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,28946.779063916976,33510.18261637744,19894.894672257116
1,Deaths,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,0.000426364930143378,0.0004872992601194437,0.0002980859602994288
1,Deaths,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,0.3668164123535839,0.4246443080078442,0.25211004898733835
1,Deaths,1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,27262.506511463984,33236.51698205975,16621.165962510673
1,Deaths,1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,0.00040153695193772637,0.0004855254836826417,0.0002453765753812754
1,Deaths,1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,0.34547314601807044,0.42117639035306054,0.21062503893919038
1,Deaths,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,103891.40900413705,118430.03700338621,78307.968131228
1,Deaths,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.0015304106489947295,0.0017117684139170474,0.0011557212368173073
1,Deaths,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,1.316522084930702,1.5007569993386956,0.9923262227265177
1,Deaths,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,13538.632359171681,18012.660514746138,9276.677863741144
1,Deaths,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,0.00019944344782891037,0.0002642799326293868,0.00013531297604580997
1,Deaths,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,0.1715628719589043,0.22825819385198778,0.11755496820643394
1,Deaths,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,6525.614864870627,9035.375779080223,3955.210424207185
1,Deaths,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,9.61647425932366e-05,0.00013372786190431362,5.755839861177618e-05
1,Deaths,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,0.0826932291101387,0.1144971646147696,0.05012081291350593
1,Deaths,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,260535.58841235758,283073.9348051099,240145.29664343747
1,Deaths,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,0.0038388931611005434,0.004134036237618211,0.003522295197597688
1,Deaths,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,3.3015324302861773,3.58714055773678,3.0431446608903907
1,Deaths,1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,10432.789207134603,12230.905595767701,8013.519827086506
1,Deaths,1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00015370084177679426,0.000178427421183585,0.00011970661364665646
1,Deaths,1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,0.1322053241002092,0.1549912306501632,0.10154810615735621
1,Deaths,1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,2762.037948038075,3760.785293502421,1666.2751742671587
1,Deaths,1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,4.067118927705417e-05,5.4438120050548464e-05,2.4851180879202407e-05
1,Deaths,1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,0.035000814724382025,0.04765703866218004,0.021115201800825604
1,Deaths,1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,7670.751259096537,9444.955883630317,5932.471295040907
1,Deaths,1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,0.00011302965249974009,0.00013625135085621964,8.805745141910725e-05
1,Deaths,1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,0.09720450937582745,0.11968740371497229,0.07517685584404547
1,Deaths,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,50203.1391987285,61280.375070367925,43231.997697590225
1,Deaths,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.000739680066501749,0.0009002359906172458,0.0006499688539860504
1,Deaths,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,0.6361790846954846,0.7765508998897435,0.5478400985232977
1,Deaths,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,66114.25807447915,74466.87636626887,53305.42997764134
1,Deaths,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0009740470989367628,0.0010745453675383646,0.0007883003520736513
1,Deaths,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,0.8378063375807476,0.9436515326122197,0.6754916165348881
1,Deaths,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,5193.809796042352,5932.303384033241,4294.571807622043
1,Deaths,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,7.651489082098262e-05,8.646138437999838e-05,6.361759029895387e-05
1,Deaths,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,0.0658164651626477,0.0751747280593517,0.05442123351922227
1,Deaths,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,649183.9940098322,735922.7303073491,561585.0382653427
1,Deaths,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.009561474286800186,0.010694019706140995,0.008420075743838917
1,Deaths,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,8.22652299636661,9.325684736969379,7.116460470889698
1,Deaths,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,520268.9697328536,583093.4737937278,458392.518300797
1,Deaths,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.00766670863067397,0.00864829350243631,0.006797449118832625
1,Deaths,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,6.592899213929888,7.389017467246342,5.808794776149081
1,Deaths,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,138328.2702067007,173904.67584730606,108287.74939860971
1,Deaths,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,0.0020382765063552254,0.0025379952170370996,0.001583752367644245
1,Deaths,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,1.7529093545177623,2.203737042555423,1.3722329399251265
1,Deaths,1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,9833234.394941507,10526278.615770895,9074786.549792176
1,Deaths,1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.1448755125470441,0.15201878060750124,0.1357995779118864
1,Deaths,1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,124.60770694451872,133.3900310202193,114.99658175160292
1,Deaths,1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,7887553.952962122,8403574.74966847,7507141.196795269
1,Deaths,1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.1162680775921881,0.1248465780851337,0.10789291150922238
1,Deaths,1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,99.95185429378051,106.49092024407864,95.13122668189521
1,Deaths,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,99354.79913403916,116827.96342839557,61436.25169861621
1,Deaths,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.0014636860986081998,0.00170651732418175,0.0008991995954685085
1,Deaths,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,1.2590337214370386,1.4804553664762992,0.7785261837518116
1,Deaths,1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,1,Number,2021,2685536.497485054,3597236.6226681606,2081724.7975378195
1,Deaths,1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,2,Percent,2021,0.039551532747257354,0.05230594230414713,0.03104629972155964
1,Deaths,1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,3,Rate,2021,34.03138086890046,45.58453392691563,26.37982001569825
1,Deaths,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,9776321.164194856,10467969.754910745,9021866.405953903
1,Deaths,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.1440369182819949,0.1511499497763097,0.1350068705291622
1,Deaths,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,123.88649692416254,132.65113543871382,114.32597251866798
1,Deaths,1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,748131.2444025845,1536034.8901330386,267703.3128384155
1,Deaths,1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.01101131519695054,0.022796502136071213,0.00397911786186031
1,Deaths,1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,9.480392220337176,19.464784196003336,3.3923625344887913
1,Deaths,1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,7712.884459429922,8842.75887955919,6731.412488321055
1,Deaths,1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,0.00011368107427022365,0.00012964924931571393,9.79080152075358e-05
1,Deaths,1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,0.09773842540680065,0.11205630444566533,0.08530111670061272
1,Deaths,1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,5482.232239735168,17781.296407311525,1609.4769815707843
1,Deaths,1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,8.071317171228394e-05,0.0002579620242783394,2.4105131550103395e-05
1,Deaths,1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,0.06947138254755049,0.22532632527866028,0.020395449553881406
1,Deaths,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,5482.232239735168,17781.296407311525,1609.4769815707843
1,Deaths,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,8.071317171228394e-05,0.0002579620242783394,2.4105131550103395e-05
1,Deaths,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,0.06947138254755049,0.22532632527866028,0.020395449553881406
1,Deaths,1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,1055.3233044229505,2995.0206619681385,371.26318783416417
1,Deaths,1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,1.5532625643960077e-05,4.32898402845281e-05,5.434787293899631e-06
1,Deaths,1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.01337316001710528,0.03795319443735528,0.004704683388074832
1,Deaths,1,Global,3,Both,22,All ages,351,Schistosomiasis,1,Number,2021,12857.573424201824,14387.796071076242,11335.03535909281
1,Deaths,1,Global,3,Both,22,All ages,351,Schistosomiasis,2,Percent,2021,0.00018937974760704267,0.00020954071143274047,0.00016959785930064709
1,Deaths,1,Global,3,Both,22,All ages,351,Schistosomiasis,3,Rate,2021,0.1629324265965599,0.18232355747814272,0.1436386754858799
1,Deaths,1,Global,3,Both,22,All ages,352,Cysticercosis,1,Number,2021,1643.3419355073922,2287.0824610052614,1113.778296860659
1,Deaths,1,Global,3,Both,22,All ages,352,Cysticercosis,2,Percent,2021,2.421215772654175e-05,3.369648915685737e-05,1.64276552629182e-05
1,Deaths,1,Global,3,Both,22,All ages,352,Cysticercosis,3,Rate,2021,0.020824589558719818,0.02898213239028437,0.014113907392238452
1,Deaths,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,1363.7195043471647,1775.056524979661,985.6801311568057
1,Deaths,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,2.009364130083138e-05,2.583792990712032e-05,1.4538730484044425e-05
1,Deaths,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,0.01728118679237756,0.022493689704824463,0.012490634921446185
1,Deaths,1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,29075.965615825524,38980.48719657974,17627.53317258741
1,Deaths,1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0004284831807589714,0.0005710705174892726,0.000258396878148194
1,Deaths,1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,0.36845347696069514,0.4939645420884805,0.22337782254580563
1,Deaths,1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,4601.911183119873,10002.378531545362,1756.9809712880171
1,Deaths,1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,6.779418064846202e-05,0.00014894100161333556,2.5376807635192538e-05
1,Deaths,1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,0.058315868112113284,0.1267511179686839,0.02226463452249026
1,Deaths,1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,10084.207728480995,14171.857352074552,6016.00011960151
1,Deaths,1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,0.0001485721777218217,0.0002059273514752708,8.868289186792499e-05
1,Deaths,1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,0.12778806554683836,0.17958716093407384,0.07623534126951464
1,Deaths,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,1,Number,2021,3472.7326166737157,4656.0918472698695,2238.2690432967515
1,Deaths,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,2,Percent,2021,5.113553461530063e-05,6.768838177035276e-05,3.3336376500435104e-05
1,Deaths,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,3,Rate,2021,0.04400680699910486,0.0590024507815893,0.028363563992086577
1,Deaths,1,Global,3,Both,22,All ages,361,Ascariasis,1,Number,2021,3472.7326166737157,4656.0918472698695,2238.2690432967515
1,Deaths,1,Global,3,Both,22,All ages,361,Ascariasis,2,Percent,2021,5.113553461530063e-05,6.768838177035276e-05,3.3336376500435104e-05
1,Deaths,1,Global,3,Both,22,All ages,361,Ascariasis,3,Rate,2021,0.04400680699910486,0.0590024507815893,0.028363563992086577
1,Deaths,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,1,Number,2021,21942.90650693832,26891.42923651018,15207.289395344034
1,Deaths,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,2,Percent,2021,0.0003232351087650558,0.00039634846383675767,0.0002300460032202908
1,Deaths,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,3,Rate,2021,0.2780626550440133,0.3407708185361791,0.19270825694649685
1,Deaths,1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,191152.4081553945,227096.97371329457,161459.99721684272
1,Deaths,1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.0028154359950318107,0.0032950718891245063,0.0023836502177850714
1,Deaths,1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,2.422301991440336,2.8777950379186135,2.0460368591243006
1,Deaths,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,46874.43840914303,56596.01129401681,39076.09275711482
1,Deaths,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.0006904795360015029,0.0008205151973033608,0.0005791341659516109
1,Deaths,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,0.5939974630809299,0.7171901844607128,0.4951760650920966
1,Deaths,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,17664.86680723467,21190.578816995494,14627.83972095323
1,Deaths,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,0.00026017936680398695,0.0003097970915810023,0.00021716519743459814
1,Deaths,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,0.2238509180114939,0.26852908505580375,0.18536541406127796
1,Deaths,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,38147.323157748324,46096.18389919997,31879.041373292534
1,Deaths,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.000561912737229205,0.0006766204014875846,0.0004692176754593702
1,Deaths,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,0.4834066059895687,0.5841353458966668,0.403974326815491
1,Deaths,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,11672.980175432978,13865.180432170404,9757.18004945774
1,Deaths,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.00017195173653407998,0.00020207580928725122,0.00014525014666037276
1,Deaths,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,0.14792114521522948,0.17570092104318685,0.12364393884815642
1,Deaths,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,6441.556266535422,7796.124953683909,5368.211650594034
1,Deaths,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,9.484950664055535e-05,0.00011171578472966311,8.038586537696556e-05
1,Deaths,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,0.08162803033963983,0.09879325708245498,0.06802650250231854
1,Deaths,1,Global,3,Both,22,All ages,375,Indirect maternal deaths,1,Number,2021,19169.178869038995,22430.696756105855,16375.900736572907
1,Deaths,1,Global,3,Both,22,All ages,375,Indirect maternal deaths,2,Percent,2021,0.00028231867613195873,0.0003237417740673524,0.00024391617910949015
1,Deaths,1,Global,3,Both,22,All ages,375,Indirect maternal deaths,3,Rate,2021,0.24291370742764481,0.2842439807378185,0.2075170140340731
1,Deaths,1,Global,3,Both,22,All ages,376,Late maternal deaths,1,Number,2021,5590.2117326411235,6911.007618469063,4444.519760435222
1,Deaths,1,Global,3,Both,22,All ages,376,Late maternal deaths,2,Percent,2021,8.234687090402227e-05,0.0001015709853888387,6.634918259702513e-05
1,Deaths,1,Global,3,Both,22,All ages,376,Late maternal deaths,3,Rate,2021,0.07083970923108462,0.08757696373601524,0.056321388626954384
1,Deaths,1,Global,3,Both,22,All ages,379,Other direct maternal disorders,1,Number,2021,27620.013165217966,33902.10656741472,22979.16842483102
1,Deaths,1,Global,3,Both,22,All ages,379,Other direct maternal disorders,2,Percent,2021,0.0004066996841735496,0.0004892787105025724,0.0003412840951782461
1,Deaths,1,Global,3,Both,22,All ages,379,Other direct maternal disorders,3,Rate,2021,0.35000350526228957,0.4296108066057536,0.29119426730873904
1,Deaths,1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,1831534.820974625,2121829.2719252873,1570938.3077425933
1,Deaths,1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.02697057202548296,0.030538617873222762,0.02351623898553111
1,Deaths,1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,23.209388189514968,26.88802783328148,19.90708371396163
1,Deaths,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,739670.7113140529,877043.0819465697,622745.543242045
1,Deaths,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.010892565820350723,0.01266526206013005,0.009270488517745631
1,Deaths,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,9.373179518458288,11.113975620182078,7.891492365241387
1,Deaths,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,603605.6199175254,725270.8179207218,511190.6339044534
1,Deaths,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,0.00888818811132019,0.010401270765120856,0.007631825530999401
1,Deaths,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,7.648949386932102,9.190702662530642,6.477857655373002
1,Deaths,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,232656.28389616738,272484.72126109136,197143.83386477112
1,Deaths,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.0034259739317360166,0.003939879884134377,0.002945791249487715
1,Deaths,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,2.9482431596920042,3.452953009157161,2.498225923382602
1,Deaths,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,33661.27081667934,43078.42305280507,25908.0498438215
1,Deaths,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,0.0004957084270313374,0.0006298806771820649,0.00038613213483147934
1,Deaths,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,0.42655891244315375,0.5458939856205746,0.32830933879737956
1,Deaths,1,Global,3,Both,22,All ages,385,Other neonatal disorders,1,Number,2021,221940.93503019924,268608.35363074415,159905.74902551336
1,Deaths,1,Global,3,Both,22,All ages,385,Other neonatal disorders,2,Percent,2021,0.003268135735044714,0.0038979269043437075,0.0023471692646803784
1,Deaths,1,Global,3,Both,22,All ages,385,Other neonatal disorders,3,Rate,2021,2.8124572119894116,3.4038312998302684,2.026341274196126
1,Deaths,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,222274.1579410696,247630.34113057813,199730.7495095341
1,Deaths,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.0032744723898621357,0.0036033221668446396,0.0029616431178435265
1,Deaths,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,2.8166798452713255,3.1379958759087283,2.531007571170703
1,Deaths,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,189345.49512672023,213754.71141775514,167550.8492191349
1,Deaths,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.0027892592284782334,0.0031026966489042995,0.0024865973713111885
1,Deaths,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,2.399404613008367,2.708720586591109,2.1232207307641846
1,Deaths,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,431964.39342447725,502419.3274294189,365199.2600782644
1,Deaths,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.006362481997417147,0.0073131434519219,0.005460196112379923
1,Deaths,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,5.473894995729356,6.366706802778264,4.62784070311569
1,Deaths,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,368272.5702853173,427547.6895109273,314030.7277567765
1,Deaths,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.005427044556249408,0.006319881440779705,0.004673400757518305
1,Deaths,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,4.666785990317125,5.417926092231697,3.9794280624511797
1,Deaths,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,354253.94877811766,418947.3790991901,299197.7771563276
1,Deaths,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,0.00522021448274148,0.006136080442450845,0.0044032118620183375
1,Deaths,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,4.489140648980215,5.308942118457114,3.7914634632859174
1,Deaths,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,173247.58002911278,214525.49844832724,137379.36322637033
1,Deaths,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,0.0025524628192868217,0.003141895420505292,0.0020401939292116773
1,Deaths,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,2.195410260150031,2.7184880751472216,1.7408847125562688
1,Deaths,1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,2516332.3000153443,2738621.2825350263,2295019.0495699756
1,Deaths,1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.037076365457915254,0.040081083868476995,0.03416777233712436
1,Deaths,1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,31.887208747575492,34.70407645135534,29.082705615968877
1,Deaths,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,230217.44726907922,270857.55028676125,193005.00030061445
1,Deaths,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,0.003391813524668281,0.003966103776913563,0.002868329232122796
1,Deaths,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,2.917337983682965,3.432333339598358,2.445778220099959
1,Deaths,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,42795.083479467605,49202.39022343606,37095.34420968647
1,Deaths,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0006304354674963344,0.0007137680345459545,0.0005471069887197682
1,Deaths,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,0.542303478865404,0.6234974959089491,0.47007582598300923
1,Deaths,1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,29319.583191897298,34328.25656660485,25275.79668328604
1,Deaths,1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,0.00043199582463327753,0.0004957474699431495,0.0003782498312670423
1,Deaths,1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,0.3715406226857373,0.435011021029688,0.32029736497691647
1,Deaths,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,232300.2891123163,260326.0322278261,203723.02459534496
1,Deaths,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,0.0034227180454125946,0.003815027751628191,0.003031268996905459
1,Deaths,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,2.9437319590109046,3.2988769138424754,2.5815980710972113
1,Deaths,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,48011.729594195764,56309.03384672722,42565.00208398194
1,Deaths,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.0007076239515629168,0.0008360630905963634,0.0006270040120495042
1,Deaths,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,0.6084093280895111,0.7135535782114055,0.5393878649432119
1,Deaths,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,42422.65913526437,46502.09665899696,37536.90390356831
1,Deaths,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,0.0006251588128746917,0.0006853252535713481,0.0005525678486941462
1,Deaths,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,0.5375840811903756,0.5892791120458641,0.4756713135635804
1,Deaths,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,91514.9241445257,98537.59050595762,81930.40733391214
1,Deaths,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,0.0013488098239562824,0.0014562380174060294,0.001200650264414952
1,Deaths,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,1.1596860596262393,1.2486779738619673,1.038230126209649
1,Deaths,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,131110.4044775651,155749.55516739134,113367.44516707901
1,Deaths,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0019320306600942483,0.0023072490578802314,0.0016599399469050989
1,Deaths,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,1.6614438548238164,1.9736735795722804,1.4366033409816041
1,Deaths,1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,122415.9704166794,141361.82329999155,109847.62506278438
1,Deaths,1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,0.0018037798703061168,0.0020675243090337867,0.0016255788438910668
1,Deaths,1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,1.5512671369714894,1.7913508356893981,1.391999836738992
1,Deaths,1,Global,3,Both,22,All ages,541,Other digestive diseases,1,Number,2021,121082.34944037221,137058.52757841922,104792.62788667373
1,Deaths,1,Global,3,Both,22,All ages,541,Other digestive diseases,2,Percent,2021,0.0017844516074616967,0.0020273938885074045,0.0015419754052774417
1,Deaths,1,Global,3,Both,22,All ages,541,Other digestive diseases,3,Rate,2021,1.5343673616670113,1.7368190518802846,1.3279424186578976
1,Deaths,1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,2607635.055377635,5592301.4547462,1193363.7976183752
1,Deaths,1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.0384175039190635,0.0829208654457034,0.01752573014350062
1,Deaths,1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,33.04420618366467,70.8661903937627,15.12242263322079
1,Deaths,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,1952676.9993192917,4984737.475120099,512981.21767268534
1,Deaths,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.028766365522967498,0.07392264837082102,0.007461277070353242
1,Deaths,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,24.744513708902367,63.16708028587789,6.500548107821307
1,Deaths,1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,388194.25823521934,417387.7803950442,347249.611420703
1,Deaths,1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,0.00572046419773008,0.006125368621244452,0.0051550211862388855
1,Deaths,1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,4.919235566336448,5.28917873130779,4.400381001674108
1,Deaths,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,139850.92648451487,153369.61685194672,116952.54624191058
1,Deaths,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,0.0020604279979731855,0.0022206532212429727,0.0017198015049266506
1,Deaths,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,1.7722046036313914,1.9435147687226668,1.4820340920607098
1,Deaths,1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,16302.192418505912,17039.512968077364,15357.184340540725
1,Deaths,1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,0.0002402686155260292,0.00025183729744147437,0.0002239927625911666
1,Deaths,1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,0.20658297502633963,0.21592637306558815,0.19460774033653408
1,Deaths,1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,39081.63811731974,42432.81612039652,35756.51243904375
1,Deaths,1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,0.0005759473150323625,0.0006224936831077253,0.0005216188264492616
1,Deaths,1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,0.4952463364383866,0.5377127914982929,0.45311001898362757
1,Deaths,1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,71529.04080278447,76362.01675037519,64521.49881030673
1,Deaths,1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,0.0010540302698343505,0.0011159689598755108,0.0009619051042842714
1,Deaths,1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,0.9064229933297465,0.967666936711905,0.8176227365750338
1,Deaths,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,90352.77664496542,102228.14871284904,67793.81917214961
1,Deaths,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0013309672011658192,0.0014751972844500901,0.0009948261845866204
1,Deaths,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,1.1449592129717958,1.2954450880215347,0.8590898999009544
1,Deaths,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,122330.45150335877,133910.61035705137,103909.71210021076
1,Deaths,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.0018024900417883223,0.00197497766618894,0.0015486812844085398
1,Deaths,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,1.5501834329468231,1.6969283373044586,1.3167540235523296
1,Deaths,1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,88531.1663690311,106475.09500021808,68123.97942063079
1,Deaths,1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.0013045767022524044,0.0015874153949839102,0.0010028844142508737
1,Deaths,1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,1.1218755895866435,1.349262806295171,0.8632737228258545
1,Deaths,1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,79367.21395606411,95256.50702424311,59826.32876371096
1,Deaths,1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.0011695782478979284,0.0014091854554392136,0.000882688652221668
1,Deaths,1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,1.0057490893055239,1.20709976342489,0.758125083033707
1,Deaths,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,9163.952412966992,12268.340455623926,7665.247653328646
1,Deaths,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.00013499845435447315,0.00018092480835393935,0.00011539510464811603
1,Deaths,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,0.11612650028112136,0.15546560885158933,0.0971347671458429
1,Deaths,1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,106988.86214755148,117459.56243918795,83299.60812909965
1,Deaths,1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.0015763290991559226,0.0016999237978910884,0.0012358247873772172
1,Deaths,1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,1.3557733137804358,1.4884590508473086,1.0555807724550688
1,Deaths,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,103915.0799063853,113554.77253961183,82080.95682557311
1,Deaths,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,0.0015310524200923942,0.0016528744658669404,0.0012165697456754053
1,Deaths,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,1.3168220449166,1.4389771717479352,1.0401379040764296
1,Deaths,1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,3073.782241166158,4189.411374309916,1319.6755203235518
1,Deaths,1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,4.52766790635279e-05,6.095634081619898e-05,1.969704078499247e-05
1,Deaths,1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,0.03895126886383728,0.05308863023427902,0.0167230571238011
1,Deaths,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,1252359.2710154837,1324696.452877613,1180942.125708028
1,Deaths,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.018453525537682484,0.019332136526206207,0.017502178699632623
1,Deaths,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,15.870019035875627,16.786682871663523,14.9650139931947
1,Deaths,1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,746379.2277909358,799846.8321811323,691760.2242271468
1,Deaths,1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.010997369443597502,0.011712430755230797,0.01023948263528758
1,Deaths,1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,9.458190494665045,10.135737201200028,8.766053145312387
1,Deaths,1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,56874.91385198535,67838.89249176113,46629.62159004452
1,Deaths,1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,0.0008382506640709018,0.001006249321195212,0.0006836435901900215
1,Deaths,1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,0.7207244649236388,0.8596610734106654,0.5908951204310877
1,Deaths,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,689504.3139389508,740710.5995703238,639533.9218907917
1,Deaths,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.010159118779526594,0.010820467660083202,0.009439230466130393
1,Deaths,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,8.7374660297414,9.386357084037229,8.104236339676984
1,Deaths,1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,397409.9674524831,418988.6282030725,376687.975323199
1,Deaths,1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.005856004128505371,0.006119656849176604,0.0056055581271312995
1,Deaths,1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,5.036017933898169,5.309464831131486,4.773426825129245
1,Deaths,1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,171917.25413612757,181811.94364859047,162592.40934460002
1,Deaths,1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,0.0025334581187498894,0.002681245937201616,0.00240196001931399
1,Deaths,1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,2.178552240463338,2.303938712661156,2.060386896242158
1,Deaths,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,83061.02013850427,87471.87986678157,78403.15340219271
1,Deaths,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.001223911633032729,0.0012765891980652884,0.001176546672488481
1,Deaths,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,1.0525573621285669,1.108452207539482,0.9935324197796365
1,Deaths,1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,142431.69317785074,152923.9369838939,132742.36367172346
1,Deaths,1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.002098634376722759,0.0022424636831887114,0.0019825313129870027
1,Deaths,1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,1.8049083313062662,1.9378670698924663,1.6821242011720858
1,Deaths,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,9427.039657415282,10366.678850898685,8572.949950230308
1,Deaths,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,0.0001389497403901164,0.00015408731172329943,0.00012545422616563943
1,Deaths,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,0.11946036754598764,0.13136756720710802,0.10863725933329386
1,Deaths,1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,1,Number,2021,1265.4126912060879,1755.7218386576803,781.1281781358949
1,Deaths,1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,2,Percent,2021,1.8632175971563388e-05,2.564094642640733e-05,1.1451831905533002e-05
1,Deaths,1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,3,Rate,2021,0.01603543325182997,0.02224867867078332,0.009898532588355177
1,Deaths,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,36023.550170622446,43653.602927820975,23328.33283722405
1,Deaths,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,0.0005308441067218775,0.0006400258673101718,0.000343786098077238
1,Deaths,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,0.45649394720736663,0.5531827211909619,0.2956189128554076
1,Deaths,1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,47.90579765806047,56.418095991103044,39.30675042258415
1,Deaths,1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,7.05941096609322e-07,8.311649933102435e-07,5.802651039234114e-07
1,Deaths,1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.0006070669482454173,0.0007149356243601392,0.0004980989815638219
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,2883054326.3927264,3147689598.012937,2635339087.2726936
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,36534.34609400553,39887.83011043433,33395.27438248002
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,830640996.6503873,908405545.6071784,761377077.3655312
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.28833590210296484,0.3079805926558168,0.2694545396077303
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,10525.963861896766,11511.403823753593,9648.244709741075
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,46977462.561743826,52463556.452161774,42482993.954904094
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.016314541793168304,0.018126734324802465,0.014666440513064568
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,595.3029952079871,664.8233129702674,538.3486499194697
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,40266791.745204404,44796386.902029544,37138091.60153836
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,0.013988312279223016,0.015613371687575768,0.01276501759111669
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,510.2647189986211,567.6641913603631,470.6175251089106
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,29388359.850106288,33760894.17227204,26046315.96843254
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,0.010207980237827565,0.011707246327932777,0.008968214863021172
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,372.41216721793506,427.8213493382726,330.0614606368375
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,58983816.792969696,73219864.0668883,47248934.87882884
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.020470067374179376,0.02499120910221214,0.016468751385924088
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,747.4486890283537,927.8492709232928,598.7431189325148
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,7087732.575528114,12265049.947484892,3617773.3024424342
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,0.0024606394594888885,0.0043084418394243006,0.0012193816580308736
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,89.81643965762302,155.42391121097393,45.844776739417135
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,1011841.8881956032,1979018.8673381186,454693.38593306544
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,0.0003513169541562786,0.0006927597087584396,0.0001506734689373372
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,12.82215926260512,25.078320433996815,5.761919009385665
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,1,Number,2021,105381.67496445322,139604.40632415927,76716.69305441185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,2,Percent,2021,3.65638679328712e-05,4.796088297096245e-05,2.7006133994581593e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,3,Rate,2021,1.335406880776509,1.769080676074726,0.972161429487985
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,82534840.53909253,93402507.13601492,72611990.1643261
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.028668016260024992,0.03243065438696429,0.024801429598961235
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,1045.8895628378853,1183.6056957083358,920.1462334416826
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,5678886.772827445,8381211.862397412,3262480.2855206253
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.0019623774511000596,0.0028013724516363623,0.0011851336703369545
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,71.96340800374026,106.20753555176023,41.342468917404716
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,2479622.897227385,3973786.952666279,1458845.3248078777
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,0.0008559465652985793,0.0012845315908269024,0.0005306852725564845
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,31.42202360899452,50.356216497037714,18.48663048290153
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,14511046.482412158,18634696.609544724,11401702.39290015
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,0.005037761310436602,0.006504607625376778,0.003941324516832821
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,183.8853987319665,236.1406960172417,144.48348665155277
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,4952818.577897604,5697350.504342121,4095518.386053902
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,0.001719885874886081,0.0019833173866018556,0.0014200238448360291
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,62.76260090184743,72.1973822133722,51.8988091138988
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,318203.8241430244,453613.52646193607,213604.0971522798
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,0.00011043363244892935,0.00015383652768904737,7.530431950728166e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,4.032309947562783,5.748234924666912,2.7068119879042247
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,4614086.055527066,9259373.274806414,2076853.3309058081
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,0.0016018038380907187,0.0032315158128666307,0.0007215009252338055
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,58.470149284723476,117.33568276482143,26.318088314602626
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,1341513.3705532718,2141652.884559244,597545.7605696257
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,0.0004659695785611635,0.0007378736310366022,0.00021197775316637778
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,16.999788495436345,27.13923458931533,7.572158257236626
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,4878526.633494856,7568710.19192612,2820720.5038413787
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,0.0016933499796969122,0.002616209956188583,0.0009594152146882289
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,61.82116612416758,95.91143500338914,35.744445804716605
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,886066.5406654413,1060071.540392626,744313.3140620196
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.00030720330612609727,0.00034990404967296556,0.0002650802373239542
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,11.228321770645605,13.433330127208341,9.432011034055641
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,71629913.00608243,122926456.7396074,38735013.528142884
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.024835793161183013,0.042270051610451324,0.013644840758264656
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,907.7012557449964,1557.7360695293576,490.85387577965014
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,55174060.702019885,108337905.75195654,21761299.60488346
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.01914274165411497,0.03707617705166615,0.007797755991141667
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,699.1710876365498,1372.8685261349356,275.76131463845996
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,20635718.17792674,21993502.548924237,19358110.659119315
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.007169153529861039,0.00781523269335985,0.006483186655774676
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,261.4978368284966,278.7038130312139,245.30786952988672
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,9911653.091017734,10798305.828807436,9053316.790635016
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0034438108155344176,0.0038636478976705095,0.0030994333331641147
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,125.60143632258237,136.83718644045712,114.72451486600104
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,2562942.9808763117,2846492.772038889,2291153.8491698885
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0008904188445900069,0.0009945327800299252,0.0007834043296267843
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,32.47786384923723,36.07103450522627,29.03372541887486
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,8141561.072273841,8809184.402068809,7177066.88649635
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0028283528607357406,0.0031156597198746016,0.0024580609014594112
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,103.17065732580231,111.63084538673264,90.94849277403677
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,24401100.179965254,26161517.725994132,22689368.548913475
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.008478247249518503,0.009319001136126749,0.007615331452843699
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,309.2131254303373,331.52130856369195,287.5218949681115
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,5874069.625403691,6347557.284551391,5326986.055673246
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0020410880705343045,0.0022585454610529096,0.0018048998544011243
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,74.43678418064967,80.43686605638271,67.50408773580533
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,2490191.448386309,2778564.4616856277,2213997.559511345
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0008652078636210542,0.0009885085222040254,0.0007566479101891477
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,31.555949321811543,35.210240319938706,28.055993378271403
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,2843780.8510169946,3063043.2721369313,2622258.953508786
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0009882240517454486,0.0010974103099333516,0.0008830032887894336
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,36.03666877708634,38.81518359911823,33.22952164951491
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,3732121.3150722515,4316985.565555863,3102893.2088940963
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0012971342010451915,0.0015058913079830268,0.0010460764912081926
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,47.29380592708644,54.705262849549186,39.320165890982324
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,11316963.350583198,12169335.89337873,10464696.932125457
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.0039331916273707595,0.004385874795049419,0.003492894381288294
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,143.4096652284387,154.2110133662253,132.60966190862894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,1678836.3114432055,1837368.7901162268,1474533.6568084026
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0005833159314119617,0.000654544989711201,0.0005079275646183197
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,21.2743777583242,23.28331681644713,18.685434558738
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,1212872.3836802046,1337924.1910309757,1070080.3130568082
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0004214565883951258,0.00047758943737730863,0.00036125145320062486
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,15.369637341755055,16.95430606187253,13.56016227225049
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,5163256.304643558,5608304.106082585,4692422.554983194
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0017943424921722073,0.0019975202855944934,0.0015917897703477185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,65.42928833461315,71.0689775549317,59.462837059186604
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,560921.4615696082,597363.2440546541,528325.4765316775
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.0001948363313999217,0.000209667356014922,0.00017970925730445656
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,7.108051562170929,7.569845390127325,6.6949920551928574
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,4016362.117183706,4246783.02557002,3806832.2089451384
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0013956208466465992,0.001526136703448536,0.0012732016911368826
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,50.895733141330346,53.81564940416881,48.24054967338271
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,4397066.632743376,4813655.421880667,4063656.740687883
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0015276619637650177,0.0017057419438331863,0.001374937307650198
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,55.720057956745976,60.99911179277531,51.49505523098703
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,8912595.213850375,10356061.055731695,7612510.587358823
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.003097001005444776,0.0036371661405107183,0.0026521131881422104
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,112.94127729670538,131.23301746940973,96.46647789354336
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,1246484.7780890486,1375852.5280519635,1094415.6438578663
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0004328565541426752,0.00048162070389564987,0.00038215285719478745
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,15.795576887582929,17.43493765414246,13.868541961685752
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,689358.8282873848,741736.0123053512,638833.5753424028
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.0002396021225191445,0.00026918201537852113,0.000214032732574001
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,8.735622421351044,9.399351214396738,8.095361479793022
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,1196188.2240620719,1528816.4257418904,847435.7780594656
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.000415748091122668,0.0005408501860808498,0.000298949668632079
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,15.15821404105741,19.37331111000588,10.738788972736812
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,7766063.220113368,8486078.377864607,7130941.784683835
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.002698059773000557,0.003022090663561507,0.0024303854267971256
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,98.41231185766415,107.5364142810572,90.36399097751733
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,2595594.988860918,2889968.1939776624,2270483.59965342
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0009022421223924826,0.0010472415693725924,0.0007801608457084516
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,32.891633284468945,36.62195929951602,28.771789997550705
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,10982836.18560453,12286933.092897888,9018076.586239398
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.003815793157292403,0.004356256597969564,0.003174691439638519
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,139.17557315012093,155.70121656759696,114.27794755298625
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,569,Dysthymia,1,Number,2021,10311517.072881617,14658132.435753249,6604701.557641096
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,569,Dysthymia,2,Percent,2021,0.003561368692970389,0.004891058703978811,0.002430760291020925
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,569,Dysthymia,3,Rate,2021,130.66855176685502,185.74928630277523,83.69542340757395
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,570,Bipolar disorder,1,Number,2021,8007783.132923044,11498108.62982909,5185275.374707732
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,570,Bipolar disorder,2,Percent,2021,0.0027723533595426777,0.0039026910281810346,0.001851952268343943
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,570,Bipolar disorder,3,Rate,2021,101.47541020845071,145.70515590465686,65.70831614169558
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,571,Anxiety disorders,1,Number,2021,42509645.27941539,57729820.415835634,29396722.98920212
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,571,Anxiety disorders,2,Percent,2021,0.014704423089515476,0.019119844716685163,0.010636726470199398
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,571,Anxiety disorders,3,Rate,2021,538.68637810747,731.5579244238018,372.5181457336233
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,3403145.791933371,5364474.282307237,2071756.0115699286
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,0.001175538338311122,0.00174962461083063,0.0007436976095300986
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,43.12499595746985,67.97914220625316,26.25349458597814
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,798443.3229806205,1259377.2005957123,496896.9783881989
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,0.00027595182055783655,0.000421893835652594,0.0001787133839763713
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,10.11795179549046,15.958950925157168,6.296727056202947
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,574,Bulimia nervosa,1,Number,2021,2604702.468952751,4359142.969631143,1474415.0686323163
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,574,Bulimia nervosa,2,Percent,2021,0.0008995865177532842,0.001427474731472396,0.0005350088930265379
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,574,Bulimia nervosa,3,Rate,2021,33.007044161979366,55.23948559270443,18.68393179778475
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,1,Number,2021,11544038.080669444,16288865.174303172,7842314.670964265
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,2,Percent,2021,0.004010733789525755,0.005597384867367242,0.0027890052625006542
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,3,Rate,2021,146.2871783929422,206.4140908857509,99.37857769249574
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,1,Number,2021,1030941.3513749616,1670195.4772006213,572105.187722903
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,2,Percent,2021,0.0003558265572648674,0.0005523480470505587,0.0002057259703986033
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,3,Rate,2021,13.064189526002004,21.164880262605983,7.249772832618264
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,579,Conduct disorder,1,Number,2021,5002614.360377089,7799887.250276936,2715125.6371160564
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,579,Conduct disorder,2,Percent,2021,0.0017272008721907657,0.002599815132082352,0.0009906440615570532
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,579,Conduct disorder,3,Rate,2021,63.39361792239839,98.84093327245239,34.40633733711786
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,1,Number,2021,3810634.655527162,6516405.929530588,1761640.867321032
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,2,Percent,2021,0.00131449586536614,0.0021927044447868334,0.0006309762065969364
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,3,Rate,2021,48.28873464796333,82.57653258181105,22.323685180285274
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,585,Other mental disorders,1,Number,2021,8962343.979627114,13487270.942410257,5723960.372816101
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,585,Other mental disorders,2,Percent,2021,0.003097912227079138,0.004395937722064105,0.002128201663873467
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,585,Other mental disorders,3,Rate,2021,113.57169851700559,170.9120150677725,72.53458506641753
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,78938587.05039968,94495830.37546831,66772200.717917204
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.027341160737610844,0.030467476793658535,0.024601316099392437
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,1000.3174872807567,1197.4603946146815,846.1438510383754
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,312303.17065783445,393513.9553801704,208980.9671739238
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,0.00010852822797446513,0.00014059537826676484,7.173836501923238e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,3.9575362901137243,4.986647288283462,2.6482272331458354
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,44453683.61051758,48508462.33677073,40840761.53827436
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.01543667398013155,0.016641562957315406,0.0141896034264789
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,563.3214217687404,614.7039739334427,517.538120292366
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,10850727.597753659,12320650.109573275,9207080.09905053
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,0.0037695354654498827,0.004378825086886945,0.0031941009215445976
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,137.50148021806964,156.1284818970079,116.67301853268029
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,6959757.6420278335,7961672.877617986,6018414.334074441
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,0.002417849182219071,0.002814925302998572,0.002064795507842429
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,88.19472879735397,100.8910965483242,76.26593443118067
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,11488635.795574503,13046210.11907628,10007837.916117933
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.003985865708914862,0.004334203334266597,0.0035715159165019767
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,145.58511522350142,165.32284922352284,126.82029982336098
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,11353107.892407538,13114772.169260643,9882770.194471788
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.003938181249329359,0.004338687534535592,0.0035008214520975325
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,143.86769239370278,166.19167422186553,125.2354294357377
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,6848127.121061866,7369067.908544123,6174869.950304067
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.0023794727499288123,0.002630586113064505,0.00210562090223248
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,86.78013592954362,93.3815484836296,78.24855528551466
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,693443.5109360437,850489.8113173696,567765.2253843802
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.00024041280649430844,0.0002867246947383556,0.00019906475023668857
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,8.787383918942044,10.777489980555305,7.194776405856882
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,1,Number,2021,2235713.8797735013,3402625.949457681,1345704.2824392384
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,2,Percent,2021,0.0007717498351956834,0.0011313103173910878,0.0004998105547494844
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,3,Rate,2021,28.331184710284422,43.1184084628301,17.052896140300952
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,65143646.66178717,69913815.80935532,60670928.15303749
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.022618091830184664,0.023870426679923458,0.021340753456049345
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,825.5066549318782,885.9547044080236,768.8279290113093
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,21307001.379137885,23720473.547415376,18852676.836478584
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.007398570673165802,0.008176369286181928,0.006563157077189076
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,270.00440313757707,300.5881582464941,238.9029627492792
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,4070370.309257601,4660790.947314772,3547554.4053524463
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.0014116698899230174,0.00155765698438247,0.001271825665600136
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,51.58013022780774,59.06199823645312,44.95495601521497
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,14035076.380949078,15272665.857434817,12767815.924295798
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.0048741739378027876,0.005318808665570968,0.0043496562554229245
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,177.8538591046818,193.53671386129068,161.7950107885815
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,24798769.44135719,26939876.753352597,22831657.551023733
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.008610520342437767,0.009299163049725969,0.007953667633802806
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,314.2524291623693,341.3847502028537,289.3249951042685
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,932429.1510853475,1092084.0210703402,810032.0757071036
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,0.0003231569868552681,0.0003533290781627526,0.00029752967881602606
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,11.815833299442133,13.838995409926275,10.264805602243705
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,4485873.598196637,4947534.920534986,4108919.87215105
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,0.001557319299602361,0.0016862013222098762,0.0014530786848248915
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,56.84542849927306,62.69564587954319,52.06863405502636
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,108119970.95975801,125083407.93689486,93352016.03053495
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.037484919515891224,0.04055082430520614,0.03352926502653886
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,1370.1068351563038,1585.0691658321862,1182.9658674867903
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,43804122.62423419,52811147.34112057,35938837.23581828
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.015171385914586015,0.01708954037428042,0.013329464460523788
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,555.0901214894521,669.2280186742465,455.4204566212056
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,15697285.354853336,17406454.99377224,14080437.005039226
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,0.005452682925639992,0.006123592156067998,0.004853927480256503
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,198.91753361724773,220.576298264863,178.4286733648154
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,8470611.491859864,10126587.035960037,6900996.820183706
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.0029367583136655348,0.0033907367312425523,0.0024347586276597857
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,107.34041639051424,128.3251002716058,87.45010592210363
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,2880957.559910405,3379160.0867195437,2074833.0566815105
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,0.0010002294649807159,0.0011795471016236088,0.0007372450010094071
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,36.50777566429068,42.82104675763386,26.292487202254662
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,1228861.1964028093,1414898.5672391513,867811.1269465872
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,0.00042692691269276603,0.0005049837947594081,0.0003040066555656431
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,15.572249138658199,17.929732877460257,10.996987384474549
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,1652096.3635075963,2057574.9727572724,1139789.1361264405
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,0.0005733025522879509,0.0007056034673274584,0.0003869246407145953
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,20.93552652563248,26.07379107667856,14.443519288633272
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,10315630.852825675,12947011.20576014,8158413.547724577
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.003572550142433396,0.004213919488567305,0.002939945141727302
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,130.72068198821646,164.06579090239998,103.38421354117466
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,1050340.1797555557,1332601.1654033419,798905.3669975633
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,0.00036426213595652714,0.00045041182329348445,0.0002764351211655897
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,13.310013374476465,16.886852161067768,10.123806862414146
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,9265290.673070125,11705604.102756705,7267500.120038389
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0032082880064768643,0.0038270073998055345,0.002603515795273994
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,117.4106686137398,148.33455880958297,92.09447154466879
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,4846980.934884624,5494171.089239372,3914844.9988509966
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.0016835495624607994,0.001892732555364261,0.001370012206757843
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,61.421415949412655,69.62267281487496,49.60929829975257
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,4888709.4560838705,5956806.971912254,3835326.8628485054
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.001697472507984412,0.002104406152509731,0.0013322586488838124
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,61.95020384686162,75.48523991891724,48.60163671152986
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,4022502.406970216,4954021.026982902,3047069.2249648822
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.0013974146104468426,0.0017447164207669695,0.001061985059967087
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,50.97354349340188,62.777838454133764,38.61275891271427
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,866207.0491136573,1109910.9811987556,685002.3415719373
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.0003000578975375665,0.0003647412985445112,0.0002493002645189842
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,10.97666035345974,14.064900390340037,8.68041659607087
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,978,Contact dermatitis,1,Number,2021,2272765.7691874024,3462431.544996444,1395453.582863411
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,978,Contact dermatitis,2,Percent,2021,0.0007847538785181545,0.0011379687576157107,0.0005203818605322383
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,978,Contact dermatitis,3,Rate,2021,28.800709872849755,43.87627081241166,17.683324135705924
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,1,Number,2021,282828.14987132495,451330.62548297015,165090.84954473184
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,2,Percent,2021,9.758708039332878e-05,0.00014663732174205756,5.9248000201039244e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,3,Rate,2021,3.58402594704305,5.719305780425554,2.0920473745519788
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,2269423.947498302,2566781.7498921496,1918910.3135290842
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0007879840715745259,0.0008795336255090966,0.0006768624076979615
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,28.758361981914646,32.52650910524775,24.316618967615813
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,981,Blindness and vision loss,1,Number,2021,29163992.737770442,42917325.82588366,19033505.674832806
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,981,Blindness and vision loss,2,Percent,2021,0.010068972605544029,0.014272701696336309,0.0070014034888135
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,981,Blindness and vision loss,3,Rate,2021,369.5689652500944,543.8525458220761,241.19444345560223
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,15206382.808753755,20738651.43295846,11711514.292724598
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.00526441430376657,0.006823905817355041,0.004147615309456978
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,192.69676859265272,262.8022170926788,148.40945331427253
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,1007805.621935613,1214979.6434649732,855250.5446580311
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,0.000350008570093656,0.00042265435454818753,0.0002918365517378507
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,12.771011302221527,15.396340743623652,10.837818458564467
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,995474.5702348761,1201788.682503065,808799.2110142345
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,0.00034594244686368046,0.00042449608372135603,0.0002736459065143984
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,12.614751010345048,15.229183597577828,10.24918262040669
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,3875627.5927886735,4845503.34374846,3062395.7415668895
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,0.0013463097219402827,0.0017036503277817303,0.0010736230153556808
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,49.1123314986508,61.40269177017678,38.80697802847192
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,11278934.982372906,13103870.81202478,9682785.185502663
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,0.003917113901607468,0.004520881808031143,0.0033243602218442697
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,142.92776603116516,166.05353115792687,122.7011998638543
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,999,Refraction disorders,1,Number,2021,6618600.065539285,9528675.976834845,4599082.3212913815
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,999,Refraction disorders,2,Percent,2021,0.002284714105836815,0.003077366131635976,0.0016691371650178648
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,999,Refraction disorders,3,Rate,2021,83.87154665752263,120.74831291538396,58.28002049864722
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1000,Near vision loss,1,Number,2021,11649944.7504364,22421658.631396636,5214018.648869341
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1000,Near vision loss,2,Percent,2021,0.004020045393002521,0.007557225101545934,0.001837149012568371
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1000,Near vision loss,3,Rate,2021,147.62923805914713,284.12944873849244,66.07255372004501
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,642104.2886512369,728993.2436129441,552272.6923057167
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,0.00022310962739543731,0.00025742697438295474,0.0001893683659101023
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,8.136808278386232,9.237873604577725,6.998453513087493
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,213477.90941574413,267250.2603987218,170089.5106097231
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,7.410630118739527e-05,9.048931922394081e-05,5.87083174826586e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,2.7052129245784973,3.3866214097104685,2.1553908959290173
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,392126.39000134246,512401.1032843596,244124.8793733356
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,0.00013624946128859135,0.00018103832413814217,8.583280678198261e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,4.969063924239959,6.493196841616164,3.093574322042749
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,7373936.830112032,8075260.464626005,6790341.126263464
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,0.002561810311711963,0.0028918018534324166,0.0023222209679393006
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,93.44324793342433,102.33048954822173,86.04786615785586
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,468748.4871560018,565452.0377367154,345681.17606170266
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00016275051850163008,0.00019512086064423387,0.00011934146132332928
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,5.940026625244407,7.165463465990813,4.380505635571143
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,243204.26906358203,330473.91731785715,147357.65962261334
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,8.443212227089306e-05,0.00011303486343163283,5.00350034836232e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,3.081908258255346,4.187797767043429,1.867330659353614
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,225544.21809241973,283161.104863289,169663.8152611061
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,7.831839623073697e-05,9.641843855324561e-05,5.9580338902461e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,2.858118366989063,3.5882451852304054,2.149996442881564
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,1677891.905736146,2115701.386201514,1428208.6955316416
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0005827618030266524,0.0007302332126749428,0.000494218143570118
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,21.262410156937367,26.81037466670485,18.098400123561678
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,2525827.79628869,2844214.8556197523,2064232.7353797723
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0008775345306191771,0.0010055100568369941,0.0007187299765041826
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,32.00753660404664,36.042168525814056,26.158158895084007
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,285478.6136708956,341109.68536407826,227709.37704725802
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,9.914889361946466e-05,0.00011904833915176867,7.885444838580421e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,3.6176128832574337,4.322575258823263,2.885555472797459
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,1,Number,2021,1139666.9290564023,2306309.680403299,535835.9877865056
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,2,Percent,2021,0.00039303664204252216,0.0007754019204476873,0.0001910703440273822
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,3,Rate,2021,14.441970668702309,29.225781592965955,6.790165987579394
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,1144233.293398351,1352033.8506340594,956987.9512320901
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,0.00039730675065067616,0.00047464150043883744,0.0003357502176334133
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,14.499836083770214,17.13310504685477,12.127044814258506
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,2469636.570199761,2958212.626767558,2083397.6957449822
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.0008575728085721387,0.001034478924109372,0.0007241823607484072
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,31.295475897251755,37.48675941920531,26.40101914521899
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,1067270.13885705,1275041.7955440655,896161.4882873257
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.00037022292060375926,0.0004301769396591051,0.00031868502982612055
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,13.524551470241462,16.157454202749445,11.356245933170923
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,396856.4021645153,479325.29412610095,332642.6824736468
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,0.0001377932268593835,0.00016704271367239736,0.00011402110840861463
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,5.029003100486577,6.074056956507215,4.215280570982604
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,1,Number,2021,1137139.9513313936,1329680.2097643288,971505.0664926388
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,2,Percent,2021,0.00039499762993126255,0.0004702887552824416,0.0003347013584177615
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,3,Rate,2021,14.40994856008916,16.849837525837337,12.311007117139926
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,376,Late maternal deaths,1,Number,2021,332451.0719348508,411591.66154859005,263625.71026469464
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,376,Late maternal deaths,2,Percent,2021,0.00011551725422410128,0.00014280161844094962,9.136698697867856e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,376,Late maternal deaths,3,Rate,2021,4.21285246351493,5.21572974701366,3.340690756299124
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,1,Number,2021,1731940.1982888104,2076715.2049452104,1456204.1025692024
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,2,Percent,2021,0.0006011410699916183,0.0007241741063570426,0.0005106509833743211
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,3,Rate,2021,21.94731540059946,26.31633796893524,18.4531606566497
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,186366011.77438888,214332542.0920204,162043026.569458
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.06468315330132648,0.07219216121623753,0.05669561678133452
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,2361.6483088766972,2716.042913348563,2053.425064041709
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,80335171.20548418,93716788.96584333,69875880.73332828
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.02787817424127386,0.03133097326504377,0.02440857230837452
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,1018.0151381381017,1187.5883057607707,885.4739874184107
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,58575090.58344165,68835375.45214722,50032890.54147683
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,0.02033171914897691,0.02330109158693804,0.017325372088499554
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,742.2692705692948,872.2886028395247,634.0216770777606
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,23452920.570015322,26978710.69736424,19989429.13320464
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.00814056625871233,0.009370490542712022,0.007011752903688874
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,297.19770077736797,341.87685773538567,253.30799891233627
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,3754620.725869802,4575408.368325019,3009225.0824096
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,0.0013029345882695372,0.0016009487192220318,0.0010569807508863877
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,47.57892065887075,57.98002185374881,38.13319424093943
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,385,Other neonatal disorders,1,Number,2021,20248208.689577993,24437164.679181937,14658057.394645065
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,385,Other neonatal disorders,2,Percent,2021,0.007029759064093786,0.008469125234013407,0.005113808781086436
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,385,Other neonatal disorders,3,Rate,2021,256.587278733063,309.6701382878571,185.74833537452093
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,48919261.058334105,64985437.0290359,35986110.49468544
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.016905327441747428,0.02119271207548687,0.013340714366080562
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,619.9096554674943,823.5018070088175,456.01950797609464
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,11826130.803078312,13963539.452446252,9881913.805205652
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.004101522721794489,0.004674146034436624,0.0035310996631568907
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,149.86188493133096,176.94733615764682,125.22457718728933
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,388,Iodine deficiency,1,Number,2021,2246334.372497986,4038016.912462958,1189687.9854990232
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,388,Iodine deficiency,2,Percent,2021,0.0007757401915079205,0.0013381595823593142,0.00042825617898267586
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,388,Iodine deficiency,3,Rate,2021,28.465768631694853,51.17014482274915,15.075842382923193
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,1,Number,2021,1104931.4906998908,1561755.9243107229,711386.7620638355
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,2,Percent,2021,0.0003812477632737507,0.0005017355052455092,0.00026709792583475694
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,3,Rate,2021,14.001799800249893,19.790723654008282,9.014762550261354
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,1,Number,2021,32315750.897590935,46496969.19476132,21779579.623938635
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,2,Percent,2021,0.011152228362774751,0.014966366214384876,0.008058514393205287
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,3,Rate,2021,409.50835257324667,589.2141363181248,275.9929608258568
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,1,Number,2021,1426113.4944669786,1680570.5049269453,1211565.6627610154
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,2,Percent,2021,0.0004945884023965016,0.0005686307009855117,0.00043903482005099503
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,3,Rate,2021,18.07184953097238,21.296353627578156,15.353078446602451
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,238589.28521429858,271774.84087973787,207472.13940210955
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,8.281961522759702e-05,9.237934006071954e-05,7.23193978903806e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,3.0234267320404324,3.443957335610432,2.629107220211261
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,781187.607463255,1636591.7117733,468168.16542346764
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,0.0002705533387082228,0.0005707779112967251,0.00016736144144912813
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,9.89928568259763,20.739050064074963,5.932672731553196
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,388211.99761276494,1248114.7459862898,121442.35112472702
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,0.00013492444596053271,0.0004308005749621655,4.267185860300198e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,4.919460361461803,15.816232000022136,1.5389293381827656
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,1,Number,2021,392975.60985049035,553071.18577632,265308.35195134813
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,2,Percent,2021,0.00013562889274769022,0.0001757679963513486,9.908888944057765e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,3,Rate,2021,4.979825321135826,7.008572100358559,3.362013356143892
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,61962.48267660358,176263.81437801156,22232.70200478014
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,2.1539618514335616e-05,6.110302804488553e-05,7.529797432939416e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.7851946341168218,2.233632276500715,0.28173497190523744
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,351,Schistosomiasis,1,Number,2021,1746333.3056925577,2984204.1807461204,1038122.1459197281
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,351,Schistosomiasis,2,Percent,2021,0.000603929768065612,0.0010162893564867968,0.00038004535971044185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,351,Schistosomiasis,3,Rate,2021,22.129706263804135,37.81612693055635,13.155185256025822
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,352,Cysticercosis,1,Number,2021,1235938.9924628714,1808363.2063169596,787769.4640169009
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,352,Cysticercosis,2,Percent,2021,0.00042804997322590954,0.0006163062487874607,0.0002887109859730329
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,352,Cysticercosis,3,Rate,2021,15.661939661821075,22.915755224742057,9.98269161188266
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,105071.56760447581,133308.93111921655,78966.62638060797
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,3.639573571758832e-05,4.5019348928125946e-05,2.8409688616102998e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,1.3314771700138661,1.6893037992194828,1.0006728044125546
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,1,Number,2021,1314563.3995424944,2224976.2811064227,768842.0750468655
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,2,Percent,2021,0.0004532691536792511,0.0007300498739374519,0.00028210007355707864
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,3,Rate,2021,16.658275829817246,28.19511681092839,9.74284188967769
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,355,Onchocerciasis,1,Number,2021,1262988.1254184735,1907363.1281017726,753578.3103827081
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,355,Onchocerciasis,2,Percent,2021,0.00043603904876091153,0.0006199812469844112,0.00028807439797614605
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,355,Onchocerciasis,3,Rate,2021,16.004708917292994,24.170291905738736,9.549417972607243
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,356,Trachoma,1,Number,2021,123190.23740696213,174324.77882535895,80954.09783120376
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,356,Trachoma,2,Percent,2021,4.255214480037513e-05,5.80584420587545e-05,2.9515718185231857e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,356,Trachoma,3,Rate,2021,1.5610787239170398,2.209060628536721,1.025858236807397
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,2076524.6906403261,3130717.694765458,1056228.3529356974
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0007206107216259224,0.0010499129941918773,0.0003677446080208842
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,26.31392375305077,39.67276049435353,13.384628880280658
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,317791.9486190491,686270.600063767,120003.86238801773
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,0.00011027349279764073,0.00024196986438808967,4.1496105395976164e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,4.027090620683371,8.696488091586234,1.5207006683730566
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,569550.281705966,828522.1619450308,323361.73768426577
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,0.00019784909425840042,0.0002861473309958907,0.00011064712825510985
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,7.217396813961256,10.499113781503597,4.097671531877589
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,1,Number,2021,1381640.9735708872,2019784.3627721695,920413.4042596684
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,2,Percent,2021,0.0004774810780076661,0.0006716459839053317,0.00033114818792070143
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,3,Rate,2021,17.508289401280454,25.59490477486308,11.663568581747201
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,361,Ascariasis,1,Number,2021,647525.4067383289,903596.2463469993,443528.38491454977
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,361,Ascariasis,2,Percent,2021,0.00022411318290673057,0.00030698200993990374,0.00015890407069989458
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,361,Ascariasis,3,Rate,2021,8.205505216420704,11.450459913667492,5.620435025675672
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,362,Trichuriasis,1,Number,2021,193919.49554857588,316481.00149559113,107413.0398206606
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,362,Trichuriasis,2,Percent,2021,6.69426042072784e-05,0.00010559955683743409,3.8057012824908966e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,362,Trichuriasis,3,Rate,2021,2.4573667932268974,4.010478170657401,1.36114853469558
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,363,Hookworm disease,1,Number,2021,540196.0712839832,826648.0070508118,336191.36465523083
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,363,Hookworm disease,2,Percent,2021,0.0001864252908936564,0.0002732112770548133,0.00012218562490995134
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,363,Hookworm disease,3,Rate,2021,6.845417391632857,10.475364307582016,4.260249818288407
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,7953311.087690656,14355377.905631857,3797836.413168756
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.002762705248600092,0.005083236799198584,0.0013190023979170206
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,100.78513512943111,181.91275131842676,48.12655407042903
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,6691400.437881563,13200357.402669009,2637154.191591239
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0023267697344589093,0.004609222868404849,0.0009122029839305347
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,84.79408008832793,167.2762186611615,33.418275561737524
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,163616.68291286,227159.84152588027,116492.71519324201
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,5.65509769851141e-05,7.298177977280264e-05,4.334620860664403e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,2.0733665909690933,2.8785917049817877,1.4762070680871984
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,72321.5796038928,103343.42202206983,51328.40609136571
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,2.4994162511706693e-05,3.371033374403585e-05,1.907822685644375e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,0.9164661224472082,1.3095779403564611,0.6504385766958217
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,67952.20722802366,82055.24309505633,53315.81284153115
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,2.36075580848937e-05,2.846626739179963e-05,1.8533444638647086e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.8610970088192599,1.0398120571711291,0.6756231892004896
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,58031.78305565075,81646.9113480818,47990.64427313376
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,2.014870836863991e-05,2.8640982161336527e-05,1.676807098517997e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.7353844244968224,1.0346376373800865,0.6081421328410096
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,59818.8384654957,77762.87815301106,48644.8402247976
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,2.0771232889001667e-05,2.7472937704138706e-05,1.6760775483790337e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.7580301652429319,0.9854187892681031,0.6164321678544282
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,21422859.890543565,26887091.723167714,16956877.70605281
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.0074207244648456265,0.008957266835937155,0.006262451577870847
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,271.4725735133073,340.7158531433349,214.87921095187545
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,4042150.4889248433,4516882.923377891,3489794.6423450606
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,0.0014044501985149731,0.0016113673492699739,0.001197136531708375
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,51.22252590751822,57.238381697533185,44.2230186553457
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,1,Number,2021,2811236.9270185316,3403572.769076403,2352763.587705114
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,2,Percent,2021,0.0009762928965194568,0.001188119224673309,0.0008101575066043365
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,3,Rate,2021,35.6242689926867,43.130406653541364,29.814450044769572
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,46417777.1594818,50687931.17435807,43056396.911132544
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.01612926893131795,0.017905353367589312,0.01439473245773738
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,588.2106071101235,642.3224159740903,545.6148682013804
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,13882279.583691396,15998379.590006554,11749492.552460697
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.0048230704881179086,0.005581982268991146,0.004028363229028012
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,175.91760316182152,202.7330291815511,148.8907175320657
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,11822889.720887084,13698291.52001317,10109233.470286764
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.004108549198883937,0.00489552543632118,0.0034260553025758827
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,149.8208136211548,173.5860884435413,128.1051941919775
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,11146733.980520494,13296818.474390317,9444536.525971835
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,0.0038741057036671745,0.004555438164848918,0.0031974617525388186
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,141.25250201985756,168.49858278611168,119.68208957375342
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,6894081.298482881,8275685.973191613,5716909.275903381
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,0.002394796622779844,0.0028751590040657997,0.0019662121554201157
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,87.36247175547489,104.87030117402787,72.44523287745828
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,90020095.3012632,99692579.73760039,82759687.9039182
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.031245831190631138,0.03341552056228028,0.029323354414191278
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,1140.7434424819457,1263.3141102460092,1048.7388506121972
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,6057593.61655872,7041853.946042504,5162099.330148391
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,0.0021041813168145027,0.0024520718920559856,0.0017548320840727056
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,76.76241812657682,89.23506118251008,65.41462704077584
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,2812627.492501162,3611598.254410965,2174996.330584641
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0009734514472138631,0.001179933284309913,0.0007849685891930854
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,35.64189037433864,45.7665259274697,27.561765994952356
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,1330162.7848715163,1566639.1661139256,1148501.1032772548
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,0.000461657489925401,0.0005310518604696533,0.00040678653873278214
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,16.855952764742486,19.852604571223647,14.553918187514133
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,6664762.311523442,7430251.354247947,5758628.061404465
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,0.0023155070974464694,0.002606729879807819,0.0019973828220037786
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,84.456519148614,94.15687108511663,72.97389740318894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,2344644.5369550446,2864460.1045095194,1964674.0649464922
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.000812598800843137,0.0009477346476541287,0.0007084514762782873
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,29.711564640445957,36.29871829767475,24.89654169662507
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,1510783.814759216,1750363.1847265202,1308507.793172639
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,0.0005238435673254268,0.0005843127456746911,0.0004693149012945569
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,19.144800101875177,22.180773284635443,16.581538594275028
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,1708446.8392166472,1836379.4463129733,1580467.769689833
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,0.0005938093453521892,0.0006627888458104142,0.0005288641153170151
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,21.64960525917207,23.27077975511494,20.02784198677077
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,7734159.29912451,10306276.05682571,5859795.854357373
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0026776363317725983,0.003469941054283345,0.002150678072258688
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,98.00802225392943,130.6021370993556,74.25590555942537
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,4101153.965670044,4684282.658888197,3647630.9278475875
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,0.001424684135596315,0.0016548971555998752,0.001243058355568007
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,51.97022372938199,59.35968750061551,46.22313548559515
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,1,Number,2021,6336161.699693883,11241352.504317302,3189793.9358525276
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,2,Percent,2021,0.0021867815397382043,0.0037024256101530224,0.0011442229129806137
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,3,Rate,2021,80.29246009173738,142.45151719749438,40.421380393066435
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,1,Number,2021,45177825.367834285,61369851.16638304,31731478.908428013
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,2,Percent,2021,0.015626588395754534,0.02054639060259015,0.011669945221414273
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,3,Rate,2021,572.4978168649906,777.6847497201235,402.10440084410277
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,142184835.29274097,173358874.25219002,118107592.0711582
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.049230727419808336,0.056271813906962495,0.043571423409829516
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,1801.78012406852,2196.820591418139,1496.6709456551303
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,52325332.69132468,62682127.13793898,45186944.83052382
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.01815854957206037,0.021235783130584607,0.016067219543581507
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,663.071727968691,794.3140390390167,572.6133795871492
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,5294602.552755118,6485533.169771692,4326463.6735797115
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,0.0018375305819859661,0.0022211230599373253,0.0015024150522349186
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,67.09372082300867,82.18530995392534,54.82537036042392
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,22310093.479134735,27213661.736132756,18696085.02043003
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,0.007747786286722411,0.009308025626497265,0.006396968787974364
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,282.71568422928624,344.8541802530141,236.91861595753323
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,408775.3360439474,671119.8790520453,252320.08032108768
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,0.00014140784819495025,0.00023244012750338485,9.000704907753114e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,5.180040995068178,8.50449667472364,3.1974247091111443
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,2353047.5901601156,3754933.8927814104,1759096.2527784389
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,0.0008168660675467929,0.001298940079605381,0.0006154277631389541
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,29.818048951625954,47.58288914057057,22.29143957619662
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,646,Turner syndrome,1,Number,2021,9176.787175838686,15926.383802005788,4254.187662277889
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,646,Turner syndrome,2,Percent,2021,3.1862786984264433e-06,5.566841462976782e-06,1.4894703983835885e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,646,Turner syndrome,3,Rate,2021,0.11628914365016793,0.20182069152212803,0.053909481683952494
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,1,Number,2021,6559.535379096564,13348.928000770742,3181.661913467461
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,2,Percent,2021,2.2623913911447617e-06,4.4385124554698084e-06,1.159132431867961e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,3,Rate,2021,0.08312307318039183,0.16915891979542472,0.04031833061091684
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,2220693.820363252,3139305.351582071,1843303.9809662672
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,0.0007706657264760699,0.0011067667266531959,0.0006537647681532352
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,28.140849050001147,39.781584120534454,23.35852813475783
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,3858032.137150393,5050546.150563651,2860408.467734796
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,0.0013341772373104265,0.0016616552658731474,0.0010599464553770841
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,48.88936016575365,64.00101425050458,36.2473755606268
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,882185.2035190059,1258014.6963460993,659007.1218063498
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,0.00030585223602413596,0.0004298503722792125,0.00023085699737391028
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,11.17913708712532,15.941685138191506,8.351002631508504
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,4430696.396516441,5508669.103460219,3345178.036196279
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,0.0015380443057388437,0.0018804302140260163,0.0011845918350188397
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,56.14621760885428,69.80639306751513,42.39042289340917
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,652,Other congenital birth defects,1,Number,2021,10551469.853126716,13995644.569357146,8374428.803487215
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,652,Other congenital birth defects,2,Percent,2021,0.0036607706119712114,0.004940572500586797,0.0030027973907868375
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,652,Other congenital birth defects,3,Rate,2021,133.70925684113732,177.35417533576202,106.12157996655583
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,41944109.05956446,59789982.33338389,27746947.851854473
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.014486979534746824,0.019632050746361193,0.010279574418685811
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,531.5198478775042,757.6644975176121,351.6120340126699
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,654,Dermatitis,1,Number,2021,8177101.563788819,12991190.780866463,4847630.095751273
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,654,Dermatitis,2,Percent,2021,0.0028221025505397014,0.004217458137178991,0.0018065979972903096
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,654,Dermatitis,3,Rate,2021,103.6210299065311,164.62563879442357,61.42964217933683
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,655,Psoriasis,1,Number,2021,3689928.256191686,4917112.79314259,2684039.876303613
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,655,Psoriasis,2,Percent,2021,0.0012765158304676228,0.001609794804267245,0.0009837200280387618
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,655,Psoriasis,3,Rate,2021,46.75913136275522,62.31013370903186,34.012415539071746
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,876105.6105313108,993087.6019190871,726219.4737875656
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.00030418624320948827,0.00034358453302083913,0.0002523741142372039
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,11.102095890818413,12.584503114644274,9.2027241223575
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,1393318.3369669914,1649203.2949258862,1182155.9274719502
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.00048379782836503656,0.0005613148731392534,0.00040767002664908176
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,17.656266091096242,20.898865277916745,14.980395407733683
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,658,Scabies,1,Number,2021,5315518.988184459,8740279.673302758,2968358.835500801
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,658,Scabies,2,Percent,2021,0.0018337635243144816,0.002827771247054695,0.0010803586465843178
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,658,Scabies,3,Rate,2021,67.35877593627262,110.75767793192358,37.615333167541884
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,659,Fungal skin diseases,1,Number,2021,3429496.8383021043,7044258.966406154,1407893.9330940386
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,659,Fungal skin diseases,2,Percent,2021,0.0011838130174270628,0.0024117963625037006,0.000495180950756011
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,659,Fungal skin diseases,3,Rate,2021,43.458918991510984,89.26553783552504,17.840969469231446
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,660,Viral skin diseases,1,Number,2021,4199075.027267598,6261658.221507372,2671026.670867524
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,660,Viral skin diseases,2,Percent,2021,0.0014486970121804458,0.002053857610255138,0.0009749446084435732
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,660,Viral skin diseases,3,Rate,2021,53.21108898868271,79.34834473728306,33.84751092841554
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,4135056.136943078,4895237.534197003,3446487.1274792906
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,0.0014369438188152998,0.0017231613194226905,0.0012029404252095065
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,52.39983535594367,62.03292829049435,43.67422159588932
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,686351.3811060465,875686.9941113004,485645.0337621609
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,0.00023847088301664918,0.000307879657412534,0.00016871583231521176
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,8.697511756846191,11.09679114264586,6.154141314604174
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,1210874.5331246182,1334385.8612284702,1068480.7144447668
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,0.00042076676542731744,0.0004772398270791472,0.00036037032900049237
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,15.344320384327723,16.90946800092582,13.539892002360391
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),1,Number,2021,1997.8505555867948,3770.9477165403937,920.9641989247934
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),2,Percent,2021,6.898229678089837e-07,1.2536547245315844e-06,3.344575446274354e-07
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),3,Rate,2021,0.025316957427310927,0.04778581787977027,0.011670548305555452
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,1011911.9797431168,1242518.2739392046,866484.088065549
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,0.0003514327332099225,0.0004373397034439467,0.0003000572734884095
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,12.823047469543035,15.745312959474793,10.980171018124384
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,42564265.1683773,48240480.71318791,36845853.63245267
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.014781530856338753,0.01665328675020743,0.012955518393819192
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,539.3785266766749,611.3080846180103,466.9142570134583
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,157.94729439990226,260.947012052923,103.34224833624813
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,5.46407439771505e-08,8.697322313783363e-08,3.643953146083434e-08
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,0.002001523545842387,0.003306746030854875,0.0013095630672950611
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,936,Guinea worm disease,1,Number,2021,0.8548760095735951,1.4101677383735405,0.48270982599810713
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,936,Guinea worm disease,2,Percent,2021,2.947752920585225e-10,4.555125893363057e-10,1.8094001923785583e-10
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,936,Guinea worm disease,3,Rate,2021,1.0833072313383002e-05,1.7869783351880563e-05,6.116946075052817e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,1,Number,2021,2185527.63427376,2368735.702209519,1928589.253519927
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,2,Percent,2021,0.0007596803668545478,0.0008688326595617041,0.0006587252481479699
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,3,Rate,2021,27.695219704192983,30.016850240220325,24.439271440797267
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,941,Sexual violence,1,Number,2021,2045141.6434780378,2857108.0693105073,1383338.457834899
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,941,Sexual violence,2,Percent,2021,0.0007105073293208326,0.0010361085591343825,0.00048179248875403994
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,941,Sexual violence,3,Rate,2021,25.916234713335033,36.205552589350376,17.529800087715603
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,963138.6941890082,1148365.7204228123,795811.4439637038
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,0.00033456020038792904,0.0003967617049228446,0.00028112499411319633
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,12.204987629926654,14.55220260275594,10.084600367457574
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,1439157.2716578087,1876919.1434485945,1013666.1064193083
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,0.0005000905901374537,0.0006631100844215182,0.0003464725868844061
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,18.23714154989146,23.784502757883356,12.8452759341592
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,1,Number,2021,8505291.199208101,9352722.107723072,7759408.041832311
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,2,Percent,2021,0.0029549897778959606,0.0032781566255872053,0.002635158575347118
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,3,Rate,2021,107.77988103018482,118.51860829557815,98.32797678828594
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,8727823.186955787,10886282.323176458,7243612.547192866
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.003031662323500185,0.0037536856761734723,0.00249440565171005
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,110.59982811995525,137.95203317226904,91.79176588779133
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,4125461.0634345463,8064271.650449265,1707701.294453915
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,0.001433105260564905,0.0028549711570577717,0.0005955744797608671
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,52.27824564701971,102.1912382213839,21.640157643100167
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,287736.3299319582,531851.6600224556,124816.33719328392
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,9.990567626462913e-05,0.00019206260828181755,4.445665443884119e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,3.6462228842930102,6.739676196890681,1.581684819276749
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,9910865.774809137,12110494.39890549,7825965.892617088
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,0.0034441715993832824,0.004218440760751019,0.0026630489329311172
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,125.59145937466727,153.46536819953724,99.17140437602988
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,925471.2818196211,1668293.091379416,413529.6351698663
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,0.0003215451197760478,0.0005961573597640627,0.00014544400945834085
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,11.727662500333754,21.140773043619514,5.240287938079504
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,42094.83846939643,74093.38775809834,19698.027457242402
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,1.461532223611672e-05,2.5925803492822186e-05,6.7442466689732875e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.533429905684925,0.9389186484802224,0.24961532840504894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,1,Number,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,2,Percent,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,3,Rate,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,1,Number,2021,998028.5173432152,1638112.1684971182,569766.3687563195
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,2,Percent,2021,0.00034462989757796047,0.0005487886730575852,0.00020376512357783564
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,3,Rate,2021,12.647114877618643,20.75831744022546,7.220135090174715
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,1,Number,2021,4218302.247168106,5602012.773873162,3095236.3371763234
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,2,Percent,2021,0.0014587076469405624,0.0017945616463302064,0.0011278582258182884
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,3,Rate,2021,53.45473819773173,70.98925317852047,39.22313726451016
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,12314021.231347067,14527456.007473338,10581000.349691728
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.004275816895083163,0.005147536550360396,0.0036775869602479047
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,156.04448010449428,184.09334183672692,134.083470178693
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,2955462.593932173,3536900.73151576,2492505.0110180476
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.0010265291590035872,0.0012430470445572138,0.0008723069525732691
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,37.451910734441384,44.81995161950899,31.585267013512404
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,6454745.913878909,7075039.00833258,5700718.304393805
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0022427150161683394,0.0025129138856656193,0.0019561051554852276
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,81.7951708393845,89.65558553397929,72.24005930465599
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,1215448.6701364976,1449303.0761709735,1042236.3174569246
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.00042191601141530706,0.000497833033776258,0.0003728536159859263
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,15.402284295428384,18.365710175911712,13.207320439693381
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,428327412.28382427,453711663.4306539,403683550.4113841
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.14880578836807418,0.16128830168478892,0.1362416679829974
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,5427.806815387559,5749.478525922334,5115.517390072737
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,13426369.18219696,15780163.692271337,11517020.93298075
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.004658739883447029,0.005367677771102498,0.0041356911761638694
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,170.14026201234165,199.96777600609406,145.9448144578975
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,188360557.32268006,198154476.56482708,177036930.4133399
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.06545789890758272,0.07165247071498354,0.0589805552894012
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,2386.923384928668,2511.032886415943,2243.4292784326394
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,160457220.63007683,171642573.5817998,147781420.21714133
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.05574340276834111,0.06084286941494948,0.05033796217880945
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,2033.3295762470786,2175.0714616430278,1872.700595008229
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,70357911.87818086,76007063.00587128,64329575.55414495
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.024438492981145202,0.026811312345151703,0.02194612752237847
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,891.5823331796822,963.1689281831186,815.1906663223459
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,79457426.8445527,85480164.79927103,72748913.09255415
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,0.027608406667311132,0.030384188480419856,0.024553878843815023
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,1006.8922758421098,1083.212999616501,921.8813341653472
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,10641881.907343177,12121262.538311593,9398962.530138154
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,0.0036965031198847205,0.004263747790209852,0.0032292608080679982
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,134.8549672252866,153.601823114122,119.10457144603998
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,1,Number,2021,25462184.707367495,28047521.029989004,21493311.5334281
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,2,Percent,2021,0.008847789528824866,0.00991131414221684,0.007444992726037886
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,3,Rate,2021,322.659292227899,355.4209266915262,272.36534361495677
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,11653957.527670862,12625959.034557372,10707767.73101693
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,0.00404923034513844,0.004473209461249076,0.0036493512850840114
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,147.68008836430437,159.997386422617,135.68987881982346
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,8358893.711971431,10133488.633771634,6970688.2417668095
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.0028982787217040843,0.003368211355891968,0.002469246306167267
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,105.92471776911347,128.4125579933498,88.33324242514904
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,501,Aortic aneurysm,1,Number,2021,3107762.316075626,3353857.832665843,2857319.748771222
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,501,Aortic aneurysm,2,Percent,2021,0.0010803566546835946,0.0012178716672035213,0.000954686578873922
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,501,Aortic aneurysm,3,Rate,2021,39.381867692890914,42.5004141222742,36.20823501215731
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,1558242.6857373822,2045868.9529944835,1266994.5536935697
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.0005403586002499541,0.0006885264793664756,0.00044413314269593285
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,19.74620355156894,25.925451250584434,16.05547876781685
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,2076412.89062605,2308504.1873936113,1827083.8095210085
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,0.000721443202909235,0.0008079895645807566,0.0006288299758236313
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,26.312507012347204,29.25359059994713,23.1529845375178
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,3238184.620265596,3594473.7384917797,2934104.1495534983
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,0.0011247638599269708,0.0012517324008314214,0.0009879645111445414
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,41.034591873644004,45.549522388703025,37.181254440587736
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,1,Number,2021,9985522.400504965,12107363.148141734,8386125.00510126
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,2,Percent,2021,0.003460416267870841,0.003968785383898565,0.0031049719952120115
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,3,Rate,2021,126.53751542932218,153.42568868394054,106.26979537610984
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,108503006.88207886,118043567.81878777,100351187.61792499
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.037676616998311735,0.040819735553537795,0.03472353966080073
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,1374.9607037859726,1495.8596240740217,1271.660053650456
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,79779695.05315077,86011405.86287773,74026373.39607602
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.02771992050832935,0.030275710872432096,0.024706776867919535
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,1010.9760900665702,1089.944938275957,938.0694359374758
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,447064.5224412201,513649.9675964077,392686.9680780256
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,0.00015522893010232257,0.00017625596640494869,0.0001360473167084051
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,5.665245305888819,6.509022572190551,4.976167624395301
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,261261.69369205032,311316.61511135317,214143.2743852739
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,9.070143075978728e-05,0.0001071181472876539,7.460293567559996e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,3.310733707329804,3.9450345618437606,2.7136444944775087
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,598,Male infertility,1,Number,2021,317613.60632749385,752758.232541996,116288.10701535556
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,598,Male infertility,2,Percent,2021,0.00010968262604509489,0.00024241399514963598,4.109067552414945e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,598,Male infertility,3,Rate,2021,4.024830649741012,9.5390258660894,1.4736142532671181
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,602,Other urinary diseases,1,Number,2021,1258209.7743086354,1479437.5688955658,951636.7129508961
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,602,Other urinary diseases,2,Percent,2021,0.00043686323166546476,0.0005122587790792694,0.0003345102804727159
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,602,Other urinary diseases,3,Rate,2021,15.944157185191585,18.747577411811168,12.059233399951497
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,27737635.893985625,38513255.245308846,19434576.120692555
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.009581672404902061,0.012501179241228552,0.007257655624025602
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,351.49403197279156,488.0437331541353,246.2768473295004
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,142884.83242429807,192988.05528195197,102182.79288683203
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,4.9505478938459165e-05,6.360533211221807e-05,3.611402611127762e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,1.8106505561082513,2.445563491167966,1.294870334563053
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,1,Number,2021,607756.8655272287,1268607.2162667671,272745.15461923
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,2,Percent,2021,0.00020955772645190124,0.0004102066144407898,9.606495569205047e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,3,Rate,2021,7.701554376868557,16.075914585499053,3.4562532461154314
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,606,Female infertility,1,Number,2021,601133.5005802423,1468475.006931312,213157.97048310423
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,606,Female infertility,2,Percent,2021,0.00020754987970884314,0.0004915528389063148,7.539774849122261e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,606,Female infertility,3,Rate,2021,7.617622449167828,18.608658755574762,2.7011586271665444
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,2049472.6546035751,3133967.045699653,1195196.6925636395
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,0.0007081074156609198,0.0010446675962812485,0.0004349952383923369
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,25.971117709450933,39.71393658684822,15.145649257038185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,389357.9600111244,731017.1625008704,191055.00208971527
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,0.00013443676019113697,0.00024893322634462426,7.020390290932296e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,4.933982108932579,9.263520902459279,2.4210676522596297
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,1,Number,2021,8110853.117059702,12364434.936707135,4920019.6288087
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,2,Percent,2021,0.0027989461367758954,0.004148493837818658,0.001805671737562678
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,3,Rate,2021,102.78152311720865,156.6833275041582,62.34696941458616
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,15836176.96377942,22274733.389706872,10799764.359865949
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,0.005473569007174901,0.007249411315368129,0.003927032469847504
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,200.6775816550546,282.2675977214304,136.8556690885268
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,11920415.820543597,15093453.918258566,9204637.24665879
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.004124371259060837,0.004902509749751581,0.0033887913774484444
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,151.05667388415168,191.26572265931944,116.6420624685093
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,818004.0410344589,1042039.401462517,578220.9961965026
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,0.0002841166776905578,0.0003638273646612031,0.00020463723546653968
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,10.365827125720635,13.204825100973864,7.3272729551007645
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,3018714.0075168265,3807797.9353311704,2294996.210384966
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,0.0010471231390393621,0.0013053965275843299,0.000792907218075957
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,38.25343882695151,48.252787452496484,29.082416195585076
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,377004.48209352256,517421.6000581408,276697.04828521644
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,0.00013086045857675963,0.00017928266323626653,9.354732433733011e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,4.777437629845009,6.5568170672283035,3.5063320287447213
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,1,Number,2021,3984511.1755544213,5352534.306714308,2959058.4272715095
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0013776287671680425,0.0017017071538069214,0.0010951564381396445
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,3,Rate,2021,50.492114897216304,67.82783766902236,37.49747748582479
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,12862747.877879905,16975277.992031768,9943682.896328378
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.004452936856539242,0.005665024920597754,0.0035731592295352096
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,162.99799777910468,215.1123811734804,126.00732114474134
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,161877699.3339084,216145507.9932382,118018720.23721406
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.0559366235738043,0.06993252969738664,0.04399867907876333
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,2051.330021160607,2739.016994372765,1495.544753092749
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,3075303.1663426203,3974046.220040106,2310381.039701426
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,0.0010647676091172563,0.0013271506486336668,0.0008452796609910416
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,38.97054217626547,50.35950195852888,29.277374255757334
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,628,Osteoarthritis,1,Number,2021,21304565.816655383,42935419.73814723,10189161.469999824
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,628,Osteoarthritis,2,Percent,2021,0.007341617498188567,0.014381341458895879,0.003717911369942094
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,628,Osteoarthritis,3,Rate,2021,269.97353945184767,544.0818336460273,129.1180496131836
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,630,Low back pain,1,Number,2021,70156962.18649575,94104688.44413131,50194204.954853036
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,630,Low back pain,2,Percent,2021,0.024248763811171834,0.030587253127128282,0.018649643224252124
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,630,Low back pain,3,Rate,2021,889.0358790541737,1192.5038058468162,636.0658690842331
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,631,Neck pain,1,Number,2021,20415496.55499668,28856642.591458924,13638705.322556373
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,631,Neck pain,2,Percent,2021,0.0070501738682665,0.009406111191853488,0.005004466813929634
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,631,Neck pain,3,Rate,2021,258.7071669074142,365.67419416840045,172.83100632788927
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,632,Gout,1,Number,2021,1747546.2415835077,2484546.8573640827,1186175.0658859387
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,632,Gout,2,Percent,2021,0.0006047123913055734,0.000845988595090896,0.00042437364144317605
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,632,Gout,3,Rate,2021,22.145076705916175,31.484420512910035,15.031326322379362
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,5666102.716358029,6456623.046579478,4311822.612683072
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.001966642599248487,0.002210098394806166,0.0014921821650916243
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,71.80140719117708,81.81895804835922,54.639837406332646
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,4576486.839446828,5247679.688206473,3401165.0805386472
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,0.0015901067106261545,0.0018450228240165937,0.0011653348488215864
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,57.993688345169254,66.49910969915673,43.099896189163466
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,714,Foreign body in eyes,1,Number,2021,341609.6668983494,598770.5130400992,182633.999394859
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,714,Foreign body in eyes,2,Percent,2021,0.00011777351996724276,0.00019530692310070483,6.520423046611629e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,714,Foreign body in eyes,3,Rate,2021,4.328911073672976,7.587678440198892,2.3143558833914484
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,748006.2100128452,985612.0409816538,556444.4235611231
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,0.00025876236865508964,0.000323440211505181,0.0002020939937605909
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,9.478807772334733,12.489772076094356,7.051318099127707
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,70094433.06300665,74577631.91992986,66003914.41732444
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.024350169174708898,0.02640212587370785,0.02252162570139566
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,888.243503892321,945.0550378088585,836.4080519768783
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,33525091.29481815,35841263.81144282,31307616.58417438
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.011649235073595167,0.012742935467248535,0.01055957169574475
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,424.83323223760004,454.1839966547469,396.733176060466
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,2534306.717042191,3169577.7052661725,1982182.9338737156
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,0.00088082325451398,0.0011188515318582993,0.0006846475719722349
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,32.1149823162125,40.165198343981615,25.11841579426032
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,30990784.57777598,33187124.94267161,28795104.730420634
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.010768411819081199,0.011776210205278734,0.009742541315875264
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,392.71824992138676,420.55048960440797,364.8943803811692
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,26829606.60148959,28718384.559657283,25190603.76602479
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.009317839044403654,0.009998905449952078,0.00872783210476143
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,339.98739606522247,363.92217488181376,319.2177920061654
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,10013230.671651077,10576692.862086449,9457361.284820981
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,0.0034797558920909434,0.0038106107923059733,0.003168484868753551
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,126.88863734834104,134.02888527492405,119.84460617084893
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,5202266.983522681,5574663.317583639,4879460.486636987
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.0018063728134402814,0.001917144262959913,0.0016956229789949233
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,65.92363546865258,70.64267819641995,61.83300000242064
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,9568967.302837817,10487523.30692905,8767954.224606538
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.003321203009551586,0.0035556304530243743,0.0031017417132294042
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,121.25888853489394,132.89891996024159,111.10837254980603
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,1092510.3723861952,1337024.3339439356,912834.0764699795
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,0.00037920589336567443,0.0004552504464145219,0.0003239556046325748
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,13.844398175454637,16.942902984950912,11.567522599507637
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,1,Number,2021,71225.38930454997,99061.77999454511,43982.28797276738
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,2,Percent,2021,2.472750515298036e-05,3.455602535174034e-05,1.4993134276277306e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,3,Rate,2021,0.9025750918778367,1.255320554273852,0.5573478501925443
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,837,Thalassemias trait,1,Number,2021,1979454.7639498007,2884705.636292194,1289280.6254524644
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,837,Thalassemias trait,2,Percent,2021,0.000683259410388596,0.0009512188854538747,0.00047382647288549167
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,837,Thalassemias trait,3,Rate,2021,25.08384415844647,36.555271654382004,16.337890046460377
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,838,Sickle cell trait,1,Number,2021,1726833.0480156033,2432204.7418793635,1129671.8071909053
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,838,Sickle cell trait,2,Percent,2021,0.0005958989701814458,0.0008031365353939688,0.0004140635138443834
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,838,Sickle cell trait,3,Rate,2021,21.882597093376695,30.82113611174379,14.315311507914751
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,839,G6PD trait,1,Number,2021,15894.302378965445,22955.480823303882,10711.85625162386
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,839,G6PD trait,2,Percent,2021,5.483836016070959e-06,7.407602531519851e-06,3.976315517873144e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,839,G6PD trait,3,Rate,2021,0.20141415259505485,0.2908940957079451,0.1357416889523966
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,1683247.504555038,2059971.754128192,1200235.5138838221
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,0.0005838697863893528,0.0006868902930583379,0.00042506516163203585
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,21.330276828404074,26.10416332437269,15.209501693092605
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,2602.3308494258254,3062.4264014588725,2130.081007014369
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,9.0446631298516e-07,1.076372462504552e-06,7.208466376783582e-07
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.0329769907676307,0.03880736655361855,0.026992594626512097
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,3719776.679318278,4353159.046539861,2587454.867911294
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,0.0012920319015289191,0.0015353497423160865,0.0009139826952596663
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,47.13737349676025,55.163656734671655,32.78848087651806
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,1002494.7165793295,1150043.4016934359,780350.4160624507
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,0.0003482559637940794,0.0004077126115599141,0.00027307952318308065
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,12.703710990679445,14.573462343724154,9.88867671137434
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,1,Number,2021,12019069.902344575,23267858.34157148,5858107.8822425995
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,2,Percent,2021,0.004142121664437996,0.008028790214918789,0.0021371468855627043
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,3,Rate,2021,152.3068280470853,294.8525741382334,74.2345154118747
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,1,Number,2021,6167307.934762234,12737380.264057342,2803411.048618337
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,2,Percent,2021,0.002124582464695714,0.004198904364546396,0.00104337110829575
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,3,Rate,2021,78.15272868577142,161.4093271285228,35.525098697023175
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,397,Trichomoniasis,1,Number,2021,274361.544386087,583896.2970138608,113212.02693393931
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,397,Trichomoniasis,2,Percent,2021,9.473489805114327e-05,0.00019203266958568613,3.9970986506763647e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,397,Trichomoniasis,3,Rate,2021,3.4767362951598266,7.399190921526456,1.434633865947136
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,398,Genital herpes,1,Number,2021,259917.02796040423,515995.2007229759,109671.70311619938
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,398,Genital herpes,2,Percent,2021,8.970843513299817e-05,0.0001806543548766176,3.9128476732592085e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,398,Genital herpes,3,Rate,2021,3.2936939718066203,6.53874159549608,1.3897705366445645
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,491693.8149458425,679508.5487861241,354847.5048012848
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,0.00016994704146022153,0.00021829429796093084,0.00013257261351225244
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,6.230792060720375,8.610798717153969,4.496662248895295
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,4228048.1290571205,5559112.532097109,3342181.801245557
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0014681432781199948,0.0019383402125773969,0.0011584841478567147
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,53.5782389651869,70.44561712344691,42.352454311386104
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,1817363.1744064714,2792339.014326415,1275384.284339833
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0006311840320776399,0.0009947074010604661,0.00044544622436064557
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,23.029803699655336,35.384792796755285,16.161794254230035
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,1914971.679291874,2381815.1933834283,1407011.5159017672
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.000664963413712581,0.0008278624012131548,0.0004965425639435529
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,24.266708209763397,30.182594830222204,17.829787392360185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,266087.9795624655,455055.4449314519,117649.59786913739
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,9.239998544428116e-05,0.0001564455461334481,4.0570911068592774e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,3.371892873400387,5.766507056385824,1.4908671983817958
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,229625.29579631097,374727.5450733014,127411.31738964267
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,7.959584688549196e-05,0.00013194746943269155,4.554369183927872e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,2.9098341823677587,4.748584061471533,1.6145686618505666
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,405,Leprosy,1,Number,2021,21427.508513152632,31592.81657374651,14005.547103443034
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,405,Leprosy,2,Percent,2021,7.391777327833509e-06,1.0277965081842603e-05,5.0684732901531894e-06
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,405,Leprosy,3,Rate,2021,0.27153148131317295,0.40034725819192274,0.1774796612151607
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,5851960.763236187,7818377.664707489,3867076.818442977
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0020268234528508225,0.0026586546113569224,0.0013885607020574214
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,74.15661851926134,99.07524561060131,49.00397525074466
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,1727188944.9886506,1941634668.455298,1537884455.2050781
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.5987648821626604,0.6213615048281866,0.5784994625959217
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,21887.107054589706,24604.58421337519,19488.22206529587
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,253309811.43183988,270577912.4591783,237490220.79327977
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.08801693813638005,0.0966574769218089,0.07992322673002086
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,3209.9666784417996,3428.7897417270424,3009.499280320381
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,12999264.904907202,14605268.10013292,11522861.151708188
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.004516470343701271,0.005199793813761237,0.0039047996397219243
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,164.72795488309728,185.07938427703047,146.01882228019193
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,22786633.095688548,26118868.996398017,19576343.74779903
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.00791735551713652,0.009242701913406665,0.006759959364000995
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,288.7544408074415,330.98085969553495,248.073340550672
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,12887652.414924737,14472227.986672346,11673532.558287889
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.004477781258530201,0.005111224119353426,0.003955635169996547
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,163.31359050567158,183.39348696144435,147.92814506473374
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,5668199.298350189,6885071.365499515,4706886.478550686
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,0.001968946169606564,0.0023888957551110087,0.0016144169784925774
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,71.8279752830147,87.24829700445324,59.64612531173686
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,3098870.407220998,3609081.5688877134,2662298.401423288
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,0.0010767717800827692,0.0012582601982791442,0.0009036180051568182
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,39.26918855515937,45.73463424264277,33.73690544527973
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,2316027.038657426,2845788.988232933,1887012.9479532484
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,0.0008050946507062313,0.0009834235457389727,0.0006420148725500809
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,29.34892090613315,36.06211608807862,23.912412434715453
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,1,Number,2021,1978521.0504921577,4152837.9275738425,913347.1431126301
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,2,Percent,2021,0.0006818767270123344,0.0014130278932913012,0.00033335195910565055
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,3,Rate,2021,25.07201205028885,52.6251679440702,11.574024230129126
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,21465450.56133346,24280527.136288613,18623590.174951006
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.007456980071437056,0.008427101443267266,0.006400475412105307
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,272.0122866545997,307.6852120410668,235.99995419298858
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,15187848.107670559,17259750.375645395,13299367.095762677
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.005277720964410989,0.0061225676642430536,0.004507130018399364
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,192.4618950497148,218.71724301114494,168.53087916513863
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,3667267.146134802,4607306.742166838,2903575.823062285
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,0.0012746893647327786,0.0016249286630517562,0.0009740519444636465
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,46.471967562158945,58.38424116349423,36.79439650472071
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,252094362.7617035,269347284.5573059,236335498.66176575
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.08759502212496471,0.09619750047482006,0.0795370916990277
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,3194.5643941463727,3413.195104724069,2994.866528655265
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,212009595.96699756,234674235.34016714,197942418.52434057
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.07368680800834929,0.08249184304659793,0.06543148618141548
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,2686.6063131040264,2973.814837541106,2508.3456662091544
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,8773812.091806827,10772028.079149686,6644198.627288412
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.0030405724051368863,0.0035583688332337104,0.0022815280430942184
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,111.18260401527277,136.50419222949856,84.19593413294749
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,1,Number,2021,77380460.47094086,102013398.14589563,59949132.425220564
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,2,Percent,2021,0.02688871591398767,0.03613794394107009,0.020567867978795812
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,3,Rate,2021,980.5727550392917,1292.7237478563025,759.6812630300849
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,250881490.3780233,268111633.70946014,235185702.94303948
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.08717356553656957,0.09573393407685007,0.07916154626268282
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,3179.1947568046166,3397.5368164589877,2980.296204974299
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,595603.1910455093,732313.410517299,484796.55700237094
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,0.00020691991008356926,0.0002572432573875998,0.0001644720959500506
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,7.547541826440985,9.279947083964892,6.143389334209246
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,3143308.765139411,3383513.9435549695,2922791.9937580535
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0010921213460708711,0.001195254579642543,0.0009856742912315623
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,39.832315768260386,42.87621925681747,37.0379056971677
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,46536272.12165932,51205051.410641946,41903412.294428945
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.01617301680332857,0.018238740264569515,0.01408208134142457
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,589.7121868476111,648.8754141301284,531.0041344936953
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,541,Other digestive diseases,1,Number,2021,3001821.7809071476,3382741.5959614394,2666064.1924014557
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,541,Other digestive diseases,2,Percent,2021,0.0010424111872850562,0.001197929753396034,0.0009213590908340128
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,541,Other digestive diseases,3,Rate,2021,38.03937888100924,42.86643199265509,33.784625916467036
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,112028843.85036743,178637758.35559338,65444986.285464354
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.038732895762497714,0.060137351610504056,0.0232865703713713
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,1419.6404543169529,2263.7151265152943,829.3252600835318
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,36332686.73680246,76873276.22028312,17237624.043362252
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.012597010519892211,0.026430639561546163,0.0061778596801478226
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,460.41135597616596,974.1456666638393,218.43685596674447
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,7471821.424322477,8137066.753605481,6736684.882116154
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,0.0025948665253291126,0.002831373644653888,0.0023356910539064296
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,94.68365107443276,103.11370488054867,85.36792898988894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,13877827.484414238,17619992.920069113,10732568.67009084
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,0.004812409357833749,0.005851629876936274,0.0038229174381213234
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,175.8611857248181,223.2822717292227,136.00415874278147
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,973298.2653784077,1133291.2455082152,838209.8455669419
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,0.00033764742231133434,0.0003801637621359062,0.0002978046662094263
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,12.333730708613142,14.36117738388524,10.62187705483219
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,547,Migraine,1,Number,2021,43378889.8135105,95079454.08536285,6732642.208434143
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,547,Migraine,2,Percent,2021,0.014930361051264348,0.03149420421696842,0.002282670112063154
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,547,Migraine,3,Rate,2021,549.7015297673727,1204.8561312856007,85.31669983402752
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,548,Tension-type headache,1,Number,2021,4596785.251350272,15012932.745364796,1347300.8420642565
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,548,Tension-type headache,2,Percent,2021,0.0015876539073263651,0.005006956212595448,0.0004904624641099754
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,548,Tension-type headache,3,Rate,2021,58.25091180393329,190.24535048961528,17.073127899850597
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,1040565.9783974624,1123956.289427348,963064.2622493729
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,0.00036162917196897,0.00040331371982123363,0.0003223171538417238
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,13.186153739942327,14.242883908417692,12.204044421115718
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,4356968.89619153,5272524.090245232,3626186.505956283
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,0.0015113178065716527,0.0017549653004720676,0.0012859729702937544
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,55.21193552167407,66.8139403890516,45.95138967630162
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,155418118.96466106,198163305.25428602,117024985.39190418
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,0.053770186059199275,0.0653595610667965,0.04341792733723733
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,1969.4735876304787,2511.144764431316,1482.9520480466222
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,559,Schizophrenia,1,Number,2021,14816611.183696533,19095362.418752827,10926460.046453213
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,559,Schizophrenia,2,Percent,2021,0.0051394633612720855,0.006526999708434475,0.0037985007326681317
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,559,Schizophrenia,3,Rate,2021,187.75754447984153,241.97829815786514,138.46116920693362
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,16980984.234290704,21197117.698376514,13531791.325726807
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.005879844733392896,0.007029490914005253,0.004921804328964572
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,215.18469123287696,268.6119463995027,171.47618171473255
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,15562161.528307352,18119263.56392617,12752221.98909255
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.005397562396219956,0.006086859914072503,0.004601497729499146
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,197.2052312858674,229.60907810615052,161.59740291818255
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,11218518.581020419,13159551.368064716,9188657.50323401
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,0.0038924004433541857,0.004504659488721116,0.003231837312634185
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,142.16216349063734,166.75912060396934,116.4395655986342
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,1133623.6855776533,1427944.229016061,917462.3782822945
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,0.0003930247143075746,0.00048290943975886583,0.00032335845977651167
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,14.365390096924028,18.09504877803827,11.626172892251237
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,1677366.570567939,2343857.5708790515,1171027.1821273295
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,0.0005814232363949512,0.0007820894008265739,0.0004199056529115054
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,21.2557530583614,29.70159212944563,14.839370859465411
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,565,Cannabis use disorders,1,Number,2021,653848.5439390105,1017565.3275664453,389510.17946612684
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,565,Cannabis use disorders,2,Percent,2021,0.00022568730015961791,0.00032707109372221083,0.00014422543911739798
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,565,Cannabis use disorders,3,Rate,2021,8.285632628788484,12.894687245483603,4.935911048737976
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,878804.1472023304,971466.9965078565,800305.985803658
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.000305026702003628,0.0003295566617931433,0.00028264618203983747
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,11.136292011156423,12.310524690573388,10.141555640763272
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,567,Depressive disorders,1,Number,2021,56330361.14911696,76538170.95809424,39339990.825258836
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,567,Depressive disorders,2,Percent,2021,0.019472238599131234,0.025399274685922762,0.014578153610871093
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,567,Depressive disorders,3,Rate,2021,713.8238398709334,969.899180042115,498.52020719405147
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,568,Major depressive disorder,1,Number,2021,46018844.076235354,62719193.7896806,31460385.344729446
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,568,Major depressive disorder,2,Percent,2021,0.01591086990616084,0.021243887458267163,0.011418522257735094
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,568,Major depressive disorder,3,Rate,2021,583.1552881040782,794.7837512712414,398.66907671949195
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,661,Acne vulgaris,1,Number,2021,5125473.488867777,8069826.906486757,3225014.362003683
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,661,Acne vulgaris,2,Percent,2021,0.0017697864220480816,0.0026638830677958706,0.001158018087836127
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,661,Acne vulgaris,3,Rate,2021,64.95050080177978,102.26163496863093,40.86769707423514
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,662,Alopecia areata,1,Number,2021,571860.2706807873,808502.0896695844,371725.07646294707
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,662,Alopecia areata,2,Percent,2021,0.00019738351699513014,0.00026338506299194525,0.00013725711512422908
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,662,Alopecia areata,3,Rate,2021,7.246669219932563,10.245417469698987,4.7105364859045755
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,663,Pruritus,1,Number,2021,851113.0503753112,1556084.7467840486,413005.3668196894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,663,Pruritus,2,Percent,2021,0.0002937995576304518,0.0005070910365528035,0.0001467479670401465
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,663,Pruritus,3,Rate,2021,10.785387726787032,19.71885793832498,5.233644358325854
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,664,Urticaria,1,Number,2021,3980785.676250508,5658916.575961197,2616526.390546891
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,664,Urticaria,2,Percent,2021,0.0013744913867537749,0.001834709736988863,0.0009914773032250516
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,664,Urticaria,3,Rate,2021,50.4449050060615,71.71034371799365,33.15687805159923
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,803747.4037738226,903723.2302878379,612264.1888646832
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,0.0002791938965033049,0.0003181189823294521,0.0002130340739775008
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,10.185165625502425,11.452069066571934,7.758671618559318
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,3530584.5483833007,6296866.071446102,1830685.6036097156
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.0012194487483122415,0.0020467983390063246,0.0006681240937723393
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,44.739912329773105,79.79450205145925,23.198626824099616
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,669,Sense organ diseases,1,Number,2021,77327292.9942278,107972583.375837,53419191.94899225
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,669,Sense organ diseases,2,Percent,2021,0.026698525043877073,0.035455433297502836,0.019505177492742602
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,669,Sense organ diseases,3,Rate,2021,979.8990115800042,1368.2391252933166,676.9332193502158
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,670,Glaucoma,1,Number,2021,759900.230716271,1049127.1676979891,530942.903091785
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,670,Glaucoma,2,Percent,2021,0.000262615859622489,0.0003414472216674647,0.0001966574596781014
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,670,Glaucoma,3,Rate,2021,9.629529964716008,13.294641967173584,6.728160340281074
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,671,Cataract,1,Number,2021,6553846.480704116,8804276.7054034,4736091.921126926
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,671,Cataract,2,Percent,2021,0.0022642095723354517,0.0028675059437366104,0.0017691266658535522
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,671,Cataract,3,Rate,2021,83.05098290416599,111.56865457511417,60.016219533389645
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,1,Number,2021,578020.3784384315,797569.822767952,401241.31581864145
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,2,Percent,2021,0.00019971358174482106,0.0002610355962622958,0.00014868248898042207
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,3,Rate,2021,7.32473070727045,10.106882715455901,5.084569154710953
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,1,Number,2021,44449944.07336713,62029878.36082989,30689648.464790203
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,2,Percent,2021,0.015347505738575113,0.019970541296417316,0.01141509992994039
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,3,Rate,2021,563.274033988623,786.0486788117918,388.90222367709845
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,675,Other vision loss,1,Number,2021,3003680.8319359184,4068865.0071741296,2148641.597200229
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,675,Other vision loss,2,Percent,2021,0.0010376740930019318,0.0013082683043712639,0.0007996060837016806
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,675,Other vision loss,3,Rate,2021,38.06293695727223,51.561054892740344,27.22779623868832
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,679,Other sense organ diseases,1,Number,2021,3713356.183090227,5592061.128040312,2245880.7896174253
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,679,Other sense organ diseases,2,Percent,2021,0.0012820466997579148,0.0018549300136299245,0.0008214327462634395
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,679,Other sense organ diseases,3,Rate,2021,47.056012341285864,70.86314495026613,28.460020785118026
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,680,Oral disorders,1,Number,2021,23239420.62383663,35026532.73727378,13849366.435526337
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,680,Oral disorders,2,Percent,2021,0.008021443497539417,0.011725056594489188,0.00507731545698937
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,680,Oral disorders,3,Rate,2021,294.49220860077594,443.8596448849087,175.50052453271016
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,1,Number,2021,200728.1764929506,385501.90316567995,88103.15592676323
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,2,Percent,2021,6.925003370816032e-05,0.0001280276730175255,3.1097092337129036e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,3,Rate,2021,2.543647063351631,4.885117779856306,1.1164517994462662
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,1,Number,2021,2198064.468725245,4174724.950901057,988182.9960371736
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,2,Percent,2021,0.0007583944348007688,0.0013910382011287038,0.00035940760198239233
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,3,Rate,2021,27.85408769519158,52.90252244200106,12.522351469736241
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,683,Periodontal diseases,1,Number,2021,6903283.6783909025,14106182.309556942,2772283.935939934
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,683,Periodontal diseases,2,Percent,2021,0.0023829498620654534,0.004659686517932982,0.0009861915756088037
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,683,Periodontal diseases,3,Rate,2021,87.47908521272767,178.7549203789404,35.130652884091596
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,684,Edentulism,1,Number,2021,9590986.729492253,13470473.176659193,6202443.6906894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,684,Edentulism,2,Percent,2021,0.0033109692373067207,0.004349276762696874,0.002267966133049246
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,684,Edentulism,3,Rate,2021,121.53792086072308,170.69915213905924,78.59797241758946
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,685,Other oral disorders,1,Number,2021,4346357.570735295,6506000.671875937,2681134.529585805
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,685,Other oral disorders,2,Percent,2021,0.0014998799296583214,0.002093884189014664,0.0009706416211445647
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,685,Other oral disorders,3,Rate,2021,55.077467768782476,82.4446761402337,33.97559870161579
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,1,Number,2021,2746174.492763149,3686289.7893454377,1598180.4156496283
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,2,Percent,2021,0.0009535725803770304,0.0012713139540133644,0.0005521361139640818
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,3,Rate,2021,34.799791469303074,46.713024355407,20.252298366871464
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,247843924.28274822,272347783.66707975,226826041.99691623
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.0860104998203871,0.09075895168363926,0.08100968458180553
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,3140.7024224797733,3451.2177225872542,2874.361764739057
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,69629520.2599838,74668367.20531331,64851121.618436016
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.024175411129787015,0.02556374394292614,0.02278786054979457
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,882.3520834311506,946.2048442099349,821.7997490032876
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,48220102.83289511,55219173.06834553,42803597.00115667
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.016751017527823105,0.019748974086944593,0.014800302711643645
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,611.0498541280524,699.7427559500372,542.4113630440052
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,349680408.7378886,376755273.38848525,327870998.4724572
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.12148769007794132,0.13273392943337253,0.11112137319309838
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,4431.184302762635,4774.279632787469,4154.8133251333675
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,71929007.63246451,88193657.08409387,58296705.10131243
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.024965729446643152,0.029962105894818965,0.02017129800151335
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,911.4914120715937,1117.5986389537832,738.7415425419224
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,8099574.463723717,13877830.880735613,4227133.2377444515
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,0.0028119564136451646,0.004868156260439375,0.001409625333661124
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,102.63859892022799,175.86122876333448,53.56664537308926
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,4740234.700806706,7597208.383884659,2762281.982004773
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,0.001647141790885745,0.002660604173869768,0.0009462977054578024
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,60.0687172422349,96.27256687611711,35.00390714664978
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,41582270.37698675,52992389.628477186,32748689.672190424
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.014431374251217335,0.018078458375083532,0.011559351147801582
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,526.9345927407985,671.5247386467212,414.9945950224214
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,198680033.00573605,227571348.68465143,173450108.6253039
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.06895897019640963,0.07672861090480756,0.06065534380963401
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,2517.692788981195,2883.80636390135,2197.976722307695
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,1214106.9242989814,1448472.940418558,1041719.039486273
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,0.00042144949479099253,0.0004976819569169498,0.0003723638701042714
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,15.385281561088888,18.355190614554125,13.200765442712026
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,1,Number,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,2,Percent,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,3,Rate,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,1,Number,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,2,Percent,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,3,Rate,2021,0.0,0.0,0.0
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,1341.745837514885,2186.622552967191,423.3471370276825
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,4.6651662431510394e-07,7.728129686482305e-07,1.4641850043680184e-07
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,0.017002734339485587,0.027709094620848015,0.005364696280776526
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,2242999.5011021523,2459248.203995073,2004168.0758981598
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,0.0007793361122561115,0.0008693638359331905,0.0006740872925075695
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,28.423508815555028,31.16383350577857,25.39701366190851
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,943258.3547042541,1134001.2222035234,818239.2570759419
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,0.00032739194158739465,0.00038149447509977784,0.0002840227590487444
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,11.953062025697392,14.370174277931813,10.368807806378571
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,1,Number,2021,51926.76445919049,67293.89392033582,36206.55801192506
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,2,Percent,2021,1.803580608346393e-05,2.300575427501954e-05,1.2667876881892682e-05
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,3,Rate,2021,0.6580210323915863,0.8527547982680447,0.45881304045193727
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,2671792.5758999246,3602043.7917818176,1895293.466401896
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,0.0009287469178690993,0.0012794043467866522,0.0006454933422357597
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,33.857216551813806,45.645450843576896,24.017343973490583
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,972,Headache disorders,1,Number,2021,47975675.06486085,100667852.51845007,9800212.25967029
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,972,Headache disorders,2,Percent,2021,0.01651801495859073,0.033698933815604314,0.003523091465073118
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,972,Headache disorders,3,Rate,2021,607.9524415713054,1275.6728622075816,124.18924722015032
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,32543145.76259807,38776444.19761542,26828985.998033352
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.01127740712961287,0.012787250222471121,0.009731774394002182
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,412.3899225187442,491.3788892709185,339.9795317175927
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,123704573.83157514,142177998.25738817,109574227.66852677
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.04288636294571687,0.04567278415701426,0.04023927618688719
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,1567.596445339611,1801.6934844885618,1388.5353182484564
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,3597713.336548795,4249993.599889747,3037759.104293358
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,0.0012468863901688232,0.001384135969629846,0.0011212347742750792
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,45.59057489178529,53.856334115616534,38.4947801539803
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,75340873.71385093,90254281.75094804,63483094.22634784
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.026094274347442003,0.029175539798469128,0.02340578447032178
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,954.7269123889706,1143.7110760520081,804.4639722365821
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,977,Atopic dermatitis,1,Number,2021,5621507.644730092,9367134.693358796,2889265.6066408036
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,977,Atopic dermatitis,2,Percent,2021,0.0019397615916282173,0.0031428982863771406,0.0010623931426465706
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,977,Atopic dermatitis,3,Rate,2021,71.23629408663828,118.70124598884144,36.61305604414164
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,1,Number,2021,2198064.468725245,4174724.9509010566,988182.9960371736
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,2,Percent,2021,0.0024176838490911,0.0043811311166714,0.0011604212426121
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,682,Caries of permanent teeth,3,Rate,2021,27.85408769519,52.902522442,12.52235146973
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,34734.194587455815,48976.264306885656,23319.662458685365
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,3.83680769306e-05,5.00139160916e-05,2.82175190559e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,0.44015510729,0.6206320062,0.29550904097
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,906432915.9697318,1172557201.1063938,680607236.1892636
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,11486.406468264999,14858.7594094486,8624.72139126661
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,685,Other oral disorders,1,Number,2021,4346357.570735295,6506000.671875937,2681134.529585805
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,685,Other oral disorders,2,Percent,2021,0.0047789283915958,0.0062287690845945,0.0033676841012509
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,685,Other oral disorders,3,Rate,2021,55.077467768780004,82.44467614023,33.97559870161
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,7203.578598703382,10318.342030117408,4797.358227864133
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,7.9500020407e-06,1.03460962673e-05,5.8947318536e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.09128445178,0.13075503829000001,0.06079259216
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,4385026.901773316,5920443.479422484,2949783.1178956195
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.0048486635231658,0.0059228668730005,0.0036953845142175
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,55.56748930963,75.02443818942,37.37993985923
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,8664.907314140728,12528.7190928443,5671.384327695184
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,9.5576153231e-06,1.22223970085e-05,7.1217945748e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.10980255203,0.15876515238,0.07186833629
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,8988868.990010122,11898676.502979605,6462559.050017573
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.009906145090661,0.0108804268361375,0.0089578664434119
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,113.90782604003,150.78119112808,81.89417966386
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,2104543.231619474,2862841.023610913,1496552.3125686026
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.0023180880604322,0.002664598911863,0.0020205529783578
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,26.6689774417,36.27820114634,18.96445711571
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,59940.53899205926,84873.75141323269,40209.69978336533
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,6.6189498453e-05,8.5337148755e-05,4.91552276329e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,0.75957236621,1.07552846994,0.50954124408
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,9337.858491759296,13081.668507784474,6287.215891938653
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,1.03138041586e-05,1.30225107452e-05,7.7760683246e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.1183302551,0.16577218139000002,0.07967221403
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,10192765.024120664,15033072.535367262,6508275.676865116
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.0112081989442182,0.0143643181457547,0.0086161847743595
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,129.16371420305998,190.50056387615,82.47350522572
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,436521.09813762025,596536.1366605312,289614.5619759499
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,0.0004832093735572,0.0006269182800107,0.0003581691846396
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,5.53163800304,7.55936420442,3.67002402425
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,604289.0489732296,822265.3558893257,419270.3494836698
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.0006651940606035,0.0007827775914665,0.0005521514775268
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,7.6576098667000005,10.41982692388,5.3130348307199995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,714332.4667723333,969677.2343249086,504730.4321959063
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,0.0007873701990143,0.0009374750411237,0.0006818246308197
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,9.05209080812,12.28784464933,6.395993348169999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,5996.618259433445,9515.765352067863,3488.0342629686493
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,6.5732653995e-06,9.1937596531e-06,4.56274432e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,0.07598973244,0.12058470822,0.04420071096
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,154105.7989170799,213288.42364412977,103524.75368267937
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.0001697035824725,0.0002063492817309,0.0001380714450893
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,1.95284373978,2.70281174237,1.31187579288
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,106833.32662782323,149398.32553816878,70734.36345548378
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,0.0001176529909619,0.0001440986353928,9.19205544642e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,1.35380235248,1.8931901772100002,0.89635276435
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,1231913.290365396,1678359.7626120774,867122.1637685241
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.0013573021579464,0.0015608011157402,0.0011532727579291
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,15.610925571529998,21.26833888497,10.988256775770001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,120695.85368381084,166372.49247857774,81549.04105593056
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.0001328679652537,0.0001658857132009,0.0001041003242907
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,1.52946964968,2.10828847902,1.0333974154799999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,24172949.650409546,32805343.946659457,16816844.523293454
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.0266332125789911,0.0304232460651159,0.0229604007811399
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,306.32197962985003,415.71252352351996,213.10469677892002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,17110650.887556918,24023919.051852643,11918345.22444636
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.0188495640985861,0.0226404098785357,0.0157318486647095
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,216.82783973129,304.43344932488,151.03043508811
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,1708581.418803356,2472426.867611057,1117470.2310930132
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0018798705137835,0.0024054750545791,0.0013805799515529
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,21.65131066484,31.33083481865,14.16069194352
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,2882532.219655267,3841659.276157973,2032648.3904996216
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.0031771521628317,0.0036026209831909,0.0027589743389985
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,36.52772990641,48.681881671650004,25.75791899102
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,602896.5028965537,792524.254480812,427023.3113369807
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,0.0006656967541086,0.0007657880447533,0.0005736126262055
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,7.63996338676,10.04294478117,5.41128112078
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,75.65558720238117,126.99053865153851,44.83565203000735
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,8.2969854e-08,1.202413676e-07,5.33302393e-08
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,0.00095871499,0.00160923651,0.00056816176
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,1,Number,2021,691095.3212257326,799248.6440956307,577214.9457360166
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,2,Percent,2021,0.0007718708413911,0.000949145256227,0.0006171039028281
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,3,Rate,2021,8.75762742952,10.12815690333,7.31452418538
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,7645149.944780201,9940869.124086125,5690053.237319057
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.0084444916765786,0.0093421507468959,0.0076028334973646
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,96.8800870196,125.97166474798,72.10491053272
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,49815.28591783363,68306.57148919451,34311.87113662981
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,5.50774886605e-05,6.69038267836e-05,4.23636863196e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,0.63126417003,0.86558754736,0.43480338325999995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,202993.09155497607,288729.6498742359,130131.72573800923
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,0.0002238422657816,0.0002981645612163,0.0001595916326341
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,2.5723482882999997,3.65881033165,1.64904194222
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,182125.4405969625,243376.7836683688,124737.07437906622
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,0.0002012723366778,0.0002426247243504,0.0001560935763023
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,2.30791137662,3.0840943801800003,1.5806803931499998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,100582.29451474435,135948.445949602,72078.29903108861
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,0.0001108553236873,0.0001280687535509,9.43366467524e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,1.27458866283,1.72275198903,0.91338324726
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,327765.19181971333,451455.3439746774,222958.5996140953
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,0.0003613325458024,0.0004394040763069,0.0003004893174279
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,4.15347253289,5.72088622534,2.82535315702
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,276912.0944550637,383661.6484790575,185556.95323540008
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,0.0003052840773506,0.000381897541016,0.0002480204739725
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,3.50905711482,4.86179789268,2.35139584003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,1111990.113574884,1547568.5366137289,748601.6902560409
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.0012277254349152,0.0015455400724072,0.0009599136944205
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,14.09124735893,19.61093969102,9.486353756149999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,71065533.110817,128889654.26020353,32123542.986631226
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.0779248751500181,0.128433293755961,0.0388190320158581
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,900.54937857314,1633.30229110554,407.07267514714
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,1670296.2318695842,2206908.1873461143,1173095.1187599753
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,0.0018538392608035,0.0023875666468308,0.0014608006626155
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,21.16615703561,27.96615616157,14.8655759545
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,13462500.20455609,18689765.063923664,9420917.96698624
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.0148244127499162,0.0172881959388929,0.0123407693623873
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,170.59811785762,236.83852885123002,119.38279288679001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,366999.06453321344,631172.6859829046,177268.02965263385
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,0.0004041683798514,0.0006602325413184,0.000220037364242
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,4.6506480010099995,7.99828194137,2.2463577905700003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,541,Other digestive diseases,1,Number,2021,364219.6227961246,495408.9622107039,253520.2729062533
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,541,Other digestive diseases,2,Percent,2021,0.0004017061829965,0.0004894896828449,0.0003405415627236
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,541,Other digestive diseases,3,Rate,2021,4.61542664377,6.27787076982,3.21263366681
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,602438.4471706896,847613.6695537618,407786.3168983015
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.0006636099548697,0.000826019545241,0.0005406915933445
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,7.634158859849999,10.74104323113,5.16750804783
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,383764.6901183877,572361.9979969019,251579.44864448145
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.0004230197296054,0.0005677536277573,0.0003198811770239
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,4.8631036464,7.253027157499999,3.18803935215
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,188645.7365795789,274525.8709674639,129926.32668043968
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,0.0002075235486844,0.00025884198741,0.000163524176813
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,2.3905372043299997,3.4788186576499998,1.6464391053
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,683,Periodontal diseases,1,Number,2021,6903283.678390894,14106182.309556942,2772283.935939934
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,683,Periodontal diseases,2,Percent,2021,0.0076063214511741,0.0149537746289865,0.003162392105656
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,683,Periodontal diseases,3,Rate,2021,87.47908521272001,178.75492037894,35.130652884090004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,117886602.29662058,160882624.21891147,85222373.83409905
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.1299707860943162,0.1502805005457549,0.1147965120531202
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,1493.87054164182,2038.7203320860601,1079.94624732006
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,483882.7699846844,629476.6976256408,343395.4891136165
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,0.0005370792329941,0.00066942685648,0.0004004532523815
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,6.13180973585,7.97679021121,4.35154118726
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,684,Edentulism,1,Number,2021,9590986.729492256,13470473.176659197,6202443.690689399
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,684,Edentulism,2,Percent,2021,0.0105558723224329,0.0130378578557962,0.0081825767238253
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,684,Edentulism,3,Rate,2021,121.53792086072,170.69915213905,78.59797241758
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,56745659.16227492,75466435.47274809,41546114.097119644
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.0626042177479219,0.0694331599174808,0.0553856565662551
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,719.08653686764,956.3180432648999,526.4764168299
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,57889.0977371311,78030.5854840338,40686.61000585296
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,6.39650033942e-05,7.756564307e-05,5.12886669685e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,0.7335763022,0.98881120272,0.51558469701
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,155405240.99762714,198149931.5368178,117011643.74349496
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,0.1721242346491805,0.203070440906013,0.1417129266345737
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,1969.3103967740599,2510.9752913769603,1482.78298137452
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,4988205.626825989,7273114.070020928,3349907.3890385344
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0054937698625332,0.0071601862264067,0.0043364092795707
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,63.21102904312,92.16561206732,42.45035371467
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,351,Schistosomiasis,1,Number,2021,1245871.9992927038,2480844.183419683,572098.7988497566
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,351,Schistosomiasis,2,Percent,2021,0.0013729877435965,0.0026059814304693,0.0006746219044958
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,351,Schistosomiasis,3,Rate,2021,15.7878116948,31.43749986694,7.24969187219
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,334884.2688892477,467688.9294944545,225914.220657844
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,0.0003686763939874,0.000443231256278,0.0003030978953815
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,4.24368617304,5.92659980704,2.86280707565
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,8274536.52323779,10938896.40786866,5963709.39135748
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.0091187748916466,0.0100121795774235,0.0082390104680413
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,104.85573523191,138.6187639938,75.57270805248
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,1,Number,2021,6336161.699693877,11241352.504317302,3189793.935852528
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,2,Percent,2021,0.0069719595942345,0.0113368249002774,0.0039555448160566
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,3,Rate,2021,80.29246009172999,142.45151719749,40.42138039306
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,69625.0837314591,105958.58281106094,44894.58832070702
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,7.65494878582e-05,0.0001019889420415,5.81067712223e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,0.8822958633099999,1.34271751337,0.56890860933
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,1,Number,2021,8846.352765101248,12434.523895221057,6189.1494346298805
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,2,Percent,2021,9.7287065746e-06,1.1326773318e-05,8.4407093771e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,3,Rate,2021,0.11210184650999999,0.15757150163,0.07842950631
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,898346.4700965754,1187432.933647133,639515.4674653544
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.0009911048741819,0.001137650305548,0.000862080646892
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,11.38393423612,15.04726614554,8.10400248339
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,556121.2535902605,834694.0117301345,343999.2410730037
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,0.0006159599360813,0.000888710941329,0.0004131551715026
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,7.04722285768,10.577324064959999,4.35919199107
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,10997964.934410663,15353228.320277251,7681105.003993258
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.012131350003161,0.0149703524065569,0.0097354644551453
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,139.36728613303998,194.55760926125,97.33571304270001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,3542263.091594944,4820256.190234527,2541302.094236519
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,0.0039044752972748,0.0044580010791212,0.0033832329817085
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,44.88790397032,61.08275737424,32.20362841945
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,579202.5364821778,799563.7062671024,391900.5668041258
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,0.000638407351796,0.0007953252025685,0.0005027482036493
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,7.3397111295,10.13214940195,4.96620227062
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,5269389.295741029,7768600.244871689,3349898.4471964138
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0058116640952976,0.0078911432186886,0.0042938932454395
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,66.77421596682001,98.44446128326001,42.45024040277
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,400311.7578463191,541363.9155277035,285984.66534788575
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,0.0004413220661985,0.0005064573718583,0.0003865275002785
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,5.07278970527,6.86021642799,3.6240256195500002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,39167314.04449564,52944952.8640016,27536569.5880787
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.0431582142953305,0.049364916044091,0.0372537434596475
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,496.33203015796,670.92361533278,348.94610010047
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,496627.8254520784,656495.5475816577,355042.5747400203
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,0.0005488065449327,0.0006466320078326,0.0004574655998396
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,6.2933163239,8.319175717559999,4.49913419422
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,4204001.383504564,5621419.546004519,3023198.784864946
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,0.0046376609136075,0.0052326345217868,0.0040876200953254
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,53.273516256209994,71.23517769098,38.31027036366
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,7553564.938937053,10537928.110677402,5291358.366921552
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.0083087717396496,0.0095967051878498,0.0071676751330575
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,95.71951287784,133.53765455781,67.05261018317
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,1655236.02375133,2226958.938107703,1160809.13695338
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.0018249104442377,0.002093530088769,0.0015768710536154
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,20.97531260698,28.22024123415,14.709886792730002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,568,Major depressive disorder,1,Number,2021,46018844.076235406,62719193.7896806,31460385.34472945
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,568,Major depressive disorder,2,Percent,2021,0.0508646339840044,0.065294574431317,0.0391178297918307
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,568,Major depressive disorder,3,Rate,2021,583.15528810407,794.7837512712399,398.66907671948996
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,570,Bipolar disorder,1,Number,2021,8007783.132923042,11498108.629829092,5185275.374707732
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,570,Bipolar disorder,2,Percent,2021,0.0088885828937763,0.0127786868949528,0.0060621449023528
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,570,Bipolar disorder,3,Rate,2021,101.47541020845,145.70515590465,65.70831614168999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,356,Trachoma,1,Number,2021,123190.23740696204,174324.77882535895,80954.09783120376
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,356,Trachoma,2,Percent,2021,0.0001358180307472,0.0001751135655399,0.0001023554875059
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,356,Trachoma,3,Rate,2021,1.5610787239200001,2.20906062854,1.02585823681
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,1009730.6559911272,1465849.7503159223,673251.5894633925
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.0011115872941589,0.0013590268553636,0.0008944714970119
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,12.795405521840001,18.57539124726,8.53150991732
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,714,Foreign body in eyes,1,Number,2021,341609.66689834965,598770.5130400993,182633.999394859
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,714,Foreign body in eyes,2,Percent,2021,0.0003744347442203,0.0005877231268308,0.0002255369371424
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,714,Foreign body in eyes,3,Rate,2021,4.32891107367,7.5876784401999995,2.31435588339
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,813620.8833658495,1091902.6577323752,585384.9184024733
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.0008981252485644,0.0010328003429584,0.000763782146873
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,10.31028332351,13.83669715598,7.4180548771999995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,11582108.01026109,15296793.445377752,7961941.517549717
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.0128453807997701,0.0163928612449025,0.010094281104476
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,146.7696042601,193.84246101293,100.89450077978
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,565,Cannabis use disorders,1,Number,2021,653848.5439390098,1017565.3275664452,389510.1794661269
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,565,Cannabis use disorders,2,Percent,2021,0.0007197704800311,0.0010017070684856,0.0005029267590309
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,565,Cannabis use disorders,3,Rate,2021,8.28563262879,12.89468724548,4.9359110487399995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,567,Depressive disorders,1,Number,2021,56330361.149117015,76538170.95809424,39339990.82525884
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,567,Depressive disorders,2,Percent,2021,0.0622249697431215,0.0775677818083097,0.0495853324448126
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,567,Depressive disorders,3,Rate,2021,713.82383987093,969.89918004211,498.52020719405
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,224886.3321973392,346705.0440339628,128628.98265686537
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.0002471898459997,0.000336424294299,0.0001670370590429
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,2.84978157265,4.39348019055,1.6299990350799998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,50853.09736464937,69521.01170062639,34920.72064922881
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,5.60484684518e-05,7.01911672866e-05,4.52343209294e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,0.64441541807,0.88097705237,0.44251878377000003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,5303520.446902462,7651304.8657589555,3597747.752129493
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.0058416665765011,0.007495778212114,0.0046672057682785
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,67.20672924889999,96.95808277956999,45.59101100938
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,78.36634683915746,177.69276113746918,27.96184358858893
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,8.56630371e-08,1.838115819e-07,3.32996037e-08
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,0.0009930660000000001,0.00225174003,0.00035433521
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,7265007.234354009,10970850.04747204,4414551.999791854
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,0.0080536716121854,0.0113839909270596,0.0052389659090785
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,92.06288145372,139.02368363667,55.94163423627
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,547,Migraine,1,Number,2021,43378889.8135105,95079454.08536284,6732642.208434143
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,547,Migraine,2,Percent,2021,0.0472677629913304,0.0993761352614138,0.0075073412090873
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,547,Migraine,3,Rate,2021,549.70152976737,1204.8561312856,85.31669983402
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,839,G6PD trait,1,Number,2021,15894.302378965438,22955.48082330388,10711.85625162386
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,839,G6PD trait,2,Percent,2021,1.7460629469e-05,2.0815848055e-05,1.39970826105e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,839,G6PD trait,3,Rate,2021,0.2014141526,0.29089409570999997,0.13574168895
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,1,Number,2021,11544038.080669446,16288865.17430317,7842314.670964265
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,2,Percent,2021,0.0129651176018261,0.019672371164398,0.0083271075667656
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,575,Autism spectrum disorders,3,Rate,2021,146.28717839294,206.41409088575,99.37857769249
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,2364838.9909628537,3296187.959265588,1622805.360434931
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.0026052483727495,0.0031379717905567,0.0021294501786269
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,29.967470734589998,41.76961585228,20.564348073
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,448180.3837902664,616811.5136479649,303954.77020602406
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.0004929605542942,0.0005716588654853,0.0004101044779954
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,5.67938560992,7.81629576248,3.8517445439599998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,548,Tension-type headache,1,Number,2021,4596785.251350273,15012932.745364796,1347300.8420642563
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,548,Tension-type headache,2,Percent,2021,0.005052857237861,0.0157509868166519,0.0016835380476376
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,548,Tension-type headache,3,Rate,2021,58.250911803929995,190.24535048961002,17.07312789985
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,2030674.701749729,2901184.1512315418,1344579.3594059043
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,0.0022503190116791,0.003040854611428,0.0016089509794869
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,25.73290821435,36.76408900561,17.03864100571
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,13.272066707514869,36.97239257155875,3.5396317088577414
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,1.46552842e-08,3.92824585e-08,3.965977e-09
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.00016818492999999998,0.00046851776999999996,4.485456e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,4406144.772685839,6728769.638788386,2678150.136179682
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.0048434680123156,0.0065973505954307,0.0034225678674597
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,55.83509703301,85.26762625313,33.9377801768
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,3390267.824899458,5351268.010651792,2058615.026204248
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,0.0037346412820608,0.0052382219239255,0.002607920104428
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,42.961805101050004,67.8117910416,26.08697073557
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,2451432.6996692326,3935796.38514662,1428369.8659819923
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,0.0026980843317784,0.0039244898761385,0.0018327478019261
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,31.064794671389997,49.874796313800005,18.10044249125
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,218673.7570523024,304387.434503415,147356.13459133083
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.0002405902252643,0.0002858501998514,0.0001972366756593
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,2.77105521346,3.85722730821,1.86731133401
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,2897121.0939587434,4106470.454045341,1941036.658549288
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.003192389682074,0.0040455583325017,0.0025556924011821
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,36.712601546900004,52.037594789479996,24.59700617342
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,22751.212988844505,30182.379187824736,16528.161229602614
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,2.5134601256e-05,2.94595521992e-05,2.15149203126e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,0.28830559375,0.38247405784,0.20944647387999998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,636.3686840142936,1207.8720829679828,288.3045383733829
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,7.063797051e-07,1.2824309358e-06,3.326377265e-07
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.00806412614,0.01530627304,0.0036534232800000004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,352,Cysticercosis,1,Number,2021,1154653.5884038606,1732314.6721145674,712368.7480564364
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,352,Cysticercosis,2,Percent,2021,0.0012816452142403,0.0018715813768171,0.0008362951791746
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,352,Cysticercosis,3,Rate,2021,14.63188308012,21.9520607695,9.0272063727
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,8821216.668318111,11268007.29577466,6381420.793620108
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.009771728544545,0.0119079886656661,0.0079145159714132
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,111.78331944016999,142.78928931897,80.86598775171
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,6636467.310357442,8617061.58579629,4606665.224310236
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,0.0073885178144038,0.009651231839505,0.0052142433272322
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,84.09796212946,109.19624628881999,58.376111786539994
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,92541.8214092354,135484.03785287996,60630.53165056691
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,0.0001026290821344,0.0001432409840836,7.09574435652e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,1.1726990020899999,1.7168669642499998,0.7683160205899999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,579,Conduct disorder,1,Number,2021,5002614.360377078,7799887.250276936,2715125.6371160564
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,579,Conduct disorder,2,Percent,2021,0.0055041562638765,0.0081274894882093,0.0034411274895982
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,579,Conduct disorder,3,Rate,2021,63.39361792239,98.84093327245,34.40633733711
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,585,Other mental disorders,1,Number,2021,8962343.979627103,13487270.942410257,5723960.372816102
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,585,Other mental disorders,2,Percent,2021,0.009901158721086,0.0134159871670179,0.0071263392516609
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,585,Other mental disorders,3,Rate,2021,113.571698517,170.91201506777,72.53458506641
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,1213518.4817001245,1880378.0413349771,717649.2595410512
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,0.0013468573558382,0.0020262012671101,0.0008347071173383
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,15.377824758980001,23.82833424982,9.09412153013
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,572748.8902595348,788396.0648580529,395106.07829940086
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,0.0006318214845666,0.0007725320194605,0.0005147846625773
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,7.257929894049999,9.99063195896,5.00682282546
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,5227453.874482565,6577271.544989896,4018579.632682043
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.0058076801901537,0.007037325818501,0.0048918829192302
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,66.24280621161,83.34782760738,50.92383371437
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,363,Hookworm disease,1,Number,2021,540196.0712839833,826648.0070508119,336191.36465523083
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,363,Hookworm disease,2,Percent,2021,0.0005942472974361,0.0008089088247141,0.000416415068261
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,363,Hookworm disease,3,Rate,2021,6.84541739163,10.47536430758,4.26024981829
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,559,Schizophrenia,1,Number,2021,14816611.183696533,19095362.418752827,10926460.046453211
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,559,Schizophrenia,2,Percent,2021,0.0165570286368893,0.0222035855573225,0.0120046750757555
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,559,Schizophrenia,3,Rate,2021,187.75754447984,241.97829815786002,138.46116920693
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,9225384.597856203,11764607.442131145,6536451.091821465
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.0102527849055598,0.012903022859995,0.007586356811809
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,116.90497492986,149.08225489067,82.83054683674
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,49192.9483581048,84315.62774507294,26879.04532605056
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,5.40452045282e-05,8.06627109319e-05,3.32674238742e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,0.6233778476699999,1.0684558722900002,0.34061388841
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,11899.620006825346,16817.10429842676,8011.2440035350255
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,1.30747363137e-05,1.56225985627e-05,1.06519059906e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,0.15079314729999999,0.21310798867000003,0.1015192667
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,2949.8243532880624,3922.8425777383695,2171.805461921396
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,3.2607251374e-06,3.715511569e-06,2.8103182286e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,0.0373804624,0.0497106444,0.027521330999999996
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,8589476.12776907,11040421.98096456,6748363.786795213
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.0095398583619302,0.011451587958969,0.0079725454249581
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,108.84668066964,139.90530597496,85.51592521099
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,279503.27025836776,411614.5345851105,172188.08860697204
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.0003074139924783,0.0003933578833906,0.0002226285650234
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,3.54189274775,5.21601959637,2.1819842813399997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,1,Number,2021,2235713.879773499,3402625.949457681,1345704.2824392384
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,2,Percent,2021,0.0024623527310881,0.0034399765475053,0.0016773493943886
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,3,Rate,2021,28.331184710280002,43.118408462830004,17.0528961403
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,1021806.9354448938,1354551.5189737054,688294.0860001682
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,0.0011331875301553,0.0014341519060832,0.0008577373643193
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,12.948437314909999,17.16500918602,8.72212990306
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,567665.6779972095,1270946.0523952744,125866.794521356
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0006264594085289,0.001233171368174,0.0001542839255626
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,7.19351493164,16.10555254542,1.59499631717
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,569,Dysthymia,1,Number,2021,10311517.072881622,14658132.435753249,6604701.557641096
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,569,Dysthymia,2,Percent,2021,0.0113603357591171,0.0144814569043718,0.0086157089460025
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,569,Dysthymia,3,Rate,2021,130.66855176685,185.74928630277,83.69542340757
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,58230.07836718349,86039.04987766405,38886.05234492388
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,6.41174803291e-05,8.11424369271e-05,4.9825620211e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,0.7378972420600001,1.09029524593,0.49276785442
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,3232947.8015076425,4755929.1040131,2118942.25525242
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.0035616752840256,0.0046858902964817,0.0026228360682853
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,40.96823039471,60.26759825298,26.85144327594
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,393512.6974434922,553787.9705187457,265667.85224274616
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,0.0004326585138461,0.0005039325962453,0.0003602099057424
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,4.98663134759,7.01765526664,3.36656897896
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,27416253.08278409,38204468.21666303,19112463.34097457
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.0302221864411668,0.0370069948447356,0.0248643470159765
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,347.42143759064,484.13075375910995,242.19500271498998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,537.0875930024612,774.8005116036724,344.6084763465634
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,5.904323151e-07,7.762685396e-07,4.555643422e-07
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,0.00680602645,0.00981834778,0.0043669122799999995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,315314.8200764738,424561.7675556152,227054.37812344971
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,0.0003478967139679,0.0004030803581561,0.0003038507958477
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,3.99570020578,5.38008819749,2.8772552624400003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,318421.9961939894,421593.88920382713,234713.14023216988
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,0.000351604067658,0.0004078358082738,0.0003083056624634
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,4.03507464511,5.34247895306,2.97430784413
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,2050269.3514446877,2746374.3691911157,1471131.6651844075
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.0022616376753668,0.0025300762418782,0.0019710107165846
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,25.981213529650002,34.80232432292,18.642324188499998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,79634.94574733073,141601.3653525452,38153.09581432842
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,8.76113894177e-05,0.0001462936225112,4.5282521872e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,1.00914181272,1.79438633598,0.48347975766000006
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,1,Number,2021,392975.6098504899,553071.18577632,265308.35195134813
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,2,Percent,2021,0.000432068081531,0.0005032261378676,0.0003596530656899
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,3,Rate,2021,4.97982532114,7.0085721003599994,3.36201335614
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,2195331.05519595,3384913.864091129,1455524.2979778426
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.0024424016860087,0.0035280863016818,0.0016426100556109
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,27.819449611889997,42.89395918662,18.444546106449998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,606,Female infertility,1,Number,2021,601133.5005802432,1468475.006931312,213157.9704831042
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,606,Female infertility,2,Percent,2021,0.0006629958320178,0.0016112740670488,0.0002288487280912
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,606,Female infertility,3,Rate,2021,7.617622449170001,18.60865875557,2.70115862717
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,574,Bulimia nervosa,1,Number,2021,2604702.468952748,4359142.969631143,1474415.0686323163
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,574,Bulimia nervosa,2,Percent,2021,0.0028683131964409,0.0042522573391659,0.0018472448289094
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,574,Bulimia nervosa,3,Rate,2021,33.00704416197,55.23948559269999,18.683931797779998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,1,Number,2021,1030941.3513749624,1670195.4772006213,572105.187722903
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,2,Percent,2021,0.0011332283146789,0.0016609891141435,0.0007024611307996
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,3,Rate,2021,13.064189526,21.1648802626,7.249772832620001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,126935.34817478388,194485.4013841456,78458.5552490302
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.0001395716304408,0.0001850207910259,0.0001025295378363
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,1.60853713346,2.46453800726,0.9942344773999999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,837,Thalassemias trait,1,Number,2021,1979454.7639498,2884705.636292194,1289280.625452465
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,837,Thalassemias trait,2,Percent,2021,0.0021775071543987,0.0027643543077599,0.0016752787603736
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,837,Thalassemias trait,3,Rate,2021,25.083844158439998,36.55527165438,16.33789004646
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,165429.00826936256,240775.27385006504,99840.07478724094
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.0001816793192052,0.0002300040517515,0.0001363945438129
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,2.09633255495,3.0511277936,1.2651831819300001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,9234.580250581535,15231.52792497784,5184.3351157803245
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,1.02089422308e-05,1.69945441646e-05,6.1268718998e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,0.11702150314,0.19301540996,0.06569640109000001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,362,Trichuriasis,1,Number,2021,193919.49554857565,316481.00149559113,107413.0398206606
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,362,Trichuriasis,2,Percent,2021,0.0002135913239256,0.0003198970684631,0.000127473444671
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,362,Trichuriasis,3,Rate,2021,2.4573667932300003,4.01047817066,1.3611485347
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,1,Number,2021,998028.5173432163,1638112.1684971182,569766.3687563196
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,2,Percent,2021,0.0010990213410368,0.0016981088989813,0.0006896084649417
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,364,Food-borne trematodiases,3,Rate,2021,12.647114877609999,20.75831744022,7.22013509017
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,1,Number,2021,8110853.117059702,12364434.936707135,4920019.6288087
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,2,Percent,2021,0.0089176663617474,0.012125148644492,0.0064818925501041
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,609,Premenstrual syndrome,3,Rate,2021,102.7815231172,156.68332750415001,62.346969414579995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,45549.61977713564,64646.03996595988,29086.04014929116
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,5.00553955937e-05,6.30472325779e-05,3.91602270005e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,0.5772092319400001,0.81920093427,0.36858114243
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,355,Onchocerciasis,1,Number,2021,1262988.1254184733,1907363.1281017729,753578.310382708
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,355,Onchocerciasis,2,Percent,2021,0.0013902651974746,0.0018333824721733,0.0009570144144596
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,355,Onchocerciasis,3,Rate,2021,16.00470891729,24.17029190573,9.54941797261
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,1,Number,2021,607756.8655272285,1268607.2162667671,272745.1546192301
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,2,Percent,2021,0.0006678119918122,0.0012620463500473,0.0003161666635863
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,3,Rate,2021,7.70155437687,16.07591458549,3.45625324612
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,504049.99165108753,693982.5931276781,357533.3442978448
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,0.0005553511780323,0.0006440478374652,0.0004651275343915
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,6.3873707391100005,8.79421522114,4.5306974694
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,33649.445812309335,49342.55407943827,22287.58962381386
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,3.69640851235e-05,4.48151589453e-05,2.94686387959e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,0.42640906483,0.62527366599,0.28243051318
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,380598.70039957314,722488.873573351,182690.83075538115
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,0.0004191980773549,0.0007329120990089,0.0002234283151622
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,4.82298391537,9.15544959197,2.3150760559399997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,1,Number,2021,1314563.3995424944,2224976.2811064227,768842.0750468655
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,2,Percent,2021,0.0014407544124009,0.0022279867399742,0.0009836136147944
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,354,Lymphatic filariasis,3,Rate,2021,16.65827582981,28.195116810920002,9.74284188968
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,7787.479177430471,12152.74487301198,4246.078204015965
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,8.5675907169e-06,1.27187370396e-05,5.5578940004e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,0.09868369696,0.15400077034,0.053806717840000004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,1795.7961507393356,2722.49545145508,1087.3085767392247
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,1.9719063715e-06,2.5965644875e-06,1.404393775e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,0.02275650427,0.03449972834,0.013778480509999998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,7287254.393226108,10204325.145451758,4860646.889850033
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0080154757402779,0.0096745727158844,0.0063939076089531
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,92.34479962446001,129.31020518997,61.59459226587
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,173977.1969114679,285938.3051435251,96166.09736612014
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.000191034815229,0.0002813965252596,0.0001175157910219
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,2.20465603657,3.62343813851,1.2186261811
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,5398169.7615302615,7195237.305067071,3951659.2544666794
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.0059528471076242,0.0066717521150712,0.0053291792635804
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,68.40613461096,91.17875009338,50.07581214361
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,1473920.133832093,1914471.119117484,1031989.6930973412
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,0.0016339344814348,0.0020381038719157,0.0012790712880623
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,18.67765993564,24.26036506232,13.07747421472
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,1,Number,2021,1097345.7915330927,1728076.4926454504,649049.8250903455
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,2,Percent,2021,0.001207982752022,0.0017246174506446,0.0007758005783458
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,3,Rate,2021,13.905673079289999,21.8983541452,8.22482279471
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,10431.514061846252,14513.551340349428,7064.034119362611
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,1.15269188233e-05,1.46627002065e-05,8.9509483768e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,0.13218916533,0.18391714054,0.08951613051
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),1,Number,2021,1997.8505555867944,3770.9477165403937,920.9641989247934
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),2,Percent,2021,2.2028036748e-06,3.908195042e-06,1.1283440689e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),3,Rate,2021,0.02531695743,0.04778581788,0.01167054831
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,2354469.056152068,3234902.27943596,1607009.8592592245
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,0.0026022405260972,0.0033239163938421,0.0020291706392242
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,29.83606190755,40.99299772997,20.364185938909998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,1,Number,2021,132514.08682741152,182057.10361254532,87195.60592530915
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,2,Percent,2021,0.0001461096362686,0.0001773936125684,0.0001164390416303
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,3,Rate,2021,1.6792314547,2.30704540368,1.10495123716
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,52.218977343695606,90.83809865312736,25.449076269519708
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,5.73065641e-08,8.6135803e-08,3.22983849e-08
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,0.00066172398,0.00115110926,0.00032249318
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,361,Ascariasis,1,Number,2021,363230.22470053326,622567.9158150507,189989.2724252164
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,361,Ascariasis,2,Percent,2021,0.0004001441306602,0.0006422784498968,0.00023397152339
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,361,Ascariasis,3,Rate,2021,4.6028888944399995,7.8892414531299995,2.40756262183
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,630,Low back pain,1,Number,2021,70156962.18649575,94104688.44413131,50194204.95485304
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,630,Low back pain,2,Percent,2021,0.0774864790983127,0.0910419843108099,0.0651221713238598
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,630,Low back pain,3,Rate,2021,889.0358790541701,1192.50380584681,636.06586908423
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,7598790.763338246,11751593.55911201,4754901.541856486
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.0083665018296466,0.0115662388368317,0.0059010218452563
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,96.29261894314,148.91734169360998,60.25457688493999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,95372.09883324247,127075.6056272306,67472.76458327881
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,0.0001053310653719,0.0001234182346469,8.76512369711e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,1.20856455412,1.6103144896,0.85502146478
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,45084.025402748666,63715.24367584914,27788.124648611916
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,4.96930861629e-05,6.17198630075e-05,3.29939352242e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,0.57130917454,0.8074057927399999,0.3521338304
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,39321.811114025295,51618.58227869049,27930.68362592625
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,4.35010079121e-05,5.28098788416e-05,3.41676809888e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,0.49828983212,0.65411571769,0.35394035169
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,2529866.4482219405,3627217.693300208,1603069.8636341505
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.002804156559016,0.0038477435801379,0.0019003204915578
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,32.05871479591,45.96445698306,20.31425792942
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,571,Anxiety disorders,1,Number,2021,42509645.27941541,57729820.415835634,29396722.98920212
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,571,Anxiety disorders,2,Percent,2021,0.0470361493231564,0.0597593105027898,0.0355258030775235
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,571,Anxiety disorders,3,Rate,2021,538.6863781074601,731.5579244237999,372.51814573362
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,158967221.4852185,213188882.71227425,115030582.53223369
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.1753425814957355,0.2030849893513298,0.1529257785303523
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,2014.44816151282,2701.55034995466,1457.67878015879
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,293045.2615927131,415282.4154931109,195749.4581913984
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.0003234071234006,0.0004144507753287,0.0002494174810611
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,3.71349818497,5.26249934158,2.48055625862
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,1,Number,2021,46128.04073883544,64350.62281711664,30955.97526693013
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,2,Percent,2021,5.07244050019e-05,6.1671630993e-05,4.15931282893e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,3,Rate,2021,0.58453903888,0.8154573793,0.39227714293
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,1,Number,2021,2813712.943643241,4064281.163966095,1890225.0244547955
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,2,Percent,2021,0.0030928548337904,0.0036780688223245,0.0024331846731603
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,3,Rate,2021,35.65564531725,51.50296798377,23.953116181949998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,134769.52561089772,200270.19556047453,81483.67173084409
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.000148086208472,0.0001970976190645,0.0001056789086383
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,1.7078125953199998,2.5378434842299997,1.032569049
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,258892.2773554882,384147.9133745037,160890.6172345781
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,0.0002849404716844,0.0003663898665661,0.0002059233334402
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,3.28070823202,4.86795988894,2.0388216203600003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,728847.8395848537,932404.867651708,524236.9905489232
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,0.0008082568276508,0.0009752982161604,0.0006510448787882
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,9.23603103053,11.81552557739,6.643182361380001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,602,Other urinary diseases,1,Number,2021,107071.78355556802,147274.5987118695,76098.62947852851
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,602,Other urinary diseases,2,Percent,2021,0.00011797136796,0.0001393460828031,9.59113125091e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,602,Other urinary diseases,3,Rate,2021,1.35682410196,1.86627810338,0.96432926747
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,941,Sexual violence,1,Number,2021,2045141.6434780385,2857108.0693105077,1383338.457834899
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,941,Sexual violence,2,Percent,2021,0.0022963131985643,0.0034786538905747,0.0014318797442197
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,941,Sexual violence,3,Rate,2021,25.91623471333,36.20555258935,17.529800087709997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,947757.9786461146,1292735.4617558126,625405.3712605323
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.0010448362875141,0.0012695501347811,0.000832928348667
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,12.01008169989,16.38167006962,7.92519796575
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,385,Other neonatal disorders,1,Number,2021,290875.6815782842,373441.1287864526,208408.85970632583
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,385,Other neonatal disorders,2,Percent,2021,0.0003221543901522,0.0003822329912375,0.0002613184738908
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,385,Other neonatal disorders,3,Rate,2021,3.6860050550700003,4.7322824686,2.64097743142
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,785565.3559467096,1246622.4913990824,483768.4297747837
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,0.0008663280856198,0.0012680531994583,0.0005706322513343
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,9.95476093908,15.797322004099998,6.1303608055300005
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,7162841.133525525,9793678.687165182,5079549.09824371
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.0079056307571038,0.0094594285862381,0.0064897333529628
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,90.76822264255,124.10645315104,64.36854243704
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,65675.39913568312,113568.47147629826,37969.15964467147
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,7.22048665363e-05,0.0001075135880552,4.43277945314e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,0.83224507423,1.43915076601,0.48114890055000004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,384377.61508272623,567619.9027179339,242762.6236295236
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.0004252241897562,0.0005781735396434,0.0002976679153652
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,4.87087069143,7.19293486283,3.0763116841700002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,632,Gout,1,Number,2021,1747546.241583506,2484546.8573640827,1186175.0658859387
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,632,Gout,2,Percent,2021,0.0019369615370353,0.0026007199296845,0.0013558464454885
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,632,Gout,3,Rate,2021,22.14507670591,31.484420512910003,15.03132632237
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,2046841.1092229788,3130367.09289136,1191566.71258289
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,0.00225729513919,0.0032085661379489,0.0015272290329797
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,25.93777050929,39.668317633150004,15.099649796069999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,201552.38212073236,335675.55949570844,113813.43263435952
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,0.0002220812692841,0.0003450154655392,0.0001400629562875
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,2.55409147759,4.2537134849100005,1.44225493774
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,34008.33316493669,52637.703324375485,21123.74442714745
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,3.74459732308e-05,5.1517776231e-05,2.68992129282e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,0.43095692043000006,0.66703011915,0.26768215314
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,1,Number,2021,1104931.4906998903,1561755.9243107229,711386.7620638355
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,2,Percent,2021,0.0012139177695364,0.0014280632410488,0.0009838484532886
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,389,Vitamin A deficiency,3,Rate,2021,14.00179980024,19.790723654,9.01476255026
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,1,Number,2021,457197.2766711475,675641.8896177516,293818.1619095664
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,2,Percent,2021,0.0005033032762368,0.0006791376108293,0.0003780186600393
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,3,Rate,2021,5.79364855744,8.56180003441,3.7232924533
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,199219.0713066544,362759.9569216236,99930.53900045875
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,0.000220961377338,0.0004003249062181,0.000119937961602
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,2.5245235349899997,4.5969296152,1.26632955327
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,21663173.120571088,27284831.740833007,15719707.363722458
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.0240010234041584,0.0281294376024258,0.0199411116705919
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,274.51784624244,345.75605350577,199.20166750423
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,4284141.721345121,5591168.3020310495,3100159.2173178606
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,0.0047518294325466,0.0058578627137512,0.0036927086380381
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,54.28906244691,70.85183097184,39.28552048262
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,13829441.429840894,17875552.22202547,9959537.634329043
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.0153146261947926,0.0183575127511081,0.012471760305776
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,175.24803291402,226.52074417136,126.20823393366
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,646,Turner syndrome,1,Number,2021,9176.787175838686,15926.38380200579,4254.187662277889
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,646,Turner syndrome,2,Percent,2021,1.02730756037e-05,1.7914413227e-05,4.6196138296e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,646,Turner syndrome,3,Rate,2021,0.11628914365,0.20182069151999998,0.053909481679999996
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,397536.8614961825,543218.1684752118,280079.77182073274
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,0.0004390832387203,0.0005392528175557,0.0003573759451151
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,5.0376259476200005,6.883713702490001,3.5491982318699997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,875595.2571077305,1160054.798867358,624085.1183059609
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.000965970272926,0.0011130255248913,0.0008398140499737
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,11.09562864237,14.70032774681,7.90846759133
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,4176573.250216082,5623079.102585485,2783810.890123964
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.004617493203597,0.005653233538584,0.0035363876626217
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,52.92594427149,71.25620775411,35.27672357367
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,1043110.3854428072,1608663.1122696032,598139.774404
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,0.0011647252040415,0.00183101561561,0.0006557119479496
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,13.218396714599999,20.38513612258,7.57968565858
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,171215.9692415118,237281.79066117515,117695.2304930068
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,0.0001889668055358,0.0002402693033859,0.0001479329178171
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,2.16966548976,3.00685803332,1.49144545945
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,584081.0282093367,792317.614664065,389450.8185234368
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,0.0006433005122263,0.0007999108345885,0.0005217828601114
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,7.401531853280001,10.04032622123,4.93515882107
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,1,Number,2021,2905111.2902903697,4118101.207730268,1982437.642312971
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0031957422128272,0.0037988453653725,0.002547086492625
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,3,Rate,2021,36.81385409544,52.18498083648,25.12164348448
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,39800012.50873651,54632807.42951744,28016294.51145073
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.0438211566236504,0.0501672705269623,0.0377533271118581
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,504.34964691048,692.31227328778,355.02522119782
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,397,Trichomoniasis,1,Number,2021,274361.54438608704,583896.2970138609,113212.02693393933
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,397,Trichomoniasis,2,Percent,2021,0.000302943420159,0.0005930536020046,0.0001273552310067
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,397,Trichomoniasis,3,Rate,2021,3.4767362951600003,7.399190921530001,1.43463386595
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,1,Number,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,2,Percent,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,3,Rate,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,25943644.916523203,45447523.63750486,15275646.634635236
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.0286391403281155,0.0488435873000405,0.0189450859322677
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,328.76040303623,575.91545968736,193.57448656118999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,2523431.2972691143,3591275.453105881,1641303.762128518
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.0027768041594742,0.0035654345297666,0.0021767793870204
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,31.977167934329998,45.50899340382,20.79876162653
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,936,Guinea worm disease,1,Number,2021,0.8548760095735957,1.4101677383735405,0.4827098259981071
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,936,Guinea worm disease,2,Percent,2021,9.37328e-10,1.3600806e-09,6.226367e-10
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,936,Guinea worm disease,3,Rate,2021,1.0833070000000001e-05,1.786978e-05,6.11695e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,1,Number,2021,32315750.89759092,46496969.19476132,21779579.623938635
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,2,Percent,2021,0.0355290145079422,0.0424423905186279,0.0282116986262822
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,390,Dietary iron deficiency,3,Rate,2021,409.50835257323996,589.2141363181199,275.99296082585
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,39070788.30800708,56908766.07158624,24896408.097751647
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.0430183586218906,0.0558954778217429,0.0324847511161373
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,495.10884659476,721.15344355773,315.48971575534
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,1,Number,2021,3810634.6555271614,6516405.929530588,1761640.867321032
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,2,Percent,2021,0.0041792018687082,0.0062584857857268,0.0022618199211831
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,3,Rate,2021,48.28873464796,82.57653258181,22.323685180280002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,41163477.513802506,56483423.65242352,28987089.22863623
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.0453205998950798,0.0517352942087818,0.0391165218167539
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,521.62760866311,715.7634628668,367.32722669914
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,38647645.33472908,55257787.27450693,26130555.708433755
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.0424999314176576,0.0505538874474622,0.0336749026900921
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,489.74673749697,700.2320789430601,331.12895485222003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,373398.3672781841,551526.0267281698,246374.29000079536
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,0.0004104562931685,0.0005141335527123,0.0003257269911935
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,4.731740590589999,6.98899169394,3.12207907328
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,236688.63364698912,364797.83279803966,141208.85685852752
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,0.0002600984092277,0.0003695251336584,0.0001700654232418
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,2.99934148969,4.622753777400001,1.7894124299999998
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,652,Other congenital birth defects,1,Number,2021,1841189.7822634664,3190829.629707719,1026080.4325365636
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,652,Other congenital birth defects,2,Percent,2021,0.0020302959763422,0.0031141937303009,0.0012126373610142
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,652,Other congenital birth defects,3,Rate,2021,23.33173680224,40.43450480678,13.00259148757
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,655,Psoriasis,1,Number,2021,3689928.256191685,4917112.79314259,2684039.876303613
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,655,Psoriasis,2,Percent,2021,0.0040861497428244,0.0049564293200085,0.0033773326297127
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,655,Psoriasis,3,Rate,2021,46.75913136275,62.310133709030005,34.01241553907
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,388,Iodine deficiency,1,Number,2021,2246334.3724979865,4038016.912462958,1189687.985499023
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,388,Iodine deficiency,2,Percent,2021,0.0024768917044677,0.0041780619024612,0.0014547678908387
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,388,Iodine deficiency,3,Rate,2021,28.46576863169,51.17014482274,15.07584238292
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,628,Osteoarthritis,1,Number,2021,21304565.816655364,42935419.73814723,10189161.469999824
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,628,Osteoarthritis,2,Percent,2021,0.0233100724676121,0.0446435226946314,0.0136890767931238
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,628,Osteoarthritis,3,Rate,2021,269.97353945184,544.08183364602,129.11804961318
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,981,Blindness and vision loss,1,Number,2021,29163992.737770434,42917325.82588366,19033505.67483281
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,981,Blindness and vision loss,2,Percent,2021,0.0321237582975103,0.0440296007241292,0.0238693601582316
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,981,Blindness and vision loss,3,Rate,2021,369.56896525009,543.8525458220699,241.1944434556
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,34697.12928885015,53691.63485711119,19375.95792518547
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,3.82024576536e-05,5.63711192835e-05,2.38005907105e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,0.43968541219999996,0.6803856425,0.24553403183
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,30668.31091248044,46655.968211134845,18824.849629043245
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,3.36796690056e-05,4.57178612158e-05,2.387190351e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,0.38863183212999997,0.59122898739,0.23855033366
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,22610931.0992172,28424200.49366717,16386402.413130486
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.0250458596916726,0.0291614087206244,0.0209383560630851
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,286.52792794234,360.19424565625,207.65009230540002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,1194168.3780256943,1941693.800055408,725141.8920750415
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.0013151861940167,0.0019797462339684,0.0008810246281732
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,15.132618354740002,24.60533353478,9.18906890162
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,122202.68729507033,185245.1744362804,76981.05858979336
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,0.000134308191651,0.00017473628056,0.0001015915207081
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,1.54856439242,2.3474449486199997,0.9755114953799999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,1,Number,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,2,Percent,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,3,Rate,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,575699.7989542893,793010.2155358394,415330.7600983364
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,0.000641597426452,0.0008951775007925,0.000464670789887
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,7.295324097329999,10.04910292714,5.26311196914
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,193057.44221346223,399891.7976687014,79550.36636984124
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.000212855930874,0.0004253862406138,9.33835024918e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,2.44644276914,5.06746792887,1.0080700145900001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,660,Viral skin diseases,1,Number,2021,4199075.027267596,6261658.221507372,2671026.670867524
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,660,Viral skin diseases,2,Percent,2021,0.0046134428543453,0.0059714856159915,0.0034289563854371
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,660,Viral skin diseases,3,Rate,2021,53.211088988680004,79.34834473728,33.84751092841
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,56036.83921522977,84146.84064551062,36100.67836094463
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,6.15945023006e-05,7.91321028784e-05,4.75316622536e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,0.71010430125,1.0663169856799999,0.45747132316999994
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,108251.91189071925,150767.2689644482,75149.04853535743
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0001193501323622,0.0001442187882106,9.87690074533e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,1.37177880352,1.91053756205,0.9522960849900001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,75937507.79821831,105904766.33207816,53556522.82269021
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.0836510523817452,0.1003480809286402,0.0700460634083552
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,962.2875177963,1342.03554569227,678.67348959873
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,333190.32491478027,456200.8999809976,229302.2194245232
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,0.0003676686186505,0.0004606580079428,0.0002971601844233
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,4.222220349500001,5.78102237468,2.90574012702
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,159386.12821298814,207787.13137695944,114680.08897885386
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0001764045470254,0.0002155181162692,0.0001418954631224
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,2.01975658849,2.63309882929,1.45323729161
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,396174.2544221588,581194.338639219,264163.5394802768
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0004352266645525,0.000534303520463,0.0003301205684571
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,5.02035885765,7.36495144103,3.34750618066
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,1948506.085416686,2516108.6494468963,1358644.971651991
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,0.0021605119310633,0.0027175950498876,0.0017015543792844
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,24.69165948043,31.88437462572,17.216881818290002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1000,Near vision loss,1,Number,2021,11649944.750436405,22421658.63139664,5214018.648869342
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1000,Near vision loss,2,Percent,2021,0.0128252817855677,0.0240653554424506,0.0059569200641441
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1000,Near vision loss,3,Rate,2021,147.62923805914,284.12944873849,66.07255372003999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,838,Sickle cell trait,1,Number,2021,1726833.0480156036,2432204.7418793635,1129671.807190905
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,838,Sickle cell trait,2,Percent,2021,0.0018980405138648,0.0023167637612016,0.001497491085105
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,838,Sickle cell trait,3,Rate,2021,21.88259709337,30.82113611174,14.315311507910002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,42712.09227661607,59962.58691020647,28705.023363565862
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,4.71671386432e-05,6.12765919714e-05,3.37792199777e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,0.54125180623,0.7598517595800001,0.3637528605
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,398,Genital herpes,1,Number,2021,259917.0279604043,515995.2007229759,109671.7031161994
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,398,Genital herpes,2,Percent,2021,0.0002865336543753,0.0005529079018066,0.0001286977822734
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,398,Genital herpes,3,Rate,2021,3.29369397181,6.5387415955,1.38977053664
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,4082047.6455516582,5263889.717373735,2958524.668563543
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.0045170996779099,0.0053739424641093,0.0038211963349633
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,51.728106574179996,66.70452477245,37.49071364333
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,126500.36823051446,167808.5301080899,89517.74211687644
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.000139773433614,0.000166750997984,0.0001142342105042
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,1.6030250251100002,2.12648608816,1.13437757385
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,127842.6866122673,199386.5318105477,78464.88913729921
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.0001404785269193,0.0001967458635443,9.55785307854e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,1.62003501478,2.52664561086,0.99431474105
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,1,Number,2021,1086.036360999126,1531.4637024367585,701.8459864330273
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,2,Percent,2021,1.1942183874e-06,1.4681540624e-06,9.607071218e-07
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,3,Rate,2021,0.01376235887,0.019406857660000002,0.00889386091
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,662,Alopecia areata,1,Number,2021,571860.2706807873,808502.0896695843,371725.0764629471
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,662,Alopecia areata,2,Percent,2021,0.0006292038061369,0.0007844240452654,0.0004791242541185
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,662,Alopecia areata,3,Rate,2021,7.24666921993,10.24541746969,4.7105364859
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,101926.79289695312,135393.98042911015,71277.57337243573
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,0.0001130058666879,0.0001481038620346,8.56933345767e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,1.29162627768,1.71572574778,0.90323637348
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,669,Sense organ diseases,1,Number,2021,77327292.99422768,107972583.375837,53419191.94899225
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,669,Sense organ diseases,2,Percent,2021,0.0851577282752754,0.1056811013912493,0.0675602795050499
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,669,Sense organ diseases,3,Rate,2021,979.89901158,1368.23912529331,676.93321935021
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,226373.80466240173,331806.5420220621,145938.6810983561
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0002486907783548,0.0003112400882029,0.0001896404436799
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,2.86863096905,4.20468491749,1.8493492248599999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,664,Urticaria,1,Number,2021,3980785.676250508,5658916.575961198,2616526.390546891
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,664,Urticaria,2,Percent,2021,0.0043801721524222,0.0054108017699833,0.0035543598784851
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,664,Urticaria,3,Rate,2021,50.44490500606,71.71034371799,33.15687805159
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,1,Number,2021,6559.535379096566,13348.928000770742,3181.661913467461
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,2,Percent,2021,7.2124510377e-06,1.3006302206e-05,3.7508583812e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,647,Klinefelter syndrome,3,Rate,2021,0.08312307318,0.1691589198,0.04031833061
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,2719295.3144300217,3909870.147797485,1786905.972615574
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,0.0029925240493915,0.0038062436903166,0.0022999868912183
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,34.45917589541,49.54625650116,22.64384706293
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,1363465.0050659676,1974147.4096219477,886106.8481195453
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,0.0014994432714293,0.0018339546928365,0.0011870288154113
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,17.27796175262,25.01658884588,11.22883255064
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,20630.60787890582,29140.46920273245,13888.80153738117
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,2.27209444504e-05,2.80602820683e-05,1.72129185729e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,0.26143307862,0.36927087272,0.17600025
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,731800654.5108358,947956953.194182,546970874.0432942
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.8074249961577629,0.8276481477437303,0.7857315164880478
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,9273.44938975552,12012.60312480756,6931.26835408661
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,109577.06535970177,143959.15463839011,80533.4191108068
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0001209175319565,0.0001350468415483,0.000107888963715
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,1.38857127775,1.8242644721599999,1.02052735496
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,1475639.1779796078,2010058.1707482303,1062632.0578819655
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.0016277117530517,0.0018692866166805,0.0013639116197046
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,18.699443831019998,25.4716535193,13.46577725499
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,977,Atopic dermatitis,1,Number,2021,5621507.644730095,9367134.693358798,2889265.606640804
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,977,Atopic dermatitis,2,Percent,2021,0.0061755544642495,0.0097891827956477,0.0036903885742785
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,977,Atopic dermatitis,3,Rate,2021,71.23629408663001,118.70124598884,36.61305604414
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,632984.8942769954,858446.7096318903,423432.2382044225
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,0.0007012714428793,0.000882999463003,0.0005142466933697
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,8.02124642193,10.87832057337,5.3657746912
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,675,Other vision loss,1,Number,2021,3003680.831935917,4068865.0071741296,2148641.5972002284
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,675,Other vision loss,2,Percent,2021,0.0033116418041076,0.0038021659681803,0.0028920007874435
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,675,Other vision loss,3,Rate,2021,38.06293695727,51.561054892739996,27.22779623868
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,680,Oral disorders,1,Number,2021,23239420.623836644,35026532.73727378,13849366.435526336
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,680,Oral disorders,2,Percent,2021,0.0255795823295243,0.0360288722923337,0.0173559544497287
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,680,Oral disorders,3,Rate,2021,294.49220860077,443.8596448849,175.50052453271
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,671,Cataract,1,Number,2021,6553846.480704118,8804276.7054034,4736091.921126926
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,671,Cataract,2,Percent,2021,0.0072264019086662,0.0082253514831774,0.0063170464084517
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,671,Cataract,3,Rate,2021,83.05098290416001,111.56865457511,60.01621953338
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,1,Number,2021,44449944.07336716,62029878.36082989,30689648.464790203
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,2,Percent,2021,0.048944750311068,0.0590671153096249,0.0392455335236115
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,3,Rate,2021,563.27403398862,786.0486788117901,388.90222367709
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,2399396.0000157715,3447887.08719258,1610374.7489578808
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0026378558836139,0.0031546095951078,0.0020883559802005
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,30.405380529480002,43.69196202215,20.40682614992
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,654,Dermatitis,1,Number,2021,8177101.56378882,12991190.780866465,4847630.095751273
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,654,Dermatitis,2,Percent,2021,0.0089895212500981,0.0127432431243319,0.0062237348130768
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,654,Dermatitis,3,Rate,2021,103.62102990653,164.62563879442,61.42964217933
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,7998581.894100515,10388663.902788268,5950657.172270837
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.0088342640340723,0.0097486215702684,0.0079837887450069
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,101.35881121114,131.64616393255,75.40730905703
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,91450.69336301416,120596.05204024677,65134.04756436759
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,0.0001012049330835,0.0001225584814213,8.12344588205e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,1.1588721208900001,1.5282049535,0.8253850142299999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,707.8094751708528,1085.086655748676,431.9354605726114
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,7.836525436e-07,1.1686811701e-06,5.133958842e-07
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.00896943082,0.01375032411,0.0054735283599999995
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,1,Number,2021,12019069.902344575,23267858.34157148,5858107.8822426
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,2,Percent,2021,0.0131541246148362,0.0247090501743411,0.0076543911740679
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,3,Rate,2021,152.30682804708002,294.85257413823,74.23451541186999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,11289.452235009294,21102.142717702467,5393.638249059399
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,1.23776902727e-05,2.14841778975e-05,6.4640141933e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,0.14306104168,0.26740841417,0.06834871084000001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,405,Leprosy,1,Number,2021,21427.508513152647,31592.81657374651,14005.547103443036
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,405,Leprosy,2,Percent,2021,2.35242884959e-05,2.93250303996e-05,1.8209645065e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,405,Leprosy,3,Rate,2021,0.27153148131000004,0.40034725819,0.17747966122
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,598,Male infertility,1,Number,2021,317613.60632749385,752758.232541996,116288.10701535558
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,598,Male infertility,2,Percent,2021,0.0003505300690984,0.0007866671237914,0.000134027954948
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,598,Male infertility,3,Rate,2021,4.02483064974,9.53902586609,1.47361425327
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,49081.03203726707,67639.0804600927,33867.03550091901
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,5.42167152649e-05,6.9523429427e-05,4.25567704141e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,0.62195963312,0.8571290358199999,0.42916638262
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,23725.11603736707,32068.396114576743,16123.527808817267
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,2.62352894845e-05,3.32829533885e-05,2.02926496325e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,0.30064698833000003,0.4063738486,0.20431891963999999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,8379627.38738648,13840560.144391531,4817164.19138141
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.0092205065020054,0.0136785010337772,0.0058183683164322
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,106.18745692962,175.38893035108,61.043575262690005
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,56954.37720094153,76443.08703864459,40138.53452369008
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,54115.8592243559,71621.31466735809,37892.50225819276
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,5.98463567743e-05,7.30337194061e-05,4.70988860311e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,0.68576145513,0.9075922967600001,0.48017749065
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,659,Fungal skin diseases,1,Number,2021,3429496.838302107,7044258.966406154,1407893.9330940386
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,659,Fungal skin diseases,2,Percent,2021,0.0037813740845346,0.0078161062264005,0.0016350026301319
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,659,Fungal skin diseases,3,Rate,2021,43.458918991510004,89.26553783552,17.84096946923
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,661,Acne vulgaris,1,Number,2021,5125473.488867778,8069826.906486757,3225014.362003683
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,661,Acne vulgaris,2,Percent,2021,0.0056465721527692,0.0079834810559458,0.0039089563915671
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,661,Acne vulgaris,3,Rate,2021,64.95050080177,102.26163496862999,40.86769707423
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,35789.701371821924,48769.53429961645,24061.95739300034
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,3.95518840286e-05,4.91669496773e-05,3.10598702912e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,0.45353059238,0.61801230335,0.3049154749
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,999,Refraction disorders,1,Number,2021,6618600.065539285,9528675.976834849,4599082.3212913815
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,999,Refraction disorders,2,Percent,2021,0.0072844077974074,0.0087348298823055,0.0058586718256979
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,999,Refraction disorders,3,Rate,2021,83.87154665752,120.74831291538,58.28002049864
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,331029.5175666141,459127.3162038025,231456.5431021446
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.0003643988246568,0.000439099551108,0.0003047289624522
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,4.19483838768,5.81810620696,2.93303992714
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,282158.8999967647,365880.8713632088,206449.18914042023
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0003113910486421,0.0003555036307559,0.0002729974615577
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,3.57554514725,4.63647814791,2.61614429455
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,44277.19230624308,61455.03526175248,30688.682501856667
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,4.87320390868e-05,5.52208377755e-05,4.19468945514e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,0.56108490672,0.7787642109,0.38888998290000004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,44089.26803743744,65849.06240207434,29048.44843651413
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,4.85899564975e-05,6.35061922499e-05,3.70678610029e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,0.55870351202,0.83444575211,0.36810477658
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,1082312.6420537853,1410698.6909259409,806943.2054303391
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.0011952133886063,0.0013437517997602,0.0010671211124413
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,13.71517154037,17.87651163449,10.22566313631
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,3293593.832010526,6086268.356318738,1598859.1160037145
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.0036301076262865,0.006131504930915,0.0018694494514349
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,41.73674281827,77.12578723029,20.26089892406
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,6.28679995612e-05,7.46895128389e-05,5.28128362243e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,0.72173143225,0.96869426733,0.50863943096
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,125928.33763991276,165905.69313967234,89609.78181633865
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.0001391189015896,0.0001647285643953,0.0001162634345269
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,1.5957761975799998,2.1023731521999998,1.13554390991
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,336361.7352905069,435311.5989640943,247979.53583511597
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,0.0003720426338175,0.0004317662862,0.0003209923484464
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,4.2624087716200005,5.51631111134,3.14242090532
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,268344.7279939971,384794.7189944779,186346.20550423357
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,0.0002986716115858,0.0004040345588894,0.000213932735341
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,3.4004906100100003,4.876156272949999,2.3613973218899997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,139.94796009656827,225.25889060347663,91.46464007417552
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,1.548231451e-07,2.349142922e-07,1.048092909e-07
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,0.00177343422,0.00285450267,0.00115904885
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,75621.70199089263,114708.51148812854,48581.9053830129
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,8.31227532577e-05,0.0001094450469926,6.41016872344e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,0.95828559575,1.45359746442,0.61563465139
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,4184098.963289324,5714238.885143526,2940732.857302566
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.0046052393290409,0.0051784957660425,0.0039789199791994
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,53.02131084281,72.41139342485,37.26525407279
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,325723.76911613444,425362.16541641584,232731.28550636396
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.0003603825795541,0.0004366511372697,0.0002893401556452
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,4.12760342495,5.39023091738,2.94919358742
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,670,Glaucoma,1,Number,2021,759900.2307162702,1049127.1676979891,530942.903091785
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,670,Glaucoma,2,Percent,2021,0.0008385078604742,0.0010207717942919,0.0006879011581907
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,670,Glaucoma,3,Rate,2021,9.62952996472,13.29464196717,6.72816034028
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,847627.31068797,1093844.501116757,632088.9473022264
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0009364073423865,0.0010415664222226,0.0008424805991608
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,10.74121609291,13.86130438507,8.00989289433
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,160873.21583759782,210399.6277603756,118043.3588789592
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0001776952929148,0.0002016850212262,0.00015654410786
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,2.03860110816,2.6662046387,1.49585697637
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,10854.577580918402,14209.374120796076,7788.508128825921
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,1.20080126154e-05,1.42877718942e-05,9.573584416e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,0.13755026758,0.18006257709,0.09869673592999999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,3601.0130970872783,5693.9287121187135,1969.2724461917892
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,3.958666778e-06,5.4788177677e-06,2.3714236074e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,0.045632389780000004,0.07215402092999999,0.02495481283
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,94539.67196482222,137388.28418661834,62313.25697864793
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0001048318858092,0.0001456546332626,7.24325457345e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,1.19801595952,1.74099775984,0.78963968034
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,15603394.390858674,22034611.061889425,10581106.619740335
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,0.0172250141725078,0.0223607936139779,0.0133032030332015
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,197.7277381485,279.22474412374,134.08481684313
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,42230.51456971866,61290.42007853856,27327.47713624496
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,4.64606323683e-05,5.92653953025e-05,3.50658496017e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,0.53514920648,0.77667819121,0.34629646012
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,1,Number,2021,1139666.9290564032,2306309.680403299,535835.9877865056
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,2,Percent,2021,0.0012502891661112,0.0024286421415466,0.0006681254203415
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,3,Rate,2021,14.4419706687,29.22578159296,6.79016598758
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,679,Other sense organ diseases,1,Number,2021,3713356.183090227,5592061.128040312,2245880.789617425
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,679,Other sense organ diseases,2,Percent,2021,0.004089219666697,0.0057765826384515,0.0028286630814518
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,679,Other sense organ diseases,3,Rate,2021,47.05601234128,70.86314495026,28.460020785110004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,157844.93262649362,207638.5668334888,116035.6981105714
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0001741777456026,0.0001931912920419,0.0001575507989501
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,2.00022640745,2.63121620488,1.47041570297
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,134755.0010420934,181181.68054300937,95161.6906353322
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0001485511774833,0.000166654274731,0.0001270853044874
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,1.7076285385599999,2.2959519570099998,1.2058982408799999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,157130.33187629146,209802.8815528326,114654.4607774234
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0001734618392028,0.0001981136793037,0.0001525519956343
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,1.99117091693,2.65864261246,1.45291252854
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,1,Number,2021,6167307.934762242,12737380.264057342,2803411.048618337
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,2,Percent,2021,0.0067393010997423,0.0129080734270689,0.0036606662221417
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,3,Rate,2021,78.15272868577,161.40932712852,35.52509869702
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,281130.1184933461,370714.6657295996,205088.9780873147
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0003102631174384,0.0003477252650464,0.0002788417736882
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,3.56250832753,4.69773246238,2.5989075672
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,32690.01062462821,46533.79263213043,22299.612432251903
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,3.59220570844e-05,4.36030836288e-05,2.91381580593e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,0.4142510084,0.58968076651,0.28258286738
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,1,Number,2021,364837.755789276,533514.36924983,246307.74829213828
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,2,Percent,2021,0.000401405202739,0.000489712218103,0.0003247100872253
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,3,Rate,2021,4.62325968545,6.760746210660001,3.1212358502399997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,31774.10150778735,42997.52749547028,22968.871841894823
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,3.50460477155e-05,4.17519393704e-05,2.91722204601e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,0.40264451858999994,0.54486886921,0.291063788
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,83396.30980058429,108793.709928362,60668.84447336562
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,9.24323691031e-05,0.0001125717793112,7.16780970681e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,1.05680618548,1.37864452119,0.7688015244199999
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,5546.504636191794,7746.590630963639,3698.293543302211
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,6.1233736569e-06,7.8533820238e-06,4.7155745246e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,0.07028584863,0.09816555331000001,0.0468651371
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,15210424.47866483,19424864.466749907,10985667.174310338
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.0168785607885499,0.0202712491677651,0.0134596783321664
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,192.74798502863,246.15378030192,139.21144771558
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,2687376.4899045643,3470267.4385633366,1908567.9165260685
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,0.002980421956278,0.003622254621338,0.0023292154410813
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,34.0546974326,43.97556802124,24.18555910235
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,167775.00729064218,226578.38549813488,115690.41334984964
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.000184797539555,0.0002211054179497,0.0001540393707403
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,2.12606128375,2.87122343739,1.46604022074
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,548279.9733195964,701515.3506651819,398231.3316405581
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.0006078534335557,0.0007394001307279,0.0004825463599688
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,6.94785738801,8.8896710606,5.04642634114
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,346611.68310747744,451507.6946606594,254413.02855796416
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0003833324373575,0.0004444777963988,0.0003306212454395
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,4.3922971117600005,5.72154961834,3.22394675365
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,236511.44113529057,316687.82150229753,170822.78986470558
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0002609071039209,0.0002962925783236,0.000228752342913
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,2.9970960888700002,4.01309901399,2.16468308229
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,2672127.4485740573,4028487.622748779,1650928.2515815415
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.0029344453745555,0.0039351341111353,0.0021159707717484
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,33.86146009105,51.049388732489994,20.92072409718
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,3546521.1249484965,5025243.439409624,2392086.9020754
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.0039070401043203,0.0049251421912564,0.0031080712383869
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,44.941862184979996,63.68037582272,30.31275892629
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,506127.70692773774,999359.7260561888,242340.3794702621
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.000556238989691,0.0009851629478189,0.0002785699901978
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,6.41369975008,12.66398408448,3.07096096493
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,32470170.86731241,41787495.21168329,23906841.90394655
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.0358888956813091,0.0401583357130222,0.0312396076465826
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,411.46517751614,529.5352218962199,302.94983626835
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,28045.588157455382,44226.67896084215,17141.139594187196
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,3.11305209098e-05,4.62918069652e-05,1.98143780701e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,0.35539643314,0.56044479667,0.21721419560000002
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,380432.7974552551,655414.1411535861,215033.06207576924
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,0.0004189066938848,0.0006490307617808,0.0002714037746868
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,4.820881577050001,8.30547202965,2.72491997102
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,4053664.489482617,5612883.330059389,2653626.0809223037
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.0044670898391134,0.0055010306995239,0.0035595901900982
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,51.368432447480004,71.12700592854,33.627008952610005
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,51072.76261298069,66171.84703444761,36953.2096426978
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,5.64693716152e-05,6.54149719638e-05,4.71652667857e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,0.6471990375600001,0.83853611051,0.46827468286
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,103534.94793112224,136796.18891491205,72500.29557407025
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.0001146107764799,0.0001380250026018,8.90834760897e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,1.31200497539,1.7334946707099999,0.91873082868
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,1204681.3336155098,1538361.2763358173,861778.1068498846
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,0.0013354985233397,0.0016051394331365,0.0010533973654613
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,15.26583955508,19.494264389239998,10.92053636439
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,443655.80715273926,641779.9629599666,302603.9610299869
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,0.0004880516648253,0.0005840125442042,0.0004015197818972
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,5.62204973273,8.13269839154,3.83462695811
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,972,Headache disorders,1,Number,2021,47975675.0648608,100667852.51845008,9800212.25967029
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,972,Headache disorders,2,Percent,2021,0.0523206202291913,0.1039017670719845,0.0118757285608677
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,972,Headache disorders,3,Rate,2021,607.9524415713,1275.67286220758,124.18924722015
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,155645.724364628,201143.4043579417,113442.62067274298
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0001722190364421,0.0002020246578116,0.0001453605997385
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,1.9723578254999998,2.54890887142,1.43755597233
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,7639612.016775333,10649228.725304583,5352490.066390272
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.0084033554702889,0.009714894401164,0.0072464715551765
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,96.80990985487,134.94806682025998,67.82727705131
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,49986489.97827128,67375103.99081612,35667342.338320315
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.0550943003459963,0.0618058545568439,0.0486698724239108
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,633.4336846075499,853.7839002152599,451.98004675546997
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,1,Number,2021,1017718.4598329922,1440227.0822816656,665608.9957109836
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,2,Percent,2021,0.0011222900394313,0.0014573541091962,0.0008620429852776
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,3,Rate,2021,12.89662775252,18.25069829463,8.43466222262
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,3966615.7637580754,5660334.863610754,2559115.4259449886
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.0043811646972118,0.0057556112537881,0.0032602540738474
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,50.26534249057,71.72831639765,32.4293606992
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,631,Neck pain,1,Number,2021,20415496.55499668,28856642.591458928,13638705.322556373
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,631,Neck pain,2,Percent,2021,0.0224813204622025,0.0288767177814089,0.017245572319753
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,631,Neck pain,3,Rate,2021,258.70716690741,365.6741941684,172.83100632788
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,1,Number,2021,42988181.62933535,59205437.92178203,29647810.87833092
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,2,Percent,2021,0.0475255074044756,0.0617538274417099,0.0359682932402118
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,3,Rate,2021,544.75043748591,750.2570936247,375.69995599556
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,1,Number,2021,4166830.599270596,6046934.016741545,2646070.254687142
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,2,Percent,2021,0.0045843285052162,0.0060369067448527,0.0035111620961966
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,3,Rate,2021,52.802484446870004,76.62733863626,33.53126078437
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,1579.0230822811425,2518.3582554656728,961.7048073907076
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,1.732270807e-06,2.2973694446e-06,1.2577950477e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,0.02000953477,0.03191288185,0.01218681728
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,122712.1024565342,172329.31302290037,84294.41931424398
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0001350493508947,0.0001583157527741,0.0001123551330158
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,1.55501975111,2.18377389093,1.06818711698
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,14857504.67473644,17130012.983007975,12405348.940007698
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.0166255378576116,0.021020547496729,0.0129351803429479
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,188.27575079353,217.07319809650002,157.20179375121
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,26237826.65721248,32464798.73492633,20945372.05601801
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.0291550065152313,0.0343779206903691,0.0249106519951323
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,332.48830279535,411.3971013297,265.42180102437
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,229000.13621825053,301171.30825932254,161684.6565245245
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.000253093084625,0.0002961341972809,0.0002077229624827
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,2.90191209912,3.81647224223,2.04888376382
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,1,Number,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,2,Percent,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,3,Rate,2021,0.0,0.0,0.0
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,177794.37897352365,314127.052902058,98571.3109303577
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,0.0001956312062132,0.0002997273654099,0.0001239581121538
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,2.2530277405900003,3.9806487041000005,1.24910528237
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,258892.2773554882,384147.9133745037,160890.6172345781
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0002849404716844,0.0003663898665661,0.0002059233334402
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,3.28070823202,4.86795988894,2.0388216203600003
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,1,Number,2021,282828.14987132495,451330.62548297015,165090.84954473184
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,2,Percent,2021,0.0003108318251628,0.0004409134134139,0.0001995964048098
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,3,Rate,2021,3.58402594704,5.71930578043,2.09204737455
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,254717.6814194577,386562.67873066186,156367.95137810038
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,0.0002797444252717,0.0003609955521461,0.0002075492731175
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,3.22780734447,4.89856003145,1.98150995677
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,20223349.53226688,26266077.010439143,14418545.626231246
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.0223841349087208,0.0269647721611749,0.0180167089569781
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,256.27226106291,332.84629403145,182.71321884525
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,11318366.655144757,14471899.726694452,8183926.632993044
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.012562640308932,0.0151570208442657,0.0099676404613488
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,143.42744804094,183.38932721893,103.70751785028
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,10080.934872500728,14069.57786744555,6633.9587890731145
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,1.11439832666e-05,1.43406406306e-05,8.3597042947e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,0.12774659160000001,0.17829106531,0.0840661739
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,978,Contact dermatitis,1,Number,2021,2272765.769187401,3462431.5449964446,1395453.582863411
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,978,Contact dermatitis,2,Percent,2021,0.0025031349606858,0.0033498649966931,0.0017573330025778
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,978,Contact dermatitis,3,Rate,2021,28.80070987284,43.87627081241,17.6833241357
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,334914.52319054096,569705.8177826207,189302.44827582192
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0003688575489049,0.0005881037375029,0.000234382807266
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,4.2440695585,7.21936778232,2.39885911911
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,34809.52967193664,48911.27500122426,23220.407813757352
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,3.83039026493e-05,4.60452802926e-05,3.17691309593e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,0.44110976084000003,0.61980845537,0.29425127641000004
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,294935.8680727873,393036.4553305624,206538.62409878103
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,0.0003269949239815,0.0004214226496044,0.000241343610126
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,3.7374561349999995,4.980596361,2.61727762308
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,150159.85811537647,219405.66494425456,95738.54827099304
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,0.0001650385032808,0.0002157254463302,0.000126076096343
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,1.9028403924200001,2.7803300217699998,1.2132082372
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,17763.786521559145,25920.653792184425,11658.86149510125
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,1.95151861803e-05,2.44923356471e-05,1.5253404039e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,0.2251044383,0.32846905726000003,0.14774223192
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,10249.947816970753,19782.57998054463,4807.2346315055765
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,1.12898035399e-05,1.95287664959e-05,5.599263033e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,0.12988834014,0.25068678624,0.06091774691
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,2277.079275365993,3491.228428935142,1402.7238254269369
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,2.5021879125e-06,3.3257703872e-06,1.7885613217e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,0.02885537104,0.04424118774,0.01777545336
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,141857.0809770786,202171.71116430263,95336.59965331678
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.0001560016180309,0.0001867410675859,0.0001288804269738
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,1.79762678936,2.5619396757399997,1.20811470505
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,17029.59478181853,23538.299847480022,11513.300058134457
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,1.87622776724e-05,2.33767078799e-05,1.42093796972e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,0.21580068883999998,0.29827963532,0.14589766317
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,66236.97034332684,89397.74883547984,45822.49163806431
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,7.30563922865e-05,8.59501074291e-05,5.79677283873e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,0.83936135944,1.13285700727,0.58066709082
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,51372.25900620566,70239.74305798693,36143.85891343892
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,5.66281828892e-05,6.9163901864e-05,4.85124952535e-05
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,0.65099428512,0.89008488635,0.45801851134999993
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,658,Scabies,1,Number,2021,5315518.988184458,8740279.673302758,2968358.835500801
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,658,Scabies,2,Percent,2021,0.0058423608167848,0.0083407550463412,0.0037769688602008
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,658,Scabies,3,Rate,2021,67.35877593627,110.75767793192,37.61533316754
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,5581.619631848707,8270.807591763827,3663.609552057578
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,6.1490381364e-06,8.155481225e-06,4.385143175e-06
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,0.07073082929,0.10480848185,0.04642561817
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,1,Number,2021,1978521.0504921584,4152837.927573842,913347.14311263
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,2,Percent,2021,0.0021663575869223,0.0044108078828163,0.0011890038274011
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1017,Osteoarthritis other,3,Rate,2021,25.07201205028,52.62516794407,11.574024230120001
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,663,Pruritus,1,Number,2021,851113.0503753108,1556084.7467840489,413005.3668196894
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,663,Pruritus,2,Percent,2021,0.0009375907200953,0.0016343147747651,0.000475187963791
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,663,Pruritus,3,Rate,2021,10.78538772678,19.71885793832,5.23364435833
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,7739689.616745025,10041169.012102276,5769697.606497956
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.0085493235623879,0.0094391133418192,0.0077156463152009
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,98.07810297911999,127.24267472807001,73.11417176009
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,14252860.158604568,33727827.886568144,5138706.534068899
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.0157559639065613,0.0361642541201554,0.0059974996208045
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,180.61363641226998,427.40233013529996,65.11819124341
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,1,Number,2021,578020.3784384321,797569.822767952,401241.3158186415
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,2,Percent,2021,0.000637517141287,0.0007783950214916,0.0005117617882664
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,672,Age-related macular degeneration,3,Rate,2021,7.3247307072700005,10.10688271545,5.08456915471
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,1,Number,2021,200728.17649295065,385501.90316568,88103.15592676323
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,2,Percent,2021,0.0002207763152301,0.0003938021108058,0.0001044523005578
3,YLDs (Years Lived with Disability),1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,3,Rate,2021,2.54364706335,4.88511777986,1.11645179945
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,52809221.71105702,105829146.70028393,19553713.43737263
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.026676189948306245,0.053050583459159445,0.009964936687583463
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,669.2036169019502,1341.0772863302539,247.78656704600223
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,180359.20684711542,205364.78433656826,158894.81399020355
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,9.131068310810875e-05,0.00010385346383928175,7.958171152196091e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,2.285529489982719,2.602402610935385,2.013530606661888
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,387674.91001976223,1247610.6661378592,120867.20719331871
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,0.00019599971287605992,0.0006180025069538394,6.310198999072029e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,4.912654335010653,15.809844250934997,1.5316410580932855
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,387674.91001976223,1247610.6661378592,120867.20719331871
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,0.00019599971287605992,0.0006180025069538394,6.310198999072029e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,4.912654335010653,15.809844250934997,1.5316410580932855
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,61326.11399258931,175725.10211839702,21341.102092359364
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,3.097188679465553e-05,8.571827611628513e-05,1.0885880392000023e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.7771305079807552,2.2268056621155234,0.2704365307071064
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,351,Schistosomiasis,1,Number,2021,500461.3063998558,569933.0424644377,430719.7135820447
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,351,Schistosomiasis,2,Percent,2021,0.00025302788154914663,0.0002797696421676772,0.00022357640944861563
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,351,Schistosomiasis,3,Rate,2021,6.341894568996005,7.2222471956877525,5.458122291162752
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,352,Cysticercosis,1,Number,2021,81285.4040590107,116997.6590093496,54026.63853754648
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,352,Cysticercosis,2,Percent,2021,4.11149083439919e-05,5.879284057924303e-05,2.720704640255143e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,352,Cysticercosis,3,Rate,2021,1.0300565816942744,1.482605765457145,0.684630841866969
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,59521.94782734013,79907.4147433515,40789.941468389305
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,3.0106317896799287e-05,3.973750168042501e-05,2.0796728932209978e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,0.754267938070469,1.0125945664588114,0.5168941234017401
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,1508859.012643118,2062330.330813224,892487.3639149816
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0007632202729567154,0.0010298209931323152,0.000452800584773287
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,19.12040882140978,26.134051438554717,11.3096870701683
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,317713.58227221016,686135.5915478482,119973.95563044043
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,0.00016070091324255726,0.0003490815681224745,6.029168982534689e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,4.02609755467995,8.694777250482385,1.5203216870191931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,569498.0627286219,828445.8119944563,323330.0018439604
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,0.0002880429052541526,0.0004088594909315832,0.00016446339730659341
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,7.216735089978644,10.498146267470645,4.097269372208697
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,1,Number,2021,284295.1820377957,383248.0171747013,176764.14783854413
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,2,Percent,2021,0.00014362793462866272,0.0001902187184823443,9.227291143691233e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,360,Intestinal nematode infections,3,Rate,2021,3.6026163219833447,4.856556316377444,2.2399725509943904
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,361,Ascariasis,1,Number,2021,284295.1820377957,383248.0171747013,176764.14783854413
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,361,Ascariasis,2,Percent,2021,0.00014362793462866272,0.0001902187184823443,9.227291143691233e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,361,Ascariasis,3,Rate,2021,3.6026163219833447,4.856556316377444,2.2399725509943904
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,1,Number,2021,1404589.3035248683,1803424.6071415173,905698.8063195257
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,2,Percent,2021,0.0007100434916852632,0.000902722071769625,0.0004599490097216761
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,3,Rate,2021,17.79909288047369,22.85317281349734,11.477103759056208
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,11366263.252700957,13447723.144921238,9611950.232161753
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.005747341756772623,0.006676058002062725,0.0049546019488714
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,144.0343984045994,170.41086151423286,121.80357241465269
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,2820693.0683212727,3398797.8683131943,2357265.4998698547
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.001426611745450295,0.0016774028243470849,0.0012060660197905878
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,35.74409813912551,43.06989864456955,29.871498715551038
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,1064598.3476510188,1279542.5170541885,880113.112100693
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,0.0005383111867119649,0.0006367056959329855,0.0004541908526208548
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,13.490694271048797,16.214487785439267,11.152879342232335
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,2295659.373288297,2775552.4219113505,1912051.8770045617
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.0011609794194548015,0.0013765242525639264,0.000984350974728066
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,29.09081986068606,35.17207145764742,24.229708189918405
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,682892.5237743225,807766.9005017346,573552.3754375874
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.0003454169212973921,0.0004075073801520813,0.0002943981278999989
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,8.653680778813554,10.236101080737146,7.268111736726751
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,389068.92298708495,470679.44068227167,324383.2754841894
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,0.00019663368648229808,0.0002276479678589232,0.00016749246290615575
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,4.930319403525483,5.964495856980477,4.110616558680887
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,1,Number,2021,1137139.9513313936,1329680.2097643286,971505.0664926388
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,2,Percent,2021,0.0005749491836813498,0.0006578563249150084,0.000503930066538546
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,375,Indirect maternal deaths,3,Rate,2021,14.40994856008916,16.849837525837337,12.311007117139926
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,376,Late maternal deaths,1,Number,2021,332451.0719348508,411591.66154859,263625.71026469464
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,376,Late maternal deaths,2,Percent,2021,0.00016813878325095966,0.00020732761431195817,0.00013555363694518093
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,376,Late maternal deaths,3,Rate,2021,4.21285246351493,5.21572974701366,3.340690756299124
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,1,Number,2021,1599426.1114613998,1955424.179465671,1332983.3828562812
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,2,Percent,2021,0.0008083178715357232,0.0009485339637906705,0.000688500388183736
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,379,Other direct maternal disorders,3,Rate,2021,20.26808394590078,24.779326244112582,16.891695657973468
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,164702838.65381786,190806654.15320385,141275203.5839192
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.08323293555919416,0.09204864969093818,0.07402162646277337
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,2087.1304626342485,2417.920562944947,1790.2531821847167
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,66505729.77564327,78854557.47063416,55994023.32338902
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.03361082141002951,0.038005637653886024,0.029213668076726314
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,842.7671052240789,999.2526562364072,709.5617340836221
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,54290948.86209648,65231905.117027305,45979553.73408126
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,0.027434898210710365,0.031454511690401206,0.023968312110952017
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,687.9802081223777,826.6250746993965,582.6573970496953
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,20923054.1217934,24505082.394093018,17729686.24040426
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.010573607858054595,0.011899091307287283,0.009269022775386443
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,265.13898598145295,310.53079820666625,224.67231620137778
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,3025772.8862849507,3872113.3989100736,2329032.0095478534
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,0.001529043512768873,0.0019479611298261225,0.0012039983154668744
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,38.34288962834272,49.06779929048985,29.513721167822226
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,385,Other neonatal disorders,1,Number,2021,19957333.007999722,24153608.063844815,14380509.575486315
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,385,Other neonatal disorders,2,Percent,2021,0.010084564567630924,0.011758752389849919,0.0073140422484997926
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,385,Other neonatal disorders,3,Rate,2021,252.90127367799758,306.07688115526156,182.23122229414778
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,10271615.72360502,12135584.824601317,8536644.606090572
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.0051918780474663586,0.00593939910071826,0.004392454241332141
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,130.1629179705222,153.78331652525063,108.17719446537907
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,9302699.505809193,11123335.807992231,7581493.928727665
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.004701663452369874,0.005442810257915077,0.003909560551899417
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,117.8847169969945,140.95599809161405,96.07343176508967
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,13728173.784774313,15807830.270354789,11607632.282509651
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.006944657212982927,0.007920931707623407,0.005977680540087595
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,173.96475942204597,200.3183695865495,147.09305033171668
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,11702193.867203264,13567346.586005973,10002627.695618974
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.005922354613917159,0.006935580566807143,0.005106131196476085
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,148.29134397147527,171.92674144668416,126.75427540016766
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,11039900.653892683,13175876.423988134,9341406.640533347
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,0.005587586790224324,0.006619787377026129,0.004718826002603065
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,139.8986996673787,166.96599330756365,118.37521758984629
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,6705435.561903291,8091066.2538196,5558473.408591064
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,0.003392465974999619,0.004049518487070128,0.0028247779789279015
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,84.97193455114129,102.53078205308417,70.43751808793694
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,72909444.41370618,78862496.54872547,67795279.77636316
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.03689279308747042,0.03948525349433332,0.03463032364920532
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,923.9156027506473,999.3532610096158,859.1084088202474
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,5722709.347669472,6693440.375924382,4838576.605823383
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,0.002895685580275046,0.0033898904498722796,0.002442905101680393
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,72.51873195353622,84.8199303825053,61.31491547045861
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,1104046.073697804,1311474.5642126924,918317.2033699132
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0005585665500544177,0.000659542563213741,0.0004688558977923575
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,13.990579709495583,16.619133806743537,11.637005319276632
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,1127169.6933165414,1309718.9806614213,957548.8954207952
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,0.0005703058245878259,0.0006552719893440343,0.0004925925394810627
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,14.283604476446147,16.596886880464023,12.134153153821158
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,6482636.870926482,7207504.751989583,5567193.4759388
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,0.003279437739844545,0.003595669068552196,0.0028850004844599656
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,82.14860777199497,91.33420437929948,70.54801963330456
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,1232654.4233801616,1460192.2764078712,1046311.0462910718
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.0006238187511959253,0.0007352524655145332,0.0005197517212973658
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,15.62031728150762,18.503699185171733,13.258955801574414
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,931581.278277038,1023099.1054814111,827968.7559480931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,0.0004714630875514166,0.0005141693529044563,0.0004180006868996266
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,11.805088972379343,12.964811819863607,10.492100966643493
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,1658631.553298814,1783742.0437382446,1531205.3938786504
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,0.0008396218518935106,0.0009049743499334335,0.000765538123960559
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,21.018341089144744,22.60375344709501,19.403584347633398
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,2464770.003383472,2953251.7688057697,2155618.410239533
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0012474555475793124,0.0014966420451106388,0.001103781448016922
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,31.233806287099643,37.423894942445365,27.316207095146243
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,3734154.9011368332,4333353.965567656,3350415.0713862227
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,0.001889660611852619,0.002208709697925796,0.0016966802145297669
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,47.31957572837505,54.91268481366605,42.45678711498639
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,1,Number,2021,968916.2177958317,1110465.7232586627,859148.6601514868
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,2,Percent,2021,0.0004902145950964835,0.0005483033614679552,0.00043826998956725743
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,391,Other nutritional deficiencies,3,Rate,2021,12.27820097352748,14.071930135920622,10.887215758937403
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,6759142.709664954,13277878.807368623,2699688.720063897
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.0034180648651117285,0.006616288413276799,0.0013572264286227285
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,85.65251677468241,168.25857747523656,34.21071921606993
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,6583148.525990847,13094605.827261785,2535762.9185338425
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0033290105897006914,0.006558289280918878,0.0012750859254721705
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,83.42230128480409,165.93612436583552,32.13343544378334
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,41413.99561778971,56787.46912048763,25777.35962677943
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,2.0952548292943042e-05,2.855854438986442e-05,1.3406098176986187e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,0.5248021985520682,0.7196163567428852,0.32665321959879
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,16284.7403886631,24435.572676293617,9979.868675940952
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,8.242718450127636e-06,1.2274013194902546e-05,5.125967686877785e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,0.20636182119913488,0.30964996427172015,0.1264658708792867
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,118295.44766765831,160037.0887856001,74404.57340598908
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,5.985900866796382e-05,8.038328360707683e-05,3.899272424272202e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,1.4990514701271818,2.028005624467637,0.9428620234126514
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,3831873.874634965,5192383.400117226,2950477.19480303
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0019382064932747317,0.0025783826780850154,0.001501110615469453
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,48.55788010753623,65.7983897341278,37.38873526961105
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,1590989.3697440666,2583709.66006315,1059241.004625663
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0008050315752832654,0.0012915887301911011,0.0005388693865193507
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,20.161172730602118,32.74102123676535,13.422805496827323
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,1787128.992679606,2236494.580699609,1306352.5310246279
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.0009037439002370448,0.0011322554674501638,0.0006674632409834563
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,22.64667319497964,28.341077828693326,16.554226901769646
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,254798.52732745584,440162.2061229981,107639.43455213586
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,0.000128860665441751,0.00022393879249525274,5.449673612066002e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,3.228831831716296,5.577778479158657,1.36401743085125
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,198956.9848838302,347423.61416856607,99263.24046909492
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,0.00010057035231266915,0.00017476571196170507,5.0397317162035884e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,2.5212023502381773,4.402585981494829,1.2578734810897243
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,3452564.763220413,5124341.555717534,1930343.715708301
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0017459335941613801,0.0025974066272091223,0.0009809478826444508
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,43.751237989776506,64.93615683431175,24.461504157056595
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,995388290.4778126,1046186372.5689307,943244092.173318
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.5036741420234503,0.5186138235173232,0.4888699960802354
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,12613.657664834165,13257.375923987014,11952.881289511932
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,245311229.5377398,262515894.9848465,230166168.41607308
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.12413715134854875,0.1310824494120569,0.11739528720038317
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,3108.6078672306558,3326.627068645649,2916.688173047807
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,12839878.776694212,14412363.65678897,11375538.914212532
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.006496052602729621,0.007314899258399166,0.005821936113474092
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,162.70819829460376,182.6348803245096,144.15194049349182
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,22460909.326572433,25781643.87941964,19337839.926966995
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.011365254449201079,0.012999877859837625,0.009698453564082964
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,284.62683738249234,326.70751006681155,245.05099683163328
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,12761152.046694227,14332216.684758883,11560541.156679004
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.006456247177931812,0.007160175789990341,0.005913041327827629
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,161.71056548056373,181.61925006470892,146.49630698446043
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,5619118.266312932,6833106.115746381,4667772.4697309835
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,0.002842123144814576,0.003411858605526824,0.002390097613712055
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,71.20601564989732,86.58978828265685,59.15046877059531
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,541,Other digestive diseases,1,Number,2021,2637602.1581110237,3042385.615446639,2332074.2963564782
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,541,Other digestive diseases,2,Percent,2021,0.001334815129533412,0.0015537542251896587,0.0011861478104351613
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,541,Other digestive diseases,3,Rate,2021,33.423952237241814,38.55340775531767,29.552273323487842
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,40963310.73955041,79408073.7428937,23021323.133752905
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.020719510737672354,0.04103985043180171,0.011723833201664311
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,519.0910757438036,1006.2668685161651,291.7284558986472
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,24750578.726541385,63537377.88029002,6224336.237553345
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.012515491129290984,0.03301338757117077,0.0031361031205054644
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,313.64175171606473,805.1518600027665,78.8753969103174
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,5801525.192452891,6239801.431790571,5253800.5439962
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,0.0029365885851915133,0.0031693921966578784,0.002663190985786538
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,73.51749403881806,79.07137336261714,66.5766737817223
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,6612820.250060234,7376815.298795112,5503206.703619477
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,0.0033451449284308122,0.0036318713362720116,0.0027564980741432567
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,83.79830427109307,93.47972416979819,69.73717300306524
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,489415.49539372255,513909.54239283584,466198.0165880629
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,0.00024774194796594684,0.0002603520615876639,0.00023265664820179406
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,6.201920972767606,6.512311929370945,5.907706813030448
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,982676.8806603325,1064643.8437900087,904588.12515133
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,0.0004974026588043694,0.000541812074618203,0.00045356310880023014
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,12.452577437741924,13.491270802566955,11.463029098780998
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,2326294.1944418023,2507981.0672106137,2089918.7331805986
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,0.0011771414879887432,0.001247873909513977,0.0010667300326082773
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,29.47902730731804,31.7813811095714,26.48365436869841
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,4277085.0462441305,4937547.063763981,3190231.388273288
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0021636410802369772,0.002464918094204987,0.0015996550382017922
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,54.199639570611794,62.56907878274282,40.42692383288073
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,4720045.586709845,5376782.987186611,3779648.396564281
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.002387216480563155,0.00265348665886343,0.001961539951918831
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,59.81287881595423,68.13511931702602,47.896073747075974
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,4286271.008913177,5328482.30180844,3255766.25081052
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.0021686948656778867,0.0027248567644374234,0.0016192240436340144
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,54.31604498700837,67.52304831301146,41.25738801360743
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,3803828.6499179117,4762504.886029662,2833301.0491795978
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.001924759326066527,0.002429388220019898,0.00141770771442804
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,48.20248827994664,60.350927205143,35.903867704342375
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,482442.3589952693,648551.598765185,377570.68397732126
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.0002439355396113607,0.0003262905209079727,0.00019561314047182962
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,6.113556707061746,8.218509222042403,4.784612595433554
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,4656372.060366889,5341088.085876238,3358239.60858358
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.0023550041423351154,0.0026494689203285333,0.0016720671303774607
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,59.00600166933122,67.68279004028422,42.5559404147965
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,4481114.740613585,5157241.886379591,3288799.824625601
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,0.0022664033846732904,0.002565058585055702,0.001638107728347039
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,56.78512379104769,65.35307303877285,41.67599268832131
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,175257.31975331044,258887.9489909798,54134.746625217966
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,8.860075766182454e-05,0.00013008900759873748,2.798032064389928e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,2.2208778782835332,3.2806533825666477,0.6860007981159354
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,3063080.7058491744,3560707.8349363483,2629604.878757852
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,0.0015501728090306212,0.0018008744569467962,0.0013218278141540452
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,38.815657962777024,45.12163755997194,33.32260993195663
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,2292301.922620057,2815358.527485306,1867763.8123444014
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,0.0011600632373570954,0.0014155164588051958,0.00094100208166849
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,29.04827391780039,35.676498316475644,23.66848550766931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,590056.6864093179,725119.4427248435,480617.63923725963
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,0.0002985474246267245,0.00036616786068057816,0.00024380273465168036
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,7.4772559778062355,9.18878442125935,6.090433680015941
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,3033731.69977971,3262341.718720266,2823684.266307482
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0015352415825534193,0.001638858238718478,0.0014346616237231255
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,38.44374449051216,41.340712985372804,35.78200289224209
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,45987992.14833974,50583685.257446125,41384709.83057056
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.023271773923529596,0.025449673682239795,0.021035263838060005
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,582.7643294595985,641.001401530317,524.4310861952519
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,12877.967033910763,14549.331991108904,10886.8495696685
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,6.519550839834365e-06,7.345083330458621e-06,5.446162274373495e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,0.16319085641121553,0.18437055643860661,0.1379592213752353
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,5983019.2998800455,6571879.676508393,4817719.474034949
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.0030281027864659574,0.0033260453696184696,0.0024864178516035775
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,75.81740509982907,83.27950132321324,61.05061185872601
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,6336776.930451145,6724564.491911001,5985724.1269833045
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.0032077505580595687,0.003439718573316889,0.002995059088928308
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,80.30025635600049,85.21433822106583,75.85168093313902
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,4582051.270662969,4943959.422045367,4288170.217017858
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,0.002319532986439038,0.00253268895440317,0.0021542606089640453
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,58.06420136117663,62.65033681336204,54.34011193766052
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,577502.4319873925,658215.5252934906,528948.6230358107
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,0.00029237453933606743,0.00033394489787617253,0.00026581096167721654
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,7.318167239240314,8.340971443159795,6.702888628573684
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,463848.08886781725,515489.85018515744,419953.7837920819
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,0.0002347743940556738,0.00026089963901155063,0.0002125479068247882
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,5.8779282993751805,6.532337744108877,5.321695377049623
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,713375.1389329685,758967.063885018,667231.8228172107
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.0003610686382287913,0.0003830047295777653,0.000338994103105087
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,9.039959456208349,9.617704783461413,8.455226846258725
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,12877.967033910763,14549.331991108904,10886.8495696685
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,6.519550839834365e-06,7.345083330458621e-06,5.446162274373495e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,0.16319085641121553,0.18437055643860661,0.1379592213752353
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,12877.967033910763,14549.331991108904,10886.8495696685
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,6.519550839834365e-06,7.345083330458621e-06,5.446162274373495e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,0.16319085641121553,0.18437055643860661,0.1379592213752353
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,37775109.53659728,40022912.848215684,35381841.25122914
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.019115572618163882,0.019981320552972675,0.018100339932651567
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,478.68987861764583,507.17426178938797,448.36214908684417
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,310507.3745070952,391579.47311095666,206880.3820942187
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,0.00015709162153301363,0.00019786940569409324,0.00010395003420233545
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,3.9347797858450453,4.962133339972055,2.6216084137918925
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,35632466.94219944,38261079.7685334,32786545.149020944
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.01803070877201273,0.0192262342749067,0.016801301568859908
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,451.5381023285632,484.8481408752821,415.4743033232393
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,9376807.46392157,10845538.59134879,7783739.220523021
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,0.004745447122096651,0.005485018486784492,0.003933580154100442
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,118.82382028242759,137.43572462194916,98.63630386177321
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,5937950.706582935,6921329.791230422,5092348.252323066
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,0.0030044196491659588,0.003450872061867389,0.002581534583256792
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,75.24629148243608,87.70776731770752,64.53073456800068
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,7406588.150022853,8461808.796128338,6429995.306477253
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.0037474535217424843,0.004232447277857932,0.0032569189157608098
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,93.85700864931756,107.22886777019454,81.48152872429472
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,8120160.090899893,8756114.65880818,7262240.497377915
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.004109597803306664,0.00442281825575413,0.003636444036024179
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,102.89946199898861,110.95834041530193,92.02782109245825
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,6568623.850803497,7082219.167537072,5900791.487527272
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.003324645878707366,0.0035796035201493977,0.00295867181688313
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,83.23824318179167,89.74657321290908,74.7754062281644
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,400398.24934332893,485562.82521153765,308934.6471716458
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.00020260716792165162,0.00024719553232766217,0.00015586528694500285
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,5.073885733969506,6.153099559819028,3.9148500313971972
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,602,Other urinary diseases,1,Number,2021,1151137.9907530681,1351985.5536153906,858336.5916347367
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,602,Other urinary diseases,2,Percent,2021,0.0005823447566776431,0.0006760425787990755,0.0004304190521598274
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,602,Other urinary diseases,3,Rate,2021,14.587333083227472,17.132493022315654,10.876925147355305
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,321382.8112015041,373095.2292114045,227259.92590893625
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.00016261819538129215,0.00018776762180181214,0.00011508871478063497
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,4.072594382149975,4.727899195394836,2.8798599840619628
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,77209.433288615,96837.72757762863,46468.80070354121
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,3.906571488389214e-05,4.8240318139717125e-05,2.3595686798084055e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,0.9784054818757676,1.2271371447601982,0.5888571824453654
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,2631.545380595493,5993.282564275944,1051.012431639444
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,1.3321661014986433e-06,2.9360797191872323e-06,5.236071187017345e-07
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,0.033347200160827276,0.07594746218895901,0.013318532216027077
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,8759.2596115514,12658.322704576354,6243.718254486906
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,4.4347495075374045e-06,6.363295326730968e-06,3.187151959384483e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,0.110998193563721,0.16040750201097817,0.07912100772249261
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,232782.57292074215,282883.98328890855,166501.53493418553
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,0.00011778556488836399,0.00014273431074037784,8.383171968788844e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,2.9498435065496564,3.584733473565506,2.109923717628921
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,4633161.427317499,5885329.300827594,3375383.5383201037
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0023425474475596737,0.0029270740151724987,0.0017556441954586232
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,58.711874259686134,74.57946788767431,42.773189967353204
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,3674692.6539155273,4299470.322689952,2561499.8462998956
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,0.0018587632384065506,0.0021345947497215523,0.0012771410894491517
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,46.566064322216974,54.48330798074018,32.45957630689288
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,911044.0232163159,1050843.2340230062,704583.1302806556
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,0.00046101404257364875,0.000523881656253549,0.00035796467253973755
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,11.54483886979177,13.316388127301227,8.928546263600575
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,4095734.3258290477,4851329.770458098,3415731.6042739614
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,0.002072231866716357,0.0024286097428610222,0.001740012658165391
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,51.90154552382646,61.47652481867422,43.28448460106424
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,675919.8670442001,864272.7441420795,477067.7192901132
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,0.0003419836293718143,0.00043422895221042237,0.00024015799712929662
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,8.565322591511647,10.95214865188129,6.045448747624002
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,1118332.7117153825,1241666.71329232,983042.1304604082
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,0.0005659895756618745,0.0006263330627566884,0.0004902494075790753
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,14.171621382236808,15.73452189976131,12.457205918892841
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,743567.2517491193,927702.2342149358,651163.0745981592
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,0.00037636362049612936,0.00046947935764325504,0.0003302552252799368
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,9.422556859537444,11.755933347047783,8.25160209893501
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,38387691.91816124,44064499.26931257,32908851.237751644
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.019420022355896033,0.021901486081104555,0.016995053735475597
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,486.45258240517774,558.3896397742817,417.0241780287508
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,17.99933430333366,39.7811143590647,8.313512428541246
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,9.110420380380876e-09,1.9734195066300454e-08,4.195697229358926e-09
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,0.00022808932279901845,0.0005041101677115275,0.00010534964171180472
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,1,Number,2021,2139399.5935349246,2319069.5704329917,1882599.3862277546
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,2,Percent,2021,0.0010830756459458937,0.0011936095442571675,0.0009504665449762917
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,3,Rate,2021,27.11068066531209,29.387476166043776,23.856483349331825
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,61504956.93523762,65137975.72326212,58266013.16904288
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.031127237661774627,0.032806419724787365,0.029668414799035495
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,779.3968232226721,825.434792244847,738.3526113776481
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,32626744.82472158,34915859.55695673,30309829.55121787
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.01651205099938282,0.01757818958923103,0.015429144341600858
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,413.44929800147264,442.45718353133213,384.08912129658836
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,2511555.5040533436,3146282.3792363913,1962282.8859489271
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,0.001271317281841509,0.0016015021792273108,0.0009890964416977123
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,31.82667672245945,39.86999769661484,24.866240442753433
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,30115189.32066822,32271565.922186337,28001012.22360743
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.015240733717541309,0.01631835966283557,0.01418469316966353
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,381.6226212790131,408.9484362481158,354.8315625532203
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,21602152.72700709,22844303.624332413,20370233.267054006
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.010931470147959886,0.011450792235093986,0.01046212967232088
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,273.7445898536057,289.4852473807379,258.13358610045145
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,9694808.675457107,10255062.392671071,9164323.17227386
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,0.004906528235252609,0.005186755865527166,0.004672121094252231
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,122.85356270323324,129.95315254369203,116.13119857928058
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,4388646.1001568325,4627884.18653044,4132637.639582354
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.002220869267605775,0.0023169424193115445,0.0021316614043469942
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,55.61335214513625,58.64500054885434,52.3691879211051
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,7518697.951393129,8193992.923547424,6911645.272986833
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.0038040726451015056,0.004120318312444203,0.0035799857230679488
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,95.27767500523628,103.8350788676519,87.58504415636227
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,516810.5734319049,568323.6133734812,469987.54018144624
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,0.00026167053054794936,0.000292163768428217,0.00023406312841265663
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,6.549074078124284,7.201852353008415,5.9557280262364065
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,1,Number,2021,71225.38930454997,99061.77999454511,43982.28797276738
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,2,Percent,2021,3.598775721572366e-05,4.9274627141431996e-05,2.2428244472182406e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,741,Maternal deaths aggravated by HIV/AIDS,3,Rate,2021,0.9025750918778367,1.255320554273852,0.5573478501925443
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,1179197.5129039504,1455783.2227226787,741009.1727290055
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,0.0005966930020955888,0.0007304210923605774,0.0003787488293193517
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,14.942906089295452,18.44782722611524,9.390140632274179
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,2589.058782718314,3049.1041600563567,2124.3250791501064
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,1.3104464881900865e-06,1.5485232371128644e-06,1.07794697304181e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.03280880584165261,0.03863854580900345,0.0269196549462709
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,930448.6835643799,1117866.9281547926,767533.7588762261
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,0.00047071404855585336,0.0005645990758669892,0.0003919365984445403
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,11.790736621527804,14.165718927450675,9.726262779342878
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,1396445.179381192,1826496.8917233364,976890.4205016348
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,0.0007067870105117092,0.0009170503041224398,0.0005009147006236638
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,17.695889743656714,23.145547057844738,12.379250849282698
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,1,Number,2021,8140453.44341883,8951833.831463272,7411304.529359126
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,2,Percent,2021,0.004118995020230307,0.00447222096746634,0.0037610687931447476
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,944,Other cardiomyopathy,3,Rate,2021,103.1566213447377,113.43851289264829,93.91677506904996
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,6532492.131759835,7735401.565898419,5655954.993610004
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.003307352893935782,0.003965653747445727,0.0028301491613420505
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,82.78037850805725,98.02376437985602,71.67281425709731
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,3926241.992127896,7834892.624866486,1565151.004660761
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,0.0019855107370956248,0.0039015242747600584,0.0008095635425039405
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,49.753722112026004,99.28452479922223,19.83374644389807
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,278501.74968137674,522257.5720554189,119458.72462887611
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,0.00014086344305623235,0.0002624454416589312,6.022059626877033e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,3.5292013811534058,6.618098976844809,1.5137926294300967
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,9277880.88053214,11463926.270405028,7224401.371294791
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,0.00469791183228526,0.005768093929574998,0.003560143428279617
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,117.57021295274235,145.2719937064714,91.5483199899087
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,897425.6936621666,1638476.1584298946,392641.32625187485
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,0.00045415906034189943,0.0008303245005369284,0.00019880487764772486
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,11.372266067191815,20.76292995621486,4.975589246715183
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,41387.02899422566,73335.94453998501,19112.487526069606
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,2.0951875152490156e-05,3.757419696906611e-05,9.565683472088688e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.524460474863667,0.9293202540192573,0.2421953091908799
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,42821933.07136482,49850931.905278735,37613025.35608627
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.021673893575235397,0.025367047473748294,0.018871054719376352
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,542.6437195170887,631.7158794627805,476.63593204683633
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,323736763.8213654,344206721.4594617,306426424.37338096
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.16384635008662274,0.1727408164776801,0.15505958734999123
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,4102.423899726397,4361.821202799607,3883.06558704809
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,19160078.99994714,20428802.300907873,17885921.262811407
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.009696747601863231,0.010243693535330332,0.009113061442240961
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,242.79839299746925,258.87577861955185,226.65214166924164
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,9629494.19102097,10511768.862303661,8809749.153112663
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.004872148564052121,0.005234048317137624,0.004540336052255228
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,122.02589117533448,133.20616200670202,111.63800196713562
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,2326431.5397410206,2586803.962687539,2084669.9700028498
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0011775508958117812,0.0013122971624048717,0.0010503429908550119
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,29.480767760368163,32.7802325419302,26.417141528913916
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,7293933.76158587,7828255.415433946,6385921.853788181
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0036917053867057165,0.003980607869567355,0.0032161670204236253
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,92.42944123288457,99.20041743284797,80.92302562591051
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,23318787.53791143,25061548.680319354,21570059.849797692
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.011801305945312488,0.012651822655802605,0.010939079790085415
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,295.4979538899571,317.58239335162347,273.33790577818434
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,5713196.40956608,6171742.54936525,5183525.818877171
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.002891554816121595,0.0030955988405013076,0.0026196377813394087
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,72.39818307249078,78.20892455527573,65.6861455992818
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,2433237.0711853695,2709176.9407432373,2160389.676713931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0012310709139487577,0.0013505386780741158,0.0011114319104558476
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,30.834217889566474,34.330954875503046,27.37666905005518
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,2792708.0884040124,3005733.0981610036,2578256.303727268
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0014134716998475362,0.0015355066277168562,0.0012965570827818175
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,35.389469739524564,38.08894347537974,32.671915772492554
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,3678005.4558478957,4255991.263597386,3058152.8757472937
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.001861771793284976,0.0021440478716211377,0.0015135316545299596
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,46.6080444719595,53.93233709608223,38.75321201828456
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,11213428.402652055,12053449.17067539,10374402.402627137
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.005675314701953978,0.006078229663400676,0.005274401806171673
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,142.0976602530509,152.74248549417467,131.46544080919003
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,1544081.310401111,1688580.5317391448,1342840.1826874185
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0007815678053820947,0.0008504179468486355,0.0006834311957797563
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,19.566749219763206,21.397857469909603,17.01660198842777
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,1118332.7117153825,1241666.71329232,983042.1304604082
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0005659895756618745,0.0006263330627566884,0.0004902494075790753
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,14.171621382236808,15.73452189976131,12.457205918892841
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,5007610.5802789265,5448921.7991744885,4561040.0581739545
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0025344390227534574,0.002732700973799741,0.0022839822813033334
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,63.45693050911768,69.04926939038697,57.797945223752805
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,516644.26926336484,546860.6276425325,488123.2357984236
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.0002614698388811878,0.00027563094762061497,0.00024760540931474
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,6.546966655452878,6.92987130092526,6.185545332924208
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,3858517.184557205,4070550.632384954,3653789.298448075
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.001952754384004989,0.0020446542790753244,0.0018471358469147822
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,48.895506733881206,51.582415300094894,46.301174959507826
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,4115936.5142500275,4490065.235419333,3792643.2750604926
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.002083171084638614,0.0022847335237980416,0.0019222483985598107
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,52.157549629219695,56.89854533567563,48.060746116959535
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,8786666.876210468,10217760.39388371,7498486.699768333
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.004446034846386402,0.005150097159048032,0.003808963561632939
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,111.3455010991283,129.48045797071092,95.02155605003888
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,1123772.6756325131,1230831.2774849234,986367.5223101588
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005687397697827606,0.0006254757107980975,0.0005020693027421321
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,14.240557136470771,15.597214198604629,12.49934560929853
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,678504.2507064664,729972.0291550714,628731.708075501
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.00034343273762569296,0.0003691368879364748,0.000315283180846579
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,8.598072153770177,9.250276870593398,7.967349630850006
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,1164414.122554284,1493867.2936227485,819923.1360171835
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.0005892944639019713,0.00075307764918681,0.0004189855649508246
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,14.755569522470074,18.930432293315857,10.39014608483436
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,7419451.537005896,8114201.768227991,6829142.839331063
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0037542403097823745,0.0040666763756441425,0.003479534143270057
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,94.0200147459,102.82395755197133,86.53956525671596
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,2512198.679060331,2803431.230870097,2188126.3189623742
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0012715994197620296,0.001418752067947165,0.001104391234573257
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,31.83482709898518,35.525354448489246,27.72815049045459
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,10753836.049386293,12069350.736521251,8862609.117097659
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.005440779787580077,0.0059681490609673465,0.004620844830806952
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,136.27366105100342,152.9439916901319,112.30784859509036
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,6297615.582002605,6894140.966781088,5565303.435734825
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.003186659366487063,0.0034423223307277063,0.002839459392052351
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,79.80399992245738,87.36322787797938,70.52406885918579
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,956556.3927810092,1174421.9218161262,827201.9591647678
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.00048420991368220627,0.0005999067118719541,0.00041701082658599496
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,12.121576063403818,14.882389332462669,10.482384042890333
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,395857241.4165125,420155285.6683802,370970929.7446177
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.20032400628222566,0.21031254715341396,0.18939715672802424
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,5016.341637871413,5324.248828512497,4700.979865010935
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,10754241.733622922,12710189.715916388,9409748.151838563
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.00544198006150241,0.006389645732081484,0.004805515063570381
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,136.2788019212846,161.06476584600603,119.24124789796616
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,775773.5264647402,985009.704790579,543292.4512454037
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,0.00039227254354444485,0.0004973190680211871,0.0002751795113499026
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,9.830677919237099,12.48213921303374,6.8846550210155195
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,2434632.9793074876,3220191.0742855696,1709562.9835668975
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,0.001230772254506149,0.0016194490158212465,0.0008690403337513528
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,30.85190697366799,40.80657590104344,21.663749149424035
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,343355.0362812133,481158.1430952215,238124.05057867148
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,0.00017365583617268184,0.0002447503986719178,0.00012079749300468084
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,4.351028565012515,6.097282997710426,3.017531233285056
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,1,Number,2021,1079399.885264056,1456370.0986199765,793165.2881040004
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0005458468133363998,0.0007290272402472859,0.00040009034937781674
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,3,Rate,2021,13.678260801768555,18.455264174822666,10.05106802187807
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,5263957.114541647,5792162.212410154,4505129.772407907
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.002663564566623186,0.0028651225054578764,0.0022930032988604373
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,66.7053788359556,73.39884544096782,57.08944462017684
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,2910477.8486895305,3142243.904380652,2521477.1373887477
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.001472988962648035,0.0015803659685051145,0.0012869057054074233
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,36.8818596477864,39.818821748690155,31.952404629413934
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,720834.1101905539,828117.5039878153,607330.1584611326
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,0.0003648323583822338,0.0004151330522902621,0.00030819433383088256
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,9.13448026871446,10.493985916335307,7.69614710323837
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,1,Number,2021,2189643.7384989727,2376078.117972469,1879923.8576606056
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,2,Percent,2021,0.0011081566042658022,0.001195624896291736,0.0009738336839275302
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,3,Rate,2021,27.747379379071923,30.109894050111116,23.822578789933903
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,66247327.49452281,76857918.76582429,58255348.2857507
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.03349422077587214,0.03799816852156591,0.030404998741503184
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,839.4926062722184,973.9510555005373,738.2174649346272
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,45162491.557799146,54952796.84960663,38456450.930706814
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.02282816237493837,0.027446468385578657,0.02025161144907054
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,572.3035053261343,696.3672104816326,487.32390332980447
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,4961412.227840337,6113819.972337583,3961426.7560287463
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,0.002507178450187147,0.0030471861157780953,0.002056938434840821
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,62.87150047350814,77.47492400023478,50.19958687767477
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,21266983.09369192,26023394.966379885,17537589.161852118
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,0.010750411989458879,0.012810212799478402,0.008962373793973619
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,269.49728751468086,329.7710034594798,222.23804325437698
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,154057.6546244896,395099.05706184503,43465.415052885306
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,7.780715165076006e-05,0.00019996019346057655,2.23580187416162e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,1.95223365059656,5.00673385165563,0.5507979860541122
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,2181831.620918601,3590813.496899325,1595580.3172040922
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,0.0011030018445902555,0.0017921487074174748,0.0008338391545437586
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,27.64838346186162,45.50313944964348,20.219349665344026
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,1823156.9588670728,2757200.4190003257,1466087.33780289
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,0.0009216939155007604,0.0013779817874805074,0.0007658500569282434
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,23.103223102383843,34.939513083796555,18.578401979107813
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,1138736.8227203686,1532780.2184669736,866266.6698392279
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,0.0005755157205022639,0.0007654967231135925,0.00045419608795982955
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,14.430184270342133,19.42354067867456,10.977415873119016
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,645496.5698720156,1024521.2603560009,440385.15513479465
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,0.0003263218476556071,0.0005185773607046637,0.000226938158733636
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,8.179795597436557,12.982833505376746,5.580603710817917
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,4280536.538401064,5342687.753851712,3198479.371817236
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,0.0021634799685110724,0.0026540762768901415,0.0016604021993114077
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,54.24337721642987,67.70306118915451,40.5314430861649
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,652,Other congenital birth defects,1,Number,2021,8710280.070863266,12068288.472354742,6742127.782539341
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,652,Other congenital birth defects,2,Percent,2021,0.004402751486881632,0.0061002751843865985,0.003495493191585262
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,652,Other congenital birth defects,3,Rate,2021,110.37752003889545,152.9305305748323,85.43690195581453
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,2873320.751557403,3105252.1959975553,2657667.988435989
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.0014539998462350498,0.0015552307597076732,0.001360951537197419
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,36.41100128273705,39.35005920602675,33.67822839952047
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,734248.5295542337,838953.1151969684,588754.4683367341
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.0003716414549256515,0.00042649911587570015,0.00029752824390858644
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,9.304469101459077,10.631295840200183,7.460754143165744
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,1200260.8947535267,1343923.5563383382,978641.5608291879
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.0006073722876533971,0.000666901345179574,0.00048807425054691786
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,15.209823321953188,17.030330605176154,12.401441470597156
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,64289395.61568915,80401637.32415742,50888989.337732024
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.032502541227116245,0.03939181633438859,0.025930088657944852
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,814.6815022167159,1018.857403287567,644.8702446634372
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,8023952.761732831,13758715.821944673,4143639.1275618575
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,0.004055522599150256,0.0067717520262955445,0.0021006715432352104
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,101.68031332447597,174.3517911009783,52.50859985160976
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,4738655.677724419,7595549.652578792,2760490.19143542
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,0.002395560357575303,0.0038155904840614773,0.0013791891664631075
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,60.0487077074682,96.25154727095367,34.98120140149976
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,37398171.41369739,49328788.603705265,28839226.41861232
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.018902499982250902,0.023946740767554753,0.014920582391050003
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,473.91328189798634,625.099228532647,365.45349472455507
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,176069101.90651846,202788599.1606355,152292648.86650297
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.08898027731596686,0.09810364446920855,0.07955543654382148
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,2231.1648610388493,2569.7569406966504,1929.8673251930138
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,955214.6469434947,1173441.700152722,826598.5547128927
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,0.000483530890355238,0.0005993985990640749,0.00041645418983682727
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,12.104573329064326,14.869967867777866,10.47473764272449
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,1341.745837514885,2186.622552967191,423.34713702768244
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,6.790233269682531e-07,1.1159257051889368e-06,2.120837052535438e-07
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,0.017002734339485587,0.027709094620848015,0.005364696280776526
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,2065205.1221286287,2236237.4922697074,1829133.0130574303
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,0.0010455401490367439,0.0011491710644192079,0.0009164973558643787
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,26.170481074966187,28.337819978992478,23.178952244935356
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,741705.9725835229,843034.691872835,639527.5768870449
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,0.0003754419724893557,0.00043452108059046653,0.00032632730283722763
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,9.398970548106888,10.683017978600505,8.104155935169608
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,1,Number,2021,50840.728098191365,66105.25976793398,35198.412386023156
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,2,Percent,2021,2.5719395005285133e-05,3.311559161064838e-05,1.8066674374394146e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,3,Rate,2021,0.644258673520929,0.8376923101610869,0.44603772058623703
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,1976621410.422993,2091953352.5992186,1869926736.6648076
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,25047.939625740524,26509.43726475034,23695.894295971866
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,712754394.3537673,781824620.1235609,652488858.3179617
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.3604831166482098,0.37935100273078814,0.343806620813958
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,9032.093320254931,9907.357969264187,8268.40255975937
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,42592435.65997049,48100942.882587,38093887.65505664
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.021546396536047882,0.0238540144858344,0.019916590577709475
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,539.7355058983572,609.539847596005,482.72946607889315
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,36062790.36169989,40398207.90790556,33269705.82951813
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,0.01825582871012367,0.02049737395065377,0.01667487646413416
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,456.9912027424068,511.9300374515261,421.5969626705523
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,25846096.758511376,30128049.14576649,22569586.258934695
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,0.013082805942344015,0.015343017813436362,0.0112530292421957
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,327.5242632476083,381.7855822390435,286.00400208695555
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,51430251.85403255,65879666.81888373,39944518.064888895
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.026002685569620473,0.032676091992209645,0.02036768179693671
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,651.7291761505095,834.8335742706394,506.1808354360216
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,7018107.491796655,12186584.544996103,3552389.6809003553
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,0.0035468557074718587,0.006028837238843852,0.0017793205931842667
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,88.93414379431476,154.4295899646873,45.01622909935703
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,1005845.2699361708,1970186.5942048635,449189.8227588603
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,0.000508666891678395,0.0010099068226969835,0.0002260960431755184
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,12.746169530161225,24.966397005952757,5.6921773191525125
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,1,Number,2021,96535.32219935197,129869.50179432292,67989.71446295216
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,2,Percent,2021,4.877270077024459e-05,6.449065364417216e-05,3.550972938822326e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,321,Other intestinal infectious diseases,3,Rate,2021,1.2233050342621379,1.6457190147874956,0.8615723041646719
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,82086660.15530227,92994855.58155112,72180867.02163444
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.041508821630484694,0.04559290783436049,0.03712605310207576
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,1040.2101772279632,1178.4398953832429,914.6829988574285
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,1272742.000141615,2976552.176202272,298716.24542417016
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.0006427088493471657,0.001475017688257099,0.00015065228489946552
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,16.1283109707231,37.71915998138767,3.7853614461311107
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,28190.197558152755,76356.3529418836,8995.518008501758
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,1.4244139785522964e-05,3.830710712597307e-05,4.661976820136707e-06
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,0.35722893759569435,0.9675951643773542,0.11399208305195664
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,13908149.979515607,18025143.48587795,10860633.643856134
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,0.007030284327922414,0.0091197713404071,0.005610170724319709
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,176.24543534520387,228.41637928173714,137.62701060208553
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,4456190.7524455255,5235177.242324009,3645503.9367683446
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,0.0022536438418359487,0.002566300790888276,0.0018433819966534606
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,56.469284577946915,66.34067748346446,46.19618204683524
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,318128.1685558217,453485.7068155272,213544.7172201696
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,0.00016072307008599537,0.0002214749055332095,0.00011063027653357096
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,4.031351232570325,5.746615181619836,2.7060595196031962
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,4564893.107168961,9212343.11128349,2042388.8743817806
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,0.002304960755866664,0.004441115724832536,0.0010352022511519743
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,57.84677143705445,116.73971193788456,25.881351354405957
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,1338563.5461999842,2138675.4578195116,594946.9710593132
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,0.0006770391786098402,0.0010982108965319763,0.0003063464950575543
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,16.962408033038212,27.10150434677944,7.539226142664223
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,2637784.242734985,3562395.851864922,1869040.0803770302
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,0.0013348978209783771,0.001789261998659906,0.0009280177786527491
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,33.42625963138611,45.143028275407474,23.684658500868196
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,12319796.230331188,13035477.245711906,11368283.442321537
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.006235853344525532,0.006633250821259357,0.005761361670230695
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,156.11766145582953,165.18684120366433,144.05999844484074
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,73718083.85330379,78390433.13043205,69053242.9313895
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.03730337301170965,0.039061300414401284,0.035183468972181976
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,934.1627607320536,993.3712272531345,875.0494408217992
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,2234248.3314828286,2470127.961411558,1980546.6562157965
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,0.0011304053505982964,0.001229712160690138,0.0010131045132922409
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,28.31261313916317,31.30170285469577,25.09768072391736
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,35540861.20511446,37650455.33635709,33217121.76881648
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.01798516726756557,0.018853969653836133,0.016966199328517118
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,450.377265478483,477.1102484136794,420.9306123159594
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,1934509.4243077617,2122519.591860971,1599865.338483154
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0009790137425790487,0.0010678865341268273,0.0007986200827838271
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,24.51429242341226,26.896775634949655,20.273649873632262
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,6826755.4213672755,7745177.291119313,5998074.272312537
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.0034542521303294687,0.0038969199359288427,0.0030473434567087226
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,86.50931166303175,98.14764332492845,76.00818318134118
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,973108.492646763,1180226.7030619734,827378.5544665257
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,0.0004919952016921151,0.0005784175218696884,0.00042480554569928166
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,12.331325890017254,14.95594808752821,10.484621875807298
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,985393.6353623748,1188974.1391270563,801132.2769494359
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,0.0004986168244547357,0.0006006697955671429,0.00040603863193129614
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,12.48700441874897,15.066796451955941,10.15202648288994
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,3580691.7247158866,4518920.696888493,2826227.5777482935
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,0.0018118940214562616,0.0022835600181737655,0.0014236976402325259
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,45.374875363653445,57.264204562546865,35.81423198329765
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,9330428.896956224,11065789.119669236,7888759.081457516
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,0.004721494457551368,0.005504487133705209,0.003985181056864663
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,118.23610655072828,140.22676083496245,99.96712579981343
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,624340.5021296787,714708.4482221176,536394.1983602862
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,0.0003158692569248347,0.00035921485058298545,0.00027537358701957556
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,7.911703840090494,9.056855281782715,6.797239686506652
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,211200.83014037806,263921.6577255515,167890.602613038
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,0.00010672373764805942,0.00012969415581710718,8.782155800656272e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,2.6763575535339306,3.3444410314367117,2.127526118965107
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,4866627.013488033,7555399.412296877,2809547.451207321
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,0.002457493598790879,0.0037349314775365823,0.0014369093652323295
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,61.67037297686663,95.74275950348475,35.60285979014784
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,661180.2084681017,772751.5131428852,553753.7591421283
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.00033421512170305194,0.0003780580620236462,0.00028823434911036616
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,8.37854019799345,9.792382671176519,7.017221736736445
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,58167412.80152633,110102582.22009243,25442723.997352026
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.029385676413550905,0.05496359751016906,0.012898449261280462
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,737.1031378873747,1395.2306787453203,322.4126842093015
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,184306892.8331976,194426012.4642129,172862024.24983713
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.09327614528087029,0.09789885194078142,0.08803410609626564
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,2335.554952481178,2463.785425067773,2190.524459646845
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,145246796.151412,156384761.7683372,133950053.7602756
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.07349443281947765,0.07817570889522037,0.06814989896213508
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,1840.5815912184462,1981.7229796781705,1697.4281679636758
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,59039545.2230362,64045610.062809214,53954029.94123447
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.029876571689927387,0.031906740972780095,0.027382392503059003
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,748.154885138739,811.5922278731493,683.7107386407555
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,76770050.35464819,83125243.63491662,70172725.6329569
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,0.03884256951976798,0.04136001376274364,0.03597511353201637
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,972.8375784095049,1053.3712085496395,889.2356349877931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,9437200.573727675,10905310.712765241,8297577.359608323
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,0.004775291609782233,0.005567021226930027,0.004206585661872046
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,119.58912767020436,138.19316278418236,105.1477109614551
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,1,Number,2021,24444466.24753451,26939398.183637224,20447317.267417293
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,2,Percent,2021,0.012369909863207683,0.013535943333350032,0.01036878945335578
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,498,Hypertensive heart disease,3,Rate,2021,309.7626644753727,341.378685720665,259.11040208404285
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,11210301.720518127,12120754.940239469,10287606.924908
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,0.0056727847147320576,0.006093917612253497,0.005221246562124931
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,142.05803863157772,153.59539078176044,130.36556003574896
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,4392277.948213367,4751311.43427731,3845951.682642017
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.002223285234967109,0.0024152902774770796,0.0019518718782219906
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,55.65937527853466,60.20908269095423,48.73627546598174
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,501,Aortic aneurysm,1,Number,2021,3107762.316075626,3353857.832665843,2857319.748771222
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,501,Aortic aneurysm,2,Percent,2021,0.0015731993713268022,0.0017140393620935406,0.0014233798111681717
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,501,Aortic aneurysm,3,Rate,2021,39.381867692890914,42.5004141222742,36.20823501215731
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,1052114.9788096463,1158732.3613342599,948360.3141659541
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.0005326499622057314,0.0005932994895457381,0.0004745079326063415
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,13.33250380148501,14.683569689190616,12.017714554449608
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,2041603.3609541124,2269687.554018616,1791607.99706344
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,0.00103309444983013,0.001136557840319365,0.0009103728079752415
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,25.871397251507094,28.76170242949404,22.70343157612338
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,2857751.82281034,3064464.0877488707,2577139.9864587
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,0.001446701516531386,0.001568746676983553,0.0012861975174811716
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,36.21371029659402,38.83318831336421,32.65776969100279
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,1,Number,2021,5818691.801234383,6366578.4859968,5284395.6004399
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,2,Percent,2021,0.002943953750649592,0.003174209865020263,0.002723224547388482
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,3,Rate,2021,73.73503098244828,80.67790457944093,66.96437732606664
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,82265180.22486652,90100817.30950789,75459202.18445832
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.041633725075702954,0.045279533611755546,0.038405852287020745
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,1042.4724009906165,1141.7663596568395,956.226382329017
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,64922190.37841427,71143568.0304054,59331482.55102694
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.03285649721157859,0.035592893695709865,0.030132770591601136
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,822.7003392730409,901.5382446980641,751.854343480864
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,387123.98344916076,449624.11835109704,336167.08398897096
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,0.0001958570956254175,0.00022657696074736007,0.00017161000852212142
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,4.905672939683314,5.697680755327345,4.2599421313133785
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,226527.49910459435,273089.4844969658,179256.0217622641
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,0.00011458670521605172,0.0001389211620751899,9.265085063083484e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,2.8705786000403744,3.460616627966597,2.2715498208080054
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,58614.34873626434,71920.06514963656,44207.939048499364
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,2.9672139609816417e-05,3.639110221645598e-05,2.2309114934626357e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.7427667537173268,0.911378092055531,0.5602073226699817
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,50828.2044569474,75452.04876960386,41475.84681175332
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,2.5715123228934906e-05,3.843264995002877e-05,2.1123087227359437e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.6440999727155456,0.9561357335571037,0.5255859829247421
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,51153.931151354955,69665.824123982,40234.46815802882
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,2.5883127570614363e-05,3.560130322902398e-05,2.066295820944248e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.6482276132100723,0.8828121295425684,0.5098551113439672
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,11230094.8664229,14180562.779184936,9405818.043155802
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.005683598680553021,0.007299959684760705,0.004757157299660414
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,142.3088593102427,179.6974769569234,119.19144517677266
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,3605629.390787222,4081412.420266045,3074196.2628683522
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,0.0018252616455012272,0.002068519761918715,0.0015368279338434708
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,45.69088790448095,51.72005693730398,38.956515387296776
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,1,Number,2021,2120141.6057928014,2692104.8057254083,1651846.28108113
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,2,Percent,2021,0.001072510442444675,0.001342574898136777,0.0008474829954359823
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,520,Other chronic respiratory diseases,3,Rate,2021,26.86664156316827,34.11461511263588,20.93235745669166
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,45813488.110508524,49962650.40237327,42432085.23342883
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.02318196241310241,0.02491874225362009,0.02160035656217705
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,580.5529972434271,633.1315871726872,537.7035296272317
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,701820.6108768694,809963.6120168696,515070.7999051724
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,0.0003551647960767341,0.0004034070689286895,0.00025905293832137027
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,8.893539347821914,10.263938023672262,6.527027498020341
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,236990.7163727739,432713.88747382356,188865.97244316168
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.0001198213075792681,0.0002164293178615151,9.71776053270238e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,3.003169511502922,5.483392657547085,2.3933280547136855
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,1,Number,2021,2746174.492763149,3686289.7893454377,1598180.4156496283
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,2,Percent,2021,0.0013877303880629214,0.0018852093089341073,0.0008106197119984104
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,686,Sudden infant death syndrome,3,Rate,2021,34.799791469303074,46.713024355407,20.252298366871464
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,191098265.12047353,204696969.58272296,174763716.49885356
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.09668557918972219,0.10130310942895604,0.08967719690781437
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,2421.6158856121274,2593.9399971301873,2214.6228896187777
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,60640651.269973636,64596326.454976775,56473870.46123201
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.030678436077925485,0.03161820605918417,0.02958350291835544
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,768.4442573911193,818.5709597988381,715.642403894693
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,56869110.138549365,60528297.508911975,52941764.680318795
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.028770085114238012,0.029641094777241903,0.027762368236123068
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,720.650919699964,767.0204995541569,670.8832143576788
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,19202458.14751842,21498448.825316086,16861792.098425884
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.009712886151153389,0.010487348911118063,0.008564501141053685
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,243.33542569587016,272.4304438796669,213.67427684231
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,2838457.0188922053,3225211.6986033735,2516428.867805987
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.001436131591342456,0.0016442495329368225,0.0012720310599869306
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,35.969204656270804,40.870197742905894,31.888432464053047
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,12379840.35719773,13500336.289329933,11098313.605345886
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.006265311870366914,0.006882911114043213,0.005635320488259607
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,156.87854649770082,171.07758042040288,140.63891429504898
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,21916237.221701946,23840136.866680723,20128269.091093592
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.011086568678370259,0.011822596713807372,0.010434631575210879
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,277.7246992559498,302.1045435191461,255.06739242315462
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,532117.3932390289,589652.7751659529,480639.3543850211
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,0.0002691868230050096,0.0002979134055901718,0.0002502192667772799
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,6.74304359417282,7.472137575068794,6.09070885648991
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,3771541.1314243013,4105134.840846735,3487726.3429401894
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,0.0019083509636874487,0.0020530860223402585,0.001796053635050203
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,47.793337691154846,52.02066976854636,44.196808963217514
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,68952656.91526234,76341582.73503354,57781785.05852473
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.034879905450022154,0.03806197857645462,0.02975148111049448
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,873.7748049983373,967.4079948731239,732.2164254528234
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,19631172.973824635,21482772.479236048,16479319.497072184
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.009933774397716751,0.010743977472422492,0.008396790865283565
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,248.76814185959915,272.2317916905858,208.82754667097316
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,15596703.060338598,17293482.95470971,13974573.329491382
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,0.007887116989939174,0.008444146771877086,0.007262726278248445
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,197.64294495442195,219.1447055486688,177.08715852555545
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,5573490.397901131,6706243.975264177,4168061.5205672933
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.0028188369088886197,0.0033620958888708557,0.0020988766352164376
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,70.62781484361068,84.98217884423109,52.81808280180474
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,2553192.3680906896,3031863.2362638847,1734175.654107785
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,0.0012912412632984393,0.00152559770739505,0.0008918349475087875
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,32.354303131398,38.42006713829361,21.97564331513808
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,1178008.0990381609,1368046.3576303185,807014.071297918
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,0.0005959433971954744,0.0006834036773759004,0.0004153752781085734
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,14.927833720584257,17.336017099908577,10.226561155516134
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,1375184.2690525323,1760419.2683586802,848877.7649299088
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,0.0006952978661029629,0.0008899206765435808,0.0004319249562882356
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,17.426469410813798,22.30820495888602,10.757061971238958
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,5012110.405923216,5892818.128560552,3760274.401824598
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.0025353889635427564,0.002899098512133908,0.0018995670479129796
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,63.51395273930813,74.67436704435329,47.65056459292534
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,735025.3596790825,992413.8406507795,499364.1327940053
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,0.00037174788330577907,0.000496912421979666,0.00025147473939298186
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,9.314313168696248,12.575965146026846,6.327991077870502
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,381876.442184372,495238.7025180221,238075.68251065377
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,0.00019313763361787398,0.00024760033796197926,0.00012071120437528426
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,4.839175584099227,6.275713222365074,3.01691830840165
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,7037575.0948215285,7695502.93727313,6501670.553216456
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,0.0035611026761645003,0.0038715651976510682,0.003326219136388735
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,89.18083916180066,97.51816505988192,82.38980445353485
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,448117.8792770965,543735.115261225,327746.4984454742
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.0002265566429556359,0.0002706463739460635,0.00016692939846566271
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,5.678593546624373,6.890264502671599,4.153235648627979
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,239603.2559664947,326086.0975980517,144559.00844684575
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,0.0001210576215002384,0.00015966447211338,7.354285890090542e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,3.0362758684756392,4.132194886870843,1.8318658782303878
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,208514.62331060143,262556.342690944,157500.96609485606
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,0.00010549902145539742,0.0001312977577007797,7.939951652164383e-05
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,2.64231767814874,3.3271396259289943,1.995867629955257
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,1626519.6467299394,2054269.2129070626,1382270.9740607124
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0008229401131882197,0.0010407794923491577,0.0007133092776951465
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,20.61141587182031,26.031900164889063,17.516272829037597
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,2459590.825945362,2769871.059546831,2011691.7723946047
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0012445149795334651,0.0014040606230547985,0.0010285192981517395
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,31.168175244606303,35.10007667870389,25.49235467896499
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,279896.9940390469,334084.7871681925,223218.61042290038
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.0001415452317109867,0.00016539227295102335,0.00011366266551454108
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,3.546882053967017,4.23355506256329,2.828648039392632
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,21134421.043766856,23940438.208782207,18325020.677512523
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.010690524258034543,0.011864220004308984,0.00944583615256918
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,267.81744826692295,303.37557192554243,232.21645235166912
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,15020073.100379918,17082490.130765297,13156097.828777667
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.007601388088389527,0.008689153366647483,0.006675493308886532
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,190.33583376596843,216.47098386997206,166.7153570167184
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,3623177.8780973624,4566843.418998191,2866021.09808317
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,0.0018335146454331148,0.002299195185728611,0.0014439739677488753
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,45.91326405013505,57.871485979096924,36.31849936074672
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,244354673.1449587,261441530.80458963,229311809.3926135
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.1236529414348666,0.13057414327277228,0.11696396759696592
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,3096.486291167251,3313.012620789712,2905.8616520329697
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,197756735.80839297,211514620.57015818,187900904.12132755
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.10013417893095745,0.1086008061957546,0.09152654479134555
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,2505.9926766917547,2680.3339365169427,2381.098614653718
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,5227290.966858346,6244827.701870226,3167633.0923748934
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.002644267905416715,0.0031059570267617117,0.0016011950591853247
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,66.24074183028657,79.13506674812535,40.14055601943765
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,1,Number,2021,77380460.47094086,102013398.14589563,59949132.425220564
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,2,Percent,2021,0.039157162138617856,0.05129838055225983,0.03033195870993868
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1058,Other COVID-19 pandemic-related outcomes,3,Rate,2021,980.5727550392917,1292.7237478563025,759.6812630300849
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,243236340.43324316,260274740.7751002,228278679.2601898
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.12308695185920471,0.12998614205343853,0.11644359899563726
4,YLLs (Years of Life Lost),1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,3082.314669785013,3298.2269435424373,2892.7697260596774
5,Prevalence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,24696657.202441312,28508882.605789505,20649635.361038294
5,Prevalence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.0032386053742107,0.0037385155361593,0.0027050280302129
5,Prevalence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,312.95845289461,361.26734565438,261.67419673257
5,Prevalence,1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,7625741734.162765,7649715784.433121,7600061917.078768
5,Prevalence,1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
5,Prevalence,1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,96634.14427850558,96937.94578575918,96308.72712753864
5,Prevalence,1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,260479186.8869346,297967236.9397321,227209547.47306576
5,Prevalence,1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.0341576989522785,0.039082797479296,0.029840107974668
5,Prevalence,1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,3300.8177046456603,3775.86993743933,2879.22158360071
5,Prevalence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,4306627.718342906,4898714.446298264,3802950.839693076
5,Prevalence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,0.0005647540998745,0.0006427011130211,0.0004985223158362
5,Prevalence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,54.57400719772,62.07698806033,48.19136458301
5,Prevalence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,46895315.42738923,54155427.87812489,40692159.19061116
5,Prevalence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.0061496455794953,0.00710820905504,0.0053327567906597
5,Prevalence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,594.26201869579,686.26287297329,515.65501682455
5,Prevalence,1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,14727524.234600171,18089092.820055768,12527625.205607928
5,Prevalence,1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,0.0019312987920959,0.0023708719145768,0.0016405476333091
5,Prevalence,1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,186.62862595723,229.22675149217997,158.7512905351
5,Prevalence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,1697259271.7321577,1823835811.8373811,1575345915.689168
5,Prevalence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.2225692387678008,0.2392071536685589,0.2067299213614037
5,Prevalence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,21507.835311000552,23111.82559354651,19962.937352477107
5,Prevalence,1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,2381826229.4853044,2497936751.420341,2269820777.764557
5,Prevalence,1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.3123397069557533,0.3279174190754923,0.2975941538993673
5,Prevalence,1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,30182.73468078339,31654.09855856292,28763.39065381835
5,Prevalence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,283640016.231696,307691593.9340019,260114176.1241749
5,Prevalence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.0371951262467367,0.0403246258516895,0.0341312535172836
5,Prevalence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,3594.3139968797595,3899.0979393253897,3296.1922525989903
5,Prevalence,1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,4482269.78766693,5295102.06048553,3912950.202644103
5,Prevalence,1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,0.0005877869488055,0.0006944150166866,0.0005116488267696
5,Prevalence,1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,56.79976066015001,67.10005063376,49.5852872571
5,Prevalence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,38293408.8617187,47226498.77150321,31167468.185606927
5,Prevalence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0050215856061006,0.0061930594580896,0.0040838661122365
5,Prevalence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,485.25781830261997,598.45880638851,394.95720186153005
5,Prevalence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,6567782.261752075,7597596.100078576,5798379.327407951
5,Prevalence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,0.000861266990682,0.0009957539384537,0.0007604752309149
5,Prevalence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,83.22757848311,96.2774800536,73.47762932962
5,Prevalence,1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,61293.80531422304,72093.52070383595,51192.68196763647
5,Prevalence,1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,8.0376815367e-06,9.4523655135e-06,6.7086971124e-06
5,Prevalence,1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.77672108925,0.9135761377799999,0.64871866734
5,Prevalence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,54842.39731330585,65440.27681349384,45280.62509070407
5,Prevalence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,7.1917373791e-06,8.5914102657e-06,5.9410127399e-06
5,Prevalence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.69496821677,0.82926558119,0.573800505
5,Prevalence,1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,3582786.4351436063,4448133.879607376,3045510.3351724334
5,Prevalence,1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,0.0004698321534382,0.0005835480410306,0.0003989482302432
5,Prevalence,1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,45.40141973884,56.367187098189994,38.59300450896
5,Prevalence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,3015815.63946316,3480606.755810274,2502786.5103980005
5,Prevalence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,0.0003954784306371,0.0004563781397827,0.0003281021848851
5,Prevalence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,38.2167104238,44.10658885953,31.715555178139997
5,Prevalence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,169431.96376030613,185188.92584997063,155127.21143656195
5,Prevalence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,2.22184915222e-05,2.43186236762e-05,2.03474603385e-05
5,Prevalence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,2.14705839801,2.3467321610400003,1.96578717901
5,Prevalence,1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,2186799.98709196,2516678.5275411075,1902752.6131547464
5,Prevalence,1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,0.0002867675682954,0.0003299593074472,0.0002497316474358
5,Prevalence,1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,27.71134308341,31.891596176599997,24.11186700988
5,Prevalence,1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,30737186.647615694,35041335.94767545,27247230.05966054
5,Prevalence,1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.0040307125030251,0.0045977009357931,0.0035730145733178
5,Prevalence,1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,389.50463217427,444.04723261336,345.27956132833
5,Prevalence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,56856688.205334105,64977511.92058765,49382064.01237394
5,Prevalence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.007455922116537,0.0085222657890263,0.00647261056157
5,Prevalence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,720.49350774865,823.40137926029,625.7743397162201
5,Prevalence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,24220856.231397998,30677995.495970763,18476943.492427777
5,Prevalence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,0.0031762554874707,0.0040221338980188,0.0024204944108641
5,Prevalence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,306.92905650453,388.75455611774004,234.14163310489
5,Prevalence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,1,Number,2021,6117674.214724833,9190304.128695784,3620746.436928261
5,Prevalence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,2,Percent,2021,0.0008022559040552,0.0012048720359961,0.0004750819307547
5,Prevalence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,3,Rate,2021,77.52376533630999,116.46043179735,45.882452590090004
5,Prevalence,1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,647478.1984813921,826189.0664333303,527687.6982700785
5,Prevalence,1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,8.49074965631e-05,0.0001082669098042,6.91109042944e-05
5,Prevalence,1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,8.20490698878,10.46954856723,6.686910066749999
5,Prevalence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,16375672.88456719,19199191.33803139,13657151.465378564
5,Prevalence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.0021474262973369,0.0025155793598847,0.0017948672562142
5,Prevalence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,207.51412667118998,243.29402836688,173.06475765189
5,Prevalence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,138559101.6111748,167350517.3491218,111487772.34266642
5,Prevalence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.0181697424196327,0.0219572961709665,0.0146359671248157
5,Prevalence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,1755.83447262713,2120.68210573526,1412.78394330951
5,Prevalence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,3830119.2658083,4511554.518230461,3312833.995798224
5,Prevalence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,0.000502262561168,0.000591362753247,0.0004344537532636
5,Prevalence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,48.53564553306,57.17085962692,41.98055605352
5,Prevalence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,251574856.957884,293541993.9664572,215272107.5920641
5,Prevalence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0329901301430944,0.038509821533574,0.028194742868028
5,Prevalence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,3187.98116584545,3719.79282614259,2727.94917915921
5,Prevalence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,247607528.36247692,280963731.8061116,216746424.3371629
5,Prevalence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.0324698913878774,0.036786011558137,0.0284208587027822
5,Prevalence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,3137.7067902825697,3560.39985916989,2746.63186499157
5,Prevalence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,241439353.13270175,275457054.4262372,210960180.6647428
5,Prevalence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0316610169277323,0.0360666057872653,0.0276474604927133
5,Prevalence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,3059.54307114966,3490.6187054182496,2673.3080198675902
5,Prevalence,1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,63040.56230789542,83778.62394684606,43194.29296744605
5,Prevalence,1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,8.2667946334e-06,1.09813467634e-05,5.6739433319e-06
5,Prevalence,1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,0.79885616453,1.0616509077,0.5473623005
5,Prevalence,1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,308730032.5170119,342695811.90549624,276784251.4920842
5,Prevalence,1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.0404854577644893,0.0449435774097625,0.0362218958079617
5,Prevalence,1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,3912.2571345031297,4342.67480931822,3507.43707630176
5,Prevalence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,21286171.734869838,24499595.927548647,18100017.62931544
5,Prevalence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.0027913737759917,0.0032166321515027,0.0023703018381322
5,Prevalence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,269.74044785038,310.46127316659,229.36519174246
5,Prevalence,1,Global,3,Both,22,All ages,559,Schizophrenia,1,Number,2021,23182108.89897669,27423876.455246814,19203758.75282276
5,Prevalence,1,Global,3,Both,22,All ages,559,Schizophrenia,2,Percent,2021,0.0030400281126965,0.0035960744881581,0.0025195860177693
5,Prevalence,1,Global,3,Both,22,All ages,559,Schizophrenia,3,Rate,2021,293.76594882408,347.51804171128,243.35190709334998
5,Prevalence,1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,1911816784.3875792,2100447765.4103656,1733433144.4277344
5,Prevalence,1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.2507043253435964,0.2753789589782517,0.2274885477701649
5,Prevalence,1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,24226.72907330779,26617.0792937842,21966.23415993042
5,Prevalence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,4229536.931974149,4956657.557562724,3549907.4911121046
5,Prevalence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,0.0005546425635804,0.0006504340741193,0.0004664664177332
5,Prevalence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,53.5971052212,62.811248827220005,44.98477454785
5,Prevalence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,1,Number,2021,825603654.1081941,925555127.87604,732989499.8815756
5,Prevalence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,2,Percent,2021,0.1082649557431941,0.121418699217523,0.0960625666297707
5,Prevalence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,3,Rate,2021,10462.13016506148,11728.725005752309,9288.51455444189
5,Prevalence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,38281638.84608728,40641176.417064175,36220038.96918778
5,Prevalence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,0.0050200809993605,0.0053276215348799,0.00474768859638
5,Prevalence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,485.10866751463,515.00895813723,458.98387245943
5,Prevalence,1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,40036935.84035035,42372668.86516557,38036248.59229034
5,Prevalence,1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,0.0052502620084342,0.0055539444197703,0.0049864265193081
5,Prevalence,1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,507.35196251574,536.95059960371,481.99905824427
5,Prevalence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,67276400.51944864,74165979.15790093,61204854.79312792
5,Prevalence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.0088223191226492,0.0097345708761799,0.0080247267133545
5,Prevalence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,852.53312018292,939.83853379058,775.59389955834
5,Prevalence,1,Global,3,Both,22,All ages,839,G6PD trait,1,Number,2021,1116432619.1095114,1151018576.4068043,1079976682.082966
5,Prevalence,1,Global,3,Both,22,All ages,839,G6PD trait,2,Percent,2021,0.1464029497389966,0.1509069216346529,0.141725805557244
5,Prevalence,1,Global,3,Both,22,All ages,839,G6PD trait,3,Rate,2021,14147.54322309908,14585.81985296502,13685.57002740994
5,Prevalence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,4832509584.697179,4941751428.796125,4717131302.659301
5,Prevalence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.6337102953287568,0.6482888083832591,0.6189784808211358
5,Prevalence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,61238.03358600876,62622.35690719014,59775.94872374473
5,Prevalence,1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,29894460.982838035,36027535.857109085,25399869.311422765
5,Prevalence,1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.0039202613635876,0.0047166593031201,0.0033267562631585
5,Prevalence,1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,378.82553021721003,456.54445421592,321.86962544235996
5,Prevalence,1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,7345928.276222723,8540845.200414611,6443420.656379033
5,Prevalence,1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,0.0009633122262306,0.0011178296391699,0.0008448306903221
5,Prevalence,1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,93.08832080214,108.23042480704,81.65165606988
5,Prevalence,1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,11767271.972931124,13419874.68235769,10438278.36745128
5,Prevalence,1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,0.0015431002434589,0.0017614367311513,0.001367855752339
5,Prevalence,1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,149.11602008527998,170.05796307587002,132.27488327602
5,Prevalence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,9172894.8985827,12083457.810985344,6702516.228095259
5,Prevalence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,0.0012028877380419,0.0015840115443378,0.0008783542575408
5,Prevalence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,116.23982033251,153.12275791598,84.93494046791
5,Prevalence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,605133.5885110286,627327.0779677109,583512.8303084876
5,Prevalence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,7.93543710487e-05,8.23075895352e-05,7.64828243921e-05
5,Prevalence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,7.668311954230001,7.94955002089,7.39433159397
5,Prevalence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,94952.53268792754,128469.47982596498,68715.65945033712
5,Prevalence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,1.24517629868e-05,1.68289300742e-05,9.0164420593e-06
5,Prevalence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,1.20324777094,1.62797779962,0.87077154997
5,Prevalence,1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,1019840416.9954122,1095325084.8557682,955169135.137436
5,Prevalence,1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.133736655723787,0.1434817713355932,0.125261065172025
5,Prevalence,1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,12923.517401000201,13880.066486862139,12103.99659901152
5,Prevalence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,204429.9813895919,233355.38417325448,176439.65379005947
5,Prevalence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,2.68080277842e-05,3.05839255883e-05,2.30899082827e-05
5,Prevalence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,2.59055669666,2.9571022267,2.23586053071
5,Prevalence,1,Global,3,Both,22,All ages,569,Dysthymia,1,Number,2021,107628890.6575559,130577177.87034784,90114181.72873484
5,Prevalence,1,Global,3,Both,22,All ages,569,Dysthymia,2,Percent,2021,0.0141137377451166,0.0171375932849282,0.0118268231720456
5,Prevalence,1,Global,3,Both,22,All ages,569,Dysthymia,3,Rate,2021,1363.883817589,1654.6867551617402,1141.93571488296
5,Prevalence,1,Global,3,Both,22,All ages,571,Anxiety disorders,1,Number,2021,359213270.2202836,419966576.5162368,307185425.2628135
5,Prevalence,1,Global,3,Both,22,All ages,571,Anxiety disorders,2,Percent,2021,0.0471052944536694,0.0551973823193694,0.0402960670156611
5,Prevalence,1,Global,3,Both,22,All ages,571,Anxiety disorders,3,Rate,2021,4551.98565481338,5321.85748769994,3892.6837204721896
5,Prevalence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,2275834.645195127,2705755.408561848,1924479.2968687408
5,Prevalence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,0.0002984419354601,0.0003545224505128,0.0002523874698532
5,Prevalence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,28.83959896944,34.28759688542,24.38718966857
5,Prevalence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,177076278.89427593,199365026.69265407,157506165.95770437
5,Prevalence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.0232206580825714,0.0262098809774641,0.0206496866381318
5,Prevalence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,2243.92790622734,2526.3730959046397,1995.93352312528
5,Prevalence,1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,452343.45504387806,583648.7272896003,350248.67445600976
5,Prevalence,1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,5.93186883044e-05,7.65884045773e-05,4.59113034247e-05
5,Prevalence,1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,5.73214045557,7.39605369379,4.43838542146
5,Prevalence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,7569579.606799957,8005306.783606257,7198813.290704282
5,Prevalence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.0009926377712556,0.0010483699299577,0.0009439806980405
5,Prevalence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,95.92245231361001,101.44402966797,91.22406533274
5,Prevalence,1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,121229852.27103016,139980026.207213,104258336.77270642
5,Prevalence,1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,0.0158976230610332,0.0183840840596897,0.0136926514364127
5,Prevalence,1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,1536.2365319479,1773.8405679302598,1321.17182946228
5,Prevalence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,1887767.5064431436,2113707.790223187,1688654.280548524
5,Prevalence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,0.0002475495091593,0.0002774221628553,0.0002218078333482
5,Prevalence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,23.921974273609997,26.78511162369,21.39879202202
5,Prevalence,1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,272732.2491439137,313676.2739313563,236194.49618044836
5,Prevalence,1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,3.57646838105e-05,4.11257228143e-05,3.08979670119e-05
5,Prevalence,1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,3.45608970667,3.9749363889500002,2.99307973144
5,Prevalence,1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,7273647.19188489,9065624.045602018,5928780.041434592
5,Prevalence,1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,0.000953833226559,0.0011889145540401,0.0007765073840462
5,Prevalence,1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,92.17236783966,114.88047360334001,75.13007991771
5,Prevalence,1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,5900340.197703158,7838797.574157692,4376043.199596943
5,Prevalence,1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,0.0007737397447047,0.0010282524344096,0.0005732695885978
5,Prevalence,1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,74.76968743942,99.33400869814001,55.45364695795
5,Prevalence,1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,2870478131.2498565,3088261583.239745,2664843918.817264
5,Prevalence,1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.3764142072928786,0.4045547740142016,0.3496324571213408
5,Prevalence,1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,36374.97932048024,39134.75250120314,33769.162490389295
5,Prevalence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,376042643.2866729,416930127.7648617,339273646.18395114
5,Prevalence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.0493124582115449,0.0547143834654916,0.0445116169121046
5,Prevalence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,4765.2491145144295,5283.37931246616,4299.308790954489
5,Prevalence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,343562.6977212916,394929.97534851416,299277.6900947691
5,Prevalence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,4.50532406e-05,5.17416519321e-05,3.92200550374e-05
5,Prevalence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,4.35366007107,5.00459123167,3.79247612785
5,Prevalence,1,Global,3,Both,22,All ages,548,Tension-type headache,1,Number,2021,2011612877.489983,2270860638.845891,1776544390.8276958
5,Prevalence,1,Global,3,Both,22,All ages,548,Tension-type headache,2,Percent,2021,0.2637865142922275,0.2978439023750341,0.233124206260753
5,Prevalence,1,Global,3,Both,22,All ages,548,Tension-type headache,3,Rate,2021,25491.354915025688,28776.56787503384,22512.544086212947
5,Prevalence,1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,1095395922.0926156,1184469688.2894547,1016483082.7497982
5,Prevalence,1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,0.1436439349717271,0.1555595517683233,0.133505661570273
5,Prevalence,1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,13880.964143248159,15009.71561086395,12880.972933433399
5,Prevalence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,1,Number,2021,84800601.05781388,117240210.9097764,63395826.8954242
5,Prevalence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,2,Percent,2021,0.0111200573079158,0.0153657334590468,0.0083113894306991
5,Prevalence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,3,Rate,2021,1074.60150149242,1485.67940683629,803.35811209323
5,Prevalence,1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,1,Number,2021,88321731.78714037,129165263.3696988,47149429.41821895
5,Prevalence,1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,2,Percent,2021,0.0115814269359879,0.0169643385191261,0.0061795952304823
5,Prevalence,1,Global,3,Both,22,All ages,582,Idiopathic developmental intellectual disability,3,Rate,2021,1119.22161410349,1636.7948366676499,597.48217601413
5,Prevalence,1,Global,3,Both,22,All ages,936,Guinea worm disease,1,Number,2021,23.91860155324393,31.007144086249472,17.998234092404473
5,Prevalence,1,Global,3,Both,22,All ages,936,Guinea worm disease,2,Percent,2021,3.1365473e-09,4.0593323e-09,2.3607495e-09
5,Prevalence,1,Global,3,Both,22,All ages,936,Guinea worm disease,3,Rate,2021,0.00030309886,0.00039292556000000006,0.00022807538
5,Prevalence,1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,4643564.2627780745,5999959.12648059,3245326.91989046
5,Prevalence,1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,0.0006089347454325,0.0007862386303662,0.0004261383425818
5,Prevalence,1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,58.84370000698,76.0320682375,41.12509979228
5,Prevalence,1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,989613.1175009204,1404363.4885570533,701947.7508568302
5,Prevalence,1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,0.0001297750125363,0.0001840725203346,9.1990730778e-05
5,Prevalence,1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,12.54047410864,17.79623133113,8.895150478069999
5,Prevalence,1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,37246.19833306227,48218.41550533366,27879.41292128391
5,Prevalence,1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,4.8842646805e-06,6.3257541643e-06,3.6625487638e-06
5,Prevalence,1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,0.47198746417,0.61102847215,0.35329064431
5,Prevalence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,5282097.141948823,6182739.631111805,4407183.35182848
5,Prevalence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.0006926765261122,0.0008112077316421,0.0005773797014777
5,Prevalence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,66.93525103550999,78.34828064956,55.848258009380004
5,Prevalence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,900480.5403956749,1082925.14015485,728498.2249922103
5,Prevalence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,0.0001180855633531,0.0001420897464102,9.55602770402e-05
5,Prevalence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,11.410977383450001,13.722933176149999,9.23160068025
5,Prevalence,1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,1001.2437687242872,1404.894906373214,669.0751998634202
5,Prevalence,1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,1.312972821e-07,1.842915335e-07,8.79620212e-08
5,Prevalence,1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,0.01268785886,0.01780296551,0.0084785863
5,Prevalence,1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,131970.16973169378,149051.93986706808,116188.89002182672
5,Prevalence,1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,1.73058449437e-05,1.95546076032e-05,1.52069150755e-05
5,Prevalence,1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,1.67233888412,1.88880074414,1.47235696583
5,Prevalence,1,Global,3,Both,22,All ages,547,Migraine,1,Number,2021,1158432823.8189986,1331312506.1266084,995861966.382874
5,Prevalence,1,Global,3,Both,22,All ages,547,Migraine,2,Percent,2021,0.1519099031391934,0.1747297870922,0.1304773387660258
5,Prevalence,1,Global,3,Both,22,All ages,547,Migraine,3,Rate,2021,14679.77392053287,16870.52214481297,12619.6601321805
5,Prevalence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,4073254.621425686,5120095.796367361,3203308.082667888
5,Prevalence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,0.0005341481222271,0.0006709194805759,0.0004194712743681
5,Prevalence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,51.616680513389994,64.88235415702,40.59263298182
5,Prevalence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,1,Number,2021,22639631.66935424,30335210.547073796,17652673.7116329
5,Prevalence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,2,Percent,2021,0.0029689316729121,0.0039737673686634,0.0023117450336417
5,Prevalence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,3,Rate,2021,286.89162437112003,384.41075175575,223.69640591278
5,Prevalence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,24467652.60349352,26230869.280127782,22861634.209310364
5,Prevalence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,0.0032085596734988,0.0034472637772582,0.0029950131819879
5,Prevalence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,310.05648424335,332.40013823321,289.70486224674
5,Prevalence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,48709072.06700462,73895674.69038501,31006171.80816284
5,Prevalence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.0063874384019701,0.0097095058578207,0.0040723916785514
5,Prevalence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,617.24612003422,936.4132091698899,392.91323840815005
5,Prevalence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,7554.40574089454,9611.466608400233,6157.402831832136
5,Prevalence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,9.906373924e-07,1.2600719347e-06,8.076571547e-07
5,Prevalence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,0.09573016760000001,0.12179744389000001,0.07802721025
5,Prevalence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,111123389.71645734,127901625.407709,96356479.8023746
5,Prevalence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.0145722249986432,0.0167675848585657,0.0126381440512771
5,Prevalence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,1408.16645107057,1620.7818929578298,1221.03872593501
5,Prevalence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,1111497287.1871111,1189217544.1052918,1049604637.9401964
5,Prevalence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.1457553685737525,0.155940874161791,0.1375019613389156
5,Prevalence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,14085.002214804148,15069.880903620431,13300.692516730938
5,Prevalence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,952439.5037723378,1180518.7681330969,730685.1443702793
5,Prevalence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.0001248993791565,0.000154816329268,9.57166044153e-05
5,Prevalence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,12.06940644367,14.95964916464,9.25931353627
5,Prevalence,1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,6364641.225661729,7428258.60573478,5415720.71170732
5,Prevalence,1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.0008346313679491,0.0009735834493159,0.0007089879794205
5,Prevalence,1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,80.65335542720001,94.13161878126,68.6285419663
5,Prevalence,1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,6209395.686312916,6694050.927312432,5825066.39141845
5,Prevalence,1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,0.0008142680144333,0.0008793254964942,0.0007657919182413
5,Prevalence,1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,78.68606878532,84.82766734933999,73.81581041204
5,Prevalence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,2367.931237078401,4391.726870948649,1130.4391202693628
5,Prevalence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,3.105077599e-07,5.768156353e-07,1.483361075e-07
5,Prevalence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.030006655979999998,0.055652391970000006,0.01432503497
5,Prevalence,1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,6297840.658530372,7206339.437561591,5422631.737330178
5,Prevalence,1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,0.0008258662279657,0.0009464549007913,0.0007114776083542
5,Prevalence,1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,79.8068521142,91.31943740101,68.71611915819
5,Prevalence,1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,173885570.145124,194458400.28992996,157990967.37815714
5,Prevalence,1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.0228024441266646,0.0254706772660548,0.0207097882156199
5,Prevalence,1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,2203.49493323077,2464.1958467595,2002.0769740896098
5,Prevalence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,38467787.9264388,44157508.62053659,33852693.3575578
5,Prevalence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.0050444623378378,0.0058016750489954,0.0044307460533803
5,Prevalence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,487.46756684732,559.56826335986,428.98463758285004
5,Prevalence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,29335101.95285734,33960500.90799611,24807274.07238487
5,Prevalence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.0038468213629226,0.0044453190601943,0.0032531880275354
5,Prevalence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,371.73727794078,430.35078539462995,314.36020067763997
5,Prevalence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,1,Number,2021,6201850.219470225,6687219.432377603,5818418.040212683
5,Prevalence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,2,Percent,2021,0.0008132785492154,0.000878428118337,0.0007648416465133
5,Prevalence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,3,Rate,2021,78.59045189231,84.7410979781,73.73156185603
5,Prevalence,1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,42178721.35062096,47871449.5497518,36486586.2551222
5,Prevalence,1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.0055311179485641,0.0062815871914772,0.0047831342155965
5,Prevalence,1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,534.4928777510299,606.6316856611701,462.36158570805
5,Prevalence,1,Global,3,Both,22,All ages,570,Bipolar disorder,1,Number,2021,37469253.05615445,44824637.94184126,31321119.47879684
5,Prevalence,1,Global,3,Both,22,All ages,570,Bipolar disorder,2,Percent,2021,0.0049135292904249,0.0058630027940645,0.0041044412719492
5,Prevalence,1,Global,3,Both,22,All ages,570,Bipolar disorder,3,Rate,2021,474.81403541576,568.0221912969399,396.90428606033004
5,Prevalence,1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,16164875.924262391,18431509.71464125,14133119.75216968
5,Prevalence,1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,0.002119771693281,0.0024210432982603,0.0018553171395536
5,Prevalence,1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,204.84288699567,233.56589183397,179.09627428347
5,Prevalence,1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,4020835.817414937,4816301.629213397,3363931.943506211
5,Prevalence,1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.0005272781026372,0.0006328958190162,0.0004413789773098
5,Prevalence,1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,50.95242430773,61.03264479062,42.628074239060005
5,Prevalence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,1726.7499980753914,2426.975871337846,1241.4641308931982
5,Prevalence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,2.264395215e-07,3.190402632e-07,1.630017608e-07
5,Prevalence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.02188154468,0.03075487535,0.01573195476
5,Prevalence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,1349707606.5632565,1510990209.5376186,1201028846.3413656
5,Prevalence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.1769940859514522,0.197855763912125,0.1576351637418962
5,Prevalence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,17103.626654719083,19147.41555667154,15219.554879501951
5,Prevalence,1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,53115936.37507399,60949054.27829854,46999805.18518785
5,Prevalence,1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.0069654339621465,0.0080066893392778,0.0061508029364502
5,Prevalence,1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,673.09033508992,772.35237044311,595.5861231151
5,Prevalence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,21801211.85890136,27477813.90272561,17686583.062829077
5,Prevalence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,0.0028589387270265,0.0036057636418198,0.0023206649936793
5,Prevalence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,276.26708662074003,348.20154231533,224.12610852403
5,Prevalence,1,Global,3,Both,22,All ages,355,Onchocerciasis,1,Number,2021,19596822.34473058,21711344.062111694,17757021.32514245
5,Prevalence,1,Global,3,Both,22,All ages,355,Onchocerciasis,2,Percent,2021,0.002569802359681,0.0028478674184291,0.0023280174068434
5,Prevalence,1,Global,3,Both,22,All ages,355,Onchocerciasis,3,Rate,2021,248.33284733170998,275.12827311987,225.01870906577
5,Prevalence,1,Global,3,Both,22,All ages,837,Thalassemias trait,1,Number,2021,357893032.6035823,409593782.6088761,313279120.347157
5,Prevalence,1,Global,3,Both,22,All ages,837,Thalassemias trait,2,Percent,2021,0.0469320499758929,0.0536959684242653,0.0410727281636092
5,Prevalence,1,Global,3,Both,22,All ages,837,Thalassemias trait,3,Rate,2021,4535.25547474936,5190.4124298999095,3969.9036199255897
5,Prevalence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,1,Number,2021,69473252.3684003,95724479.233738,49531420.00354627
5,Prevalence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,2,Percent,2021,0.0091103998754594,0.012565831227005,0.0065046292943796
5,Prevalence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,3,Rate,2021,880.37184144187,1213.02995298377,627.6669934282
5,Prevalence,1,Global,3,Both,22,All ages,351,Schistosomiasis,1,Number,2021,151376744.4956588,198666395.7595361,109062891.24718474
5,Prevalence,1,Global,3,Both,22,All ages,351,Schistosomiasis,2,Percent,2021,0.0198504939688575,0.0260287545756364,0.0142954129572901
5,Prevalence,1,Global,3,Both,22,All ages,351,Schistosomiasis,3,Rate,2021,1918.26089552323,2517.5199764650097,1382.05561316043
5,Prevalence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,633403.7749218894,782468.7759205657,517476.80989649217
5,Prevalence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,8.3062639943e-05,0.000102589971671,6.78320589238e-05
5,Prevalence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,8.026554518380001,9.915520774460001,6.55751669169
5,Prevalence,1,Global,3,Both,22,All ages,352,Cysticercosis,1,Number,2021,4357189.952150539,5716430.376855203,3150315.652771524
5,Prevalence,1,Global,3,Both,22,All ages,352,Cysticercosis,2,Percent,2021,0.0005713858056848,0.0007495115891937,0.0004127690686513
5,Prevalence,1,Global,3,Both,22,All ages,352,Cysticercosis,3,Rate,2021,55.21473676438,72.43916422193,39.92110773289
5,Prevalence,1,Global,3,Both,22,All ages,354,Lymphatic filariasis,1,Number,2021,56902555.79533651,67914348.39884499,48666870.19700055
5,Prevalence,1,Global,3,Both,22,All ages,354,Lymphatic filariasis,2,Percent,2021,0.0074618718301053,0.0088970333968614,0.006369880703161
5,Prevalence,1,Global,3,Both,22,All ages,354,Lymphatic filariasis,3,Rate,2021,721.0747463303601,860.61725803715,616.71133381447
5,Prevalence,1,Global,3,Both,22,All ages,356,Trachoma,1,Number,2021,1414047.312774968,1799564.334980762,1100377.4040748798
5,Prevalence,1,Global,3,Both,22,All ages,356,Trachoma,2,Percent,2021,0.0001854313335493,0.0002360994519342,0.0001444305340032
5,Prevalence,1,Global,3,Both,22,All ages,356,Trachoma,3,Rate,2021,17.91894569772,22.80425506753,13.94408996961
5,Prevalence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,1,Number,2021,61823539.64212848,72711237.69220328,52067672.515298985
5,Prevalence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,2,Percent,2021,0.0081072490646485,0.0095368510096157,0.0068269477326982
5,Prevalence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,3,Rate,2021,783.4339344094301,921.4039078112701,659.8066330450899
5,Prevalence,1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,124378780.6209469,148054568.36970365,103407546.82889616
5,Prevalence,1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,0.0163104988410816,0.0194739598765287,0.0135402117081412
5,Prevalence,1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,1576.14005964349,1876.1619550836501,1310.39053617345
5,Prevalence,1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,126339086.41543923,129719465.18062826,123141788.3171408
5,Prevalence,1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.0165675034239141,0.0170210075279822,0.0161535519977695
5,Prevalence,1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,1600.9812461901402,1643.8177361604098,1560.46477231742
5,Prevalence,1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,540882882.1900804,615109903.6455922,472963219.2410104
5,Prevalence,1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.0709285173318132,0.0805498934908833,0.0620538950251009
5,Prevalence,1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,6854.1207265352805,7794.73279428493,5993.43612199845
5,Prevalence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,111726710.2609526,132527344.75339696,94066728.5948206
5,Prevalence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.0146514386510321,0.0174161957731751,0.0123263080855939
5,Prevalence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,1415.8117879539,1679.39946043203,1192.02277492773
5,Prevalence,1,Global,3,Both,22,All ages,579,Conduct disorder,1,Number,2021,41043975.2133948,52491603.33476464,29785234.226913743
5,Prevalence,1,Global,3,Both,22,All ages,579,Conduct disorder,2,Percent,2021,0.0053822754819698,0.0068937319470348,0.0039075776679661
5,Prevalence,1,Global,3,Both,22,All ages,579,Conduct disorder,3,Rate,2021,520.11326383715,665.17872580674,377.44139809485
5,Prevalence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,5749469.4746558,6760597.344083672,4919310.879496934
5,Prevalence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,0.0007539637846354,0.0008863420213346,0.000645438580609
5,Prevalence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,72.85783889713,85.67095004414999,62.33798807406
5,Prevalence,1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,1513973.9463544623,1848403.9035078927,1235824.4736055955
5,Prevalence,1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.0001985351039507,0.0002423134912426,0.0001620794543757
5,Prevalence,1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,19.18522576112,23.42315485145,15.66048846767
5,Prevalence,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,1,Number,2021,642720070.0907941,714795829.9422679,586454625.2604468
5,Prevalence,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,2,Percent,2021,0.0842824637859132,0.0937556655080657,0.0768972955921617
5,Prevalence,1,Global,3,Both,22,All ages,360,Intestinal nematode infections,3,Rate,2021,8144.61152094918,9057.962591477519,7431.61030701191
5,Prevalence,1,Global,3,Both,22,All ages,362,Trichuriasis,1,Number,2021,266868167.3992972,299059851.1515466,240802973.29183492
5,Prevalence,1,Global,3,Both,22,All ages,362,Trichuriasis,2,Percent,2021,0.0349958460275036,0.0392260900995203,0.0316084253955592
5,Prevalence,1,Global,3,Both,22,All ages,362,Trichuriasis,3,Rate,2021,3381.7794898918596,3789.7156514781695,3051.47880363287
5,Prevalence,1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,3517383.5096072326,6430039.487625036,928243.8420542642
5,Prevalence,1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0004612414937962,0.0008422834783128,0.0001215991891042
5,Prevalence,1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,44.57262747668,81.48208859211,11.7627966545
5,Prevalence,1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,2369.7258947741457,5044.510267822778,919.9042364022894
5,Prevalence,1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,3.107725102e-07,6.618558365e-07,1.20709412e-07
5,Prevalence,1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,0.03002939806,0.06392452695,0.01165711636
5,Prevalence,1,Global,3,Both,22,All ages,568,Major depressive disorder,1,Number,2021,228998241.9395092,269447589.8869591,199894494.7169092
5,Prevalence,1,Global,3,Both,22,All ages,568,Major depressive disorder,2,Percent,2021,0.0300297045724533,0.0353090096916673,0.0262575276984818
5,Prevalence,1,Global,3,Both,22,All ages,568,Major depressive disorder,3,Rate,2021,2901.8880946321697,3414.46618366111,2533.08256643621
5,Prevalence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,4880181.955750381,5593282.117832296,4263269.970686099
5,Prevalence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,0.0006399625895582,0.0007343819667494,0.0005586755171238
5,Prevalence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,61.84214252951,70.87861745219,54.02457358341999
5,Prevalence,1,Global,3,Both,22,All ages,361,Ascariasis,1,Number,2021,293801144.8386031,363607845.4500879,238502051.6682878
5,Prevalence,1,Global,3,Both,22,All ages,361,Ascariasis,2,Percent,2021,0.0385268283222836,0.047740771862417,0.03127004110108
5,Prevalence,1,Global,3,Both,22,All ages,361,Ascariasis,3,Rate,2021,3723.07681131306,4607.67414146868,3022.32130002279
5,Prevalence,1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,391.2756355275446,549.3347594023446,233.6037991549956
5,Prevalence,1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,5.13105755e-08,7.19907197e-08,3.05914815e-08
5,Prevalence,1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,0.00495828308,0.0069612237399999995,0.00296025017
5,Prevalence,1,Global,3,Both,22,All ages,567,Depressive disorders,1,Number,2021,332410333.2661122,376102441.5301885,297742040.8388543
5,Prevalence,1,Global,3,Both,22,All ages,567,Depressive disorders,2,Percent,2021,0.0435904771761116,0.0493763068290703,0.0390310051506687
5,Prevalence,1,Global,3,Both,22,All ages,567,Depressive disorders,3,Rate,2021,4212.336219124551,4766.00688369846,3773.0162304477
5,Prevalence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,6675566.1018625125,8267794.698652248,5780138.851203365
5,Prevalence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,0.0008754118103067,0.0010831035864523,0.0007577202179224
5,Prevalence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,84.5934258353,104.77030217208998,73.24648423309
5,Prevalence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,475781302.6438746,591192459.2922013,381231004.9281721
5,Prevalence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.0623911109577892,0.0776839411012276,0.0500545516070499
5,Prevalence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,6029.147150201939,7491.648602741379,4830.99654013044
5,Prevalence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,673722703.2265357,722364095.7215549,629095119.0567394
5,Prevalence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.0883487245993031,0.0946224036460598,0.0825359999664033
5,Prevalence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,8537.479916954691,9153.86839484052,7971.95481030895
5,Prevalence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,10735809.09099739,11520170.778743953,9925500.13908961
5,Prevalence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,0.0014078420804845,0.0015113325350228,0.0013020678576208
5,Prevalence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,136.04522167309,145.98472961113998,125.77690746858
5,Prevalence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,15494647.394365711,16702737.617152411,14457323.510071792
5,Prevalence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,0.0020318950214721,0.0021915020209379,0.0018967408008523
5,Prevalence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,196.34968558453,211.65872291622998,183.20461597781
5,Prevalence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,2819032.884234366,3640571.6459267465,2147989.868728936
5,Prevalence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.0003696717302227,0.0004782580029555,0.0002815530161668
5,Prevalence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,35.72306012417,46.13367957541,27.21953747182
5,Prevalence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,386812.63954330864,486273.97556887066,266572.8434005841
5,Prevalence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,5.07251333969e-05,6.38814699484e-05,3.49482483282e-05
5,Prevalence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,4.901727559289999,6.16211132663,3.37803711533
5,Prevalence,1,Global,3,Both,22,All ages,363,Hookworm disease,1,Number,2021,112819265.57526344,119828376.91238308,106336950.18221202
5,Prevalence,1,Global,3,Both,22,All ages,363,Hookworm disease,2,Percent,2021,0.014794593237109,0.0157154557343902,0.0139253308368915
5,Prevalence,1,Global,3,Both,22,All ages,363,Hookworm disease,3,Rate,2021,1429.65675563781,1518.4768992811498,1347.51222166486
5,Prevalence,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,1,Number,2021,103762442.30034313,105436286.84023076,102134927.45173556
5,Prevalence,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,2,Percent,2021,0.0136068905300946,0.0138440813263094,0.013394809101946
5,Prevalence,1,Global,3,Both,22,All ages,365,Other neglected tropical diseases,3,Rate,2021,1314.8878062603699,1336.09892780185,1294.2637790931299
5,Prevalence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,3697978.93749652,5130222.108043537,2590427.822897071
5,Prevalence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,0.0004849351260478,0.0006719798363946,0.0003390676862231
5,Prevalence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,46.861150382780004,65.0106757679,32.82615445255
5,Prevalence,1,Global,3,Both,22,All ages,838,Sickle cell trait,1,Number,2021,413108090.03297496,455980687.6390793,373303806.47528577
5,Prevalence,1,Global,3,Both,22,All ages,838,Sickle cell trait,2,Percent,2021,0.0541725651494146,0.059771055024065,0.0489913106475889
5,Prevalence,1,Global,3,Both,22,All ages,838,Sickle cell trait,3,Rate,2021,5234.946076920511,5778.23182237166,4730.5423068604105
5,Prevalence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,13585498.557323596,15841222.931678368,11915482.24485846
5,Prevalence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,0.0017815439404369,0.0020776830960601,0.001562004778914
5,Prevalence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,172.15676500064,200.74152465325,150.99415513105998
5,Prevalence,1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,10275918.859073332,12799845.96982526,8107963.396201389
5,Prevalence,1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.0013475197949586,0.0016805219111486,0.0010630289120591
5,Prevalence,1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,130.21744772358,162.20089865481,102.74490429217
5,Prevalence,1,Global,3,Both,22,All ages,364,Food-borne trematodiases,1,Number,2021,44466329.42132039,50034921.070600815,40017217.653928265
5,Prevalence,1,Global,3,Both,22,All ages,364,Food-borne trematodiases,2,Percent,2021,0.0058311356298781,0.0065623311095561,0.0052441885571216
5,Prevalence,1,Global,3,Both,22,All ages,364,Food-borne trematodiases,3,Rate,2021,563.48167071871,634.04740814119,507.10209173095996
5,Prevalence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,24409335.36308047,29016916.172227256,20889175.072565258
5,Prevalence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.0032009055783148,0.0037995954639444,0.0027388704525216
5,Prevalence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,309.31748247533,367.70519664236997,264.7096673597
5,Prevalence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,1209915.8051592952,1521517.5628006498,936228.3838712547
5,Prevalence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.0001586616313794,0.0001997858404977,0.0001228456727548
5,Prevalence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,15.332171289879998,19.28081920572,11.863977548480001
5,Prevalence,1,Global,3,Both,22,All ages,630,Low back pain,1,Number,2021,628838475.1046376,700881341.0033092,551834407.3578129
5,Prevalence,1,Global,3,Both,22,All ages,630,Low back pain,2,Percent,2021,0.0824625135519954,0.0920224388134622,0.0723053940496313
5,Prevalence,1,Global,3,Both,22,All ages,630,Low back pain,3,Rate,2021,7968.7025930742,8881.63682821894,6992.89952340789
5,Prevalence,1,Global,3,Both,22,All ages,632,Gout,1,Number,2021,56474572.466154695,70288315.88220505,45161986.62071378
5,Prevalence,1,Global,3,Both,22,All ages,632,Gout,2,Percent,2021,0.007405823849978,0.0092063290462919,0.0059183131867707
5,Prevalence,1,Global,3,Both,22,All ages,632,Gout,3,Rate,2021,715.65129976965,890.70040591925,572.29710671405
5,Prevalence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,1081017593.7810106,1132833413.304296,1031278122.161672
5,Prevalence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.1417595484722665,0.1486715468276201,0.1351549417417685
5,Prevalence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,13698.76056214303,14355.37568946767,13068.45711831318
5,Prevalence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,506037583.6168959,545298325.3849418,469995870.87691057
5,Prevalence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.06635948138695,0.0714216094201611,0.0615171761772799
5,Prevalence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,6412.55769868401,6910.07365408255,5955.83359362322
5,Prevalence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,2376876.420174932,3421376.695240168,1678867.786172449
5,Prevalence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,0.0003116886680838,0.000449200688415,0.0002202074782861
5,Prevalence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,30.120010213609998,43.3560197453,21.27477660916
5,Prevalence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,1,Number,2021,112502042.8872406,142634228.05329257,88131780.85531315
5,Prevalence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,2,Percent,2021,0.0147530486386584,0.0187334247881897,0.0115413180974578
5,Prevalence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,3,Rate,2021,1425.63687874302,1807.4748730351998,1116.81453733746
5,Prevalence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,2002841.60623474,2370558.598557517,1656838.508250832
5,Prevalence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,0.0002626424276784,0.0003112325986386,0.0002173370590866
5,Prevalence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,25.380204508730003,30.03995016083,20.99561944711
5,Prevalence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,9661523.481441194,12020463.589400657,7440751.470116213
5,Prevalence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.0012669354186482,0.0015778166912524,0.0009765833803908
5,Prevalence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,122.43176947275,152.32448898562,94.28992957924
5,Prevalence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,68910.98621381192,101996.98306879713,45380.51522795909
5,Prevalence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,9.0365857881e-06,1.33822579804e-05,5.9445818715e-06
5,Prevalence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,0.8732467498,1.2925157344,0.57506632257
5,Prevalence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,3520627.866773211,5084399.911538189,2279280.8673597816
5,Prevalence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.0004616703223398,0.0006665837836837,0.0002986181387675
5,Prevalence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,44.61374028765,64.43001241703,28.8832698334
5,Prevalence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,63728.41265819095,74037.76378048974,51653.81587175985
5,Prevalence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,8.3570596946e-06,9.7148047654e-06,6.7700528997e-06
5,Prevalence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,0.8075726713699999,0.9382137759999999,0.65456220123
5,Prevalence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,525654113.331554,565380792.289232,490915907.2552074
5,Prevalence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.0689318909056629,0.0740885516364243,0.0643235411418098
5,Prevalence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,6661.14027973283,7164.56063671973,6220.934338464261
5,Prevalence,1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,152554542.63312554,165579239.6027401,139946639.22489834
5,Prevalence,1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.0200051419602643,0.0217002499548928,0.0183520922193734
5,Prevalence,1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,1933.1860685902698,2098.23630108201,1773.41748482851
5,Prevalence,1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,16046169.190819932,21244791.986400336,11928449.214955842
5,Prevalence,1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,0.0021041927213735,0.0027858309388964,0.0015641122674528
5,Prevalence,1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,203.33862367202002,269.21607963504,151.15847384299
5,Prevalence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,1,Number,2021,12367024.182776297,17468966.308797795,8168066.547352271
5,Prevalence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,2,Percent,2021,0.0016217273756485,0.0022894710452157,0.0010710628469111
5,Prevalence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,3,Rate,2021,156.71613868331,221.36844775612,103.50653729553001
5,Prevalence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,122695468.27590407,137071900.91427153,108710942.13464165
5,Prevalence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.0160896038489743,0.0179890286216043,0.0142321579859349
5,Prevalence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,1554.80896115009,1736.9885200987499,1377.5956796214
5,Prevalence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,18865689.913679056,21362353.17673404,16372571.719448766
5,Prevalence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,0.0024739476338357,0.0028019034071464,0.0021436082472763
5,Prevalence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,239.06786573492002,270.7058265245,207.47482840383003
5,Prevalence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,1995134.8881436195,2197792.313664528,1831120.4713776784
5,Prevalence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,0.000261632216658,0.0002883333684913,0.0002400938453829
5,Prevalence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,25.28254422415,27.85063891967,23.20413751094
5,Prevalence,1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,15467951.090567974,17968590.221139662,13273336.879828349
5,Prevalence,1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.0020283923558543,0.0023582952528251,0.0017411666842376
5,Prevalence,1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,196.01138741461,227.69973078580003,168.2010217257
5,Prevalence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,15126017.231573466,17609086.63253396,12950257.530830894
5,Prevalence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.0019835527139274,0.0023111122465817,0.00169717419556
5,Prevalence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,191.67836814703,223.14406618804003,164.10692865085
5,Prevalence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,15774456.855798677,17389519.736281596,14041228.959653027
5,Prevalence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,0.002068583144169,0.0022803486444712,0.0018420954799768
5,Prevalence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,199.89545841676,220.36169302738998,177.93182518311
5,Prevalence,1,Global,3,Both,22,All ages,981,Blindness and vision loss,1,Number,2021,1350054705.2121928,1673977885.599212,1087458891.734397
5,Prevalence,1,Global,3,Both,22,All ages,981,Blindness and vision loss,2,Percent,2021,0.1770397663124853,0.2193136246483158,0.1425885695612248
5,Prevalence,1,Global,3,Both,22,All ages,981,Blindness and vision loss,3,Rate,2021,17108.025122709412,21212.81131136838,13780.3853191132
5,Prevalence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,1,Number,2021,468992926.972022,487101388.26141447,452312215.0549345
5,Prevalence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,2,Percent,2021,0.0615014250234373,0.0638899783862241,0.0593428328177515
5,Prevalence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,3,Rate,2021,5943.1241904744,6172.5963811023,5731.744579381269
5,Prevalence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),1,Number,2021,485068.6611289523,554165.8064696263,416467.3005259344
5,Prevalence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),2,Percent,2021,6.36092744979e-05,7.25609290731e-05,5.4643475791e-05
5,Prevalence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),3,Rate,2021,6.14683746429,7.02244324073,5.27751432048
5,Prevalence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,13811569.51141706,15521510.177565172,12182271.255068364
5,Prevalence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.0018111843915033,0.0020358228130922,0.0015980422553246
5,Prevalence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,175.02155821769,196.69009339768002,154.37493153332
5,Prevalence,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,1,Number,2021,528429.0447360149,639167.4357706854,439582.2811959512
5,Prevalence,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,2,Percent,2021,6.92956640653e-05,8.3792696809e-05,5.76213266803e-05
5,Prevalence,1,Global,3,Both,22,All ages,938,Alcoholic cardiomyopathy,3,Rate,2021,6.6963044815999995,8.099592191760001,5.57042961383
5,Prevalence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,1845246558.0848343,1882683058.9495893,1811946448.0187292
5,Prevalence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.2419766324687746,0.2467767026120974,0.2376306972687726
5,Prevalence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,23383.1446617911,23857.54365823761,22961.16241366406
5,Prevalence,1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,22275015.210553717,30413692.29190281,15517370.142556068
5,Prevalence,1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,0.0029209785014431,0.0039861219151295,0.0020355334651964
5,Prevalence,1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,282.27116898273005,385.40528009377,196.63763046956998
5,Prevalence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,1328378028.9179304,1491353311.5965142,1178273211.9042764
5,Prevalence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.1741970193433951,0.1953225649442604,0.1546715411759515
5,Prevalence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,16833.336162930722,18898.57486746725,14931.1932567248
5,Prevalence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,524663971.4571062,562780408.2458677,488899870.4247765
5,Prevalence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.0688018953348544,0.0739152549577077,0.064095430478184
5,Prevalence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,6648.593105164489,7131.60831606871,6195.38692278535
5,Prevalence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,8560675.692322243,9496902.173752507,7673979.271863956
5,Prevalence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.0011226112220542,0.0012474391910228,0.0010059867942164
5,Prevalence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,108.4817187379,120.34567217847,97.24541506898001
5,Prevalence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,107559954.7549645,115994731.65716456,99170797.19541444
5,Prevalence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,0.0141048951894319,0.0151744005463015,0.0130152964239168
5,Prevalence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,1363.01025509644,1469.8965720658,1256.70203089408
5,Prevalence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,127218221.68954843,142911202.7093633,115160546.28420465
5,Prevalence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.0166828061800522,0.0187125856788726,0.0151125905689221
5,Prevalence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,1612.1217342738198,1810.98472293693,1459.32569352103
5,Prevalence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,12222705.876179298,18261067.14960418,8305087.982215225
5,Prevalence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,0.0016028152059634,0.0023939704711405,0.0010896843299637
5,Prevalence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,154.88732300243,231.40602699784998,105.24288630490001
5,Prevalence,1,Global,3,Both,22,All ages,388,Iodine deficiency,1,Number,2021,180812698.33833104,217237544.5236965,147603485.3688889
5,Prevalence,1,Global,3,Both,22,All ages,388,Iodine deficiency,2,Percent,2021,0.0237109779407952,0.0285189930324275,0.0193196367278165
5,Prevalence,1,Global,3,Both,22,All ages,388,Iodine deficiency,3,Rate,2021,2291.27617846482,2752.85538797701,1870.4457872272098
5,Prevalence,1,Global,3,Both,22,All ages,390,Dietary iron deficiency,1,Number,2021,1270637339.3781135,1290652748.006565,1252350457.5354643
5,Prevalence,1,Global,3,Both,22,All ages,390,Dietary iron deficiency,2,Percent,2021,0.1666250773194115,0.1692563389567715,0.1641841456904059
5,Prevalence,1,Global,3,Both,22,All ages,390,Dietary iron deficiency,3,Rate,2021,16101.640503905921,16355.27771752019,15869.90735059575
5,Prevalence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,540417645.4934949,625952119.0246117,457548768.5564199
5,Prevalence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,0.070868073189899,0.0820739424857394,0.0599673696193556
5,Prevalence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,6848.22520166324,7932.1264068355695,5798.1026969552795
5,Prevalence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,6343412.653386466,7900494.111410756,5069614.300612239
5,Prevalence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,0.0008318416538856,0.0010355525954338,0.0006645058675382
5,Prevalence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,80.38434488533,100.11583324587,64.24264771084
5,Prevalence,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,1,Number,2021,4223932.240440241,5034257.625180527,3417357.4131868947
5,Prevalence,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,2,Percent,2021,0.0005539086612712,0.0006592949581939,0.0004479464439104
5,Prevalence,1,Global,3,Both,22,All ages,944,Other cardiomyopathy,3,Rate,2021,53.52608202251,63.79460446547999,43.305087010440005
5,Prevalence,1,Global,3,Both,22,All ages,398,Genital herpes,1,Number,2021,995281203.4501415,1163485830.3590453,839157762.0415293
5,Prevalence,1,Global,3,Both,22,All ages,398,Genital herpes,2,Percent,2021,0.1305163662502772,0.1525104963687764,0.1099658134447117
5,Prevalence,1,Global,3,Both,22,All ages,398,Genital herpes,3,Rate,2021,12612.300647557271,14743.80611307928,10633.88914500813
5,Prevalence,1,Global,3,Both,22,All ages,598,Male infertility,1,Number,2021,55000818.26222798,88727953.04689956,32611257.299106427
5,Prevalence,1,Global,3,Both,22,All ages,598,Male infertility,2,Percent,2021,0.007212440750183,0.0116407713227661,0.0042890025994048
5,Prevalence,1,Global,3,Both,22,All ages,598,Male infertility,3,Rate,2021,696.97574251398,1124.36928959434,413.25303856377
5,Prevalence,1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,119544904.34214264,154944149.08193278,91228328.10814004
5,Prevalence,1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,0.015676406244923,0.020293864923334,0.0119706903000149
5,Prevalence,1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,1514.88470717623,1963.46739497041,1156.05428665317
5,Prevalence,1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,61.9776250827979,163.34989893739913,18.140436746713817
5,Prevalence,1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,8.1278442e-09,2.14809307e-08,2.3739674e-09
5,Prevalence,1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.0007853865200000001,0.0020699858800000003,0.00022987738999999998
5,Prevalence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,721066.4641582229,814072.6704765331,598861.1917556748
5,Prevalence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,9.45568980515e-05,0.000106826983294,7.84500893581e-05
5,Prevalence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,9.13742468089,10.316008413919999,7.5888275297400005
5,Prevalence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,126620.20669152954,208589.80826942448,66345.21863439391
5,Prevalence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,1.66041063999e-05,2.73182210067e-05,8.6932656486e-06
5,Prevalence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,1.60454362979,2.6432704292900002,0.8407330923599999
5,Prevalence,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,1,Number,2021,117025316.68301228,118809566.47370082,115319925.990036
5,Prevalence,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0153461204864283,0.0155902248346402,0.0151136769527242
5,Prevalence,1,Global,3,Both,22,All ages,618,Other hemoglobinopathies and hemolytic anemias,3,Rate,2021,1482.9562461999099,1505.56643386596,1461.34536872447
5,Prevalence,1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,152203474.9496016,212994413.26740852,113239108.5123613
5,Prevalence,1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,0.0199593688125908,0.0279027075046779,0.014858952140981
5,Prevalence,1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,1928.73730460588,2699.0860141499597,1434.97704635472
5,Prevalence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,653669.8838140804,1143789.340944523,375787.87805687374
5,Prevalence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,8.57177069276e-05,0.000149961102019,4.93564343011e-05
5,Prevalence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,8.28336863023,14.494210274899999,4.76202070463
5,Prevalence,1,Global,3,Both,22,All ages,397,Trichomoniasis,1,Number,2021,165722940.67692867,221511646.1188868,122759788.78250322
5,Prevalence,1,Global,3,Both,22,All ages,397,Trichomoniasis,2,Percent,2021,0.0217319760460694,0.0290060991799338,0.0161143778379552
5,Prevalence,1,Global,3,Both,22,All ages,397,Trichomoniasis,3,Rate,2021,2100.0572951335,2807.01722096439,1555.62403689373
5,Prevalence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,13415279.142305711,16121838.148493756,11362006.902152162
5,Prevalence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,0.0017592145337098,0.0021175180555891,0.0014898388500415
5,Prevalence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,169.99972794336,204.29750809640998,143.9804615146
5,Prevalence,1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,277519.805714438,327657.35955475713,215617.84206795515
5,Prevalence,1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,3.63924031446e-05,4.30008685222e-05,2.82596114458e-05
5,Prevalence,1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,3.51675809127,4.1521060719000005,2.7323303602199998
5,Prevalence,1,Global,3,Both,22,All ages,585,Other mental disorders,1,Number,2021,121978684.79280315,151917429.0104295,96165248.9986584
5,Prevalence,1,Global,3,Both,22,All ages,585,Other mental disorders,2,Percent,2021,0.0159959455488285,0.0199208061013129,0.0125887495615746
5,Prevalence,1,Global,3,Both,22,All ages,585,Other mental disorders,3,Rate,2021,1545.7258108235899,1925.1125025184501,1218.6154305073599
5,Prevalence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,808835.7715562815,909896.1708803916,713400.11816747
5,Prevalence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,0.0001060661812468,0.0001193251892901,9.35808600742e-05
5,Prevalence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,10.24964591916,11.53029317284,9.04027599551
5,Prevalence,1,Global,3,Both,22,All ages,655,Psoriasis,1,Number,2021,42983445.67966012,44313231.27957207,41654456.507895656
5,Prevalence,1,Global,3,Both,22,All ages,655,Psoriasis,2,Percent,2021,0.0056366305215042,0.0058140206830595,0.0054596583591327
5,Prevalence,1,Global,3,Both,22,All ages,655,Psoriasis,3,Rate,2021,544.69042306893,561.54159610902,527.84934244414
5,Prevalence,1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,34424594.571485125,35249449.02794582,33632690.11467961
5,Prevalence,1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.0045142745521059,0.0046211988129523,0.0044057819232533
5,Prevalence,1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,436.23182563960006,446.68446189888,426.19673499512004
5,Prevalence,1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,21553991.6127216,23361736.317842864,19890335.15237489
5,Prevalence,1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0028264910720932,0.0030670431123455,0.0026060380312755
5,Prevalence,1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,273.13428750811,296.04220502527,252.05227030593
5,Prevalence,1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,6981752.165213181,10505291.28488383,4660762.386460127
5,Prevalence,1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,0.0009155350835824,0.0013769118541243,0.000612402581399
5,Prevalence,1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,88.47344554398,133.12407751278002,59.061636310509996
5,Prevalence,1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,70541482.79823184,88207651.97059602,54910897.6591972
5,Prevalence,1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0092503540849323,0.0115869188850578,0.0072084035890605
5,Prevalence,1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,893.9085618131601,1117.7759835228098,695.8362598472701
5,Prevalence,1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,39465606.12142552,49695590.01006167,30774596.455290437
5,Prevalence,1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,0.0051753343216391,0.0065211564536827,0.0040377449106278
5,Prevalence,1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,500.11201649949,629.74737178992,389.978692912
5,Prevalence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,2192997853.079915,2271726407.441866,2116384178.3279047
5,Prevalence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.2875775181021034,0.297597745198043,0.2776644648619556
5,Prevalence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,27789.88304673346,28787.53897926629,26819.02707523821
5,Prevalence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,7304355.952637504,9072537.68845631,5794894.576651421
5,Prevalence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.0009578601538796,0.0011893516326634,0.0007594426167227
5,Prevalence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,92.56151225612,114.96808396104001,73.43347022758
5,Prevalence,1,Global,3,Both,22,All ages,941,Sexual violence,1,Number,2021,242654885.3071441,275346303.2316233,209601783.26641047
5,Prevalence,1,Global,3,Both,22,All ages,941,Sexual violence,2,Percent,2021,0.0318206715454068,0.0360793015573539,0.0274778447881252
5,Prevalence,1,Global,3,Both,22,All ages,941,Sexual violence,3,Rate,2021,3074.94641361981,3489.21525545988,2656.0942753226
5,Prevalence,1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,339873.01549728407,421470.34603837226,238895.65598514752
5,Prevalence,1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,4.45689946962e-05,5.52201653775e-05,3.13474803423e-05
5,Prevalence,1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,4.30690405745,5.340913402,3.02730909238
5,Prevalence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,35451.99784329684,41655.14242780958,30151.19879777732
5,Prevalence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,4.6490197954e-06,5.4646908698e-06,3.9559052318e-06
5,Prevalence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,0.44925118028,0.52785803449,0.38207893689
5,Prevalence,1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,2934.997692966372,7212.994988472057,1172.3485680787037
5,Prevalence,1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,3.848609484e-07,9.451200788e-07,1.538299644e-07
5,Prevalence,1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,0.037192577510000005,0.09140377719,0.01485611559
5,Prevalence,1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,1,Number,2021,1897323611.577207,2084892800.8242009,1719338323.898286
5,Prevalence,1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,2,Percent,2021,0.248803760184852,0.2733868569875599,0.2257081336171484
5,Prevalence,1,Global,3,Both,22,All ages,954,Latent tuberculosis infection,3,Rate,2021,24043.07017149416,26419.965262852304,21787.62321713904
5,Prevalence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,7776893.544501504,9344079.911596704,6517640.88094642
5,Prevalence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,0.0010198107999201,0.001224702813813,0.0008565000525375
5,Prevalence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,98.54955478641001,118.40909354193,82.5921820068
5,Prevalence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,1487651.012108019,1785668.991069355,1237258.858108044
5,Prevalence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,0.0001950852541923,0.0002339153496415,0.0001622163589181
5,Prevalence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,18.85165896664,22.62817191193,15.67866512822
5,Prevalence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,56325.836526381565,75479.9265763697,38458.99067318424
5,Prevalence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,7.3861747595e-06,9.8959027334e-06,5.0494852978e-06
5,Prevalence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,0.71376650341,0.95648900385,0.48735608719
5,Prevalence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,1,Number,2021,374738744.12489617,428353219.5156148,321858981.9414015
5,Prevalence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,2,Percent,2021,0.0491408631981777,0.0561282328391681,0.0422077922865035
5,Prevalence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,3,Rate,2021,4748.72597694747,5428.13384715013,4078.62846428709
5,Prevalence,1,Global,3,Both,22,All ages,631,Neck pain,1,Number,2021,206029628.5454742,252863254.40234116,161756682.55036992
5,Prevalence,1,Global,3,Both,22,All ages,631,Neck pain,2,Percent,2021,0.0270177306616816,0.0331931327042808,0.0212340863842986
5,Prevalence,1,Global,3,Both,22,All ages,631,Neck pain,3,Rate,2021,2610.8275817048902,3204.3078641360503,2049.79648465645
5,Prevalence,1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,155078828.60810992,167513892.02850467,143578953.00484085
5,Prevalence,1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.0203362258349281,0.0219707656328158,0.0188826431889853
5,Prevalence,1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,1965.17406708411,2122.7524056338502,1819.44651991939
5,Prevalence,1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,2393213.312810685,2771475.9350989657,2059697.678751588
5,Prevalence,1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.0003138319838624,0.0003626690241881,0.0002698020348146
5,Prevalence,1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,30.327032913180002,35.12041381849,26.10069021442
5,Prevalence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,11953148.876419785,12555072.174779143,11384011.659857197
5,Prevalence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0015674794827744,0.0016469417506484,0.001492901068312
5,Prevalence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,151.47147036618,159.09910120997,144.25930795407
5,Prevalence,1,Global,3,Both,22,All ages,662,Alopecia areata,1,Number,2021,17525630.070166763,18072092.08533833,16977877.598401017
5,Prevalence,1,Global,3,Both,22,All ages,662,Alopecia areata,2,Percent,2021,0.0022982278998589,0.002371849876894,0.0022260183981756
5,Prevalence,1,Global,3,Both,22,All ages,662,Alopecia areata,3,Rate,2021,222.08649647615002,229.0113165209,215.14532363936
5,Prevalence,1,Global,3,Both,22,All ages,405,Leprosy,1,Number,2021,408775.8041502248,472239.25562108005,357208.8007268302
5,Prevalence,1,Global,3,Both,22,All ages,405,Leprosy,2,Percent,2021,5.3604651732e-05,6.17972724483e-05,4.68432508501e-05
5,Prevalence,1,Global,3,Both,22,All ages,405,Leprosy,3,Rate,2021,5.180046926959999,5.98426198428,4.52658482156
5,Prevalence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,7255129087.317582,7305480908.407284,7201504216.731791
5,Prevalence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.9513968800499678,0.9556189442771568,0.9471215813372
5,Prevalence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,91937.70460939997,92575.76780554382,91258.16501026972
5,Prevalence,1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,505030.22410875664,587818.5759200677,432294.5602297784
5,Prevalence,1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,6.62273313587e-05,7.70507928416e-05,5.67392631135e-05
5,Prevalence,1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,6.39979234058,7.44889442303,5.47807890174
5,Prevalence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,11846.913067240195,15137.30611184437,8911.021188105078
5,Prevalence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,1.5535572058e-06,1.9891276842e-06,1.1689537296e-06
5,Prevalence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,0.15012523980999998,0.19182142194000001,0.11292133109
5,Prevalence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,162660773.57078868,175022299.8632177,149671674.29232186
5,Prevalence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.0213304101102075,0.0229753085259799,0.0196280360801725
5,Prevalence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,2061.2532143955,2217.89968327519,1896.65407932382
5,Prevalence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,1686561517.4453216,1780146354.074309,1599166936.695971
5,Prevalence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.2211666949951257,0.2335131686510711,0.2097448216618528
5,Prevalence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,21372.27232352368,22558.18851638029,20264.799657952302
5,Prevalence,1,Global,3,Both,22,All ages,628,Osteoarthritis,1,Number,2021,606989318.9956341,670519617.2751476,537873607.7009358
5,Prevalence,1,Global,3,Both,22,All ages,628,Osteoarthritis,2,Percent,2021,0.0795969004097267,0.0878643381197502,0.0706381532657841
5,Prevalence,1,Global,3,Both,22,All ages,628,Osteoarthritis,3,Rate,2021,7691.827952232071,8496.89009884214,6815.98690620737
5,Prevalence,1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,1004202.006681554,1120956.6077771508,888168.9924535314
5,Prevalence,1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0001316853258663,0.0001469324930773,0.0001164709397289
5,Prevalence,1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,12.72534593765,14.20487164948,11.254964245110001
5,Prevalence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,291232478.0847062,315588758.37702954,267916830.6201832
5,Prevalence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.0381907672303604,0.0413583098007637,0.0350849690383469
5,Prevalence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,3690.5264152529003,3999.17157868821,3395.0682526797
5,Prevalence,1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,1126173.9382560214,1305569.149295666,965137.5208353372
5,Prevalence,1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,0.0001476806517903,0.0001709738201646,0.0001265163445554
5,Prevalence,1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,14.27098617103,16.544299811960002,12.230316956469999
5,Prevalence,1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,4124006.7714004954,5026199.553757418,3318692.5470041647
5,Prevalence,1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,0.0005408077898409,0.0006600516411655,0.0004345182315843
5,Prevalence,1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,52.25981671628,63.69249179715,42.05479618677
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,31688.18908723828,38474.54872877043,25736.744931924382
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,4.1554305718e-06,5.0467670057e-06,3.3775576837e-06
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,0.40155582799999995,0.48755324039,0.32613854622
5,Prevalence,1,Global,3,Both,22,All ages,669,Sense organ diseases,1,Number,2021,2386160887.8330765,2591000613.5688787,2207871225.980574
5,Prevalence,1,Global,3,Both,22,All ages,669,Sense organ diseases,2,Percent,2021,0.3129083264973067,0.339602509922715,0.2896135605605562
5,Prevalence,1,Global,3,Both,22,All ages,669,Sense organ diseases,3,Rate,2021,30237.66389485581,32833.412911904845,27978.35988123615
5,Prevalence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,87120801.52694595,88527952.12634596,85802936.51019195
5,Prevalence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0114245903938998,0.0116157310717986,0.0112528169352582
5,Prevalence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,1104.00330851727,1121.83485838931,1087.30319427158
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,288105.90037255496,349750.3506695919,237812.47221218547
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,3.77808297441e-05,4.58544601171e-05,3.12002842053e-05
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,3.65090611702,4.43207061375,3.01358288178
5,Prevalence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,27933.415140264937,43751.11424828383,18731.29558171169
5,Prevalence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,3.6630603133e-06,5.7388903264e-06,2.4599423972e-06
5,Prevalence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,0.35397496571000003,0.55441839417,0.23736480763
5,Prevalence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,71455.40631117618,106009.42620672188,48998.78287879055
5,Prevalence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,9.3702656941e-06,1.39035766004e-05,6.4281479276e-06
5,Prevalence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,0.90548988986,1.34336180585,0.62091736375
5,Prevalence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,3253729.2567788446,3558836.142245096,2947830.8409209475
5,Prevalence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.0004266756621426,0.0004670358427302,0.0003869943125527
5,Prevalence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,41.23157502622,45.09791928732,37.35520041467
5,Prevalence,1,Global,3,Both,22,All ages,671,Cataract,1,Number,2021,100570685.8135514,114032510.51649894,88771984.68285358
5,Prevalence,1,Global,3,Both,22,All ages,671,Cataract,2,Percent,2021,0.0131883502374249,0.0149614358310374,0.0116342868761668
5,Prevalence,1,Global,3,Both,22,All ages,671,Cataract,3,Rate,2021,1274.44155623006,1445.03111406531,1124.92726278697
5,Prevalence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,1682114.837953817,1881081.771941855,1494990.3358341765
5,Prevalence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,0.0002205843038581,0.0002465589565227,0.0001960113597298
5,Prevalence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,21.31592356657,23.83725199283,18.94466359393
5,Prevalence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,179745063.45924184,220443018.9790072,142060199.21036965
5,Prevalence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.0235708831435849,0.028945618003803,0.0186646825039474
5,Prevalence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,2277.74700497072,2793.47547344461,1800.20072345595
5,Prevalence,1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,3451749.795333511,3724779.485306079,3165257.1799243246
5,Prevalence,1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0004526443126976,0.000488333403295,0.0004154882003355
5,Prevalence,1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,43.740910637089996,47.200769543,40.11044822474
5,Prevalence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,13320896.133468973,15249410.949055374,11422539.17678498
5,Prevalence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,0.0017468488780139,0.0019993749626588,0.0014962154834151
5,Prevalence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,168.8036972343,193.24202539033,144.74753241266
5,Prevalence,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,1,Number,2021,11729.701210109522,13979.813781053545,9696.152919607186
5,Prevalence,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,2,Percent,2021,1.5381626443e-06,1.8346193465e-06,1.2737089817e-06
5,Prevalence,1,Global,3,Both,22,All ages,970,Other non-rheumatic valve diseases,3,Rate,2021,0.14863991971,0.17715356604,0.12287059709999999
5,Prevalence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,5538010325.864546,5711676157.591004,5378816930.222147
5,Prevalence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.7262161057532365,0.7475930892341516,0.7057066399477339
5,Prevalence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,70178.20790441496,72378.91829093624,68160.89364188543
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,132033.1320588621,159049.2893875537,107264.09014873074
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,1.73141694158e-05,2.08745196536e-05,1.40524377541e-05
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,1.67313674888,2.01548813399,1.3592610298999999
5,Prevalence,1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,1103683.5555114674,1186559.5320532,1033145.3410919216
5,Prevalence,1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0001447314651933,0.0001555722527462,0.0001354897690767
5,Prevalence,1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,13.985985843619998,15.03619831521,13.09211869902
5,Prevalence,1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,152308806.6837591,214647714.73833328,117582719.92235656
5,Prevalence,1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.0199726526989323,0.0281274332491595,0.0154201026928617
5,Prevalence,1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,1930.0720786318702,2720.03681191452,1490.01971450631
5,Prevalence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,18549408.27214101,22636856.78274552,15159832.560297472
5,Prevalence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,0.0024324687555801,0.0029697389813304,0.0019922100573122
5,Prevalence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,235.05991387311997,286.85646073691,192.10687929632002
5,Prevalence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,3216778.395159201,3837827.076517656,2608176.6209923914
5,Prevalence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,0.0004218315380254,0.0005037546915165,0.0003421683202952
5,Prevalence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,40.763330097739995,48.63331966341,33.05106895604
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,739299.5446262226,821948.2365200855,673114.2476474836
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,9.69479875005e-05,0.0001079364821917,8.82782764693e-05
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,9.36847605793,10.41580835625,8.52976950841
5,Prevalence,1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,67826600.4300379,74750449.5407308,61771775.43092458
5,Prevalence,1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.0088944703754113,0.0098047895311002,0.0081011807184207
5,Prevalence,1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,859.50530720359,947.2449995836599,782.77797326777
5,Prevalence,1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,3384543.86162754,3697258.2477976354,3108398.9196436023
5,Prevalence,1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0004438331748775,0.0004851294501188,0.0004069301859762
5,Prevalence,1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,42.88927047925,46.85201773251,39.38993479549
5,Prevalence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,81863254.08399245,86237819.50118409,77854223.96074635
5,Prevalence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.0107351263219017,0.0113041107512789,0.010194470100159
5,Prevalence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,1037.37915366589,1092.81407402083,986.57633226806
5,Prevalence,1,Global,3,Both,22,All ages,680,Oral disorders,1,Number,2021,3692287314.292432,4002277365.158777,3404330787.242156
5,Prevalence,1,Global,3,Both,22,All ages,680,Oral disorders,2,Percent,2021,0.4841715037617748,0.5236382448344932,0.4467631879645985
5,Prevalence,1,Global,3,Both,22,All ages,680,Oral disorders,3,Rate,2021,46789.02557748425,50717.24978761198,43140.01233379497
5,Prevalence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,1,Number,2021,2242874758.2495537,2599622169.355074,1957579677.466316
5,Prevalence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,2,Percent,2021,0.2941073490133573,0.3409237531713422,0.2565528008312454
5,Prevalence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,3,Rate,2021,28421.92806193971,32942.6661091402,24806.64092536557
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,201212.1600456787,228763.0818735161,173232.68088726953
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,2.63857863653e-05,2.99790389857e-05,2.26795692209e-05
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,2.54978015022,2.8989081233,2.1952214567699997
5,Prevalence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,328248.7730514448,344202.38210030907,313841.85417492816
5,Prevalence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,4.30448812615e-05,4.51561796757e-05,4.11180198379e-05
5,Prevalence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,4.15960052151,4.36176621402,3.97703463797
5,Prevalence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,19616529.714658007,23179713.462027997,16633386.509820145
5,Prevalence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,0.0025724095187129,0.0030373348107363,0.002179966318512
5,Prevalence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,248.58258104881,293.73559361303,210.77989890861997
5,Prevalence,1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,1566169.1800527317,1856977.821138088,1314520.1273823632
5,Prevalence,1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,0.0002053794600525,0.0002434619147745,0.0001725395606594
5,Prevalence,1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,19.84664886193,23.53180437332,16.65772748077
5,Prevalence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,11679119.510037106,12538400.016840458,10774527.401461951
5,Prevalence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.001531537862935,0.0016436768377362,0.0014130729106843
5,Prevalence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,147.99894346313002,158.88782999572,136.53586388601
5,Prevalence,1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,1529781129.592573,1655157943.4221764,1395019883.6018205
5,Prevalence,1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.2006065365051638,0.2171918496929376,0.1830153581570102
5,Prevalence,1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,19385.53593145182,20974.32316542169,17677.82825629129
5,Prevalence,1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,2545804.052343493,2698187.0792557998,2404171.4166691145
5,Prevalence,1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.0003338439894041,0.0003535240601191,0.0003151732811458
5,Prevalence,1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,32.26067767242,34.191690277039996,30.46589507586
5,Prevalence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,1,Number,2021,1121753.9716398497,1432229.39426903,854998.1222694009
5,Prevalence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,2,Percent,2021,0.0001470989477855,0.0001877915392233,0.000111962149757
5,Prevalence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,3,Rate,2021,14.21497592225,18.14935081077,10.83461973739
5,Prevalence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,525219.1362658364,613340.4092889517,455884.276481268
5,Prevalence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,6.88740380751e-05,8.0370141899e-05,5.97891570442e-05
5,Prevalence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,6.6556282078599995,7.77230958892,5.77701009076
5,Prevalence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,1,Number,2021,1893379.4799865575,2378401.477234788,1525412.6559726312
5,Prevalence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,2,Percent,2021,0.0002482871308762,0.0003114927784905,0.0002002468200945
5,Prevalence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,3,Rate,2021,23.99308975064,30.13933588567,19.330178206939998
5,Prevalence,1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,158661976.43947324,169578900.1134951,148355126.35193473
5,Prevalence,1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.0208061373408243,0.0222222358571032,0.0194857853427731
5,Prevalence,1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,2010.5800664711599,2148.92038983495,1879.97065519853
5,Prevalence,1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,20643637.912570577,21799703.02141517,19562589.598955013
5,Prevalence,1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.002707107976403,0.0028558173303045,0.0025674721433961
5,Prevalence,1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,261.59819647964,276.2479664847,247.89904663276002
5,Prevalence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,314465.1491415817,353970.36642202886,265614.3080014669
5,Prevalence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,4.12369199064e-05,4.63456323642e-05,3.4826106454e-05
5,Prevalence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,3.98493309268,4.48554706566,3.3658904611000002
5,Prevalence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,2256338981.1603136,2445004682.9529896,2084040429.901441
5,Prevalence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.2958830576586841,0.3199033784927084,0.2735556122500633
5,Prevalence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,28592.54801009864,30983.33821556327,26409.163935243767
5,Prevalence,1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,1222425.2593904214,1332111.9817699443,1102105.8471668223
5,Prevalence,1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.000160302516971,0.0001746568746328,0.0001446895936428
5,Prevalence,1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,15.490692316050001,16.880653178270002,13.965992969330001
5,Prevalence,1,Global,3,Both,22,All ages,606,Female infertility,1,Number,2021,110089459.27403302,195025585.21800983,58608815.05595651
5,Prevalence,1,Global,3,Both,22,All ages,606,Female infertility,2,Percent,2021,0.0144365892617665,0.0255941051095914,0.007686769592547
5,Prevalence,1,Global,3,Both,22,All ages,606,Female infertility,3,Rate,2021,1395.06438349076,2471.3832695812202,742.69663037983
5,Prevalence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,36958262.573931366,37765495.506578594,36139204.78405788
5,Prevalence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0048465270808234,0.0049545562731064,0.0047345947193569
5,Prevalence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,468.33871410204995,478.56804868997,457.95953376809
5,Prevalence,1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,10387520.52689577,10904399.863825032,9705680.483080711
5,Prevalence,1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0013621644732444,0.001429552994672,0.0012747697673739
5,Prevalence,1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,131.63167496154,138.18162041742,122.99133131159
5,Prevalence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,1538007.6187633271,1633909.9666877077,1435013.9140441436
5,Prevalence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.000201686658311,0.0002142500307272,0.0001881957206586
5,Prevalence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,19.489782805930002,20.70506672834,18.18463651741
5,Prevalence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,439000.5787602656,471000.0082520703,401738.7830293226
5,Prevalence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,5.75683371464e-05,6.17201223732e-05,5.26394120344e-05
5,Prevalence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,5.56305822373,5.96855812054,5.09087310781
5,Prevalence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,2760903.306324079,3202143.838791751,2394427.43208043
5,Prevalence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.000362051209958,0.0004198712387511,0.0003137408918686
5,Prevalence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,34.986436433719994,40.57787956967,30.34241835118
5,Prevalence,1,Global,3,Both,22,All ages,652,Other congenital birth defects,1,Number,2021,12829860.15892395,20559607.8278293,6842606.870292198
5,Prevalence,1,Global,3,Both,22,All ages,652,Other congenital birth defects,2,Percent,2021,0.0016824449660489,0.0026986927591772,0.0008962438075782
5,Prevalence,1,Global,3,Both,22,All ages,652,Other congenital birth defects,3,Rate,2021,162.58124139141,260.53335903619,86.71018277246999
5,Prevalence,1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,3025553.4420908825,3224008.721616407,2823190.5897115846
5,Prevalence,1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0003967560949762,0.0004236976706083,0.000370309946957
5,Prevalence,1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,38.34010881007,40.85495350099,35.775746974179995
5,Prevalence,1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,1987148.475345764,2198245.2234251928,1776275.300756995
5,Prevalence,1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0002605840960075,0.0002882591776614,0.0002328463347755
5,Prevalence,1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,25.181339620910002,27.856378236399998,22.50913415054
5,Prevalence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,864284077.5089206,963733781.7259188,771564187.0673376
5,Prevalence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.1133373016385667,0.1264305480436347,0.1009948573121132
5,Prevalence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,10952.29226941314,12212.52863733352,9777.336759147249
5,Prevalence,1,Global,3,Both,22,All ages,661,Acne vulgaris,1,Number,2021,239665793.26495865,266545356.98737133,218962319.05875537
5,Prevalence,1,Global,3,Both,22,All ages,661,Acne vulgaris,2,Percent,2021,0.0314284848852751,0.0348990053123891,0.028658238004015
5,Prevalence,1,Global,3,Both,22,All ages,661,Acne vulgaris,3,Rate,2021,3037.06834723156,3377.6888048138603,2774.71189939309
5,Prevalence,1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,1961210.8463193765,2051838.0069640216,1861776.5392065016
5,Prevalence,1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0002571832950412,0.0002691548261102,0.0002444363481231
5,Prevalence,1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,24.85265545183,26.00109168565,23.59261419751
5,Prevalence,1,Global,3,Both,22,All ages,654,Dermatitis,1,Number,2021,240887382.83789375,262498101.2697105,223263286.30330843
5,Prevalence,1,Global,3,Both,22,All ages,654,Dermatitis,2,Percent,2021,0.0315890190449769,0.0345104564107712,0.0292951395625893
5,Prevalence,1,Global,3,Both,22,All ages,654,Dermatitis,3,Rate,2021,3052.54844964721,3326.40158494902,2829.21417651392
5,Prevalence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,547261.7606318807,696986.6173294649,428470.0956375421
5,Prevalence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,7.17659627852e-05,9.13994009052e-05,5.61800050368e-05
5,Prevalence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,6.93495449736,8.83228250932,5.42961491279
5,Prevalence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,1267815566.469118,1380382443.090777,1157880130.1889496
5,Prevalence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,0.1662543493866719,0.18131996267504,0.1519787036599425
5,Prevalence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,16065.882721920241,17492.34118008001,14672.77013285557
5,Prevalence,1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,162860673.31278804,180853932.54551017,145950893.0191025
5,Prevalence,1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.021356867067931,0.0236842678452348,0.0191558745781921
5,Prevalence,1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,2063.7863634560103,2291.79870236671,1849.5039755149899
5,Prevalence,1,Global,3,Both,22,All ages,663,Pruritus,1,Number,2021,80651792.70117018,89304812.92413926,72302943.55882189
5,Prevalence,1,Global,3,Both,22,All ages,663,Pruritus,2,Percent,2021,0.0105762657647582,0.0117049479685971,0.0094809768936463
5,Prevalence,1,Global,3,Both,22,All ages,663,Pruritus,3,Rate,2021,1022.02739666486,1131.67931431704,916.2299646633501
5,Prevalence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,6295710.5875469325,7114345.384539634,5459693.09031269
5,Prevalence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,0.0008255841334584,0.000932925504424,0.0007155301554397
5,Prevalence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,79.77985964659,90.15367977344,69.18576424402
5,Prevalence,1,Global,3,Both,22,All ages,999,Refraction disorders,1,Number,2021,159765916.65004984,178698347.9159242,142526915.12122345
5,Prevalence,1,Global,3,Both,22,All ages,999,Refraction disorders,2,Percent,2021,0.0209509383653364,0.0234175988782818,0.018687478242147
5,Prevalence,1,Global,3,Both,22,All ages,999,Refraction disorders,3,Rate,2021,2024.5693046728402,2264.48292334331,1806.11499307572
5,Prevalence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,2177566.1452081865,2274067.916298151,2057878.6893721228
5,Prevalence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0002855547373908,0.0002984219308925,0.0002699978076159
5,Prevalence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,27.59433093692,28.81721080825,26.077639803289998
5,Prevalence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,975279.158872534,1096203.504892512,857199.6703776191
5,Prevalence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.0001278925132137,0.0001437026428294,0.0001123401551753
5,Prevalence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,12.3588327845,13.891197911379999,10.862517970099999
5,Prevalence,1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,1715910.513246601,1909581.975340562,1449115.4520111308
5,Prevalence,1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.0002250161136233,0.0002505634432725,0.0001901393003291
5,Prevalence,1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,21.74418566566,24.198409354720003,18.36333258422
5,Prevalence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,1,Number,2021,971247648.802382,1152802896.7274852,795273977.1146691
5,Prevalence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,2,Percent,2021,0.1273627342249998,0.1508485256486857,0.1044412036263174
5,Prevalence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,3,Rate,2021,12307.74509501968,14608.43093439403,10077.78953503692
5,Prevalence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,361579.006321053,414718.0026168164,307336.2492190136
5,Prevalence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,4.74154481853e-05,5.42959864494e-05,4.0299904495e-05
5,Prevalence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,4.58196449381,5.25534704647,3.8945949763799996
5,Prevalence,1,Global,3,Both,22,All ages,978,Contact dermatitis,1,Number,2021,92257646.14862,112189458.88550374,75114486.50380647
5,Prevalence,1,Global,3,Both,22,All ages,978,Contact dermatitis,2,Percent,2021,0.0120984248211485,0.0147056822321295,0.0098672282706473
5,Prevalence,1,Global,3,Both,22,All ages,978,Contact dermatitis,3,Rate,2021,1169.09790542491,1421.6757837340401,951.8581115456001
5,Prevalence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,1,Number,2021,616532286.5525005,679274725.720198,558724637.0989604
5,Prevalence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,2,Percent,2021,0.0808489702067159,0.0891421539937777,0.0732807789864249
5,Prevalence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,3,Rate,2021,7812.75736944589,8607.8356884184,7080.21318785252
5,Prevalence,1,Global,3,Both,22,All ages,670,Glaucoma,1,Number,2021,7587672.872241228,8917725.428783435,6522905.97582959
5,Prevalence,1,Global,3,Both,22,All ages,670,Glaucoma,2,Percent,2021,0.0009950118304148,0.0011692424116948,0.0008551507947674
5,Prevalence,1,Global,3,Both,22,All ages,670,Glaucoma,3,Rate,2021,96.15173194095999,113.00628788155,82.65890180355001
5,Prevalence,1,Global,3,Both,22,All ages,672,Age-related macular degeneration,1,Number,2021,8057520.624500239,9823237.602113647,6705284.349404849
5,Prevalence,1,Global,3,Both,22,All ages,672,Age-related macular degeneration,2,Percent,2021,0.0010566375925738,0.0012885966490287,0.0008797577695502
5,Prevalence,1,Global,3,Both,22,All ages,672,Age-related macular degeneration,3,Rate,2021,102.10568856099,124.48102660913001,84.97001837158
5,Prevalence,1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,679102.8698001271,713929.915429922,651438.2784880674
5,Prevalence,1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,8.90541111427e-05,9.35819830133e-05,8.55212672162e-05
5,Prevalence,1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,8.60565791341,9.04698963818,8.25508950951
5,Prevalence,1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,1310407.0525863548,1572219.8414939626,1099973.4487291367
5,Prevalence,1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,0.0001718404122263,0.0002056809916949,0.0001442716586392
5,Prevalence,1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,16.60560619512,19.923323434860002,13.938971008
5,Prevalence,1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,443326869.4882196,482326895.1673656,408259368.5661856
5,Prevalence,1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,0.0581351013279354,0.0632075799378494,0.0535584758213148
5,Prevalence,1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,5617.88140250547,6112.0935381539,5173.50260478075
5,Prevalence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,2792431.4814565238,2998648.6268080478,2584140.4156572167
5,Prevalence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,0.0003661843881395,0.000394112661046,0.0003384370940139
5,Prevalence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,35.38596454926,37.99916836225,32.74647981373
5,Prevalence,1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,394481.730393374,425503.096301277,355593.1656630011
5,Prevalence,1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,5.17303357115e-05,5.58331415681e-05,4.65686035219e-05
5,Prevalence,1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,4.9989110278,5.39201680733,4.50611133618
5,Prevalence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,1793751.17351298,1967414.951895981,1618011.2297007623
5,Prevalence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0002352232643873,0.0002577290120962,0.0002123360484868
5,Prevalence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,22.730590117469998,24.931274483819998,20.50359637996
5,Prevalence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,254276267.85206705,295493092.65799576,221446458.0848165
5,Prevalence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.0333446455711851,0.0387743059373112,0.02907414749692
5,Prevalence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,3222.2137086202097,3744.51733938109,2806.19115182788
5,Prevalence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,317949.2376921704,458436.6053981588,199873.1028696965
5,Prevalence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,4.1694456857e-05,6.00409125411e-05,2.62061697049e-05
5,Prevalence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,4.029083803180001,5.80935345215,2.53281148686
5,Prevalence,1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,75053193.00160837,87545297.80328685,64076072.39584775
5,Prevalence,1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0098420739608393,0.0114869117735263,0.0084183924206326
5,Prevalence,1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,951.08139429747,1109.38256680369,811.97824953353
5,Prevalence,1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,51596.544440779086,54974.77797718087,48140.57728324999
5,Prevalence,1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,6.7661144486e-06,7.2105697952e-06,6.3158032442e-06
5,Prevalence,1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,0.65383645206,0.69664575748,0.61004209859
5,Prevalence,1,Global,3,Both,22,All ages,664,Urticaria,1,Number,2021,66483473.122025296,74912350.98373434,59240737.89333404
5,Prevalence,1,Global,3,Both,22,All ages,664,Urticaria,2,Percent,2021,0.0087183431747313,0.0098275451512803,0.0077676203953209
5,Prevalence,1,Global,3,Both,22,All ages,664,Urticaria,3,Rate,2021,842.48506673499,949.29663048692,750.70441831296
5,Prevalence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,607324598.1783783,623360557.442986,591593276.8960071
5,Prevalence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.0796416954213639,0.0816970081573028,0.0775612337324456
5,Prevalence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,7696.076642792089,7899.28588528165,7496.72780257606
5,Prevalence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,1,Number,2021,3354357.4840001,4113704.7593712416,2722066.7090774947
5,Prevalence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,2,Percent,2021,0.0004398782769465,0.0005400325003236,0.0003577616241419
5,Prevalence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,3,Rate,2021,42.50674575279,52.12926861335,34.494295279140005
5,Prevalence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,64055986.56296585,76095376.65281387,53310126.925859965
5,Prevalence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,0.008399944768381,0.0099791891402928,0.0069916317769077
5,Prevalence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,811.7237198969001,964.2880473452801,675.55113672159
5,Prevalence,1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,69944884.81841959,75009602.78196928,64788695.12844114
5,Prevalence,1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.0091722441055924,0.0098254929051381,0.0085068748524886
5,Prevalence,1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,886.34841392628,950.5290147755001,821.0086744230999
5,Prevalence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,54785119.44178202,67605542.11691935,43328407.44638217
5,Prevalence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.0071841734442413,0.0088521837957369,0.0056824700548085
5,Prevalence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,694.24238598785,856.7040346626901,549.0618122790701
5,Prevalence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,1,Number,2021,524630097.1774778,611230119.1732521,437684569.5997819
5,Prevalence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,2,Percent,2021,0.0687917448107507,0.0799490996503553,0.0574842984441109
5,Prevalence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,3,Rate,2021,6648.163846983581,7745.567786402489,5546.3816270751895
5,Prevalence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,2919051.688148056,3150864.807584472,2693927.0384327173
5,Prevalence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0003827884945394,0.000412713579466,0.0003528481689094
5,Prevalence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,36.99050817905,39.928066676330005,34.13770662353
5,Prevalence,1,Global,3,Both,22,All ages,1000,Near vision loss,1,Number,2021,1155063049.5872972,1514597489.3727736,875226145.9044263
5,Prevalence,1,Global,3,Both,22,All ages,1000,Near vision loss,2,Percent,2021,0.15146973717251,0.1987430687494688,0.1147686634679606
5,Prevalence,1,Global,3,Both,22,All ages,1000,Near vision loss,3,Rate,2021,14637.07181224699,19193.12735916829,11090.95122914419
5,Prevalence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,1,Number,2021,35886278.68391443,45745600.7548193,27630665.495282043
5,Prevalence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,2,Percent,2021,0.0047059499112276,0.0059988427927174,0.0036271386417421
5,Prevalence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,3,Rate,2021,454.75442951658005,579.69272203964,350.13849262957
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,33829.15607359716,44472.51469527164,18007.115971625673
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,4.4361900327e-06,5.8371803183e-06,2.3591164187e-06
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,0.42868637082,0.56356005111,0.22818793286000003
5,Prevalence,1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,93816414.09838726,99335466.95791858,89030218.63422108
5,Prevalence,1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.0123026527712913,0.0130300398582333,0.0116802246382135
5,Prevalence,1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,1188.85076517358,1258.78874221251,1128.19962864776
5,Prevalence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,7852792.32218087,8578767.27202605,7164804.056221377
5,Prevalence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,0.0010297850838047,0.0011256248574998,0.0009395792463456
5,Prevalence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,99.51135151236,108.71097700342999,90.79309699073
5,Prevalence,1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,1,Number,2021,1545690283.127131,1618714973.7294884,1480358023.3669574
5,Prevalence,1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,2,Percent,2021,0.2026934740934265,0.212210188408291,0.1940569883062821
5,Prevalence,1,Global,3,Both,22,All ages,674,Age-related and other hearing loss,3,Rate,2021,19587.13827934144,20512.51429305407,18759.24150079962
5,Prevalence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,52552044.50548778,64963854.16075647,43137875.713812046
5,Prevalence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.0068913380129943,0.0085163301053878,0.0056616549921879
5,Prevalence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,665.94464222716,823.2283067933599,546.64737554928
5,Prevalence,1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,421667.2232604647,482472.1313228004,362727.59855884
5,Prevalence,1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,5.52951520847e-05,6.3278146795e-05,4.74962572052e-05
5,Prevalence,1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,5.34340824939,6.1139339849,4.59651956686
5,Prevalence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,5256123.074150381,6094454.349220544,4361510.784993416
5,Prevalence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,0.0006892653186381,0.0007984145990504,0.0005716802961589
5,Prevalence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,66.60610511074,77.2295209321,55.2694907803
5,Prevalence,1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,1456350419.5966628,1535575907.4907317,1385784929.736092
5,Prevalence,1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.1909785150337493,0.2013188519820584,0.1817939204997573
5,Prevalence,1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,18455.01480031666,19458.96792311812,17560.80201866404
5,Prevalence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,1,Number,2021,156828985.47241437,193877157.23360723,130247768.1017705
5,Prevalence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,2,Percent,2021,0.0205656611141643,0.025454171015083,0.0170827741917341
5,Prevalence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,3,Rate,2021,1987.3522258562,2456.83027796322,1650.5124423915
5,Prevalence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,612059321.646769,649806888.8292707,570319527.8077228
5,Prevalence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.0802623573522293,0.0852914769315753,0.0748443922106636
5,Prevalence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,7756.075521158701,8234.4163803744,7227.14477571688
5,Prevalence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,17924667.3245076,20303303.3654612,15973177.811141811
5,Prevalence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,0.0023505691131935,0.0026595318257923,0.0020935229578761
5,Prevalence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,227.14313554848,257.28544384851,202.41366977759998
5,Prevalence,1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,220186.51694203657,267738.81732190365,171528.78840560914
5,Prevalence,1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,2.88739118841e-05,3.51302709356e-05,2.24297988418e-05
5,Prevalence,1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,2.79022505457,3.3928124507699997,2.17362956477
5,Prevalence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,598637.6451729903,672738.417786815,483775.59679072245
5,Prevalence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,7.85018441769e-05,8.82364599739e-05,6.34318797052e-05
5,Prevalence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,7.585994725609999,8.5250069557,6.130451626659999
5,Prevalence,1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,144456706.68849632,154930527.63841563,134448091.43440226
5,Prevalence,1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.0189433244411021,0.0203137320928648,0.0176061073490488
5,Prevalence,1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,1830.5695003538601,1963.29478270737,1703.7393500277199
5,Prevalence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,113711840.63654606,131217769.05991194,98498937.0682414
5,Prevalence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.0149115434569935,0.0172059363079764,0.0129139113784132
5,Prevalence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,1440.9675540175901,1662.8043893006698,1248.1881537228398
5,Prevalence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,139569149.54277694,168407356.48504242,112468923.55206928
5,Prevalence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.0183021943872449,0.0220959572402002,0.0147647718923424
5,Prevalence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,1768.63389869651,2134.0744745172,1425.21718729202
5,Prevalence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,396608.0534958706,472617.3799967716,328484.6459672005
5,Prevalence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,5.20086679379e-05,6.1992329987e-05,4.32260491904e-05
5,Prevalence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,5.02585600189,5.98905361331,4.1625895261400006
5,Prevalence,1,Global,3,Both,22,All ages,972,Headache disorders,1,Number,2021,2808876481.7971306,3028767343.338012,2599555367.51143
5,Prevalence,1,Global,3,Both,22,All ages,972,Headache disorders,2,Percent,2021,0.3683360184213397,0.3968106554090878,0.3412769977536714
5,Prevalence,1,Global,3,Both,22,All ages,972,Headache disorders,3,Rate,2021,35594.357200229235,38380.83568067298,32941.8195896511
5,Prevalence,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,1,Number,2021,82156085.25182253,103504229.98404016,63652926.72130693
5,Prevalence,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,2,Percent,2021,0.0107734766766916,0.0135536457530325,0.0083403511973738
5,Prevalence,1,Global,3,Both,22,All ages,507,Other cardiovascular and circulatory diseases,3,Rate,2021,1041.08993883379,1311.6157145612299,806.61610620507
5,Prevalence,1,Global,3,Both,22,All ages,684,Edentulism,1,Number,2021,353000621.3013254,416167869.43048817,300591593.4070513
5,Prevalence,1,Global,3,Both,22,All ages,684,Edentulism,2,Percent,2021,0.0462904944165257,0.0544913202547879,0.0394409406441407
5,Prevalence,1,Global,3,Both,22,All ages,684,Edentulism,3,Rate,2021,4473.25836074614,5273.719900381519,3809.12603898878
5,Prevalence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,16603836.25976742,18183398.93564818,15159476.700657573
5,Prevalence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,0.0021773512171941,0.0023832189969629,0.001986957689776
5,Prevalence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,210.40543525293998,230.42180780253,192.1023698082
5,Prevalence,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,1,Number,2021,12505435.658326369,15827876.643595072,9866065.710819673
5,Prevalence,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,2,Percent,2021,0.0016398904037212,0.0020786433299529,0.0012955415809952
5,Prevalence,1,Global,3,Both,22,All ages,498,Hypertensive heart disease,3,Rate,2021,158.47010242407,200.57239918675,125.02374858689
5,Prevalence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,1,Number,2021,62159810.95988569,80998531.08918133,48515474.89650515
5,Prevalence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,2,Percent,2021,0.0081513434603318,0.0106258962981491,0.0063648084438687
5,Prevalence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,3,Rate,2021,787.6951974012401,1026.4212993935398,614.7928377755101
5,Prevalence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,213387446.18347976,233975904.60040408,194868122.05775455
5,Prevalence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.027982679563289,0.0306875006005373,0.025568879714187
5,Prevalence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,2704.06656566112,2964.96552218099,2469.38788103055
5,Prevalence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,128660142.67306554,148128366.22477704,112254113.34051225
5,Prevalence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.0168717876533553,0.0194392520631545,0.0147049028170234
5,Prevalence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,1630.3938978504,1877.0971287130699,1422.49509130454
5,Prevalence,1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,234159.5250558498,282749.046026218,191402.67195568373
5,Prevalence,1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,3.07061554796e-05,3.70470447406e-05,2.51648888936e-05
5,Prevalence,1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,2.9672923785300003,3.5830235353899997,2.42547335877
5,Prevalence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,1267867997.476105,1380435423.314829,1157934071.2871342
5,Prevalence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,0.1662612249680428,0.1813274054839609,0.1519857838565263
5,Prevalence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,16066.54713276323,17493.01255065529,14673.45367972173
5,Prevalence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,28389034.338997874,30585669.71548319,26323458.40772688
5,Prevalence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,0.0037228128653158,0.0040153776006,0.0034481573045827
5,Prevalence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,359.74861670861003,387.58459480731,333.57343670396
5,Prevalence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,468266374.36160535,513111022.5325192,428932863.6576594
5,Prevalence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.0614059792594198,0.0673162856530334,0.0562261114858836
5,Prevalence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,5933.91724481214,6502.19300768685,5435.47915434846
5,Prevalence,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,1,Number,2021,504297455.0384965,574768515.1137594,443696176.5662362
5,Prevalence,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,2,Percent,2021,0.06613101444976,0.0752575355649838,0.0581939836080495
5,Prevalence,1,Global,3,Both,22,All ages,639,Other musculoskeletal disorders,3,Rate,2021,6390.50661933066,7283.52277751817,5622.5612978788195
5,Prevalence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,1,Number,2021,129018668.62464844,134154919.53199536,123873852.84729728
5,Prevalence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,2,Percent,2021,0.016918886943681,0.0175858702202937,0.0162448631045192
5,Prevalence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,3,Rate,2021,1634.93717373629,1700.0242470379699,1569.74156556514
5,Prevalence,1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,68319601.25924425,77054421.85850054,60983864.06066178
5,Prevalence,1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.0089590814189938,0.0101156291398827,0.0079901560653141
5,Prevalence,1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,865.75266187671,976.4411618889701,772.7934834060701
5,Prevalence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,46312.32581249209,55479.79881645488,38248.13172690661
5,Prevalence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,6.0730935425e-06,7.2798530561e-06,5.03308979e-06
5,Prevalence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.5868743173400001,0.70304543089,0.48468406203
5,Prevalence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,1,Number,2021,21068212.711038824,22491905.314136423,19728457.12590816
5,Prevalence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,2,Percent,2021,0.0027627933409394,0.0029475731411088,0.0025833386166117
5,Prevalence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,3,Rate,2021,266.97844980614,285.01962156516,250.00093613931
5,Prevalence,1,Global,3,Both,22,All ages,646,Turner syndrome,1,Number,2021,531783.5940932494,697785.8190502378,420531.6561693833
5,Prevalence,1,Global,3,Both,22,All ages,646,Turner syndrome,2,Percent,2021,6.97348699676e-05,9.14588381369e-05,5.51747094661e-05
5,Prevalence,1,Global,3,Both,22,All ages,646,Turner syndrome,3,Rate,2021,6.738813658790001,8.8424100716,5.32901823227
5,Prevalence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,3494385.1964487475,3986006.772371612,3082193.4511631555
5,Prevalence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,0.0004582326732821,0.0005230225432911,0.0004046694620394
5,Prevalence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,44.28119060543,50.51106724619999,39.05785653868
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,52431.00698829163,63204.72027167969,42487.747206242224
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,6.8755813709e-06,8.2955378478e-06,5.5736296798e-06
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,0.66441084298,0.80093639029,0.5384088835799999
5,Prevalence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,2031912754.390331,2094361907.562365,1968859874.6228209
5,Prevalence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.2664551707446461,0.2747982881437155,0.2582210057305563
5,Prevalence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,25748.59693837357,26539.958708555427,24949.584685790647
5,Prevalence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,191808.2168776277,235787.1358064392,155356.94873749593
5,Prevalence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,2.51528937085e-05,3.09670138341e-05,2.03616067235e-05
5,Prevalence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,2.43061246364,2.98791762098,1.96869843254
5,Prevalence,1,Global,3,Both,22,All ages,658,Scabies,1,Number,2021,206549644.95907557,231740498.09152508,184175476.98582163
5,Prevalence,1,Global,3,Both,22,All ages,658,Scabies,2,Percent,2021,0.0270858586482353,0.0303723998287637,0.0241294826039262
5,Prevalence,1,Global,3,Both,22,All ages,658,Scabies,3,Rate,2021,2617.41728050285,2936.6382325047102,2333.8896380241
5,Prevalence,1,Global,3,Both,22,All ages,660,Viral skin diseases,1,Number,2021,136807659.466724,140724828.65348843,133155770.776575
5,Prevalence,1,Global,3,Both,22,All ages,660,Viral skin diseases,2,Percent,2021,0.0179402644493761,0.0184780187702282,0.0174393771687045
5,Prevalence,1,Global,3,Both,22,All ages,660,Viral skin diseases,3,Rate,2021,1733.6400266594499,1783.2787772955098,1687.3629363940001
5,Prevalence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,57333.28877240133,76615.44776583652,35246.95265179215
5,Prevalence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,7.5184912605e-06,1.00481903891e-05,4.6177565769e-06
5,Prevalence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,0.7265330367,0.9708784393,0.44665282758
5,Prevalence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,480473.404632708,581648.3099888943,416397.85904525325
5,Prevalence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,6.30077047586e-05,7.62142321771e-05,5.44987042121e-05
5,Prevalence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,6.08860592502,7.37070421032,5.27663435125
5,Prevalence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,645588.1055183199,712875.8471244836,582431.8006611178
5,Prevalence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,8.46593442485e-05,9.3423036799e-05,7.63108615386e-05
5,Prevalence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,8.18095554609,9.03363238163,7.380632680670001
5,Prevalence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,1,Number,2021,194284753.65413415,248177667.63987,146479864.82906175
5,Prevalence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,2,Percent,2021,0.0254772751124382,0.0325118723556587,0.0192226332455108
5,Prevalence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,3,Rate,2021,2461.99537962568,3144.93165090743,1856.20715797053
5,Prevalence,1,Global,3,Both,22,All ages,675,Other vision loss,1,Number,2021,38767272.24890517,43775623.66078307,34102057.401812375
5,Prevalence,1,Global,3,Both,22,All ages,675,Other vision loss,2,Percent,2021,0.0050837634889894,0.0057498950997033,0.0044759638712215
5,Prevalence,1,Global,3,Both,22,All ages,675,Other vision loss,3,Rate,2021,491.26266144077,554.72897984029,432.14460311412006
5,Prevalence,1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,84624157.39031646,88982799.64362329,80562502.43489708
5,Prevalence,1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.0110971775318598,0.0116606616348243,0.0105467475360957
5,Prevalence,1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,1072.36559009962,1127.5987305661502,1020.8959016871299
5,Prevalence,1,Global,3,Both,22,All ages,683,Periodontal diseases,1,Number,2021,1066953744.4798794,1234839286.7091706,896546186.1376615
5,Prevalence,1,Global,3,Both,22,All ages,683,Periodontal diseases,2,Percent,2021,0.139913179079258,0.1618820832037826,0.1175677547565254
5,Prevalence,1,Global,3,Both,22,All ages,683,Periodontal diseases,3,Rate,2021,13520.542089782719,15648.004083070598,11361.12086191476
5,Prevalence,1,Global,3,Both,22,All ages,685,Other oral disorders,1,Number,2021,150875634.25531933,157060156.00860918,144570506.7181018
5,Prevalence,1,Global,3,Both,22,All ages,685,Other oral disorders,2,Percent,2021,0.0197851125446277,0.0205868922565062,0.0189836385802061
5,Prevalence,1,Global,3,Both,22,All ages,685,Other oral disorders,3,Rate,2021,1911.91077759995,1990.28164147587,1832.0115854470998
6,Incidence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,1,Number,2021,1347020.544105701,1532644.510669144,1178808.6822853775
6,Incidence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,2,Percent,2021,3.660377872e-05,4.21601337458e-05,3.16241512813e-05
6,Incidence,1,Global,3,Both,22,All ages,533,Vascular intestinal disorders,3,Rate,2021,17.06957593673,19.4218209762,14.937978789699999
6,Incidence,1,Global,3,Both,22,All ages,535,Pancreatitis,1,Number,2021,2747368.16462777,3133076.3070991533,2413877.6266699936
6,Incidence,1,Global,3,Both,22,All ages,535,Pancreatitis,2,Percent,2021,7.46471697481e-05,8.53796095323e-05,6.57361442949e-05
6,Incidence,1,Global,3,Both,22,All ages,535,Pancreatitis,3,Rate,2021,34.81491779579,39.70264906027,30.58889311727
6,Incidence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,1,Number,2021,117987.13358463302,132718.48777267174,98330.46900798446
6,Incidence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,2,Percent,2021,3.2062489666e-06,3.6250873393e-06,2.6548034886e-06
6,Incidence,1,Global,3,Both,22,All ages,846,Chronic lymphoid leukemia,3,Rate,2021,1.4951444839499999,1.68182164345,1.24605331
6,Incidence,1,Global,3,Both,22,All ages,294,All causes,1,Number,2021,36821501306.96513,38631228959.83688,35241993037.56998
6,Incidence,1,Global,3,Both,22,All ages,294,All causes,2,Percent,2021,1.0,1.0,1.0
6,Incidence,1,Global,3,Both,22,All ages,294,All causes,3,Rate,2021,466605.6619656951,489538.70759048435,446589.9788604006
6,Incidence,1,Global,3,Both,22,All ages,297,Tuberculosis,1,Number,2021,8407132.958051227,9393766.808931388,7519793.207754992
6,Incidence,1,Global,3,Both,22,All ages,297,Tuberculosis,2,Percent,2021,0.0002284524775181,0.0002603878093753,0.0002040230497137
6,Incidence,1,Global,3,Both,22,All ages,297,Tuberculosis,3,Rate,2021,106.53601020833,119.03873075928999,95.29155420085
6,Incidence,1,Global,3,Both,22,All ages,544,Parkinson's disease,1,Number,2021,1335142.1154918878,1485216.838998584,1196373.0419269523
6,Incidence,1,Global,3,Both,22,All ages,544,Parkinson's disease,2,Percent,2021,3.62805022718e-05,4.07561865401e-05,3.2116380919e-05
6,Incidence,1,Global,3,Both,22,All ages,544,Parkinson's disease,3,Rate,2021,16.919051328829998,18.820812887179997,15.16055607109
6,Incidence,1,Global,3,Both,22,All ages,854,Police conflict and executions,1,Number,2021,2755843.336420145,3639809.695068002,2141373.425892669
6,Incidence,1,Global,3,Both,22,All ages,854,Police conflict and executions,2,Percent,2021,7.48968724411e-05,9.76414564737e-05,5.74239857618e-05
6,Incidence,1,Global,3,Both,22,All ages,854,Police conflict and executions,3,Rate,2021,34.92231600075,46.124024059679996,27.13569326178
6,Incidence,1,Global,3,Both,22,All ages,542,Neurological disorders,1,Number,2021,823798509.6419502,910525551.4871912,733108417.8766408
6,Incidence,1,Global,3,Both,22,All ages,542,Neurological disorders,2,Percent,2021,0.0223844905135324,0.0249519555890476,0.0197708372519282
6,Incidence,1,Global,3,Both,22,All ages,542,Neurological disorders,3,Rate,2021,10439.25519802542,11538.26874538642,9290.02149489346
6,Incidence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,1,Number,2021,3272733.660133112,4125118.7483812585,2403802.4268406974
6,Incidence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,2,Percent,2021,8.89377645221e-05,0.0001128101209497,6.52089619763e-05
6,Incidence,1,Global,3,Both,22,All ages,545,Idiopathic epilepsy,3,Rate,2021,41.472400682229996,52.273907797220005,30.46121920071
6,Incidence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,1,Number,2021,324139599.33694553,358912515.95264244,287693228.7284794
6,Incidence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,2,Percent,2021,0.0088075307917517,0.0098699637113596,0.0077697555456995
6,Incidence,1,Global,3,Both,22,All ages,536,Gastroesophageal reflux disease,3,Rate,2021,4107.52867073622,4548.17446735061,3645.6767016316
6,Incidence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,1,Number,2021,9837055.83831615,11163699.620942663,8620519.199358491
6,Incidence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,2,Percent,2021,0.0002672845226628,0.0003084146261615,0.0002317158057672
6,Incidence,1,Global,3,Both,22,All ages,543,Alzheimer's disease and other dementias,3,Rate,2021,124.65613264831,141.4674922728,109.24006150568
6,Incidence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,1,Number,2021,2166062.958039866,2958610.482711277,1559799.891614819
6,Incidence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,2,Percent,2021,5.88641941439e-05,8.09643929897e-05,4.2396246226e-05
6,Incidence,1,Global,3,Both,22,All ages,320,Paratyphoid fever,3,Rate,2021,27.448561425279998,37.49180108859,19.76593661658
6,Incidence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,1,Number,2021,62920.10625596968,70635.06580992442,56015.04467687175
6,Incidence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,2,Percent,2021,1.7096236567e-06,1.9353586179e-06,1.505499316e-06
6,Incidence,1,Global,3,Both,22,All ages,546,Multiple sclerosis,3,Rate,2021,0.79732973367,0.8950944548800001,0.7098281187300001
6,Incidence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,1,Number,2021,103727.20932018568,122516.719462713,71606.72954891388
6,Incidence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,2,Percent,2021,2.8188945026e-06,3.3349062512e-06,1.9159599114e-06
6,Incidence,1,Global,3,Both,22,All ages,845,Acute lymphoid leukemia,3,Rate,2021,1.31444133049,1.5525438387300001,0.90740747271
6,Incidence,1,Global,3,Both,22,All ages,942,Myocarditis,1,Number,2021,1319703.607852706,1618747.9859735633,1072475.4168833727
6,Incidence,1,Global,3,Both,22,All ages,942,Myocarditis,2,Percent,2021,3.58596316422e-05,4.40227664256e-05,2.88632535033e-05
6,Incidence,1,Global,3,Both,22,All ages,942,Myocarditis,3,Rate,2021,16.72341305171,20.51293262743,13.59051326193
6,Incidence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,1,Number,2021,12503431.240159469,15863539.367826922,9726950.893578457
6,Incidence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,2,Percent,2021,0.0003397903867747,0.00043830196588,0.0002632109597435
6,Incidence,1,Global,3,Both,22,All ages,945,Conflict and terrorism,3,Rate,2021,158.44470224123,201.0243207124,123.26087203150999
6,Incidence,1,Global,3,Both,22,All ages,547,Migraine,1,Number,2021,90183386.870021,101838162.4804554,78857600.45503128
6,Incidence,1,Global,3,Both,22,All ages,547,Migraine,2,Percent,2021,0.0024507604296208,0.0028070838410748,0.0021299359469582
6,Incidence,1,Global,3,Both,22,All ages,547,Migraine,3,Rate,2021,1142.8126891945801,1290.50314438358,999.29121723198
6,Incidence,1,Global,3,Both,22,All ages,554,Motor neuron disease,1,Number,2021,64177.72717852947,70270.30313344226,58506.16020619031
6,Incidence,1,Global,3,Both,22,All ages,554,Motor neuron disease,2,Percent,2021,1.7438854564e-06,1.9393109284e-06,1.562667518e-06
6,Incidence,1,Global,3,Both,22,All ages,554,Motor neuron disease,3,Rate,2021,0.81326642887,0.89047214661,0.74139577809
6,Incidence,1,Global,3,Both,22,All ages,558,Mental disorders,1,Number,2021,444397716.1239453,505044001.6728041,397431025.9922088
6,Incidence,1,Global,3,Both,22,All ages,558,Mental disorders,2,Percent,2021,0.0120753332639079,0.0137988952916108,0.0106730250923277
6,Incidence,1,Global,3,Both,22,All ages,558,Mental disorders,3,Rate,2021,5631.45127569345,6399.966931217061,5036.284789770961
6,Incidence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,1,Number,2021,55779737.35959958,64314072.654016726,46555775.1280079
6,Incidence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,2,Percent,2021,0.0015155100801683,0.0017688649407828,0.0012807195835415
6,Incidence,1,Global,3,Both,22,All ages,560,Alcohol use disorders,3,Rate,2021,706.84628141507,814.99421205731,589.95933084947
6,Incidence,1,Global,3,Both,22,All ages,337,Encephalitis,1,Number,2021,1492767.7199860648,1654928.6070717103,1364664.2667389964
6,Incidence,1,Global,3,Both,22,All ages,337,Encephalitis,2,Percent,2021,4.05669090058e-05,4.50264408832e-05,3.67282680194e-05
6,Incidence,1,Global,3,Both,22,All ages,337,Encephalitis,3,Rate,2021,18.91649838876,20.97141699278,17.2931589137
6,Incidence,1,Global,3,Both,22,All ages,339,Pertussis,1,Number,2021,7224175.757756948,10251853.466466753,5124218.581255087
6,Incidence,1,Global,3,Both,22,All ages,339,Pertussis,2,Percent,2021,0.000196270006889,0.0002749065198428,0.0001379227301027
6,Incidence,1,Global,3,Both,22,All ages,339,Pertussis,3,Rate,2021,91.54546099311,129.91248871732,64.9345984899
6,Incidence,1,Global,3,Both,22,All ages,559,Schizophrenia,1,Number,2021,1223221.0313858208,1473083.2669144804,1008219.0268838172
6,Incidence,1,Global,3,Both,22,All ages,559,Schizophrenia,2,Percent,2021,3.3240465183e-05,3.9909549189e-05,2.70527952247e-05
6,Incidence,1,Global,3,Both,22,All ages,559,Schizophrenia,3,Rate,2021,15.50077641652,18.667055076300002,12.776250010110001
6,Incidence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,1,Number,2021,1645332.5648110646,1822432.032139137,1484720.986824579
6,Incidence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,2,Percent,2021,4.47089434653e-05,5.00162831408e-05,3.97430446904e-05
6,Incidence,1,Global,3,Both,22,All ages,300,HIV/AIDS resulting in other diseases,3,Rate,2021,20.84981500773,23.09403676006,18.81452939998
6,Incidence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,1,Number,2021,144645.60366596922,164851.49374840502,126237.20578132548
6,Incidence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,2,Percent,2021,3.9303892741e-06,4.5205851255e-06,3.390585076e-06
6,Incidence,1,Global,3,Both,22,All ages,847,Acute myeloid leukemia,3,Rate,2021,1.83296322131,2.08901423452,1.59969020484
6,Incidence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),1,Number,2021,1899907.0543376887,2150029.5720757158,1688002.7401476717
6,Incidence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),2,Percent,2021,5.16265581768e-05,5.90008459931e-05,4.52809555781e-05
6,Incidence,1,Global,3,Both,22,All ages,849,Non-melanoma skin cancer (squamous-cell carcinoma),3,Rate,2021,24.07580781055,27.24538479191,21.39053563841
6,Incidence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,1,Number,2021,3625507.4080374218,4737132.255413415,2738090.170003264
6,Incidence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,2,Percent,2021,9.85206650956e-05,0.0001299146073197,7.45429291971e-05
6,Incidence,1,Global,3,Both,22,All ages,565,Cannabis use disorders,3,Rate,2021,45.94278408112,60.0294027511,34.697346141459995
6,Incidence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,1,Number,2021,48310980.9718881,52313164.6524815,44191373.5563712
6,Incidence,1,Global,3,Both,22,All ages,561,Drug use disorders,1,Number,2021,13609362.377242014,15667184.196272772,11625287.783090703
6,Incidence,1,Global,3,Both,22,All ages,561,Drug use disorders,2,Percent,2021,0.0003698145966256,0.0004294129596697,0.000313736274538
6,Incidence,1,Global,3,Both,22,All ages,561,Drug use disorders,3,Rate,2021,172.4591696581,198.53608879487,147.31678255999
6,Incidence,1,Global,3,Both,22,All ages,548,Tension-type headache,1,Number,2021,719043093.3245538,804949048.8264616,629219079.8651311
6,Incidence,1,Global,3,Both,22,All ages,548,Tension-type headache,2,Percent,2021,0.0195377737853417,0.0219499070189019,0.0170818690490366
6,Incidence,1,Global,3,Both,22,All ages,548,Tension-type headache,3,Rate,2021,9111.78432800891,10200.39298900832,7973.525653783669
6,Incidence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,1,Number,2021,219145.4067725976,298956.5989085763,158098.0973667741
6,Incidence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,2,Percent,2021,5.9552110765e-06,8.2465629204e-06,4.2297336063e-06
6,Incidence,1,Global,3,Both,22,All ages,563,Cocaine use disorders,3,Rate,2021,2.77703200479,3.78840722897,2.00343453577
6,Incidence,1,Global,3,Both,22,All ages,345,Malaria,1,Number,2021,249116628.35962808,315017150.9842253,200358941.85208493
6,Incidence,1,Global,3,Both,22,All ages,345,Malaria,2,Percent,2021,0.0067686012113717,0.0085630782270796,0.0054596747701604
6,Incidence,1,Global,3,Both,22,All ages,345,Malaria,3,Rate,2021,3156.83025288321,3991.92811396143,2538.96808590892
6,Incidence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,1,Number,2021,1606.419599649059,2182.833215956432,1163.9390419875524
6,Incidence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,2,Percent,2021,4.36497111e-08,5.96839369e-08,3.17251819e-08
6,Incidence,1,Global,3,Both,22,All ages,950,HIV/AIDS - Extensively drug-resistant Tuberculosis,3,Rate,2021,0.020356706109999997,0.02766107577,0.01474954926
6,Incidence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,1,Number,2021,15845308768.381329,17550272714.32414,14469716546.361189
6,Incidence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,2,Percent,2021,0.4301270449386967,0.4570958802022638,0.4063468576830762
6,Incidence,1,Global,3,Both,22,All ages,956,Respiratory infections and tuberculosis,3,Rate,2021,200793.30077513336,222398.770470466,183361.66174445752
6,Incidence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,1,Number,2021,12822251510.836342,14464017730.05543,11429364621.601902
6,Incidence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,2,Percent,2021,0.347986972006035,0.378968200441107,0.3213131476222838
6,Incidence,1,Global,3,Both,22,All ages,328,Upper respiratory infections,3,Rate,2021,162484.8238594959,183289.44578746543,144834.02511621843
6,Incidence,1,Global,3,Both,22,All ages,298,HIV/AIDS,1,Number,2021,1645332.5648110646,1822432.032139137,1484720.986824579
6,Incidence,1,Global,3,Both,22,All ages,298,HIV/AIDS,2,Percent,2021,4.47089434653e-05,5.00162831408e-05,3.97430446904e-05
6,Incidence,1,Global,3,Both,22,All ages,298,HIV/AIDS,3,Rate,2021,20.84981500773,23.09403676006,18.81452939998
6,Incidence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,1,Number,2021,4438577275.334881,4980469022.728959,3956867911.973208
6,Incidence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,2,Percent,2021,0.1205546414115731,0.1338830103799635,0.1079761569982491
6,Incidence,1,Global,3,Both,22,All ages,302,Diarrheal diseases,3,Rate,2021,56246.08487519123,63112.99004015616,50141.816760410984
6,Incidence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,1,Number,2021,1069011.047384338,1482513.9746908045,757796.9201192752
6,Incidence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,2,Percent,2021,2.90453495481e-05,4.00539127573e-05,2.07028841495e-05
6,Incidence,1,Global,3,Both,22,All ages,564,Amphetamine use disorders,3,Rate,2021,13.54661243318,18.7865619266,9.602876607339999
6,Incidence,1,Global,3,Both,22,All ages,566,Other drug use disorders,1,Number,2021,6753173.199811408,8590638.305027688,5195841.702881442
6,Incidence,1,Global,3,Both,22,All ages,566,Other drug use disorders,2,Percent,2021,0.0001835115032232,0.000232941192415,0.0001402155424765
6,Incidence,1,Global,3,Both,22,All ages,566,Other drug use disorders,3,Rate,2021,85.5768705626,108.86140789341,65.84221368462
6,Incidence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),1,Number,2021,4436939.0411388455,4955955.194370894,3907156.8475189833
6,Incidence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),2,Percent,2021,0.0001205754834019,0.000136468163525,0.0001056053981598
6,Incidence,1,Global,3,Both,22,All ages,850,Non-melanoma skin cancer (basal-cell carcinoma),3,Rate,2021,56.2253250114,62.802348412229996,49.51187329495001
6,Incidence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,1,Number,2021,7939416.969712325,9018495.11443537,7009965.208089945
6,Incidence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,2,Percent,2021,0.0002157451933068,0.0002475604303108,0.0001888109621424
6,Incidence,1,Global,3,Both,22,All ages,934,Drug-susceptible tuberculosis,3,Rate,2021,100.60906750896999,114.28325118317,88.83096397969
6,Incidence,1,Global,3,Both,22,All ages,570,Bipolar disorder,1,Number,2021,2564001.396458484,3051281.8632964743,2151042.666530573
6,Incidence,1,Global,3,Both,22,All ages,570,Bipolar disorder,2,Percent,2021,6.96681897413e-05,8.35128973404e-05,5.8254257562e-05
6,Incidence,1,Global,3,Both,22,All ages,570,Bipolar disorder,3,Rate,2021,32.4912761949,38.66614187722,27.25822282382
6,Incidence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,1,Number,2021,35830.86594049321,42581.447832900274,27938.94644520695
6,Incidence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,2,Percent,2021,9.737462692e-07,1.1667571081e-06,7.578487588e-07
6,Incidence,1,Global,3,Both,22,All ages,848,Chronic myeloid leukemia,3,Rate,2021,0.45405223382,0.53959626708,0.35404505895000005
6,Incidence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",1,Number,2021,22406972969.9854,24033279828.7614,20881423144.443283
6,Incidence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",2,Percent,2021,0.6083712162238946,0.6284279447993173,0.5896802756157721
6,Incidence,1,Global,3,Both,22,All ages,295,"Communicable, maternal, neonatal, and nutritional diseases",3,Rate,2021,283943.35060232336,304552.07000440167,264611.43416919024
6,Incidence,1,Global,3,Both,22,All ages,332,Meningitis,1,Number,2021,2264858.110208336,2568202.515401684,1991578.2359602663
6,Incidence,1,Global,3,Both,22,All ages,332,Meningitis,2,Percent,2021,6.15478890705e-05,7.06690754267e-05,5.31308434427e-05
6,Incidence,1,Global,3,Both,22,All ages,332,Meningitis,3,Rate,2021,28.7005032457,32.544513184589995,25.2374739802
6,Incidence,1,Global,3,Both,22,All ages,936,Guinea worm disease,1,Number,2021,50.354950638410486,65.2781980764998,37.89101914205077
6,Incidence,1,Global,3,Both,22,All ages,936,Guinea worm disease,2,Percent,2021,1.3680992e-09,1.7539534e-09,1.0125828e-09
6,Incidence,1,Global,3,Both,22,All ages,936,Guinea worm disease,3,Rate,2021,0.0006381028500000001,0.0008272117,0.0004801587
6,Incidence,1,Global,3,Both,22,All ages,572,Eating disorders,1,Number,2021,9494959.56676346,13388626.485104378,6625404.340468755
6,Incidence,1,Global,3,Both,22,All ages,572,Eating disorders,2,Percent,2021,0.0002579698862717,0.0003689665710246,0.00017801108106
6,Incidence,1,Global,3,Both,22,All ages,572,Eating disorders,3,Rate,2021,120.32105527291,169.66198286738,83.95777109419
6,Incidence,1,Global,3,Both,22,All ages,568,Major depressive disorder,1,Number,2021,341115863.2558224,400624089.156463,296307636.6558488
6,Incidence,1,Global,3,Both,22,All ages,568,Major depressive disorder,2,Percent,2021,0.0092687584726444,0.0109173007512094,0.0079300158596861
6,Incidence,1,Global,3,Both,22,All ages,568,Major depressive disorder,3,Rate,2021,4322.65354567101,5076.74759814573,3754.83932050158
6,Incidence,1,Global,3,Both,22,All ages,347,Leishmaniasis,1,Number,2021,1096859.8533774468,1243290.5592419454,969151.2275799594
6,Incidence,1,Global,3,Both,22,All ages,347,Leishmaniasis,2,Percent,2021,2.98040273659e-05,3.39782562506e-05,2.6126740563e-05
6,Incidence,1,Global,3,Both,22,All ages,347,Leishmaniasis,3,Rate,2021,13.89951522351,15.75509943428,12.28117904047
6,Incidence,1,Global,3,Both,22,All ages,329,Otitis media,1,Number,2021,391325569.6538724,525454763.7657745,292407883.6805783
6,Incidence,1,Global,3,Both,22,All ages,329,Otitis media,2,Percent,2021,0.010630269674863,0.0142597536804702,0.0079402233209149
6,Incidence,1,Global,3,Both,22,All ages,329,Otitis media,3,Rate,2021,4958.9158505579,6658.61410255913,3705.4212697991097
6,Incidence,1,Global,3,Both,22,All ages,571,Anxiety disorders,1,Number,2021,53917371.009163365,65978474.7685382,44990957.61972459
6,Incidence,1,Global,3,Both,22,All ages,571,Anxiety disorders,2,Percent,2021,0.0014653921967415,0.0018079455542056,0.001202377267311
6,Incidence,1,Global,3,Both,22,All ages,571,Anxiety disorders,3,Rate,2021,683.24619307202,836.08567826204,570.12981050425
6,Incidence,1,Global,3,Both,22,All ages,557,Other neurological disorders,1,Number,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,557,Other neurological disorders,2,Percent,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,557,Other neurological disorders,3,Rate,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,1,Number,2021,12364222887.6833,12922829055.5833,11859103109.564
6,Incidence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,1,Number,2021,1267302.4697290142,1736633.5517784182,890139.134301601
6,Incidence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,2,Percent,2021,3.44317575576e-05,4.69150507828e-05,2.41825893458e-05
6,Incidence,1,Global,3,Both,22,All ages,573,Anorexia nervosa,3,Rate,2021,16.059380709899997,22.00679003455,11.27993007508
6,Incidence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,1,Number,2021,1163706.0266784537,1371347.251320321,981645.3831362956
6,Incidence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,2,Percent,2021,3.16192955805e-05,3.71292368164e-05,2.64156966415e-05
6,Incidence,1,Global,3,Both,22,All ages,575,Autism spectrum disorders,3,Rate,2021,14.74659646235,17.37784634724,12.439506200339999
6,Incidence,1,Global,3,Both,22,All ages,357,Dengue,1,Number,2021,58964184.93410243,106885036.4029386,15473438.963303467
6,Incidence,1,Global,3,Both,22,All ages,357,Dengue,2,Percent,2021,0.0016017433685749,0.0029011173125771,0.000420533429418
6,Incidence,1,Global,3,Both,22,All ages,357,Dengue,3,Rate,2021,747.19991219478,1354.45762380108,196.08093027407998
6,Incidence,1,Global,3,Both,22,All ages,319,Typhoid fever,1,Number,2021,7154555.332012578,9234542.453300122,5567666.702337571
6,Incidence,1,Global,3,Both,22,All ages,319,Typhoid fever,2,Percent,2021,0.000194416772774,0.0002519338437461,0.0001512911766066
6,Incidence,1,Global,3,Both,22,All ages,319,Typhoid fever,3,Rate,2021,90.66322415626999,117.02102416876,70.55401640446
6,Incidence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,1,Number,2021,343606787.3877178,363517284.7504956,325214314.01210463
6,Incidence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,2,Percent,2021,0.009336622125275,0.0100389992100978,0.0086879355262841
6,Incidence,1,Global,3,Both,22,All ages,322,Lower respiratory infections,3,Rate,2021,4354.218779629839,4606.5265474358,4121.14756009781
6,Incidence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,1,Number,2021,138607949.5869655,152126163.52071476,125491191.34436163
6,Incidence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,2,Percent,2021,0.0037662878269561,0.0041780747236298,0.003386012419362
6,Incidence,1,Global,3,Both,22,All ages,962,Maternal and neonatal disorders,3,Rate,2021,1756.4534789487202,1927.7576066258202,1590.23663701141
6,Incidence,1,Global,3,Both,22,All ages,935,Zika virus,1,Number,2021,169733.6205923804,427780.15393477504,62448.753751340126
6,Incidence,1,Global,3,Both,22,All ages,935,Zika virus,2,Percent,2021,4.6095327935e-06,1.159355222e-05,1.7008217326e-06
6,Incidence,1,Global,3,Both,22,All ages,935,Zika virus,3,Rate,2021,2.15088102286,5.42087190412,0.7913567086800001
6,Incidence,1,Global,3,Both,22,All ages,579,Conduct disorder,1,Number,2021,14484106.437445976,18526891.12180121,10438500.79977136
6,Incidence,1,Global,3,Both,22,All ages,579,Conduct disorder,2,Percent,2021,0.0003935222129476,0.0005057999044076,0.0002817027403636
6,Incidence,1,Global,3,Both,22,All ages,579,Conduct disorder,3,Rate,2021,183.54401185015,234.77457434412003,132.27770196011
6,Incidence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,1,Number,2021,24442180.0356036,26301698.294092186,22643512.77456641
6,Incidence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,2,Percent,2021,0.0006641431631971,0.0007207249602908,0.0006078610353115
6,Incidence,1,Global,3,Both,22,All ages,587,Diabetes mellitus,3,Rate,2021,309.73369337442,333.29769041805,286.94080611554
6,Incidence,1,Global,3,Both,22,All ages,341,Measles,1,Number,2021,4816991.209868645,5440479.951235406,4240978.917782613
6,Incidence,1,Global,3,Both,22,All ages,341,Measles,2,Percent,2021,0.0001308753897983,0.0001496447837374,0.000114484199929
6,Incidence,1,Global,3,Both,22,All ages,341,Measles,3,Rate,2021,61.04138322406,68.94229346854,53.74209918323
6,Incidence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,1,Number,2021,309802761.9373815,398594667.8924101,232164372.07485312
6,Incidence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,2,Percent,2021,0.008417131428962,0.0108224090543238,0.0062762001166343
6,Incidence,1,Global,3,Both,22,All ages,344,Neglected tropical diseases and malaria,3,Rate,2021,3925.85086652207,5051.03057361633,2942.00960503328
6,Incidence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,1,Number,2021,955220.5986433956,1075239.9445861457,854660.5203937104
6,Incidence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,2,Percent,2021,2.5956571081e-05,2.96550056125e-05,2.30112976564e-05
6,Incidence,1,Global,3,Both,22,All ages,948,HIV/AIDS - Drug-susceptible Tuberculosis,3,Rate,2021,12.10464874958,13.625545627069998,10.83034161344
6,Incidence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,1,Number,2021,19047404.0403724,24086485.61036749,14608562.993913123
6,Incidence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,2,Percent,2021,0.0005175492420608,0.0006559938665346,0.0003964054087712
6,Incidence,1,Global,3,Both,22,All ages,368,Maternal sepsis and other maternal infections,3,Rate,2021,241.37056490156,305.22629886703004,185.12113749291
6,Incidence,1,Global,3,Both,22,All ages,585,Other mental disorders,1,Number,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,585,Other mental disorders,2,Percent,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,585,Other mental disorders,3,Rate,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,943,Other leukemia,1,Number,2021,59231.92205224217,74747.01183235194,42495.963476281264
6,Incidence,1,Global,3,Both,22,All ages,943,Other leukemia,2,Percent,2021,1.6096304065e-06,2.0224163024e-06,1.1564531983e-06
6,Incidence,1,Global,3,Both,22,All ages,943,Other leukemia,3,Rate,2021,0.7505927031099999,0.94720143661,0.53851300096
6,Incidence,1,Global,3,Both,22,All ages,562,Opioid use disorders,1,Number,2021,1942525.315236239,2328363.1687322957,1643342.288752511
6,Incidence,1,Global,3,Both,22,All ages,562,Opioid use disorders,2,Percent,2021,5.27818676821e-05,6.34321252406e-05,4.44126551335e-05
6,Incidence,1,Global,3,Both,22,All ages,562,Opioid use disorders,3,Rate,2021,24.61587057639,29.50524555166,20.82459403507
6,Incidence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,1,Number,2021,528368.1648039467,613210.8898292186,446739.0372247836
6,Incidence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,2,Percent,2021,1.435750189e-05,1.6884627586e-05,1.21223778222e-05
6,Incidence,1,Global,3,Both,22,All ages,588,Acute glomerulonephritis,3,Rate,2021,6.695533005150001,7.77066830567,5.66112072543
6,Incidence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,1,Number,2021,1282204.531167472,1366295.8974325708,1195230.067238629
6,Incidence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,2,Percent,2021,3.48441985049e-05,3.76923431072e-05,3.2022608104e-05
6,Incidence,1,Global,3,Both,22,All ages,591,Chronic kidney disease due to hypertension,3,Rate,2021,16.24822108835,17.31383509726,15.14607218418
6,Incidence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,1,Number,2021,8376809.52966792,10424088.697769728,6651560.964127792
6,Incidence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,2,Percent,2021,0.0002276106854087,0.0002850704500536,0.0001799473363395
6,Incidence,1,Global,3,Both,22,All ages,374,Ectopic pregnancy,3,Rate,2021,106.15174876130999,132.09507039551,84.28923038466
6,Incidence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,1,Number,2021,86678086.71384835,92207569.3106219,81687120.8697366
6,Incidence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,2,Percent,2021,0.0023553897285411,0.0025404891063088,0.0021801265245034
6,Incidence,1,Global,3,Both,22,All ages,342,Varicella and herpes zoster,3,Rate,2021,1098.39318315314,1168.4633268413702,1035.1471763669
6,Incidence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,1,Number,2021,3880833.919821562,3990587.9339627074,3786666.7507097535
6,Incidence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,2,Percent,2021,0.0001054539619429,0.0001112044517529,9.97910397128e-05
6,Incidence,1,Global,3,Both,22,All ages,383,Neonatal sepsis and other neonatal infections,3,Rate,2021,49.17830658346,50.56912017345,47.98501101648
6,Incidence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,1,Number,2021,357288.00436327065,388483.4806061506,329226.0209692067
6,Incidence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,2,Percent,2021,9.7084047793e-06,1.06874226523e-05,8.7784165496e-06
6,Incidence,1,Global,3,Both,22,All ages,592,Chronic kidney disease due to glomerulonephritis,3,Rate,2021,4.52758849778,4.92290062048,4.1719843026
6,Incidence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,1,Number,2021,443679.90662338975,766545.3711548144,259195.79980466695
6,Incidence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,2,Percent,2021,1.20541951394e-05,2.0862659105e-05,7.0528312709e-06
6,Incidence,1,Global,3,Both,22,All ages,946,Multidrug-resistant tuberculosis without extensive drug resistance,3,Rate,2021,5.62235512357,9.713737833569999,3.28455449815
6,Incidence,1,Global,3,Both,22,All ages,567,Depressive disorders,1,Number,2021,357438729.6321912,418969488.7945632,311521927.86741304
6,Incidence,1,Global,3,Both,22,All ages,567,Depressive disorders,2,Percent,2021,0.0097121994167194,0.0113796743009422,0.0083598372805284
6,Incidence,1,Global,3,Both,22,All ages,567,Depressive disorders,3,Rate,2021,4529.4985031112,5309.22229467696,3947.63630514728
6,Incidence,1,Global,3,Both,22,All ages,569,Dysthymia,1,Number,2021,16322866.37636854,20590097.90511953,12955382.50674292
6,Incidence,1,Global,3,Both,22,All ages,569,Dysthymia,2,Percent,2021,0.000443440944075,0.0005532283825986,0.0003536865592121
6,Incidence,1,Global,3,Both,22,All ages,569,Dysthymia,3,Rate,2021,206.84495744018,260.91973227445004,164.17187284631
6,Incidence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,1,Number,2021,24036.081715520417,34586.565478636265,17144.48173819219
6,Incidence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,2,Percent,2021,6.530890719e-07,9.544422688e-07,4.63106479e-07
6,Incidence,1,Global,3,Both,22,All ages,947,Extensively drug-resistant tuberculosis,3,Rate,2021,0.30458757579,0.43828433680000006,0.21725654758000001
6,Incidence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,1,Number,2021,45589.40191811138,66723.02087411165,31326.348342005705
6,Incidence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,2,Percent,2021,1.2388722896e-06,1.835516368e-06,8.532746576e-07
6,Incidence,1,Global,3,Both,22,All ages,949,HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance,3,Rate,2021,0.57771335512,0.8455206392500001,0.39697054673000004
6,Incidence,1,Global,3,Both,22,All ages,957,Enteric infections,1,Number,2021,4448407869.509049,4991900224.074934,3965332197.107821
6,Incidence,1,Global,3,Both,22,All ages,957,Enteric infections,2,Percent,2021,0.1208217788117654,0.134161635464512,0.1082256661469541
6,Incidence,1,Global,3,Both,22,All ages,957,Enteric infections,3,Rate,2021,56370.6591250002,63257.84734042305,50249.07700858436
6,Incidence,1,Global,3,Both,22,All ages,596,Urolithiasis,1,Number,2021,105983780.31677105,128645155.20466776,88349355.86316743
6,Incidence,1,Global,3,Both,22,All ages,596,Urolithiasis,2,Percent,2021,0.0028797000283051,0.0034862476612356,0.0023995393194694
6,Incidence,1,Global,3,Both,22,All ages,596,Urolithiasis,3,Rate,2021,1343.03681862584,1630.2039751866103,1119.57166909373
6,Incidence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,1,Number,2021,568873568.4183546,625384109.176613,519070942.33354616
6,Incidence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,2,Percent,2021,0.015456284914312,0.0171446027397533,0.0139383836451668
6,Incidence,1,Global,3,Both,22,All ages,594,Urinary diseases and male infertility,3,Rate,2021,7208.821437066799,7924.928530548051,6577.717693680429
6,Incidence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),1,Number,2021,509975.88411620696,606167.2456279212,413360.6861066539
6,Incidence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),2,Percent,2021,1.38564332744e-05,1.64837339687e-05,1.12154509034e-05
6,Incidence,1,Global,3,Both,22,All ages,959,Invasive Non-typhoidal Salmonella (iNTS),3,Rate,2021,6.462464227380001,7.6814105582,5.23814699904
6,Incidence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,1,Number,2021,16188381.129355036,17180105.54843834,15192359.3334461
6,Incidence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,2,Percent,2021,0.0004399195407414,0.0004769965120606,0.0004063372559277
6,Incidence,1,Global,3,Both,22,All ages,593,Chronic kidney disease due to other and unspecified causes,3,Rate,2021,205.14074725102998,217.7079759796,192.51906174348
6,Incidence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,1,Number,2021,30217.653666575607,38445.90432954461,24629.637018972728
6,Incidence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,2,Percent,2021,8.211117164e-07,1.0599635489e-06,6.570748377e-07
6,Incidence,1,Global,3,Both,22,All ages,348,Visceral leishmaniasis,3,Rate,2021,0.38292105948000005,0.48719025576999997,0.31210916658
6,Incidence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,1,Number,2021,1066642.199710871,1211203.3641041915,942282.9820411452
6,Incidence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,2,Percent,2021,2.89829156495e-05,3.30681522695e-05,2.53390038163e-05
6,Incidence,1,Global,3,Both,22,All ages,349,Cutaneous and mucocutaneous leishmaniasis,3,Rate,2021,13.51659416403,15.34848736262,11.94070200801
6,Incidence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,1,Number,2021,722752642.3287488,873024940.9135935,608258774.0007858
6,Incidence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,2,Percent,2021,0.0196396707655222,0.0239211347904649,0.0164465006802534
6,Incidence,1,Global,3,Both,22,All ages,393,Sexually transmitted infections excluding HIV,3,Rate,2021,9158.792095407289,11063.05734444602,7707.9146100811595
6,Incidence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,1,Number,2021,23911320.584328555,25788088.77359475,22140751.31450385
6,Incidence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,2,Percent,2021,0.0006497174960848,0.0007068407382004,0.0005931199484934
6,Incidence,1,Global,3,Both,22,All ages,976,Diabetes mellitus type 2,3,Rate,2021,303.00659054371,326.78918039545,280.56976377461
6,Incidence,1,Global,3,Both,22,All ages,978,Contact dermatitis,1,Number,2021,253304736.14816883,316547750.24907494,204699259.67220613
6,Incidence,1,Global,3,Both,22,All ages,978,Contact dermatitis,2,Percent,2021,0.006881962978846,0.0086874494134895,0.0055546870276518
6,Incidence,1,Global,3,Both,22,All ages,978,Contact dermatitis,3,Rate,2021,3209.9023639512698,4011.32401738279,2593.96901736785
6,Incidence,1,Global,3,Both,22,All ages,395,Chlamydial infection,1,Number,2021,235690237.73138225,334690522.0818216,172881033.17127067
6,Incidence,1,Global,3,Both,22,All ages,395,Chlamydial infection,2,Percent,2021,0.0064049784421831,0.0092576138835501,0.0047196538677862
6,Incidence,1,Global,3,Both,22,All ages,395,Chlamydial infection,3,Rate,2021,2986.68971910444,4241.23099456816,2190.76534255639
6,Incidence,1,Global,3,Both,22,All ages,338,Diphtheria,1,Number,2021,13312.90948937339,18499.995187979453,8940.051182291194
6,Incidence,1,Global,3,Both,22,All ages,338,Diphtheria,2,Percent,2021,3.617439754e-07,4.99805168e-07,2.423770703e-07
6,Incidence,1,Global,3,Both,22,All ages,338,Diphtheria,3,Rate,2021,0.16870248969999999,0.23443374644,0.11328920200999999
6,Incidence,1,Global,3,Both,22,All ages,608,Genital prolapse,1,Number,2021,13971720.531314136,16614082.408406865,11651598.21299464
6,Incidence,1,Global,3,Both,22,All ages,608,Genital prolapse,2,Percent,2021,0.0003796238075786,0.0004513568241213,0.0003125595748276
6,Incidence,1,Global,3,Both,22,All ages,608,Genital prolapse,3,Rate,2021,177.05100758833,210.53527544953,147.65019089822
6,Incidence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,1,Number,2021,591854.5938988086,763525.7384169893,437925.61042879627
6,Incidence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,2,Percent,2021,1.608301131e-05,2.06730672817e-05,1.19332915073e-05
6,Incidence,1,Global,3,Both,22,All ages,966,Benign and in situ cervical and uterine neoplasms,3,Rate,2021,7.50003923717,9.67547275251,5.54943612001
6,Incidence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,1,Number,2021,1044370.4420184306,1179672.1000330732,906614.873000019
6,Incidence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,2,Percent,2021,2.83779632162e-05,3.2078600372e-05,2.44325176299e-05
6,Incidence,1,Global,3,Both,22,All ages,968,Non-rheumatic calcific aortic valve disease,3,Rate,2021,13.23436427463,14.948920103759999,11.48871224552
6,Incidence,1,Global,3,Both,22,All ages,604,Uterine fibroids,1,Number,2021,10100270.81413094,13285676.684713133,7350444.394681288
6,Incidence,1,Global,3,Both,22,All ages,604,Uterine fibroids,2,Percent,2021,0.0002744083383153,0.0003633299179053,0.0001972895297179
6,Incidence,1,Global,3,Both,22,All ages,604,Uterine fibroids,3,Rate,2021,127.99161853753,168.35739293878,93.14554949647
6,Incidence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,1,Number,2021,1630.4104373677264,2405.209433601821,1104.5304868465018
6,Incidence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,2,Percent,2021,4.43078005e-08,6.56146754e-08,2.96099486e-08
6,Incidence,1,Global,3,Both,22,All ages,350,African trypanosomiasis,3,Rate,2021,0.020660720349999998,0.03047904893,0.01399671824
6,Incidence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,2,Percent,2021,0.0016511780886543,0.0017749534198037,0.0015328698729464
6,Incidence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,1,Number,2021,724397974.8935595,874680882.8561678,609951130.1914357
6,Incidence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,2,Percent,2021,0.0196843797089875,0.0239633602007076,0.0164868547518189
6,Incidence,1,Global,3,Both,22,All ages,955,HIV/AIDS and sexually transmitted infections,3,Rate,2021,9179.64191041501,11084.0416025253,7729.360313069659
6,Incidence,1,Global,3,Both,22,All ages,340,Tetanus,1,Number,2021,51191.49710908218,80349.07729287018,22500.26995800064
6,Incidence,1,Global,3,Both,22,All ages,340,Tetanus,2,Percent,2021,1.3912796925e-06,2.2087087037e-06,6.085322344e-07
6,Incidence,1,Global,3,Both,22,All ages,340,Tetanus,3,Rate,2021,0.6487036527,1.0181913574399999,0.28512561915
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,2021,42291.374068055935,51129.45012063808,34032.64455592133
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,2021,1.1491756143e-06,1.4002110417e-06,9.179955507e-07
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,2021,0.53592042399,0.6479173872,0.43126499674999996
6,Incidence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,1,Number,2021,9320618.290052442,11903388.57444511,7274442.965547024
6,Incidence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,2,Percent,2021,0.0002532809669179,0.0003232049236416,0.000197069979703
6,Incidence,1,Global,3,Both,22,All ages,958,Typhoid and paratyphoid,3,Rate,2021,118.11178558156,150.84090295805,92.18245196125
6,Incidence,1,Global,3,Both,22,All ages,603,Gynecological diseases,1,Number,2021,763439804.413106,861772336.9443824,667852503.428428
6,Incidence,1,Global,3,Both,22,All ages,603,Gynecological diseases,2,Percent,2021,0.0207410594398942,0.0234663819042344,0.0179313119387816
6,Incidence,1,Global,3,Both,22,All ages,603,Gynecological diseases,3,Rate,2021,9674.38378841319,10920.463247586149,8463.092171603601
6,Incidence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,1,Number,2021,42800722.58822047,44765133.68048747,40842783.9258171
6,Incidence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,2,Percent,2021,0.0011630216471286,0.0012404742311317,0.001090140934203
6,Incidence,1,Global,3,Both,22,All ages,613,Hemoglobinopathies and hemolytic anemias,3,Rate,2021,542.37493820245,567.26814748359,517.56374818489
6,Incidence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,1,Number,2021,524216.7470744652,634188.8735126688,439374.32093262015
6,Incidence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,2,Percent,2021,1.42463030876e-05,1.7253839239e-05,1.17553090868e-05
6,Incidence,1,Global,3,Both,22,All ages,615,Sickle cell disorders,3,Rate,2021,6.642925834090001,8.03650336443,5.56779432105
6,Incidence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,1,Number,2021,8227657.097034446,12166545.862124458,5128548.815723617
6,Incidence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,2,Percent,2021,0.0002235381287141,0.0003332182970855,0.0001394817782429
6,Incidence,1,Global,3,Both,22,All ages,574,Bulimia nervosa,3,Rate,2021,104.26167456301,154.17565781758,64.98947164415
6,Incidence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),1,Number,2021,48353272.3459562,52358017.4373465,44229138.5125482
6,Incidence,1,Global,3,Both,22,All ages,359,Rabies,1,Number,2021,10180.669215085363,14293.427846165068,6080.470809132055
6,Incidence,1,Global,3,Both,22,All ages,359,Rabies,2,Percent,2021,2.766651253e-07,3.891590944e-07,1.625114519e-07
6,Incidence,1,Global,3,Both,22,All ages,359,Rabies,3,Rate,2021,0.12901043493,0.18112771411,0.07705232015
6,Incidence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,1,Number,2021,13960249.964432074,17749443.310414962,10898097.092173325
6,Incidence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,2,Percent,2021,0.0003794110771803,0.0004907788121725,0.0002939954865319
6,Incidence,1,Global,3,Both,22,All ages,367,Maternal hemorrhage,3,Rate,2021,176.90565144415,224.92267972277998,138.10175107928
6,Incidence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,2,Percent,2021,0.0013655275961592,0.0014786507857696,0.0012490853816137
6,Incidence,1,Global,3,Both,22,All ages,607,Endometriosis,1,Number,2021,3447125.8775722613,4611504.039348151,2436259.342474023
6,Incidence,1,Global,3,Both,22,All ages,607,Endometriosis,2,Percent,2021,9.36800491255e-05,0.0001262029617533,6.58849222531e-05
6,Incidence,1,Global,3,Both,22,All ages,607,Endometriosis,3,Rate,2021,43.68231589947,58.43742972344,30.872516406600003
6,Incidence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,1,Number,2021,4111621.023858782,5954940.96555675,2775202.64795898
6,Incidence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,2,Percent,2021,0.0001117216007227,0.0001662864922658,7.47705353151e-05
6,Incidence,1,Global,3,Both,22,All ages,578,Attention-deficit/hyperactivity disorder,3,Rate,2021,52.102863313360004,75.46159370407,35.16763908795
6,Incidence,1,Global,3,Both,22,All ages,405,Leprosy,1,Number,2021,48054.59325577745,55980.74242677332,41284.132857593264
6,Incidence,1,Global,3,Both,22,All ages,405,Leprosy,2,Percent,2021,1.3056414347e-06,1.540409971e-06,1.1122318419e-06
6,Incidence,1,Global,3,Both,22,All ages,405,Leprosy,3,Rate,2021,0.6089525006000001,0.7093934372599999,0.52315656497
6,Incidence,1,Global,3,Both,22,All ages,366,Maternal disorders,1,Number,2021,111545181.67122851,125202806.84195732,98523666.96035212
6,Incidence,1,Global,3,Both,22,All ages,366,Maternal disorders,2,Percent,2021,0.0030309200089732,0.0034291246209598,0.0026716475584028
6,Incidence,1,Global,3,Both,22,All ages,366,Maternal disorders,3,Rate,2021,1413.51143992985,1586.58220042222,1248.5015333317401
6,Incidence,1,Global,3,Both,22,All ages,346,Chagas disease,1,Number,2021,160315.3422414442,183478.2603134853,140377.12462272414
6,Incidence,1,Global,3,Both,22,All ages,346,Chagas disease,2,Percent,2021,4.3561337098e-06,5.0639187568e-06,3.8137158096e-06
6,Incidence,1,Global,3,Both,22,All ages,346,Chagas disease,3,Rate,2021,2.03153167945,2.32505444024,1.77887263785
6,Incidence,1,Global,3,Both,22,All ages,616,G6PD deficiency,1,Number,2021,8548771.973567346,9462072.025344696,7734371.760322857
6,Incidence,1,Global,3,Both,22,All ages,616,G6PD deficiency,2,Percent,2021,0.0002322884567326,0.000258192432547,0.0002090298785125
6,Incidence,1,Global,3,Both,22,All ages,616,G6PD deficiency,3,Rate,2021,108.33087365086,119.90430113499,98.01071458299
6,Incidence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,1,Number,2021,44905585.96475796,47325131.24228923,42722630.981626
6,Incidence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,2,Percent,2021,0.0012202363951022,0.0013078776766546,0.0011373446651604
6,Incidence,1,Global,3,Both,22,All ages,974,Diabetes and kidney diseases,3,Rate,2021,569.04797255183,599.70868669455,541.38535373425
6,Incidence,1,Global,3,Both,22,All ages,961,Other infectious diseases,1,Number,2021,353315842.27731085,371240505.5276854,336284245.1511116
6,Incidence,1,Global,3,Both,22,All ages,961,Other infectious diseases,2,Percent,2021,0.0096003944068669,0.0102659785890609,0.0090198021965166
6,Incidence,1,Global,3,Both,22,All ages,961,Other infectious diseases,3,Rate,2021,4477.25287175043,4704.3959556711,4261.42680900648
6,Incidence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",1,Number,2021,341016.5996415925,401897.2419813906,290884.2639005192
6,Incidence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",2,Percent,2021,9.2677574704e-06,1.09734886309e-05,7.8362858448e-06
6,Incidence,1,Global,3,Both,22,All ages,964,"Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms",3,Rate,2021,4.32139566745,5.09288111513,3.68611381109
6,Incidence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,1,Number,2021,474521181.5156034,558191710.5412884,395808998.4257788
6,Incidence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,2,Percent,2021,0.0128914833120099,0.015406030951177,0.0107219887384499
6,Incidence,1,Global,3,Both,22,All ages,612,Other gynecological diseases,3,Rate,2021,6013.17877215259,7073.459890447601,5015.7302979795695
6,Incidence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,1,Number,2021,1559666.332263857,2027121.5634522368,1220103.1520518458
6,Incidence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,2,Percent,2021,4.23824663457e-05,5.53752635998e-05,3.32875986934e-05
6,Incidence,1,Global,3,Both,22,All ages,965,Benign and in situ intestinal neoplasms,3,Rate,2021,19.76424413944,25.68788249871,15.46126634499
6,Incidence,1,Global,3,Both,22,All ages,628,Osteoarthritis,1,Number,2021,46632144.36927958,51644430.76643078,41122052.726918966
6,Incidence,1,Global,3,Both,22,All ages,628,Osteoarthritis,2,Percent,2021,0.0012670912055965,0.001417614592921,0.0011165565775743
6,Incidence,1,Global,3,Both,22,All ages,628,Osteoarthritis,3,Rate,2021,590.92708933602,654.44327225336,521.10266971658
6,Incidence,1,Global,3,Both,22,All ages,631,Neck pain,1,Number,2021,43286060.82322638,52883959.02666916,33941593.5710699
6,Incidence,1,Global,3,Both,22,All ages,631,Neck pain,2,Percent,2021,0.0011762852747802,0.0014562456315576,0.0009146473769088
6,Incidence,1,Global,3,Both,22,All ages,631,Neck pain,3,Rate,2021,548.52519173324,670.1506954670999,430.11118977389003
6,Incidence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,1,Number,2021,19935037.7643504,21170794.106559,18702792.561641887
6,Incidence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,2,Percent,2021,0.000541735730015,0.0005869777411305,0.000499820945239
6,Incidence,1,Global,3,Both,22,All ages,589,Chronic kidney disease,3,Rate,2021,252.61874617226,268.27837127221,237.00361457508
6,Incidence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,1,Number,2021,19072.930588302264,32508.92938044459,9650.58530784865
6,Incidence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,2,Percent,2021,5.184048318e-07,8.963052822e-07,2.595898405e-07
6,Incidence,1,Global,3,Both,22,All ages,1006,Burkitt lymphoma,3,Rate,2021,0.24169403981,0.41195632918,0.12229315986999999
6,Incidence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,1,Number,2021,135710440.97271967,145731935.72976053,125371044.37497409
6,Incidence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,2,Percent,2021,0.0036875410315451,0.0040167582533825,0.0033644858445448
6,Incidence,1,Global,3,Both,22,All ages,979,Seborrhoeic dermatitis,3,Rate,2021,1719.73596670688,1846.72932735266,1588.71412287716
6,Incidence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,2,Percent,2021,0.349479294738805,0.365268502954139,0.335201898947794
6,Incidence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,1,Number,2021,148520.90112693715,183224.15887623327,119837.68352995937
6,Incidence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,2,Percent,2021,4.0354476091e-06,4.9815444145e-06,3.2267421591e-06
6,Incidence,1,Global,3,Both,22,All ages,353,Cystic echinococcosis,3,Rate,2021,1.8820713693400002,2.321834442,1.5185948336500001
6,Incidence,1,Global,3,Both,22,All ages,358,Yellow fever,1,Number,2021,86508.96480653556,180500.6804453894,34105.76780227848
6,Incidence,1,Global,3,Both,22,All ages,358,Yellow fever,2,Percent,2021,2.3511724657e-06,5.0183210456e-06,9.147700605e-07
6,Incidence,1,Global,3,Both,22,All ages,358,Yellow fever,3,Rate,2021,1.09625005382,2.28732225724,0.43219162167
6,Incidence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,1,Number,2021,566715.0861882175,746849.7798435601,429506.8764829495
6,Incidence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,2,Percent,2021,1.53966632023e-05,2.01939110728e-05,1.16601537892e-05
6,Incidence,1,Global,3,Both,22,All ages,384,Hemolytic disease and other neonatal jaundice,3,Rate,2021,7.18146893937,9.46415337625,5.44275310095
6,Incidence,1,Global,3,Both,22,All ages,645,Down syndrome,1,Number,2021,59806.67291661364,69713.588331418,50578.00871551704
6,Incidence,1,Global,3,Both,22,All ages,645,Down syndrome,2,Percent,2021,1.6252957265e-06,1.9162839379e-06,1.3797462727e-06
6,Incidence,1,Global,3,Both,22,All ages,645,Down syndrome,3,Rate,2021,0.75787600222,0.88341740225,0.6409294678399999
6,Incidence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,1,Number,2021,1162557.793739189,1244874.028627067,1084357.9404716042
6,Incidence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,2,Percent,2021,3.1589943324e-05,3.45336138013e-05,2.917423654e-05
6,Incidence,1,Global,3,Both,22,All ages,969,Non-rheumatic degenerative mitral valve disease,3,Rate,2021,14.732045942360001,15.775165313030001,13.741089761749999
6,Incidence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,1,Number,2021,354196492.991092,390096011.499617,316314706.7795911
6,Incidence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,2,Percent,2021,0.0096241897935654,0.0106962003182719,0.008547380830391
6,Incidence,1,Global,3,Both,22,All ages,992,Upper digestive system diseases,3,Rate,2021,4488.41256363368,4943.33476950124,4008.37086776951
6,Incidence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,1,Number,2021,13471093.16972806,19008282.32214893,8938373.026286814
6,Incidence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,2,Percent,2021,0.0003659991013377,0.0005164009406235,0.000243194409935
6,Incidence,1,Global,3,Both,22,All ages,370,Maternal obstructed labor and uterine rupture,3,Rate,2021,170.7070087518,240.8748106661,113.26793625434999
6,Incidence,1,Global,3,Both,22,All ages,646,Turner syndrome,1,Number,2021,23928.981041866,32035.34056590238,17948.411234166502
6,Incidence,1,Global,3,Both,22,All ages,646,Turner syndrome,2,Percent,2021,6.500247211e-07,8.775029248e-07,4.901167275e-07
6,Incidence,1,Global,3,Both,22,All ages,646,Turner syndrome,3,Rate,2021,0.30323038559,0.40595496545,0.22744402069000003
6,Incidence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,1,Number,2021,68357.49367807388,90236.1414937954,48581.36873431607
6,Incidence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,2,Percent,2021,1.8574207515e-06,2.4569435246e-06,1.3403711473e-06
6,Incidence,1,Global,3,Both,22,All ages,647,Klinefelter syndrome,3,Rate,2021,0.86623283831,1.14348120094,0.61562785093
6,Incidence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,1,Number,2021,40420824.37184708,49166637.13603824,32370365.017077196
6,Incidence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,2,Percent,2021,0.0010984339818885,0.0013409456648382,0.000891833342372
6,Incidence,1,Global,3,Both,22,All ages,967,Other benign and in situ neoplasms,3,Rate,2021,512.21663549218,623.0444292924201,410.20042803109
6,Incidence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,1,Number,2021,586129386.9796479,614585958.3457339,562138520.1803052
6,Incidence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,2,Percent,2021,0.0159269600085778,0.0169718573052392,0.0149742743744734
6,Incidence,1,Global,3,Both,22,All ages,386,Nutritional deficiencies,3,Rate,2021,7427.488855742349,7788.09330825648,7123.47424779043
6,Incidence,1,Global,3,Both,22,All ages,388,Iodine deficiency,1,Number,2021,8079841.244912019,9808708.636152595,6550429.307102185
6,Incidence,1,Global,3,Both,22,All ages,388,Iodine deficiency,2,Percent,2021,0.0002195624291264,0.0002672063879954,0.000177956925674
6,Incidence,1,Global,3,Both,22,All ages,388,Iodine deficiency,3,Rate,2021,102.38853764354,124.29691413300999,83.00768014642
6,Incidence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,1,Number,2021,21553770.757577185,21730108.45254361,21378909.71434137
6,Incidence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,2,Percent,2021,0.000585674904167,0.000612051457041,0.0005586298361045
6,Incidence,1,Global,3,Both,22,All ages,381,Neonatal preterm birth,3,Rate,2021,273.13148881014,275.36605730868,270.9156325866
6,Incidence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,1,Number,2021,1061448.1521498542,1076766.1119810052,1047815.174502404
6,Incidence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,2,Percent,2021,2.88422886706e-05,3.01083365498e-05,2.74971018193e-05
6,Incidence,1,Global,3,Both,22,All ages,382,Neonatal encephalopathy due to birth asphyxia and trauma,3,Rate,2021,13.45077468588,13.644885369410002,13.278016261210002
6,Incidence,1,Global,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,1230232.6087569068,1409969.658515687,1052350.052297329
6,Incidence,1,Global,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,3.3429342019e-05,3.88382397505e-05,2.82669121563e-05
6,Incidence,1,Global,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,15.58962780999,17.86727326456,13.335482675680002
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,2021,206365.73830070815,252049.90160628583,169400.9082127532
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,2021,5.6077398177e-06,6.9466771868e-06,4.5898097617e-06
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,2021,2.61508679736,3.1940009780400005,2.14666485908
6,Incidence,1,Global,3,Both,22,All ages,972,Headache disorders,1,Number,2021,809226480.1945754,895990201.4576063,717818771.0414789
6,Incidence,1,Global,3,Both,22,All ages,972,Headache disorders,2,Percent,2021,0.0219885342149625,0.024587682511595,0.0193942483934494
6,Incidence,1,Global,3,Both,22,All ages,972,Headache disorders,3,Rate,2021,10254.5970172035,11354.07536973026,9096.26959642339
6,Incidence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,1,Number,2021,1000319.4866087516,1114212.6340908478,902687.4355938644
6,Incidence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,2,Percent,2021,2.71846542702e-05,3.06540872927e-05,2.40250188998e-05
6,Incidence,1,Global,3,Both,22,All ages,627,Rheumatoid arthritis,3,Rate,2021,12.676146263969999,14.119411356050001,11.43894337501
6,Incidence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,1,Number,2021,18050085.26030078,21519203.9636259,15356123.721978234
6,Incidence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,2,Percent,2021,0.0004905239216952,0.000590529761111,0.0004104558923335
6,Incidence,1,Global,3,Both,22,All ages,369,Maternal hypertensive disorders,3,Rate,2021,228.73244388399002,272.69345502007,194.59430007448
6,Incidence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,96200.95615242656,116184.8668372734,83423.50655914689
6,Incidence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,2.6139664744e-06,3.1819676716e-06,2.2388721076e-06
6,Incidence,1,Global,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,1.2190679150500001,1.4723059836399999,1.0571508254700002
6,Incidence,1,Global,3,Both,22,All ages,656,Cellulitis,1,Number,2021,55968148.178983554,59370369.995860055,52579678.75206271
6,Incidence,1,Global,3,Both,22,All ages,656,Cellulitis,2,Percent,2021,0.0015207326462093,0.0016321030194356,0.0014134229069478
6,Incidence,1,Global,3,Both,22,All ages,656,Cellulitis,3,Rate,2021,709.23384172575,752.34712898103,666.29482609958
6,Incidence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,1,Number,2021,449102228.54266,499843231.5529086,400893641.260514
6,Incidence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,2,Percent,2021,0.0122018486347101,0.0137234724668026,0.0108852124225039
6,Incidence,1,Global,3,Both,22,All ages,595,Urinary tract infections and interstitial nephritis,3,Rate,2021,5691.067316687,6334.062264150531,5080.16338874309
6,Incidence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,1,Number,2021,13787559.558922973,17015020.658498876,10907858.84467261
6,Incidence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,2,Percent,2021,0.0003747362512967,0.0004618015604378,0.000294117303008
6,Incidence,1,Global,3,Both,22,All ages,597,Benign prostatic hyperplasia,3,Rate,2021,174.71730175395,215.61600412574,138.22545296066
6,Incidence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,10867.403777451564,13556.989549204893,8279.039076966472
6,Incidence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,2.953317214e-07,3.7486078e-07,2.21145132e-07
6,Incidence,1,Global,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,0.1377128024,0.17179549606,0.10491279203
6,Incidence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,1,Number,2021,95139.57247298358,111471.11647768696,82236.5486706073
6,Incidence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,2,Percent,2021,2.5851979635e-06,3.0611602983e-06,2.2270294838e-06
6,Incidence,1,Global,3,Both,22,All ages,997,Chronic kidney disease due to diabetes mellitus type 1,3,Rate,2021,1.20561795737,1.41257287856,1.04210957914
6,Incidence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,1,Number,2021,43251.38894917586,52441.10130971932,34704.70397549379
6,Incidence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,2,Percent,2021,1.1754150179e-06,1.4413843831e-06,9.444312399e-07
6,Incidence,1,Global,3,Both,22,All ages,1004,Pulmonary Arterial Hypertension,3,Rate,2021,0.54808582636,0.6645387592099999,0.43978139937
6,Incidence,1,Global,3,Both,22,All ages,526,Digestive diseases,3,Rate,2021,6720.176082727359,7196.39569170316,6243.3807413739505
6,Incidence,1,Global,3,Both,22,All ages,658,Scabies,1,Number,2021,622473574.4509832,694992043.0645441,556234882.6814088
6,Incidence,1,Global,3,Both,22,All ages,658,Scabies,2,Percent,2021,0.016912518214379,0.0190057653001739,0.0149363346282795
6,Incidence,1,Global,3,Both,22,All ages,658,Scabies,3,Rate,2021,7888.04595015012,8807.00706936359,7048.66277662814
6,Incidence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,1,Number,2021,367193430.94667625,402083084.6827883,333085118.2890772
6,Incidence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,2,Percent,2021,0.0099781373605086,0.0110434840212137,0.0089051083977134
6,Incidence,1,Global,3,Both,22,All ages,626,Musculoskeletal disorders,3,Rate,2021,4653.11103118762,5095.23613199694,4220.887160861031
6,Incidence,1,Global,3,Both,22,All ages,380,Neonatal disorders,1,Number,2021,27062767.91573681,27342185.335399017,26800784.68427597
6,Incidence,1,Global,3,Both,22,All ages,380,Neonatal disorders,2,Percent,2021,0.0007353678179829,0.0007669965185555,0.0007011546674326
6,Incidence,1,Global,3,Both,22,All ages,380,Neonatal disorders,3,Rate,2021,342.94203901886,346.48284385947,339.62216191443
6,Incidence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,1,Number,2021,108857028.31128764,130570454.18012246,91319665.28668728
6,Incidence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,2,Percent,2021,0.0029579779941696,0.0035210731040664,0.0024832654975499
6,Incidence,1,Global,3,Both,22,All ages,387,Protein-energy malnutrition,3,Rate,2021,1379.44689792425,1654.60155190231,1157.21172030322
6,Incidence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,1,Number,2021,469192517.42344856,487302090.0128764,452515933.9802486
6,Incidence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,2,Percent,2021,0.0127494195852816,0.0134991224270848,0.0120185072854213
6,Incidence,1,Global,3,Both,22,All ages,389,Vitamin A deficiency,3,Rate,2021,5945.65342017455,6175.13969330507,5734.326125505871
6,Incidence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,1,Number,2021,5201596496.645046,5710778679.764028,4762977936.189705
6,Incidence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,2,Percent,2021,0.1412971704587889,0.1546549737745597,0.1299106678844484
6,Incidence,1,Global,3,Both,22,All ages,640,Other non-communicable diseases,3,Rate,2021,65915.13899343362,72367.5453642306,60356.921742987324
6,Incidence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,1,Number,2021,2301505.6422455814,3167177.813846602,1655989.242295546
6,Incidence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,2,Percent,2021,6.25537706841e-05,8.78071671595e-05,4.50628526113e-05
6,Incidence,1,Global,3,Both,22,All ages,605,Polycystic ovarian syndrome,3,Rate,2021,29.164904352080004,40.13478668544,20.984857465959998
6,Incidence,1,Global,3,Both,22,All ages,396,Gonococcal infection,1,Number,2021,86277273.395501,108998324.39747496,66593812.71179794
6,Incidence,1,Global,3,Both,22,All ages,396,Gonococcal infection,2,Percent,2021,0.0023446645147807,0.0029609366424175,0.0017781180135113
6,Incidence,1,Global,3,Both,22,All ages,396,Gonococcal infection,3,Rate,2021,1093.3140376242,1381.23741573282,843.88330079659
6,Incidence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,1,Number,2021,68508067.06746426,84190350.17022453,54909915.96110152
6,Incidence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,2,Percent,2021,0.0018613633549767,0.0023024678759852,0.0014855657430863
6,Incidence,1,Global,3,Both,22,All ages,1026,Total burden related to hepatitis B,3,Rate,2021,868.1409190112901,1066.8683426243201,695.82381967309
6,Incidence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,1,Number,2021,259098000.03224048,312886613.078138,206109372.85411444
6,Incidence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,2,Percent,2021,0.0070393101621805,0.0084552776025661,0.0056365766381697
6,Incidence,1,Global,3,Both,22,All ages,609,Premenstrual syndrome,3,Rate,2021,3283.3151698831603,3964.92972946523,2611.83810937487
6,Incidence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,1,Number,2021,6274.971548355072,8381.780846136324,3854.9634713985374
6,Incidence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,2,Percent,2021,1.705239321e-07,2.295196611e-07,1.049681061e-07
6,Incidence,1,Global,3,Both,22,All ages,1009,Retinoblastoma,3,Rate,2021,0.07951705251999999,0.10621474577,0.04885047373
6,Incidence,1,Global,3,Both,22,All ages,663,Pruritus,1,Number,2021,62528828.31167251,70329578.98696782,55866535.68816893
6,Incidence,1,Global,3,Both,22,All ages,663,Pruritus,2,Percent,2021,0.0016990928249662,0.0019346822359586,0.0015169841116813
6,Incidence,1,Global,3,Both,22,All ages,663,Pruritus,3,Rate,2021,792.3714213355,891.22329601415,707.9461983147601
6,Incidence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,1,Number,2021,2468317.4732273053,2720436.6899696887,2255077.2552637225
6,Incidence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,2,Percent,2021,6.70735233553e-05,7.45889479417e-05,6.03562318973e-05
6,Incidence,1,Global,3,Both,22,All ages,665,Decubitus ulcer,3,Rate,2021,31.278760171540004,34.47363951776,28.576559296259997
6,Incidence,1,Global,3,Both,22,All ages,614,Thalassemias,1,Number,2021,119679.06027419971,153985.2893699045,93217.99048788851
6,Incidence,1,Global,3,Both,22,All ages,614,Thalassemias,2,Percent,2021,3.2521178069e-06,4.2403073995e-06,2.5140151615e-06
6,Incidence,1,Global,3,Both,22,All ages,614,Thalassemias,3,Rate,2021,1.51658474425,1.95131663102,1.18126748272
6,Incidence,1,Global,3,Both,22,All ages,973,Substance use disorders,1,Number,2021,69389099.7368416,78767497.46480907,60494875.38822119
6,Incidence,1,Global,3,Both,22,All ages,973,Substance use disorders,2,Percent,2021,0.0018853246767939,0.0021600733004359,0.0016396275329454
6,Incidence,1,Global,3,Both,22,All ages,973,Substance use disorders,3,Rate,2021,879.3054510731699,998.14942333696,766.59697117547
6,Incidence,1,Global,3,Both,22,All ages,397,Trichomoniasis,1,Number,2021,341916383.3315317,464294523.0832887,258045848.3244431
6,Incidence,1,Global,3,Both,22,All ages,397,Trichomoniasis,2,Percent,2021,0.0092903645328827,0.0126800739877037,0.0069927851317653
6,Incidence,1,Global,3,Both,22,All ages,397,Trichomoniasis,3,Rate,2021,4332.79781427997,5883.58555736957,3269.9822006483496
6,Incidence,1,Global,3,Both,22,All ages,398,Genital herpes,1,Number,2021,40172738.72580766,46023911.06829929,33994980.024842866
6,Incidence,1,Global,3,Both,22,All ages,398,Genital herpes,2,Percent,2021,0.0010916583027433,0.0012766309677976,0.0009142211827818
6,Incidence,1,Global,3,Both,22,All ages,398,Genital herpes,3,Rate,2021,509.07286994799006,583.21949752254,430.78770813187
6,Incidence,1,Global,3,Both,22,All ages,644,Orofacial clefts,1,Number,2021,183302.4080797801,241690.8214562212,135255.4271317355
6,Incidence,1,Global,3,Both,22,All ages,644,Orofacial clefts,2,Percent,2021,4.980559671e-06,6.5783068015e-06,3.7003920992e-06
6,Incidence,1,Global,3,Both,22,All ages,644,Orofacial clefts,3,Rate,2021,2.3228260235500002,3.06272970231,1.71396998686
6,Incidence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",1,Number,2021,79473878.42849551,98633108.24715357,63335600.24380693
6,Incidence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",2,Percent,2021,0.0021591414110826,0.0026741803491693,0.0017259819195573
6,Incidence,1,Global,3,Both,22,All ages,619,"Endocrine, metabolic, blood, and immune disorders",3,Rate,2021,1007.10075192112,1249.88838401033,802.59491407988
6,Incidence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,1,Number,2021,16006680.599402012,16819872.23403558,15211259.968563017
6,Incidence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,2,Percent,2021,0.0004349442081549,0.0004646594982336,0.0004053815336788
6,Incidence,1,Global,3,Both,22,All ages,977,Atopic dermatitis,3,Rate,2021,202.83822038360003,213.14306422525001,192.75857243824
6,Incidence,1,Global,3,Both,22,All ages,1048,COVID-19,1,Number,2021,2279717767.545374,2372460274.956961,2181359055.585976
6,Incidence,1,Global,3,Both,22,All ages,1048,COVID-19,2,Percent,2021,0.0619447286550057,0.0656663152227394,0.0582500188115376
6,Incidence,1,Global,3,Both,22,All ages,1048,COVID-19,3,Rate,2021,28888.80627524145,30064.048389960917,27642.39506779767
6,Incidence,1,Global,3,Both,22,All ages,394,Syphilis,1,Number,2021,18696009.144525893,24331643.867720403,14033725.79325232
6,Incidence,1,Global,3,Both,22,All ages,394,Syphilis,2,Percent,2021,0.0005080049729321,0.0006629100536054,0.0003784853562725
6,Incidence,1,Global,3,Both,22,All ages,394,Syphilis,3,Rate,2021,236.91765445066002,308.33296825579,177.83674432542998
6,Incidence,1,Global,3,Both,22,All ages,400,Acute hepatitis,1,Number,2021,250774458.359044,268115472.33843705,234361297.00797585
6,Incidence,1,Global,3,Both,22,All ages,400,Acute hepatitis,2,Percent,2021,0.0068139914598941,0.0073847450377214,0.0063284374758238
6,Incidence,1,Global,3,Both,22,All ages,400,Acute hepatitis,3,Rate,2021,3177.8384366032396,3397.58545994041,2969.84925242198
6,Incidence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,1,Number,2021,63533725.97054111,78878535.07026036,50445999.41104129
6,Incidence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,2,Percent,2021,0.0017261897315995,0.0021527152932449,0.0013652457241975
6,Incidence,1,Global,3,Both,22,All ages,402,Acute hepatitis B,3,Rate,2021,805.10558264564,999.5565027214401,639.25663303298
6,Incidence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,1,Number,2021,459018.3198364783,585158.3593095406,364141.4050955554
6,Incidence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,2,Percent,2021,1.24730102089e-05,1.57585902464e-05,9.7931226901e-06
6,Incidence,1,Global,3,Both,22,All ages,651,Digestive congenital anomalies,3,Rate,2021,5.81672499435,7.41518389824,4.61443546142
6,Incidence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,1,Number,2021,1253255083.9613488,1637292359.0766487,978655131.4422522
6,Incidence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,2,Percent,2021,0.034034373210636,0.0443773045118571,0.0264887965269729
6,Incidence,1,Global,3,Both,22,All ages,681,Caries of deciduous teeth,3,Rate,2021,15881.37086504513,20747.92873515516,12401.61343873173
6,Incidence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,1,Number,2021,4693912470.725715,4895691751.536951,4497714608.9141445
6,Incidence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,2,Percent,2021,0.1275393860074524,0.1351803436591538,0.1203638933962299
6,Incidence,1,Global,3,Both,22,All ages,653,Skin and subcutaneous diseases,3,Rate,2021,59481.71741703835,62038.68417700251,56995.478943933864
6,Incidence,1,Global,3,Both,22,All ages,655,Psoriasis,1,Number,2021,5099418.337029605,5254031.025417071,4945748.062208722
6,Incidence,1,Global,3,Both,22,All ages,655,Psoriasis,2,Percent,2021,0.0001385652562588,0.000146138187098,0.0001304297109812
6,Incidence,1,Global,3,Both,22,All ages,655,Psoriasis,3,Rate,2021,64.62032737213,66.5795944648,62.67300263625
6,Incidence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,1,Number,2021,1796781.41393522,2284910.0220593503,1368838.767578124
6,Incidence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,2,Percent,2021,4.88230034204e-05,6.26593366926e-05,3.69159543606e-05
6,Incidence,1,Global,3,Both,22,All ages,1014,Osteoarthritis hip,3,Rate,2021,22.76898962015,28.95460303171,17.34605859618
6,Incidence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,1,Number,2021,10367241.353965184,13251881.072835471,7686290.997944303
6,Incidence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,2,Percent,2021,0.0002817183648321,0.0003652496397683,0.0002068887438736
6,Incidence,1,Global,3,Both,22,All ages,1016,Osteoarthritis hand,3,Rate,2021,131.37469530092,167.92913164329,97.40143046471
6,Incidence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,1,Number,2021,38639539.70672748,48577264.36693943,29946050.847715937
6,Incidence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,2,Percent,2021,0.0010498259812902,0.0013316638142954,0.0008114243228409
6,Incidence,1,Global,3,Both,22,All ages,995,Maternal abortion and miscarriage,3,Rate,2021,489.64402218702,615.57583998159,379.47928202519
6,Incidence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,1,Number,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,2,Percent,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,399,Other sexually transmitted infections,3,Rate,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,1,Number,2021,530859.4512750272,622954.9330749635,455261.0547556544
6,Incidence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,2,Percent,2021,1.44256671123e-05,1.69347555177e-05,1.23546801267e-05
6,Incidence,1,Global,3,Both,22,All ages,975,Diabetes mellitus type 1,3,Rate,2021,6.727102830710001,7.894145773659999,5.76911256417
6,Incidence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,2280688.2160554742,2509739.7279127026,2063251.874000018
6,Incidence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,6.19706263287e-05,6.86633044534e-05,5.54443939888e-05
6,Incidence,1,Global,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,28.90110389357,31.8036670298,26.14572932385
6,Incidence,1,Global,3,Both,22,All ages,641,Congenital birth defects,1,Number,2021,7198542.231282925,8356382.812022719,6203686.762869459
6,Incidence,1,Global,3,Both,22,All ages,641,Congenital birth defects,2,Percent,2021,0.0001955765093198,0.0002285309168223,0.0001666491071975
6,Incidence,1,Global,3,Both,22,All ages,641,Congenital birth defects,3,Rate,2021,91.22063044128001,105.89289939964999,78.6137247497
6,Incidence,1,Global,3,Both,22,All ages,630,Low back pain,1,Number,2021,266873320.7771847,299406380.3325901,235369488.7455485
6,Incidence,1,Global,3,Both,22,All ages,630,Low back pain,2,Percent,2021,0.0072521424298052,0.0082182661432854,0.006327639649412
6,Incidence,1,Global,3,Both,22,All ages,630,Low back pain,3,Rate,2021,3381.8447939999196,3794.1069031157203,2982.62515661928
6,Incidence,1,Global,3,Both,22,All ages,632,Gout,1,Number,2021,9401585.49037733,11731815.433090126,7438816.889054618
6,Incidence,1,Global,3,Both,22,All ages,632,Gout,2,Percent,2021,0.0002554337960563,0.0003181942628322,0.000200702016068
6,Incidence,1,Global,3,Both,22,All ages,632,Gout,3,Rate,2021,119.13780985445,148.66671134837,94.26541437902
6,Incidence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,1,Number,2021,160860121.68889195,170430684.15061322,152201084.9682494
6,Incidence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,2,Percent,2021,0.0043710510995331,0.0046822527394505,0.0040549468361672
6,Incidence,1,Global,3,Both,22,All ages,401,Acute hepatitis A,3,Rate,2021,2038.43517782719,2159.7142803713,1928.70701852869
6,Incidence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,1,Number,2021,7009910.020154443,7885766.814296725,6182801.024118055
6,Incidence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,2,Percent,2021,0.0001904699658516,0.0002169455198238,0.000165473158843
6,Incidence,1,Global,3,Both,22,All ages,403,Acute hepatitis C,3,Rate,2021,88.83026463278,99.92920749801,78.34905862773
6,Incidence,1,Global,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,576529.2776778279,645648.4621065578,509492.069037404
6,Incidence,1,Global,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,1.56661269739e-05,1.78135812764e-05,1.368115464e-05
6,Incidence,1,Global,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,7.305835332750001,8.18172039067,6.45633327543
6,Incidence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,1,Number,2021,450742.3620995812,548114.0084876225,371860.317239791
6,Incidence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,2,Percent,2021,1.22505707793e-05,1.49819176962e-05,1.00584926534e-05
6,Incidence,1,Global,3,Both,22,All ages,648,Other chromosomal abnormalities,3,Rate,2021,5.7118512493599995,6.94575426545,4.71225027024
6,Incidence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,1,Number,2021,2437890.1187247657,3355568.449974056,1737729.8483384713
6,Incidence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,2,Percent,2021,6.62236129686e-05,9.20210055421e-05,4.60663638416e-05
6,Incidence,1,Global,3,Both,22,All ages,649,Congenital musculoskeletal and limb anomalies,3,Rate,2021,30.89318176258,42.522091231919994,22.02068241166
6,Incidence,1,Global,3,Both,22,All ages,660,Viral skin diseases,1,Number,2021,84730444.82714571,87586946.28929853,82132966.32645941
6,Incidence,1,Global,3,Both,22,All ages,660,Viral skin diseases,2,Percent,2021,0.0023023347264332,0.0024279241439105,0.002180532582906
6,Incidence,1,Global,3,Both,22,All ages,660,Viral skin diseases,3,Rate,2021,1073.71247488324,1109.91034048742,1040.7969735529
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,2021,4048.421300271612,5000.454437147037,3252.4512851221107
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,2021,1.100132612e-07,1.365599049e-07,8.7466645e-08
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,2021,0.05130199024,0.06336624716,0.04121538044
6,Incidence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,1,Number,2021,585481.2142447861,625825.7312683552,543811.6301988715
6,Incidence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,2,Percent,2021,1.59095543325e-05,1.7269655929e-05,1.45656243579e-05
6,Incidence,1,Global,3,Both,22,All ages,1007,Other non-Hodgkin lymphoma,3,Rate,2021,7.4192751475200005,7.93052480884,6.89123410744
6,Incidence,1,Global,3,Both,22,All ages,688,Transport injuries,1,Number,2021,53089007.646646015,57918266.02707377,48574838.22462051
6,Incidence,1,Global,3,Both,22,All ages,688,Transport injuries,2,Percent,2021,0.0014426007303459,0.0015871191842736,0.0013014306917188
6,Incidence,1,Global,3,Both,22,All ages,688,Transport injuries,3,Rate,2021,672.74909161238,733.94592562025,615.54509566909
6,Incidence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,1,Number,2021,11641346.00614437,13202806.403520685,10131857.777797917
6,Incidence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,2,Percent,2021,0.0003163225902663,0.0003622208848798,0.0002744991069811
6,Incidence,1,Global,3,Both,22,All ages,1027,Total burden related to hepatitis C,3,Rate,2021,147.52027393139,167.30725263921002,128.39189162711
6,Incidence,1,Global,3,Both,22,All ages,662,Alopecia areata,1,Number,2021,30893047.024900537,31819276.695107736,29948975.046007328
6,Incidence,1,Global,3,Both,22,All ages,662,Alopecia areata,2,Percent,2021,0.0008394574594832,0.0008834604691292,0.0007920580943687
6,Incidence,1,Global,3,Both,22,All ages,662,Alopecia areata,3,Rate,2021,391.47971010254,403.21698297461,379.51633775163003
6,Incidence,1,Global,3,Both,22,All ages,642,Neural tube defects,1,Number,2021,120932.0395780954,135884.36383913254,106318.25117760556
6,Incidence,1,Global,3,Both,22,All ages,642,Neural tube defects,2,Percent,2021,3.286036348e-06,3.7309348832e-06,2.8710825996e-06
6,Incidence,1,Global,3,Both,22,All ages,642,Neural tube defects,3,Rate,2021,1.5324626204099998,1.72193993426,1.34727526605
6,Incidence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,1,Number,2021,2300327.374697204,2967225.2122961152,1813141.510727396
6,Incidence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,2,Percent,2021,6.2497425619e-05,8.04655415942e-05,4.90190174418e-05
6,Incidence,1,Global,3,Both,22,All ages,643,Congenital heart anomalies,3,Rate,2021,29.149973230590003,37.60096778353,22.97630636506
6,Incidence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,1,Number,2021,11521027.20351622,13320860.165122893,10037724.584473088
6,Incidence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,2,Percent,2021,0.0003130446321039,0.0003632752499017,0.0002719155547208
6,Incidence,1,Global,3,Both,22,All ages,690,Pedestrian road injuries,3,Rate,2021,145.99558230952002,168.80324143991,127.19902660462999
6,Incidence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,1,Number,2021,19370700.67945657,23239012.270780176,16103891.318374204
6,Incidence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,2,Percent,2021,0.0005262806629097,0.0006356038826902,0.0004346494017132
6,Incidence,1,Global,3,Both,22,All ages,404,Acute hepatitis E,3,Rate,2021,245.46741149762,294.48703391094,204.07008411175002
6,Incidence,1,Global,3,Both,22,All ages,1029,Total cancers,1,Number,2021,23566245.369677685,24847937.20784179,22200038.16287862
6,Incidence,1,Global,3,Both,22,All ages,1029,Total cancers,2,Percent,2021,0.0006403815604244,0.0006825920204173,0.0005934366349846
6,Incidence,1,Global,3,Both,22,All ages,1029,Total cancers,3,Rate,2021,298.63376371034,314.87548790286996,281.32105250945
6,Incidence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,1,Number,2021,1094236.4606304695,1438204.65047836,823142.891183926
6,Incidence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,2,Percent,2021,2.97325525259e-05,3.92865722946e-05,2.22537363207e-05
6,Incidence,1,Global,3,Both,22,All ages,650,Urogenital congenital anomalies,3,Rate,2021,13.86627133432,18.225069841230003,10.430947136870001
6,Incidence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,3,Rate,2021,740.26600212527,795.75769631703,687.2253577135999
6,Incidence,1,Global,3,Both,22,All ages,410,Neoplasms,1,Number,2021,66479607.267329015,74980442.94640273,58335731.397383004
6,Incidence,1,Global,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.0018065487774391,0.0020637200061103,0.0015752356894114
6,Incidence,1,Global,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,842.43607824659,950.15949849033,739.23608757853
6,Incidence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,1,Number,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,2,Percent,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,408,Other unspecified infectious diseases,3,Rate,2021,0.0,0.0,0.0
6,Incidence,1,Global,3,Both,22,All ages,669,Sense organ diseases,1,Number,2021,214542.83493900648,479939.8072724872,101374.1964442581
6,Incidence,1,Global,3,Both,22,All ages,669,Sense organ diseases,2,Percent,2021,5.8292226891e-06,1.28937580478e-05,2.7025989022e-06
6,Incidence,1,Global,3,Both,22,All ages,669,Sense organ diseases,3,Rate,2021,2.71870776485,6.08184412714,1.28462372144
6,Incidence,1,Global,3,Both,22,All ages,695,Other transport injuries,1,Number,2021,2843333.2426547115,3568481.552070915,2278468.330869356
6,Incidence,1,Global,3,Both,22,All ages,695,Other transport injuries,2,Percent,2021,7.72478747289e-05,9.70509261642e-05,6.10661324258e-05
6,Incidence,1,Global,3,Both,22,All ages,695,Other transport injuries,3,Rate,2021,36.03099664018,45.22014686298,28.87297329161
6,Incidence,1,Global,3,Both,22,All ages,697,Falls,1,Number,2021,215566471.5486884,238982230.14002505,195267829.98192543
6,Incidence,1,Global,3,Both,22,All ages,697,Falls,2,Percent,2021,0.0058574384023465,0.0065030982695773,0.0052542237789599
6,Incidence,1,Global,3,Both,22,All ages,697,Falls,3,Rate,2021,2731.67938797646,3028.40616852934,2474.45301889649
6,Incidence,1,Global,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,473613.85180723417,513666.884511488,429915.5683365334
6,Incidence,1,Global,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,1.28692404437e-05,1.40590406447e-05,1.16336380439e-05
6,Incidence,1,Global,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,6.00168100144,6.50923694499,5.44793208405
6,Incidence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,1,Number,2021,880831364.2864861,905652993.7604176,855895430.5328715
6,Incidence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,2,Percent,2021,0.0239348744922357,0.0251794433154478,0.022532390706596
6,Incidence,1,Global,3,Both,22,All ages,980,Bacterial skin diseases,3,Rate,2021,11161.98110410284,11476.52321783137,10845.9905153748
6,Incidence,1,Global,3,Both,22,All ages,657,Pyoderma,1,Number,2021,824863216.1075028,850304156.9914017,800211831.6821692
6,Incidence,1,Global,3,Both,22,All ages,657,Pyoderma,2,Percent,2021,0.0224141418460263,0.0235869089163052,0.0210682510880123
6,Incidence,1,Global,3,Both,22,All ages,657,Pyoderma,3,Rate,2021,10452.74726237708,10775.137350798499,10140.36251053705
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,2021,154061.55841608517,177255.10112927656,131916.0882205199
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,2021,4.1863056672e-06,4.8492548676e-06,3.568843269e-06
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,2021,1.9522831198300001,2.24619395906,1.6716535579299998
6,Incidence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),2,Percent,2021,0.0013667229773584,0.0014799185661845,0.0012501528219511
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,2021,99543.66558757886,120401.86916582126,80957.4039187762
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,2021,2.7048228678e-06,3.2996615031e-06,2.2153969804e-06
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,2021,1.26142705559,1.52574424915,1.0259001318699998
6,Incidence,1,Global,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,200883.03650051847,216097.5621370475,186941.1115321514
6,Incidence,1,Global,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,5.4587388468e-06,5.9632779801e-06,4.9907556045e-06
6,Incidence,1,Global,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,2.5456094645,2.7384094198,2.36893602919
6,Incidence,1,Global,3,Both,22,All ages,654,Dermatitis,1,Number,2021,405021857.72029024,467256268.77876425,355572501.61355406
6,Incidence,1,Global,3,Both,22,All ages,654,Dermatitis,2,Percent,2021,0.0110044482185462,0.0127654197873446,0.0095325844816891
6,Incidence,1,Global,3,Both,22,All ages,654,Dermatitis,3,Rate,2021,5132.47655104176,5921.11708818062,4505.849479331439
6,Incidence,1,Global,3,Both,22,All ages,683,Periodontal diseases,1,Number,2021,89613533.89232408,101005641.51985423,79069090.86145481
6,Incidence,1,Global,3,Both,22,All ages,683,Periodontal diseases,2,Percent,2021,0.0024350635592577,0.0027825855773066,0.0021281886657105
6,Incidence,1,Global,3,Both,22,All ages,683,Periodontal diseases,3,Rate,2021,1135.59145658744,1279.95335743483,1001.97124432446
6,Incidence,1,Global,3,Both,22,All ages,687,Injuries,1,Number,2021,607789603.8994757,644552986.8452537,574661711.8619125
6,Incidence,1,Global,3,Both,22,All ages,687,Injuries,2,Percent,2021,0.0165153437987217,0.0178170457712695,0.0153933722229679
6,Incidence,1,Global,3,Both,22,All ages,687,Injuries,3,Rate,2021,7701.969240720161,8167.838421134819,7282.169356276249
6,Incidence,1,Global,3,Both,22,All ages,409,Non-communicable diseases,3,Rate,2021,156680.64039821198,163759.3523328,150279.713220462
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,2021,22891.70361758626,27801.39940225683,18374.88766683325
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,2021,6.220425474e-07,7.681216864e-07,4.956461603e-07
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,2021,0.29008590473,0.35230204938,0.23284837170999997
6,Incidence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,91375.05707282203,102469.659286999,73780.36536051499
6,Incidence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,2.4828492216e-06,2.8279951816e-06,1.9963893125e-06
6,Incidence,1,Global,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,1.15791365043,1.29850553361,0.93495199808
6,Incidence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,1,Number,2021,2012024.5269916365,2154287.7152277986,1857800.0438069568
6,Incidence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,2,Percent,2021,5.4678388026e-05,5.98236323957e-05,4.95983993275e-05
6,Incidence,1,Global,3,Both,22,All ages,998,Chronic kidney disease due to diabetes mellitus type 2,3,Rate,2021,25.496571377720002,27.299344397949998,23.54222365931
6,Incidence,1,Global,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,667426.3959575087,726422.065878846,613030.0917355665
6,Incidence,1,Global,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,1.81373488906e-05,1.99193799946e-05,1.64502654981e-05
6,Incidence,1,Global,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,8.4576924961,9.20529138913,7.768377214569999
6,Incidence,1,Global,3,Both,22,All ages,703,Poisoning by other means,1,Number,2021,1824208.253775176,2281145.548946332,1457819.923152557
6,Incidence,1,Global,3,Both,22,All ages,703,Poisoning by other means,2,Percent,2021,4.95701965708e-05,6.26713514882e-05,3.97594824759e-05
6,Incidence,1,Global,3,Both,22,All ages,703,Poisoning by other means,3,Rate,2021,23.116545214160002,28.90689926064,18.47363649294
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,2021,529202.4612902864,593849.0954998265,480339.45566734456
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,1.43800997756e-05,1.61675162225e-05,1.28181541447e-05
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,6.70610529173,7.525313756309999,6.08690851064
6,Incidence,1,Global,3,Both,22,All ages,526,Digestive diseases,1,Number,2021,530312837.11978,567893008.951459,492687232.212119
6,Incidence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,1,Number,2021,6707770.220385641,7771815.462678226,5745632.678749316
6,Incidence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,2,Percent,2021,0.0001823105478669,0.0002137057303756,0.0001532108320324
6,Incidence,1,Global,3,Both,22,All ages,692,Motorcyclist road injuries,3,Rate,2021,85.00151957151999,98.48520483743,72.80921864455
6,Incidence,1,Global,3,Both,22,All ages,694,Other road injuries,1,Number,2021,2730655.0876203603,3367026.696017348,2102304.242303707
6,Incidence,1,Global,3,Both,22,All ages,694,Other road injuries,2,Percent,2021,7.41959604151e-05,9.16474623408e-05,5.82005122616e-05
6,Incidence,1,Global,3,Both,22,All ages,694,Other road injuries,3,Rate,2021,34.60312805111,42.66729124524,26.64060475035
6,Incidence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,1,Number,2021,1729224008.6711488,1894666052.625076,1562709709.0613627
6,Incidence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,2,Percent,2021,0.0469835510493432,0.0520378548325243,0.0422076269410343
6,Incidence,1,Global,3,Both,22,All ages,659,Fungal skin diseases,3,Rate,2021,21912.895580396922,24009.39332481335,19802.81010755168
6,Incidence,1,Global,3,Both,22,All ages,661,Acne vulgaris,1,Number,2021,124266429.80870368,141551957.34146038,110490151.99879542
6,Incidence,1,Global,3,Both,22,All ages,661,Acne vulgaris,2,Percent,2021,0.0033766000708731,0.0038691200747446,0.0029550127265439
6,Incidence,1,Global,3,Both,22,All ages,661,Acne vulgaris,3,Rate,2021,1574.7163391742401,1793.7602328386902,1400.14200084601
6,Incidence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,2194143.2496612896,2359390.087671456,2001271.823681398
6,Incidence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,5.96223903813e-05,6.51716588646e-05,5.41100170706e-05
6,Incidence,1,Global,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,27.804397624110003,29.89842169974,25.360312070849997
6,Incidence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,118877.91000335604,135884.3705415361,104836.07173475595
6,Incidence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,3.2301171362e-06,3.6902195972e-06,2.8320322709e-06
6,Incidence,1,Global,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,1.50643248975,1.7219400192,1.3284929433500001
6,Incidence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,508532.704079969,547207.6227474719,462090.8947233668
6,Incidence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,1.38189898307e-05,1.52038346027e-05,1.24455377227e-05
6,Incidence,1,Global,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,6.44417610896,6.9342684568,5.8556609635
6,Incidence,1,Global,3,Both,22,All ages,664,Urticaria,1,Number,2021,117014586.680102,131017655.60597354,104106687.54509915
6,Incidence,1,Global,3,Both,22,All ages,664,Urticaria,2,Percent,2021,0.0031794423700734,0.0035794545451193,0.0027949136692719
6,Incidence,1,Global,3,Both,22,All ages,664,Urticaria,3,Rate,2021,1482.82027455472,1660.2685320615801,1319.25011563415
6,Incidence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",1,Number,2021,9198163.891018838,10784349.739691189,7592028.173762441
6,Incidence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",2,Percent,2021,0.0002499257616955,0.0002940172281498,0.0002051073146397
6,Incidence,1,Global,3,Both,22,All ages,699,"Fire, heat, and hot substances",3,Rate,2021,116.5600314734,136.66033351568,96.20692274734
6,Incidence,1,Global,3,Both,22,All ages,429,Breast cancer,1,Number,2021,2121564.3227317906,2268722.629530899,1982142.6427765307
6,Incidence,1,Global,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,5.76504735106e-05,6.23576400924e-05,5.32621052706e-05
6,Incidence,1,Global,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,26.88467037121,28.74947481211,25.11790522154
6,Incidence,1,Global,3,Both,22,All ages,709,Animal contact,1,Number,2021,50547871.8557878,60586965.634446114,42041271.95208968
6,Incidence,1,Global,3,Both,22,All ages,709,Animal contact,2,Percent,2021,0.0013736458078207,0.0016538725262855,0.0011320044523113
6,Incidence,1,Global,3,Both,22,All ages,709,Animal contact,3,Rate,2021,640.54757060558,767.76394777271,532.75110554424
6,Incidence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,1,Number,2021,35022939.07967708,43052620.23854448,28357698.69613889
6,Incidence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,2,Percent,2021,0.0009518615404752,0.0011895440231077,0.0007609382200833
6,Incidence,1,Global,3,Both,22,All ages,711,Non-venomous animal contact,3,Rate,2021,443.81410570474003,545.56700983736,359.35152838084997
6,Incidence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,421577.106709329,449782.0607854663,389878.7946927639
6,Incidence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,1.14557769404e-05,1.2373799307e-05,1.04746585563e-05
6,Incidence,1,Global,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,5.34226628365,5.69968221729,4.9405821769000005
6,Incidence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,169819.52174976224,179704.1910053582,159847.1238717956
6,Incidence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,4.6146493087e-06,5.0016491695e-06,4.2701866147e-06
6,Incidence,1,Global,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,2.15196957072,2.2772290652400002,2.02559837052
6,Incidence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,6336846.095476541,6896046.598125439,5744729.381221687
6,Incidence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0001722020415787,0.0001900249475085,0.0001538786900433
6,Incidence,1,Global,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,80.30113282195,87.38737622455,72.79777197003
6,Incidence,1,Global,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,1324382.902949716,1400222.166127075,1217320.9337821156
6,Incidence,1,Global,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,3.59889494563e-05,3.89384138111e-05,3.26939372201e-05
6,Incidence,1,Global,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,16.78270953634,17.7437520887,15.42600980326
6,Incidence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,1,Number,2021,629360593.1340238,646196541.5838609,613196679.8810122
6,Incidence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,2,Percent,2021,0.0171014278015048,0.0179243592239099,0.0161156214715809
6,Incidence,1,Global,3,Both,22,All ages,668,Other skin and subcutaneous diseases,3,Rate,2021,7975.3189237527,8188.66570735521,7770.48823582117
6,Incidence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,1,Number,2021,214542.83493900648,479939.8072724872,101374.1964442581
6,Incidence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,2,Percent,2021,5.8292226891e-06,1.28937580478e-05,2.7025989022e-06
6,Incidence,1,Global,3,Both,22,All ages,679,Other sense organ diseases,3,Rate,2021,2.71870776485,6.08184412714,1.28462372144
6,Incidence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,1,Number,2021,1785264.5736444064,2365962.786534286,1269795.4725967448
6,Incidence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,2,Percent,2021,4.85060886645e-05,6.41711818673e-05,3.44880312524e-05
6,Incidence,1,Global,3,Both,22,All ages,705,Unintentional firearm injuries,3,Rate,2021,22.62304709481,29.981711581869998,16.0909722858
6,Incidence,1,Global,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,387828.715593053,406635.2473655081,365359.7090389708
6,Incidence,1,Global,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,1.05385536353e-05,1.13073227119e-05,9.7897795029e-06
6,Incidence,1,Global,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,4.91460337426,5.15292158225,4.62987392802
6,Incidence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,1,Number,2021,12481276.34166306,14290629.874617826,10886792.690528134
6,Incidence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,2,Percent,2021,0.0003391384789313,0.0003952581055077,0.0002929786504518
6,Incidence,1,Global,3,Both,22,All ages,708,Adverse effects of medical treatment,3,Rate,2021,158.16395320298,181.09225794363,137.95850059721
6,Incidence,1,Global,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,33950.772428964985,39857.26640241994,26532.90875646247
6,Incidence,1,Global,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,9.224922603e-07,1.0951349956e-06,7.109756545e-07
6,Incidence,1,Global,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,0.43022750515999997,0.50507517384,0.33622761199
6,Incidence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,357482.2970745518,407432.5710093197,310456.67881825776
6,Incidence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,9.7137695863e-06,1.11925915969e-05,8.2942725326e-06
6,Incidence,1,Global,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,4.530050594,5.1630253453599995,3.9341373651200002
6,Incidence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,1,Number,2021,1243441.808626666,1551580.4485067404,992476.749494068
6,Incidence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,2,Percent,2021,3.37879900481e-05,4.26705882631e-05,2.66159999769e-05
6,Incidence,1,Global,3,Both,22,All ages,713,Pulmonary aspiration and foreign body in airway,3,Rate,2021,15.75701608126,19.66177903049,12.576762333029999
6,Incidence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,1,Number,2021,13923297.52405296,18487544.28548722,10316020.20865916
6,Incidence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,2,Percent,2021,0.0003782479165033,0.0004994451100378,0.0002800463744875
6,Incidence,1,Global,3,Both,22,All ages,715,Foreign body in other body part,3,Rate,2021,176.43738650947,234.27596739023002,130.72561594337
6,Incidence,1,Global,3,Both,22,All ages,680,Oral disorders,1,Number,2021,3739809980.565583,4221404099.660877,3310053316.4750032
6,Incidence,1,Global,3,Both,22,All ages,680,Oral disorders,2,Percent,2021,0.1015820865370514,0.1139326149445387,0.0907622343304777
6,Incidence,1,Global,3,Both,22,All ages,680,Oral disorders,3,Rate,2021,47391.23744738877,53494.045175566265,41945.319013470275
6,Incidence,1,Global,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,298875.9981054876,324501.0164740654,270729.8249513295
6,Incidence,1,Global,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,8.1218576101e-06,8.9265341654e-06,7.2531794542e-06
6,Incidence,1,Global,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,3.78738584772,4.11210858401,3.4307147916700003
6,Incidence,1,Global,3,Both,22,All ages,1010,Other eye cancers,1,Number,2021,27675.80088060992,33668.65753230442,21826.177955361083
6,Incidence,1,Global,3,Both,22,All ages,1010,Other eye cancers,2,Percent,2021,7.519683282e-07,9.102290105e-07,5.891699606e-07
6,Incidence,1,Global,3,Both,22,All ages,1010,Other eye cancers,3,Rate,2021,0.35071045264,0.42665251763,0.27658345943
6,Incidence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,216768.34523702043,245237.5988424356,181887.986934734
6,Incidence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,5.8903805648e-06,6.6659793553e-06,4.9190056602e-06
6,Incidence,1,Global,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,2.74690964878,3.1076748118699995,2.30490234061
6,Incidence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,303104.6079212229,318904.816796458,281717.6387552156
6,Incidence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,8.2361978228e-06,8.8277717766e-06,7.6403524845e-06
6,Incidence,1,Global,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,3.8409712044299997,4.041192994949999,3.56995344168
6,Incidence,1,Global,3,Both,22,All ages,718,Self-harm,1,Number,2021,5487765.488138357,6504689.679880282,4598825.229445467
6,Incidence,1,Global,3,Both,22,All ages,718,Self-harm,2,Percent,2021,0.0001491429515252,0.0001810813552362,0.0001231834692119
6,Incidence,1,Global,3,Both,22,All ages,718,Self-harm,3,Rate,2021,69.5415004119,82.42806312158001,58.276762605650006
6,Incidence,1,Global,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,540309.7293178497,582579.4432771344,494720.8870573823
6,Incidence,1,Global,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,1.46816427174e-05,1.62313489503e-05,1.33780918588e-05
6,Incidence,1,Global,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,6.846857677340001,7.38250362232,6.2691514142599996
6,Incidence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,1,Number,2021,2370414031.8439226,2661346387.7118464,2099098156.0880923
6,Incidence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,2,Percent,2021,0.0643918082469274,0.0724914145481042,0.0573868860836274
6,Incidence,1,Global,3,Both,22,All ages,682,Caries of permanent teeth,3,Rate,2021,30038.118197317683,33724.84143451807,26599.976912597624
6,Incidence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,1,Number,2021,5371898.043825839,6363553.222836366,4503001.044583376
6,Incidence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,2,Percent,2021,0.0001459946105662,0.0001774087023216,0.000120912188818
6,Incidence,1,Global,3,Both,22,All ages,723,Self-harm by other specified means,3,Rate,2021,68.0732168375,80.6395681491,57.062469173210005
6,Incidence,1,Global,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,148754.62688850457,162049.22698722663,131780.42508745776
6,Incidence,1,Global,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,4.0417696801e-06,4.4500915963e-06,3.5823703975e-06
6,Incidence,1,Global,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,1.88503316503,2.05350363634,1.66993442145
6,Incidence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,1,Number,2021,763058.9927261034,924631.9436564082,650370.5260530342
6,Incidence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,2,Percent,2021,2.07341112698e-05,2.4824012604e-05,1.7594164772e-05
6,Incidence,1,Global,3,Both,22,All ages,729,Exposure to forces of nature,3,Rate,2021,9.66955810551,11.71702632512,8.24155884634
6,Incidence,1,Global,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,91507.37933523855,95709.71814309328,87965.91882683756
6,Incidence,1,Global,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,2.4865145338e-06,2.6545504462e-06,2.3416317613e-06
6,Incidence,1,Global,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,1.1595904510700001,1.212842899,1.11471271751
6,Incidence,1,Global,3,Both,22,All ages,843,Ebola,1,Number,2021,93.93364760732013,105.49540774863608,82.09622660560791
6,Incidence,1,Global,3,Both,22,All ages,843,Ebola,2,Percent,2021,2.5526118e-09,2.9121905e-09,2.210342e-09
6,Incidence,1,Global,3,Both,22,All ages,843,Ebola,3,Rate,2021,0.0011903363599999998,0.00133684811,0.0010403314
6,Incidence,1,Global,3,Both,22,All ages,684,Edentulism,1,Number,2021,26527330.867987998,31167558.11630436,22613423.10718004
6,Incidence,1,Global,3,Both,22,All ages,684,Edentulism,2,Percent,2021,0.00072084152023,0.0008476753412948,0.0006053929657406
6,Incidence,1,Global,3,Both,22,All ages,684,Edentulism,3,Rate,2021,336.15692843841,394.95834147211997,286.55950691071
6,Incidence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,1,Number,2021,7179572.5502388505,8451564.088782724,6068842.759993529
6,Incidence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,2,Percent,2021,0.000195094991813,0.0002310392506853,0.0001648167411853
6,Incidence,1,Global,3,Both,22,All ages,726,Physical violence by sharp object,3,Rate,2021,90.98024478978,107.09904583781,76.9049683712
6,Incidence,1,Global,3,Both,22,All ages,521,Cirrhosis and other chronic liver diseases,1,Number,2021,58417005.5929616,62796051.234199,54231380.9494484
6,Incidence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,604554.1448330878,648746.2305033756,558229.2296091716
6,Incidence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,1.64279591643e-05,1.7901470145e-05,1.50232917353e-05
6,Incidence,1,Global,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,7.660969187329999,8.22097561444,7.07393533574
6,Incidence,1,Global,3,Both,22,All ages,837,Thalassemias trait,1,Number,2021,5379938.305698814,6117061.897569096,4720270.524561329
6,Incidence,1,Global,3,Both,22,All ages,837,Thalassemias trait,2,Percent,2021,0.0001461888541942,0.0001679591227818,0.0001289199150398
6,Incidence,1,Global,3,Both,22,All ages,837,Thalassemias trait,3,Rate,2021,68.17510382148,77.51600599349,59.81572925038
6,Incidence,1,Global,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,249538.02112691847,274638.1705617816,223290.34543570815
6,Incidence,1,Global,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,6.7810692236e-06,7.5557175958e-06,6.0068268406e-06
6,Incidence,1,Global,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,3.1621701832,3.4802417290800003,2.82955707248
6,Incidence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,65182.009185848656,77142.97600200883,53167.4310277835
6,Incidence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,1.771076811e-06,2.0889380855e-06,1.4525622454e-06
6,Incidence,1,Global,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,0.8259927885799999,0.97756332865,0.67374288036
6,Incidence,1,Global,3,Both,22,All ages,526,Digestive diseases,2,Percent,2021,0.0149894868437042,0.0160517041837831,0.0139259853210691
6,Incidence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,1,Number,2021,3854686.35491052,4783797.728396123,3056084.815858652
6,Incidence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,2,Percent,2021,0.0001047383163134,0.0001316520924092,8.28097230161e-05
6,Incidence,1,Global,3,Both,22,All ages,492,Rheumatic heart disease,3,Rate,2021,48.846962086329995,60.62075218388,38.727005361319996
6,Incidence,1,Global,3,Both,22,All ages,494,Stroke,1,Number,2021,11946273.943359792,13219841.45491377,10772079.54786498
6,Incidence,1,Global,3,Both,22,All ages,494,Stroke,2,Percent,2021,0.0003246217094033,0.0003624095492923,0.0002906792557611
6,Incidence,1,Global,3,Both,22,All ages,494,Stroke,3,Rate,2021,151.38435054277002,167.52312247476,136.50484444608
6,Incidence,1,Global,3,Both,22,All ages,487,Leukemia,1,Number,2021,461422.73456352303,504397.0050451766,397547.900143482
6,Incidence,1,Global,3,Both,22,All ages,487,Leukemia,2,Percent,2021,1.25389094191e-05,1.39658106169e-05,1.07411880408e-05
6,Incidence,1,Global,3,Both,22,All ages,487,Leukemia,3,Rate,2021,5.84719397268,6.39176812674,5.03776583043
6,Incidence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,1,Number,2021,42987424.67142365,51646300.17114507,35106892.86449723
6,Incidence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,2,Percent,2021,0.0011680921885556,0.001410849171471,0.0009429917697446
6,Incidence,1,Global,3,Both,22,All ages,1056,Other unintentional injuries,3,Rate,2021,544.7408452413,654.46696153254,444.87797626813995
6,Incidence,1,Global,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,31907.886040552963,34115.30061160297,29643.1265067465
6,Incidence,1,Global,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,8.670569973e-07,9.462782012e-07,7.959002808e-07
6,Incidence,1,Global,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,0.40433984926,0.43231242235999995,0.37564059518
6,Incidence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,1,Number,2021,30845890.762967966,35188904.81669322,26534151.153534144
6,Incidence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,2,Percent,2021,0.0008381228900915,0.0009731879068384,0.0007252158802543
6,Incidence,1,Global,3,Both,22,All ages,1015,Osteoarthritis knee,3,Rate,2021,390.88214134423004,445.91723973881,336.24335576318
6,Incidence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,1,Number,2021,3622230.838411164,4655164.144070603,2883048.46439058
6,Incidence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,2,Percent,2021,9.84269472525e-05,0.0001256809682353,7.86238045132e-05
6,Incidence,1,Global,3,Both,22,All ages,1017,Osteoarthritis other,3,Rate,2021,45.9012630707,58.99069483601001,36.53427181014
6,Incidence,1,Global,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,42913361.89765127,51701423.42007452,34917159.40053094
6,Incidence,1,Global,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0011661672170147,0.001411185583529,0.0009543794847061
6,Incidence,1,Global,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,543.80231453624,655.1654887284301,442.47365527608997
6,Incidence,1,Global,3,Both,22,All ages,689,Road injuries,1,Number,2021,50245674.40399134,55170661.36224371,45645819.18214315
6,Incidence,1,Global,3,Both,22,All ages,689,Road injuries,2,Percent,2021,0.001365352855617,0.0015095963470429,0.0012246001357916
6,Incidence,1,Global,3,Both,22,All ages,689,Road injuries,3,Rate,2021,636.7180949722,699.12801087079,578.42828020218
6,Incidence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,1,Number,2021,9767471.41195338,11649554.413178723,8281233.158523805
6,Incidence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,2,Percent,2021,0.0002654074922333,0.0003222220861143,0.0002221178704494
6,Incidence,1,Global,3,Both,22,All ages,691,Cyclist road injuries,3,Rate,2021,123.77435199915001,147.62429166728,104.9405956485
6,Incidence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,1,Number,2021,19518750.48051573,21949354.57002663,17507391.650274456
6,Incidence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,2,Percent,2021,0.0005303942229977,0.0005969345649639,0.0004724441407099
6,Incidence,1,Global,3,Both,22,All ages,693,Motor vehicle road injuries,3,Rate,2021,247.34351304088,278.14436552943,221.85537743740997
6,Incidence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,1,Number,2021,4484926.307985571,5706019.355594989,3610620.3018603073
6,Incidence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,2,Percent,2021,0.0001218435104143,0.0001541330550571,9.5188072985e-05
6,Incidence,1,Global,3,Both,22,All ages,500,Atrial fibrillation and flutter,3,Rate,2021,56.83342434516,72.30723474338,45.7541332172
6,Incidence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,1,Number,2021,31872778.179137733,38267834.29509022,26284920.94053075
6,Incidence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,2,Percent,2021,0.0008660203994615,0.0010416182473226,0.0007116819249697
6,Incidence,1,Global,3,Both,22,All ages,493,Ischemic heart disease,3,Rate,2021,403.89495900725007,484.93373489570996,333.0850861546
6,Incidence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,422295.0236156829,462634.86783807207,380537.1523759118
6,Incidence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,1.14752515597e-05,1.27407676206e-05,1.02583622468e-05
6,Incidence,1,Global,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,5.35136379683,5.86255424396,4.8222039728
6,Incidence,1,Global,3,Both,22,All ages,495,Ischemic stroke,1,Number,2021,7804449.401432242,8943692.092981681,6719760.382388141
6,Incidence,1,Global,3,Both,22,All ages,495,Ischemic stroke,2,Percent,2021,0.0002120765016481,0.0002462943397444,0.0001823087389641
6,Incidence,1,Global,3,Both,22,All ages,495,Ischemic stroke,3,Rate,2021,98.8987452976,113.33533998716999,85.15346007583
6,Incidence,1,Global,3,Both,22,All ages,503,Endocarditis,1,Number,2021,1042477.4548981916,1204150.0203186409,893665.109772573
6,Incidence,1,Global,3,Both,22,All ages,503,Endocarditis,2,Percent,2021,2.83271078106e-05,3.30488271717e-05,2.39353024826e-05
6,Incidence,1,Global,3,Both,22,All ages,503,Endocarditis,3,Rate,2021,13.2103761569,15.259106701070001,11.32461158073
6,Incidence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,1,Number,2021,697486.4927319683,795785.2587628618,614334.1638083749
6,Incidence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,2,Percent,2021,1.89527970162e-05,2.18913517218e-05,1.66155790351e-05
6,Incidence,1,Global,3,Both,22,All ages,497,Subarachnoid hemorrhage,3,Rate,2021,8.83861697925,10.084268546030001,7.784902543279999
6,Incidence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,1,Number,2021,66809836.88315144,73102151.01615356,60907604.140367866
6,Incidence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,2,Percent,2021,0.0018153325465881,0.0020135547447214,0.0016495826293
6,Incidence,1,Global,3,Both,22,All ages,491,Cardiovascular diseases,3,Rate,2021,846.6207802012101,926.35759964399,771.82711024563
6,Incidence,1,Global,3,Both,22,All ages,511,Silicosis,1,Number,2021,35482.90253604502,40382.7503931278,30527.07181517469
6,Incidence,1,Global,3,Both,22,All ages,511,Silicosis,2,Percent,2021,9.641327375e-07,1.1073947022e-06,8.20128876e-07
6,Incidence,1,Global,3,Both,22,All ages,511,Silicosis,3,Rate,2021,0.44964280756,0.51173415831,0.38684203649000004
6,Incidence,1,Global,3,Both,22,All ages,696,Unintentional injuries,1,Number,2021,504555086.524801,539343467.5218561,472014395.0516891
6,Incidence,1,Global,3,Both,22,All ages,696,Unintentional injuries,2,Percent,2021,0.0137100411263039,0.014840833317311,0.01267584603308
6,Incidence,1,Global,3,Both,22,All ages,696,Unintentional injuries,3,Rate,2021,6393.77135069532,6834.6131134611105,5981.41252917271
6,Incidence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,1,Number,2021,2206928.235757618,2375325.3689123048,2048266.8725988287
6,Incidence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,2,Percent,2021,5.99679065403e-05,6.51467873573e-05,5.47326974686e-05
6,Incidence,1,Global,3,Both,22,All ages,504,Non-rheumatic valvular heart disease,3,Rate,2021,27.966410217,30.10035514047,25.95583792208
6,Incidence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,1,Number,2021,16895444.792579837,18335690.52224456,15471347.31447099
6,Incidence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,2,Percent,2021,0.0004591004563916,0.0005018361979406,0.0004151259591494
6,Incidence,1,Global,3,Both,22,All ages,509,Chronic obstructive pulmonary disease,3,Rate,2021,214.10072707044003,232.35166166654,196.05442469572003
6,Incidence,1,Global,3,Both,22,All ages,698,Drowning,1,Number,2021,856135.4464376854,963562.7886303816,764345.5748692339
6,Incidence,1,Global,3,Both,22,All ages,698,Drowning,2,Percent,2021,2.32633400005e-05,2.60933872159e-05,2.06441589348e-05
6,Incidence,1,Global,3,Both,22,All ages,698,Drowning,3,Rate,2021,10.849032020360001,12.21036179612,9.685861800129999
6,Incidence,1,Global,3,Both,22,All ages,700,Poisonings,1,Number,2021,2424848.280880664,3026220.765449072,1982274.893738956
6,Incidence,1,Global,3,Both,22,All ages,700,Poisonings,2,Percent,2021,6.58876135787e-05,8.18889258604e-05,5.38070532578e-05
6,Incidence,1,Global,3,Both,22,All ages,700,Poisonings,3,Rate,2021,30.72791431925,38.34856519686,25.119581118649997
6,Incidence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,1,Number,2021,390267.1067241628,433403.2701820532,346393.41531494295
6,Incidence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,2,Percent,2021,1.06041389103e-05,1.19433817479e-05,9.2447846095e-06
6,Incidence,1,Global,3,Both,22,All ages,516,Interstitial lung disease and pulmonary sarcoidosis,3,Rate,2021,4.9455029049000006,5.4921285825799995,4.38953120097
6,Incidence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,1,Number,2021,1319703.607852706,1618747.9859735633,1072475.4168833727
6,Incidence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,2,Percent,2021,3.58596316422e-05,4.40227664256e-05,2.88632535033e-05
6,Incidence,1,Global,3,Both,22,All ages,499,Cardiomyopathy and myocarditis,3,Rate,2021,16.72341305171,20.51293262743,13.59051326193
6,Incidence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,1,Number,2021,10038811.410300173,11601743.951449843,8689418.239746964
6,Incidence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,2,Percent,2021,0.0002727785499846,0.0003167167020923,0.0002360044921094
6,Incidence,1,Global,3,Both,22,All ages,502,Lower extremity peripheral arterial disease,3,Rate,2021,127.2127989677,147.01843282523998,110.11315687682
6,Incidence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,1,Number,2021,4767975.358622485,5423253.825542608,4076108.4693131233
6,Incidence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,2,Percent,2021,0.0001295658835594,0.0001493847029186,0.0001096925830576
6,Incidence,1,Global,3,Both,22,All ages,522,Chronic hepatitis B including cirrhosis,3,Rate,2021,60.42024956829,68.7240023208,51.65284475264
6,Incidence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,1,Number,2021,9407.531059265106,10866.589948935194,8079.0423688989
6,Incidence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,2,Percent,2021,2.556084898e-07,2.966368129e-07,2.20822197e-07
6,Incidence,1,Global,3,Both,22,All ages,514,Other pneumoconiosis,3,Rate,2021,0.11921315267999999,0.13770248948,0.10237841421
6,Incidence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,1,Number,2021,3444338.0491955685,3812043.447866363,3053009.1148974886
6,Incidence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,2,Percent,2021,9.3592410739e-05,0.0001053552349815,8.21065560419e-05
6,Incidence,1,Global,3,Both,22,All ages,496,Intracerebral hemorrhage,3,Rate,2021,43.64698826591,48.306587002120004,38.68802977825
6,Incidence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,1,Number,2021,120679305.34978196,139779786.26899812,102584646.56548733
6,Incidence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,2,Percent,2021,0.0032792081066158,0.0038582633313022,0.0027824106530549
6,Incidence,1,Global,3,Both,22,All ages,707,Other exposure to mechanical forces,3,Rate,2021,1529.25994757426,1771.3031078700699,1299.96266363945
6,Incidence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,1,Number,2021,2854369.825064615,3264251.9367753854,2438230.7206490403
6,Incidence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,2,Percent,2021,7.75660607563e-05,8.93056338474e-05,6.59014701628e-05
6,Incidence,1,Global,3,Both,22,All ages,527,Peptic ulcer disease,3,Rate,2021,36.17085329074,41.364919455190005,30.897497903439998
6,Incidence,1,Global,3,Both,22,All ages,529,Appendicitis,1,Number,2021,16963610.73833672,21634236.20406321,13791021.101453282
6,Incidence,1,Global,3,Both,22,All ages,529,Appendicitis,2,Percent,2021,0.0004609579201739,0.0005906168826587,0.0003681619502252
6,Incidence,1,Global,3,Both,22,All ages,529,Appendicitis,3,Rate,2021,214.96453259478,274.15115480936,174.76116675908
6,Incidence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,1,Number,2021,600640.0271054885,822849.4548435148,421641.9412649687
6,Incidence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,2,Percent,2021,1.63174170079e-05,2.22578945955e-05,1.12511809802e-05
6,Incidence,1,Global,3,Both,22,All ages,701,Poisoning by carbon monoxide,3,Rate,2021,7.6113691050800005,10.42722868289,5.34308787348
6,Incidence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,1,Number,2021,4477374.427573838,5356718.084173141,3691726.159348794
6,Incidence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,2,Percent,2021,0.0001216663187475,0.000144954638824,9.99150089659e-05
6,Incidence,1,Global,3,Both,22,All ages,523,Chronic hepatitis C including cirrhosis,3,Rate,2021,56.73772617878,67.88085490572,46.78191456721
6,Incidence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,1,Number,2021,397988.9183387368,461312.1009244451,338934.7097959207
6,Incidence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,2,Percent,2021,1.08139721227e-05,1.26206261645e-05,9.1741652271e-06
6,Incidence,1,Global,3,Both,22,All ages,525,Cirrhosis due to other causes,3,Rate,2021,5.043354456089999,5.84579201239,4.2950137559299995
6,Incidence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,1,Number,2021,122464569.92342636,141748604.67862993,104230774.77562857
6,Incidence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,2,Percent,2021,0.0033277141952803,0.0039118706686404,0.0028166013675487
6,Incidence,1,Global,3,Both,22,All ages,704,Exposure to mechanical forces,3,Rate,2021,1551.88299466908,1796.2521671074398,1320.8225611425498
6,Incidence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,1,Number,2021,62866.453699124766,71103.37402801157,54616.85644868463
6,Incidence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,2,Percent,2021,1.7081816421e-06,1.9434484844e-06,1.4643402047e-06
6,Incidence,1,Global,3,Both,22,All ages,510,Pneumoconiosis,3,Rate,2021,0.7966498432300001,0.90102890237,0.6921101409
6,Incidence,1,Global,3,Both,22,All ages,512,Asbestosis,1,Number,2021,10520.312910091649,11918.27071543918,9198.308640568705
6,Incidence,1,Global,3,Both,22,All ages,512,Asbestosis,2,Percent,2021,2.858551986e-07,3.235151163e-07,2.469164734e-07
6,Incidence,1,Global,3,Both,22,All ages,512,Asbestosis,3,Rate,2021,0.13331443302,0.1510294909,0.11656186575000001
6,Incidence,1,Global,3,Both,22,All ages,971,Nonalcoholic fatty liver disease including cirrhosis,3,Rate,2021,612.20147078402,662.91753339167,559.99740313531
6,Incidence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,1,Number,2021,73246893.43480626,84905970.20929822,63105083.56030476
6,Incidence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,2,Percent,2021,0.0019899241177174,0.002326269159033,0.0017016354528126
6,Incidence,1,Global,3,Both,22,All ages,534,Gallbladder and biliary diseases,3,Rate,2021,928.1917897142699,1075.93674967444,799.67378414542
6,Incidence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,1,Number,2021,28670245.525208358,41677028.11880122,20731714.523062944
6,Incidence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,2,Percent,2021,0.0007789866985276,0.0011304312497151,0.0005554749412722
6,Incidence,1,Global,3,Both,22,All ages,714,Foreign body in eyes,3,Rate,2021,363.31215233416003,528.13537210275,262.71431189275
6,Incidence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,1,Number,2021,15778197.75482437,16340916.876419138,15227795.78838849
6,Incidence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,2,Percent,2021,0.0004287446321632,0.0004545158937066,0.0004049940167322
6,Incidence,1,Global,3,Both,22,All ages,530,Paralytic ileus and intestinal obstruction,3,Rate,2021,199.94286345468998,207.07369514033,192.96811596259002
6,Incidence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,1,Number,2021,375139.746993921,436925.1425233875,327686.16827958723
6,Incidence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,2,Percent,2021,1.01939903261e-05,1.1993934898e-05,8.850802767e-06
6,Incidence,1,Global,3,Both,22,All ages,532,Inflammatory bowel disease,3,Rate,2021,4.75380752448,5.53675809297,4.15247113887
6,Incidence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,1,Number,2021,55212753.79318546,64561116.07940615,48678135.13794094
6,Incidence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,2,Percent,2021,0.0015003880585271,0.0017661769255297,0.0013038449209221
6,Incidence,1,Global,3,Both,22,All ages,508,Chronic respiratory diseases,3,Rate,2021,699.6614102680501,818.1247704796,616.85408424664
6,Incidence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,1,Number,2021,115867.44431251784,163789.33510220738,76813.80369235037
6,Incidence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,2,Percent,2021,3.1483409591e-06,4.4436669719e-06,2.0535174977e-06
6,Incidence,1,Global,3,Both,22,All ages,721,Self-harm by firearm,3,Rate,2021,1.4682835744,2.07555445638,0.9733920249800001
6,Incidence,1,Global,3,Both,22,All ages,724,Interpersonal violence,1,Number,2021,29398469.663310185,32645338.16556124,26173449.649158288
6,Incidence,1,Global,3,Both,22,All ages,724,Interpersonal violence,2,Percent,2021,0.0007988717313308,0.0008882759583813,0.0007069119938073
6,Incidence,1,Global,3,Both,22,All ages,724,Interpersonal violence,3,Rate,2021,372.54027975856,413.68491463313,331.67251105975
6,Incidence,1,Global,3,Both,22,All ages,710,Venomous animal contact,1,Number,2021,15524932.776110675,19807965.90220205,11659218.31996058
6,Incidence,1,Global,3,Both,22,All ages,710,Venomous animal contact,2,Percent,2021,0.0004217842673455,0.0005289369562761,0.0003159985143131
6,Incidence,1,Global,3,Both,22,All ages,710,Venomous animal contact,3,Rate,2021,196.73346490083,251.00847912038998,147.74675363817
6,Incidence,1,Global,3,Both,22,All ages,838,Sickle cell trait,1,Number,2021,9293969.17109495,10184490.950882904,8463740.724872421
6,Incidence,1,Global,3,Both,22,All ages,838,Sickle cell trait,2,Percent,2021,0.0002525570308464,0.0002814682645643,0.0002262704933765
6,Incidence,1,Global,3,Both,22,All ages,838,Sickle cell trait,3,Rate,2021,117.77408534255,129.05886433863,107.25334935998
6,Incidence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,1,Number,2021,17229399.274201177,18333270.174079165,16081547.573220702
6,Incidence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,2,Percent,2021,0.0004681795188457,0.0005058540804833,0.0004307394087552
6,Incidence,1,Global,3,Both,22,All ages,1059,Total Cancers excluding Non-melanoma skin cancer,3,Rate,2021,218.33263088837998,232.32099077812,203.78694199022001
6,Incidence,1,Global,3,Both,22,All ages,839,G6PD trait,1,Number,2021,18934147.33051068,19606543.66064945,18253544.50900385
6,Incidence,1,Global,3,Both,22,All ages,839,G6PD trait,2,Percent,2021,0.0005144888844608,0.0005440395259445,0.0004857462672239
6,Incidence,1,Global,3,Both,22,All ages,839,G6PD trait,3,Rate,2021,239.93536480919,248.45603679679,231.31069936120997
6,Incidence,1,Global,3,Both,22,All ages,712,Foreign body,1,Number,2021,43836984.85788796,57328834.13090387,34275691.443308674
6,Incidence,1,Global,3,Both,22,All ages,712,Foreign body,2,Percent,2021,0.0011910226050791,0.0015406599914642,0.0009363428223883
6,Incidence,1,Global,3,Both,22,All ages,712,Foreign body,3,Rate,2021,555.5065549249,726.4765870454,434.34491065174
6,Incidence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,1,Number,2021,27202523.82908176,33647646.83205042,21851452.8878623
6,Incidence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,2,Percent,2021,0.0007390929410573,0.0009102186283686,0.0005939717986663
6,Incidence,1,Global,3,Both,22,All ages,528,Gastritis and duodenitis,3,Rate,2021,344.7130396067,426.38626797889,276.9037458482
6,Incidence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,1,Number,2021,7455.707193723025,8404.756486402877,6504.252631360539
6,Incidence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,2,Percent,2021,2.025852161e-07,2.306589862e-07,1.736234734e-07
6,Incidence,1,Global,3,Both,22,All ages,513,Coal workers pneumoconiosis,3,Rate,2021,0.09447944997,0.10650589533,0.0824225248
6,Incidence,1,Global,3,Both,22,All ages,515,Asthma,1,Number,2021,37864175.440182365,46919993.68334465,31381240.96352847
6,Incidence,1,Global,3,Both,22,All ages,515,Asthma,2,Percent,2021,0.001028975281583,0.001259719498826,0.0008539903741879
6,Incidence,1,Global,3,Both,22,All ages,515,Asthma,3,Rate,2021,479.81853044947,594.57474396629,397.66615138862005
6,Incidence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,1,Number,2021,50145509.72802819,55962852.56246675,45310003.58767125
6,Incidence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,2,Percent,2021,0.0013627019420719,0.0015318333048363,0.001219596012437
6,Incidence,1,Global,3,Both,22,All ages,717,Self-harm and interpersonal violence,3,Rate,2021,635.4487984124601,709.16673515587,574.1727921803699
6,Incidence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,1,Number,2021,462685.9165384048,543247.3308922778,380016.8242712944
6,Incidence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,2,Percent,2021,1.25727572754e-05,1.4933724185e-05,1.03118626569e-05
6,Incidence,1,Global,3,Both,22,All ages,524,Cirrhosis due to alcohol,3,Rate,2021,5.86320113807,6.884083251490001,4.81561032422
6,Incidence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,1,Number,2021,1266596.3754577844,1559751.703106169,1030645.7302756977
6,Incidence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,2,Percent,2021,3.44192964849e-05,4.20944077136e-05,2.78047578869e-05
6,Incidence,1,Global,3,Both,22,All ages,725,Physical violence by firearm,3,Rate,2021,16.050433014310002,19.76532596709,13.060443386549998
6,Incidence,1,Global,3,Both,22,All ages,727,Physical violence by other means,1,Number,2021,20952300.73761356,23674722.290990174,18361518.332833115
6,Incidence,1,Global,3,Both,22,All ages,727,Physical violence by other means,2,Percent,2021,0.0005693574430328,0.0006430011556354,0.0004943130795533
6,Incidence,1,Global,3,Both,22,All ages,727,Physical violence by other means,3,Rate,2021,265.50960195447,300.00839385524,232.67895420565
6,Incidence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,1,Number,2021,3428280.714860958,4456245.646626471,2635848.3953702897
6,Incidence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,2,Percent,2021,9.31786217455e-05,0.0001211853165074,7.05810315524e-05
6,Incidence,1,Global,3,Both,22,All ages,842,Environmental heat and cold exposure,3,Rate,2021,43.44350815645,56.46998020237,33.40172838445
6,Incidence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",1,Number,2021,7241108.152032214,8601083.600436002,6021589.874978957
6,Incidence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",2,Percent,2021,0.0001967370792152,0.0002355778125094,0.0001635702660882
6,Incidence,1,Global,3,Both,22,All ages,531,"Inguinal, femoral, and abdominal hernia",3,Rate,2021,91.76002994763,108.99377169731001,76.30617519576
6,Incidence,1,Global,3,Both,22,All ages,1028,Total burden related to Non-alcoholic fatty liver disease (NAFLD),3,Rate,2021,612.73739120801,663.4859122635199,560.47596434956
